{"PMC7221263": [["Patients ::: METHODSThis study was approved by the Institutional Review Board at Seattle Children\u2019s Hospital.", [["Patients", "ORGANISM", 0, 8], ["Patients", "SPECIES", 0, 8], ["METHODSThis study", "TEST", 13, 30]]], ["We reviewed medical records of patients aged 1\u201326 years receiving CD19 CAR T cells [2] at our institution between 2014 and 2017.", [["CD19 CAR T cells", "ANATOMY", 66, 82], ["patients", "ORGANISM", 31, 39], ["CD19", "GENE_OR_GENE_PRODUCT", 66, 70], ["CD19 CAR T cells", "CELL_TYPE", 66, 82], ["patients", "SPECIES", 31, 39]]], ["The majority of patients remain under our center\u2019s care for a minimum of 28 days after therapy, as this is the time frame when the majority of complications are expected [11, 12].", [["patients", "ORGANISM", 16, 24], ["patients", "SPECIES", 16, 24], ["therapy", "TREATMENT", 87, 94], ["complications", "OBSERVATION", 143, 156]]], ["Each patient\u2019s lymphodepletion regimen was determined by the treating physician.", [["patient", "ORGANISM", 5, 12], ["patient", "SPECIES", 5, 12], ["Each patient\u2019s lymphodepletion regimen", "TREATMENT", 0, 38]]], ["Bacterial prophylaxis was not routinely prescribed.", [["Bacterial prophylaxis", "TREATMENT", 0, 21], ["prophylaxis", "OBSERVATION", 10, 21]]], ["Patients with a history of prior hematopoietic cell transplantation (HCT) were routinely started on acyclovir prophylaxis if not already receiving it.", [["hematopoietic cell", "ANATOMY", 33, 51], ["acyclovir", "CHEMICAL", 100, 109], ["acyclovir", "CHEMICAL", 100, 109], ["Patients", "ORGANISM", 0, 8], ["hematopoietic cell", "CELL", 33, 51], ["acyclovir", "SIMPLE_CHEMICAL", 100, 109], ["Patients", "SPECIES", 0, 8], ["prior hematopoietic cell transplantation", "TREATMENT", 27, 67], ["HCT", "TEST", 69, 72], ["acyclovir prophylaxis", "TREATMENT", 100, 121], ["hematopoietic cell transplantation", "OBSERVATION", 33, 67]]], ["The type and duration of fungal prophylaxis were prescribed at the discretion of the treating physician.", [["fungal prophylaxis", "TREATMENT", 25, 43], ["fungal prophylaxis", "OBSERVATION", 25, 43]]], ["All patients were prescribed prophylaxis for Pneumocystis jirovecii with trimethoprim-sulfamethoxazole or inhaled pentamidine.", [["Pneumocystis jirovecii", "DISEASE", 45, 67], ["trimethoprim-sulfamethoxazole", "CHEMICAL", 73, 102], ["pentamidine", "CHEMICAL", 114, 125], ["trimethoprim-sulfamethoxazole", "CHEMICAL", 73, 102], ["pentamidine", "CHEMICAL", 114, 125], ["patients", "ORGANISM", 4, 12], ["Pneumocystis jirovecii", "ORGANISM", 45, 67], ["trimethoprim-sulfamethoxazole", "SIMPLE_CHEMICAL", 73, 102], ["pentamidine", "SIMPLE_CHEMICAL", 114, 125], ["patients", "SPECIES", 4, 12], ["Pneumocystis jirovecii", "SPECIES", 45, 67], ["Pneumocystis jirovecii", "SPECIES", 45, 67], ["prophylaxis", "TREATMENT", 29, 40], ["Pneumocystis jirovecii", "PROBLEM", 45, 67], ["trimethoprim", "TREATMENT", 73, 85], ["sulfamethoxazole", "TREATMENT", 86, 102], ["inhaled pentamidine", "TREATMENT", 106, 125]]], ["Intravenous immunoglobulin G (IVIG) supplementation was recommended for patients with IgG levels <400 mg/dL.", [["immunoglobulin G", "CHEMICAL", 12, 28], ["IVIG", "CHEMICAL", 30, 34], ["immunoglobulin G", "SIMPLE_CHEMICAL", 12, 28], ["IVIG", "SIMPLE_CHEMICAL", 30, 34], ["patients", "ORGANISM", 72, 80], ["IgG", "GENE_OR_GENE_PRODUCT", 86, 89], ["IgG", "PROTEIN", 86, 89], ["patients", "SPECIES", 72, 80], ["Intravenous immunoglobulin G (IVIG) supplementation", "TREATMENT", 0, 51], ["IgG levels", "TEST", 86, 96]]], ["Empiric antimicrobial therapy was prescribed for fever and neutropenia.", [["fever", "DISEASE", 49, 54], ["neutropenia", "DISEASE", 59, 70], ["Empiric antimicrobial therapy", "TREATMENT", 0, 29], ["fever", "PROBLEM", 49, 54], ["neutropenia", "PROBLEM", 59, 70], ["antimicrobial therapy", "OBSERVATION", 8, 29], ["neutropenia", "OBSERVATION", 59, 70]]], ["Further details of the lymphodepleting regimens and supportive care approaches for patients who developed CRS are in the Supplementary Data.Data Collection ::: METHODSWe reviewed medical records for infections occuring in the 90 days before and after CTI.", [["CRS", "DISEASE", 106, 109], ["infections", "DISEASE", 199, 209], ["patients", "ORGANISM", 83, 91], ["patients", "SPECIES", 83, 91], ["the lymphodepleting regimens", "TREATMENT", 19, 47], ["supportive care approaches", "TREATMENT", 52, 78], ["CRS", "PROBLEM", 106, 109], ["infections", "PROBLEM", 199, 209], ["CTI", "TEST", 251, 254], ["infections", "OBSERVATION", 199, 209]]], ["Patients contributed data up to 90 days post-CTI; the date of death; the date of loss to follow-up; or the date of receipt of additional antitumor therapies for relapse, repeat CTI, or as conditioning for HCT, whichever occurred first.", [["antitumor", "ANATOMY", 137, 146], ["death", "DISEASE", 62, 67], ["HCT", "DISEASE", 205, 208], ["Patients", "ORGANISM", 0, 8], ["antitumor", "CANCER", 137, 146], ["Patients", "SPECIES", 0, 8], ["death", "PROBLEM", 62, 67], ["additional antitumor therapies", "TREATMENT", 126, 156], ["relapse", "PROBLEM", 161, 168], ["repeat CTI", "TEST", 170, 180], ["HCT", "TEST", 205, 208]]], ["Absolute neutrophil (ANC) and lymphocyte (ALC) counts were collected for each patient before lymphodepletion, from all available laboratory data between days 0 and 28 post-CTI, and on day 63 (per study protocols) post-CTI.", [["neutrophil", "ANATOMY", 9, 19], ["ANC", "ANATOMY", 21, 24], ["lymphocyte", "ANATOMY", 30, 40], ["ALC", "ANATOMY", 42, 45], ["neutrophil", "CELL", 9, 19], ["ANC", "CELL", 21, 24], ["lymphocyte", "CELL", 30, 40], ["ALC", "CELL", 42, 45], ["patient", "ORGANISM", 78, 85], ["neutrophil", "CELL_TYPE", 9, 19], ["ANC", "CELL_TYPE", 21, 24], ["patient", "SPECIES", 78, 85], ["Absolute neutrophil", "TEST", 0, 19], ["ANC", "TEST", 21, 24], ["lymphocyte (ALC) counts", "TEST", 30, 53], ["lymphodepletion", "TREATMENT", 93, 108]]], ["IgG levels were collected before lymphodepletion and on days 21 and 63 (per study protocols) post-CTI.", [["IgG", "GENE_OR_GENE_PRODUCT", 0, 3], ["IgG", "PROTEIN", 0, 3], ["IgG levels", "TEST", 0, 10], ["lymphodepletion", "TEST", 33, 48], ["study protocols", "TEST", 76, 91], ["CTI", "TEST", 98, 101]]], ["Treatment for CRS, including use of tociluzimab and/or steroids, was recorded.Definitions ::: METHODSThe primary outcome of interest was infection in the 90 days post-CTI.", [["CRS", "DISEASE", 14, 17], ["tociluzimab", "CHEMICAL", 36, 47], ["steroids", "CHEMICAL", 55, 63], ["infection", "DISEASE", 137, 146], ["tociluzimab", "CHEMICAL", 36, 47], ["steroids", "CHEMICAL", 55, 63], ["tociluzimab", "SIMPLE_CHEMICAL", 36, 47], ["steroids", "SIMPLE_CHEMICAL", 55, 63], ["Treatment", "TREATMENT", 0, 9], ["CRS", "PROBLEM", 14, 17], ["tociluzimab", "TREATMENT", 36, 47], ["steroids", "TREATMENT", 55, 63], ["infection", "PROBLEM", 137, 146], ["infection", "OBSERVATION", 137, 146]]], ["An infection episode was defined as the presence of clinical findings plus corroborating laboratory, radiographic, histopathologic, and/or microbiologic evidence.", [["infection", "DISEASE", 3, 12], ["An infection episode", "PROBLEM", 0, 20], ["microbiologic evidence", "TEST", 139, 161], ["infection", "OBSERVATION", 3, 12]]], ["Infections were classified as bacterial (bacteremia or site infection), viral (respiratory or other), or fungal (proven or probable) [13].", [["respiratory", "ANATOMY", 79, 90], ["Infections", "DISEASE", 0, 10], ["bacteremia", "DISEASE", 41, 51], ["infection", "DISEASE", 60, 69], ["viral (respiratory or other), or fungal", "DISEASE", 72, 111], ["Infections", "PROBLEM", 0, 10], ["bacterial (bacteremia", "PROBLEM", 30, 51], ["site infection", "PROBLEM", 55, 69], ["viral (respiratory or other)", "PROBLEM", 72, 100], ["fungal", "PROBLEM", 105, 111], ["bacterial", "OBSERVATION_MODIFIER", 30, 39], ["bacteremia", "OBSERVATION", 41, 51]]], ["Infection onset was defined as the day of initial positive diagnostic test or clinical diagnosis.", [["Infection onset", "PROBLEM", 0, 15]]], ["Infections were excluded if they were already present at the time of CTI.", [["Infections", "PROBLEM", 0, 10], ["CTI", "TEST", 69, 72]]], ["Infection severity was categorized as 1 (mild) if no treatment was required, 2 (moderate) if only oral treatment or minimal supportive care was required, 3 (severe) if intravenous therapy or hospitalization was required, 4 if life threatening, or 5 if fatal [14].", [["oral", "ANATOMY", 98, 102], ["intravenous", "ANATOMY", 168, 179], ["oral", "ORGANISM_SUBDIVISION", 98, 102], ["intravenous", "IMMATERIAL_ANATOMICAL_ENTITY", 168, 179], ["Infection severity", "PROBLEM", 0, 18], ["treatment", "TREATMENT", 53, 62], ["oral treatment", "TREATMENT", 98, 112], ["minimal supportive care", "TREATMENT", 116, 139], ["intravenous therapy", "TREATMENT", 168, 187], ["hospitalization", "TREATMENT", 191, 206]]], ["Testing for infection was sent based on provider discretion guided by symptoms, further outlined in the Supplementary Data.", [["infection", "DISEASE", 12, 21], ["infection", "PROBLEM", 12, 21], ["symptoms", "PROBLEM", 70, 78], ["infection", "OBSERVATION", 12, 21]]], ["Further details pertaining to the assessment of the timing, type, and severity of each infection are also described in the Supplementary Data.Definitions ::: METHODSThe severity of CRS was graded from 1\u20135 as previously described [15], and definitions of each grade are shown in Supplementary Table 1.Statistical Analysis ::: METHODSDescriptive statistics (median, range, percentage) are reported for key variables.", [["infection", "DISEASE", 87, 96], ["CRS", "DISEASE", 181, 184], ["the assessment", "TEST", 30, 44], ["each infection", "PROBLEM", 82, 96], ["CRS", "TEST", 181, 184], ["infection", "OBSERVATION", 87, 96], ["CRS", "OBSERVATION", 181, 184]]], ["We calculated the infection density per 100 days-at-risk based on the number of infections per person-days-at-risk and multiplied by 100.", [["infection", "DISEASE", 18, 27], ["infections", "DISEASE", 80, 90], ["person", "SPECIES", 95, 101], ["the infection density", "PROBLEM", 14, 35], ["infection", "OBSERVATION", 18, 27], ["infections", "OBSERVATION", 80, 90]]], ["This was calculated for the 90 days before CTI and the 0\u201328- and 29\u201390-day periods after CTI.", [["CTI", "TEST", 43, 46], ["CTI", "TEST", 89, 92]]], ["The estimates for infection densities are only based on data obtained during the person-days-at risk contributed per patient.", [["infection", "DISEASE", 18, 27], ["patient", "ORGANISM", 117, 124], ["person", "SPECIES", 81, 87], ["patient", "SPECIES", 117, 124], ["infection densities", "PROBLEM", 18, 37], ["infection", "OBSERVATION", 18, 27]]], ["We also demonstrate the cumulative incidence of any and each type of infection in the first 28 days after CTI, treating death and loss to follow-up as competing risk events.Statistical Analysis ::: METHODSPoisson regression was utilized to identify associations between pre-CTI factors and infection density within the first 28 days after CTI.", [["infection", "DISEASE", 69, 78], ["death", "DISEASE", 120, 125], ["infection", "DISEASE", 290, 299], ["pre-CTI factors", "PROTEIN", 270, 285], ["infection", "PROBLEM", 69, 78], ["death", "PROBLEM", 120, 125], ["METHODSPoisson regression", "PROBLEM", 198, 223], ["pre-CTI factors", "PROBLEM", 270, 285], ["infection density", "PROBLEM", 290, 307], ["CTI", "PROBLEM", 339, 342], ["cumulative", "OBSERVATION_MODIFIER", 24, 34], ["infection", "OBSERVATION", 69, 78], ["infection", "OBSERVATION", 290, 299]]], ["Time-dependent Cox proportional hazards models were used to assess the impact of pre- and post-CTI factors on the time to first infection within 28 days after CTI.", [["infection", "DISEASE", 128, 137], ["CTI factors", "PROTEIN", 95, 106], ["Time-dependent Cox proportional hazards models", "TREATMENT", 0, 46], ["pre- and post-CTI factors", "PROBLEM", 81, 106], ["first infection", "PROBLEM", 122, 137], ["CTI", "TEST", 159, 162], ["infection", "OBSERVATION", 128, 137]]], ["For all factors, only data occurring before an infection event were included.", [["infection", "DISEASE", 47, 56], ["an infection event", "PROBLEM", 44, 62], ["infection", "OBSERVATION", 47, 56]]], ["For each infection event, the ANC and ALC values from the day of the event were considered as dichotomous data points (ANC < 500 or no, ALC < 300 or no).", [["infection", "DISEASE", 9, 18], ["each infection event", "PROBLEM", 4, 24], ["the ANC", "TEST", 26, 33], ["ALC values", "TEST", 38, 48], ["ANC", "TEST", 119, 122], ["ALC", "TEST", 136, 139], ["infection", "OBSERVATION", 9, 18]]], ["For both Poisson and Cox regression, variables with a P value of <.25 in univariate models were considered for multivariate adjusted models.", [["Cox regression", "TEST", 21, 35], ["a P value", "TEST", 52, 61]]], ["Poisson and Cox models were evaluated for overfitting or underfitting and Schoenfeld residuals, respectively.", [["Cox models", "TEST", 12, 22], ["overfitting", "PROBLEM", 42, 53], ["underfitting and Schoenfeld residuals", "PROBLEM", 57, 94]]], ["Patients were censored from the study before day 90 post-CTI if they died, were lost to close follow-up, or received further lymphodepleting chemotherapy in the setting of relapse, repeat CTI, or as conditioning for HCT.Patient Characteristics ::: RESULTSEighty-three patients received CTI during the study period.", [["HCT", "DISEASE", 216, 219], ["Patients", "ORGANISM", 0, 8], ["HCT", "CANCER", 216, 219], ["patients", "ORGANISM", 268, 276], ["Patients", "SPECIES", 0, 8], ["Patient", "SPECIES", 220, 227], ["patients", "SPECIES", 268, 276], ["the study", "TEST", 28, 37], ["further lymphodepleting chemotherapy", "TREATMENT", 117, 153], ["relapse", "PROBLEM", 172, 179], ["repeat CTI", "TEST", 181, 191], ["HCT", "TEST", 216, 219], ["CTI", "TREATMENT", 286, 289], ["the study", "TEST", 297, 306]]], ["Patient and treatment characteristics are described in Table 1.", [["Patient", "SPECIES", 0, 7]]], ["All patients had underlying B-ALL except for 1 patient with mixed leukemia and 1 with B-cell lymphoma.", [["B-ALL", "ANATOMY", 28, 33], ["leukemia", "ANATOMY", 66, 74], ["B-cell lymphoma", "ANATOMY", 86, 101], ["B-ALL", "DISEASE", 28, 33], ["mixed leukemia", "DISEASE", 60, 74], ["B-cell lymphoma", "DISEASE", 86, 101], ["patients", "ORGANISM", 4, 12], ["B-ALL", "CANCER", 28, 33], ["patient", "ORGANISM", 47, 54], ["leukemia", "CANCER", 66, 74], ["B-cell lymphoma", "CANCER", 86, 101], ["patients", "SPECIES", 4, 12], ["patient", "SPECIES", 47, 54], ["mixed leukemia", "PROBLEM", 60, 74], ["B-cell lymphoma", "PROBLEM", 86, 101], ["mixed leukemia", "OBSERVATION", 60, 74], ["cell lymphoma", "OBSERVATION", 88, 101]]], ["All patients had relapsed or refractory disease.", [["patients", "ORGANISM", 4, 12], ["patients", "SPECIES", 4, 12], ["refractory disease", "PROBLEM", 29, 47], ["refractory", "OBSERVATION_MODIFIER", 29, 39], ["disease", "OBSERVATION", 40, 47]]], ["Forty-six patients (55%) had previously undergone allogeneic HCT, and none were on immunosuppresive therapy or had graft-vs-host disease for at least 4 weeks before CTI.", [["graft", "ANATOMY", 115, 120], ["graft-vs-host disease", "DISEASE", 115, 136], ["patients", "ORGANISM", 10, 18], ["patients", "SPECIES", 10, 18], ["allogeneic HCT", "TEST", 50, 64], ["immunosuppresive therapy", "TREATMENT", 83, 107], ["host disease", "PROBLEM", 124, 136], ["CTI", "PROBLEM", 165, 168], ["host disease", "OBSERVATION", 124, 136]]], ["Before receipt of lymphodepleting chemotherapy, 18% had an ALC <300 cells/mm3, 35% had an ANC <500 cells/mm3, and 16% had a serum IgG <400 mg/dL.", [["cells", "ANATOMY", 68, 73], ["cells", "ANATOMY", 99, 104], ["serum", "ANATOMY", 124, 129], ["serum", "ORGANISM_SUBSTANCE", 124, 129], ["IgG", "ORGANISM_SUBSTANCE", 130, 133], ["serum IgG", "PROTEIN", 124, 133], ["lymphodepleting chemotherapy", "TREATMENT", 18, 46], ["an ALC", "TEST", 56, 62], ["cells", "TEST", 68, 73], ["mm3", "TEST", 74, 77], ["an ANC", "TEST", 87, 93], ["cells", "TEST", 99, 104], ["mm3", "TEST", 105, 108], ["a serum IgG", "TEST", 122, 133]]], ["The most common lymphodepletion regimen consisted of fludarabine plus cyclophosphamide (65%).", [["fludarabine", "CHEMICAL", 53, 64], ["cyclophosphamide", "CHEMICAL", 70, 86], ["fludarabine", "CHEMICAL", 53, 64], ["cyclophosphamide", "CHEMICAL", 70, 86], ["fludarabine", "SIMPLE_CHEMICAL", 53, 64], ["cyclophosphamide", "SIMPLE_CHEMICAL", 70, 86], ["The most common lymphodepletion regimen", "TREATMENT", 0, 39], ["fludarabine", "TREATMENT", 53, 64], ["cyclophosphamide", "TREATMENT", 70, 86]]], ["Doses of CAR T cells ranged from 0.5 \u00d7 106 to 10 \u00d7 106 CAR T cells/kg.Patient Characteristics ::: RESULTSDetails of antimicrobial prophylaxis are outlined in Table 1.", [["CAR T cells", "ANATOMY", 9, 20], ["T cells", "ANATOMY", 59, 66], ["CAR T cells", "CELL", 9, 20], ["CAR T cells", "CELL_TYPE", 9, 20], ["Patient", "SPECIES", 70, 77], ["CAR T cells", "TREATMENT", 9, 20], ["antimicrobial prophylaxis", "TREATMENT", 116, 141]]], ["At the time of CTI, no patient had a positive blood culture within 48 hours or had fever with clinical signs of infection.Noninfectious Complications After Lymphodepleting Chemotherapy and CTI ::: RESULTSThe majority of patients (96%) experienced neutropenia (ANC < 500 cells/mm3) at the time of, or within 7 days of, CTI.", [["blood", "ANATOMY", 46, 51], ["cells", "ANATOMY", 270, 275], ["fever", "DISEASE", 83, 88], ["infection", "DISEASE", 112, 121], ["neutropenia", "DISEASE", 247, 258], ["patient", "ORGANISM", 23, 30], ["blood", "ORGANISM_SUBSTANCE", 46, 51], ["patients", "ORGANISM", 220, 228], ["patient", "SPECIES", 23, 30], ["patients", "SPECIES", 220, 228], ["CTI", "TEST", 15, 18], ["a positive blood culture", "PROBLEM", 35, 59], ["fever", "PROBLEM", 83, 88], ["infection", "PROBLEM", 112, 121], ["Noninfectious Complications", "PROBLEM", 122, 149], ["Lymphodepleting Chemotherapy", "TREATMENT", 156, 184], ["CTI", "TEST", 189, 192], ["neutropenia", "PROBLEM", 247, 258], ["ANC", "TEST", 260, 263], ["CTI", "PROBLEM", 318, 321], ["infection", "OBSERVATION", 112, 121]]], ["Of these, 42% for whom complete data were available did not recover from neutropenia (defined as 2 measurements of ANC >500 cells/mm3) by day 28 post-CTI.", [["cells", "ANATOMY", 124, 129], ["neutropenia", "DISEASE", 73, 84], ["neutropenia", "PROBLEM", 73, 84], ["ANC", "TEST", 115, 118], ["neutropenia", "OBSERVATION", 73, 84]]], ["Three patients died while still neutropenic in this time period.", [["neutropenic", "DISEASE", 32, 43], ["patients", "ORGANISM", 6, 14], ["patients", "SPECIES", 6, 14], ["neutropenic", "PROBLEM", 32, 43], ["neutropenic", "OBSERVATION", 32, 43]]], ["For the patients who were neutropenic and did recover by day 28 (58%), the median time to recovery was 15 days.", [["neutropenic", "DISEASE", 26, 37], ["patients", "ORGANISM", 8, 16], ["patients", "SPECIES", 8, 16], ["neutropenic", "PROBLEM", 26, 37], ["neutropenic", "OBSERVATION", 26, 37]]], ["Severe hypogammaglobulinemia (IgG <400 mg/dL) was identified in 14% of patients at day 21 (Table 1).", [["hypogammaglobulinemia", "DISEASE", 7, 28], ["patients", "ORGANISM", 71, 79], ["IgG", "PROTEIN", 30, 33], ["patients", "SPECIES", 71, 79], ["Severe hypogammaglobulinemia", "PROBLEM", 0, 28], ["IgG", "TEST", 30, 33], ["hypogammaglobulinemia", "OBSERVATION", 7, 28]]], ["By day 63 post-CTI, 13% of 40 patients with available data remained neutropenic and 20% lymphopenic.", [["neutropenic", "DISEASE", 68, 79], ["patients", "ORGANISM", 30, 38], ["patients", "SPECIES", 30, 38], ["CTI", "TEST", 15, 18], ["neutropenic", "PROBLEM", 68, 79], ["neutropenic", "OBSERVATION", 68, 79], ["lymphopenic", "OBSERVATION", 88, 99]]], ["Of 56 patients with IgG levels available, 29% remained hypogammoglubulinemic with a median IgG level of 455 mg/dL (irrespective of IgG supplementation).Noninfectious Complications After Lymphodepleting Chemotherapy and CTI ::: RESULTSForty-eight (58%) patients had an ICU admission in the 28 days post-CTI.", [["patients", "ORGANISM", 6, 14], ["IgG", "GENE_OR_GENE_PRODUCT", 20, 23], ["patients", "ORGANISM", 252, 260], ["IgG", "PROTEIN", 20, 23], ["IgG", "PROTEIN", 91, 94], ["IgG", "PROTEIN", 131, 134], ["patients", "SPECIES", 6, 14], ["patients", "SPECIES", 252, 260], ["IgG levels", "TEST", 20, 30], ["hypogammoglubulinemic", "PROBLEM", 55, 76], ["a median IgG level", "TEST", 82, 100], ["IgG supplementation", "TREATMENT", 131, 150], ["Noninfectious Complications", "PROBLEM", 152, 179], ["Lymphodepleting Chemotherapy", "TREATMENT", 186, 214], ["CTI", "TEST", 219, 222], ["RESULTSForty", "TEST", 227, 239]]], ["CRS occurred in 89% of patients at a median (range) of 5 (1\u201311) days after infusion (Table 1).", [["CRS", "DISEASE", 0, 3], ["patients", "ORGANISM", 23, 31], ["patients", "SPECIES", 23, 31], ["CRS", "TEST", 0, 3]]], ["The majority of these cases were categorized as grade 1 or 2 (79%), with CRS grade 3 or higher occuring in 8 patients (10%).", [["patients", "ORGANISM", 109, 117], ["patients", "SPECIES", 109, 117], ["CRS grade 3", "PROBLEM", 73, 84], ["higher", "OBSERVATION_MODIFIER", 88, 94]]], ["Forty-three (52%) patients received treatment for CRS with either tocilizumab and/or steroids.Infections Pre-CTI ::: RESULTSForty-five (54%) patients had at least 1 infection in the 90 days before CTI, as detailed in Supplementary Table 2.", [["CRS", "DISEASE", 50, 53], ["tocilizumab", "CHEMICAL", 66, 77], ["steroids", "CHEMICAL", 85, 93], ["infection", "DISEASE", 165, 174], ["steroids", "CHEMICAL", 85, 93], ["patients", "ORGANISM", 18, 26], ["tocilizumab", "SIMPLE_CHEMICAL", 66, 77], ["steroids", "SIMPLE_CHEMICAL", 85, 93], ["patients", "ORGANISM", 141, 149], ["patients", "SPECIES", 18, 26], ["patients", "SPECIES", 141, 149], ["treatment", "TREATMENT", 36, 45], ["CRS", "PROBLEM", 50, 53], ["tocilizumab", "TREATMENT", 66, 77], ["steroids", "TREATMENT", 85, 93], ["RESULTSForty", "TEST", 117, 129], ["1 infection", "PROBLEM", 163, 174], ["infection", "OBSERVATION", 165, 174]]], ["Forty-eight percent of the infections in this time period were bacterial, and 34% were viral.", [["infections", "DISEASE", 27, 37], ["the infections", "PROBLEM", 23, 37], ["bacterial", "PROBLEM", 63, 72], ["viral", "PROBLEM", 87, 92], ["eight percent", "OBSERVATION_MODIFIER", 6, 19], ["infections", "OBSERVATION", 27, 37], ["bacterial", "OBSERVATION_MODIFIER", 63, 72]]], ["Nine patients (11%) were being treated for proven or probable fungal infections.", [["fungal infections", "DISEASE", 62, 79], ["patients", "ORGANISM", 5, 13], ["patients", "SPECIES", 5, 13], ["fungal infections", "PROBLEM", 62, 79], ["probable", "UNCERTAINTY", 53, 61], ["fungal infections", "OBSERVATION", 62, 79]]], ["The infection density for this time period was 1.23 infections per 100 patient-days-at-risk (Figure 1).Infections in the First 28 Days Post-CTI ::: RESULTSThirty-three patients (40%) had 37 incident infections in the first 28 days post-CTI (Table 2).", [["infection", "DISEASE", 4, 13], ["infections", "DISEASE", 52, 62], ["Infections", "DISEASE", 103, 113], ["infections", "DISEASE", 199, 209], ["patient", "ORGANISM", 71, 78], ["patients", "ORGANISM", 168, 176], ["patient", "SPECIES", 71, 78], ["patients", "SPECIES", 168, 176], ["The infection density", "PROBLEM", 0, 21], ["Infections", "PROBLEM", 103, 113], ["37 incident infections", "PROBLEM", 187, 209], ["infection", "OBSERVATION", 4, 13], ["infections", "OBSERVATION", 199, 209]]], ["Twenty infections (54%) were bacterial, including 16 instances of bacteremia.", [["infections", "DISEASE", 7, 17], ["bacteremia", "DISEASE", 66, 76], ["Twenty infections", "PROBLEM", 0, 17], ["bacterial", "PROBLEM", 29, 38], ["bacteremia", "PROBLEM", 66, 76], ["bacteremia", "OBSERVATION", 66, 76]]], ["Of these episodes of bacteremia, 6 were caused by gram-negative organisms, 10 by gram-positive bacteria, and all occurred within the first 15 days post-CTI (Figure 1).", [["bacteremia", "DISEASE", 21, 31], ["bacteremia", "PROBLEM", 21, 31], ["gram-negative organisms", "PROBLEM", 50, 73], ["gram", "TEST", 81, 85], ["positive bacteria", "PROBLEM", 86, 103], ["episodes", "OBSERVATION_MODIFIER", 9, 17], ["bacteremia", "OBSERVATION", 21, 31], ["negative organisms", "OBSERVATION", 55, 73], ["positive bacteria", "OBSERVATION_MODIFIER", 86, 103]]], ["Three of the 11 patients who developed bacteremia had infection with an organism that was identified in the pre-CTI period.", [["bacteremia", "DISEASE", 39, 49], ["infection", "DISEASE", 54, 63], ["patients", "ORGANISM", 16, 24], ["patients", "SPECIES", 16, 24], ["bacteremia", "PROBLEM", 39, 49], ["infection", "PROBLEM", 54, 63], ["an organism", "PROBLEM", 69, 80], ["bacteremia", "OBSERVATION", 39, 49], ["infection", "OBSERVATION", 54, 63]]], ["Sixteen patients had viral infections, the majority of which were due to respiratory viruses (38% of total infections).", [["viral infections", "DISEASE", 21, 37], ["respiratory viruses", "DISEASE", 73, 92], ["infections", "DISEASE", 107, 117], ["patients", "ORGANISM", 8, 16], ["patients", "SPECIES", 8, 16], ["viral infections", "PROBLEM", 21, 37], ["respiratory viruses", "PROBLEM", 73, 92], ["total infections", "PROBLEM", 101, 117], ["viral infections", "OBSERVATION", 21, 37], ["respiratory viruses", "OBSERVATION", 73, 92]]], ["Two patients developed herpes zoster, with skin manifestations in both; neither patient was taking acyclovir prophylaxis.", [["skin", "ANATOMY", 43, 47], ["herpes zoster", "DISEASE", 23, 36], ["acyclovir", "CHEMICAL", 99, 108], ["acyclovir", "CHEMICAL", 99, 108], ["patients", "ORGANISM", 4, 12], ["herpes zoster", "ORGANISM", 23, 36], ["skin", "ORGAN", 43, 47], ["patient", "ORGANISM", 80, 87], ["acyclovir", "SIMPLE_CHEMICAL", 99, 108], ["patients", "SPECIES", 4, 12], ["herpes zoster", "SPECIES", 23, 36], ["patient", "SPECIES", 80, 87], ["herpes zoster", "PROBLEM", 23, 36], ["skin manifestations", "PROBLEM", 43, 62], ["acyclovir prophylaxis", "TREATMENT", 99, 120], ["herpes", "OBSERVATION_MODIFIER", 23, 29], ["zoster", "OBSERVATION", 30, 36], ["skin", "ANATOMY", 43, 47], ["manifestations", "OBSERVATION", 48, 62]]], ["One patient with pre-CTI probable pulmonary invasive mold infection on mold-active therapy with voriconazole was found to have proven pulmonary infection with Cunninghamella on day 21 post-CTI.", [["pulmonary", "ANATOMY", 34, 43], ["pulmonary", "ANATOMY", 134, 143], ["pulmonary invasive mold infection", "DISEASE", 34, 67], ["voriconazole", "CHEMICAL", 96, 108], ["pulmonary infection", "DISEASE", 134, 153], ["voriconazole", "CHEMICAL", 96, 108], ["patient", "ORGANISM", 4, 11], ["pulmonary", "ORGAN", 34, 43], ["voriconazole", "SIMPLE_CHEMICAL", 96, 108], ["pulmonary", "ORGAN", 134, 143], ["patient", "SPECIES", 4, 11], ["pulmonary invasive mold infection", "PROBLEM", 34, 67], ["mold-active therapy", "TREATMENT", 71, 90], ["voriconazole", "TREATMENT", 96, 108], ["pulmonary infection", "PROBLEM", 134, 153], ["probable", "UNCERTAINTY", 25, 33], ["pulmonary", "ANATOMY", 34, 43], ["invasive", "OBSERVATION_MODIFIER", 44, 52], ["mold infection", "OBSERVATION", 53, 67], ["active therapy", "OBSERVATION", 76, 90], ["pulmonary", "ANATOMY", 134, 143], ["infection", "OBSERVATION", 144, 153]]], ["It is unclear whether this represented worsening of previous infection or new infection.", [["infection", "DISEASE", 61, 70], ["infection", "DISEASE", 78, 87], ["previous infection", "PROBLEM", 52, 70], ["new infection", "PROBLEM", 74, 87], ["unclear whether this represented", "UNCERTAINTY", 6, 38], ["worsening", "OBSERVATION_MODIFIER", 39, 48], ["infection", "OBSERVATION", 61, 70], ["new", "OBSERVATION_MODIFIER", 74, 77], ["infection", "OBSERVATION", 78, 87]]], ["The cumulative incidences of infections overall and by infection type are in Figure 1.", [["infections", "DISEASE", 29, 39], ["infection", "DISEASE", 55, 64], ["infections", "PROBLEM", 29, 39], ["cumulative", "OBSERVATION_MODIFIER", 4, 14], ["infections", "OBSERVATION", 29, 39], ["infection", "OBSERVATION", 55, 64]]], ["The infection density during the first 28 days was 2.89 infections per 100 days-at-risk (Figure 2).Infections in Days 29\u201390 Post-CTI ::: RESULTSForty-eight patients contributed data during this time period, with a median duration of follow-up (range) of 51 (29\u201390) days.", [["infection", "DISEASE", 4, 13], ["infections", "DISEASE", 56, 66], ["Infections", "DISEASE", 99, 109], ["patients", "ORGANISM", 156, 164], ["patients", "SPECIES", 156, 164], ["The infection density", "PROBLEM", 0, 21], ["infection", "OBSERVATION", 4, 13]]], ["There were 7 viral infections in this time period, which comprised the majority of infections (58%).", [["viral infections", "DISEASE", 13, 29], ["infections", "DISEASE", 83, 93], ["7 viral infections", "PROBLEM", 11, 29], ["infections", "PROBLEM", 83, 93], ["viral", "OBSERVATION_MODIFIER", 13, 18], ["infections", "OBSERVATION", 19, 29], ["majority", "OBSERVATION_MODIFIER", 71, 79], ["infections", "OBSERVATION", 83, 93]]], ["All were due to respiratory viruses (Table 2).", [["respiratory viruses", "DISEASE", 16, 35], ["respiratory viruses", "PROBLEM", 16, 35], ["respiratory", "ANATOMY", 16, 27], ["viruses", "OBSERVATION", 28, 35]]], ["Five patients had bacterial infections, and there were no fungal infections.", [["bacterial infections", "DISEASE", 18, 38], ["fungal infections", "DISEASE", 58, 75], ["patients", "ORGANISM", 5, 13], ["patients", "SPECIES", 5, 13], ["bacterial infections", "PROBLEM", 18, 38], ["fungal infections", "PROBLEM", 58, 75], ["bacterial", "OBSERVATION_MODIFIER", 18, 27], ["infections", "OBSERVATION", 28, 38], ["no", "UNCERTAINTY", 55, 57], ["fungal", "OBSERVATION_MODIFIER", 58, 64], ["infections", "OBSERVATION", 65, 75]]], ["The infection density in the 29\u201390 days post-CTI decreased to 0.55 per 100 days-at-risk (Figure 2).Infection Severity ::: RESULTS", [["infection", "DISEASE", 4, 13], ["The infection density", "PROBLEM", 0, 21], ["CTI", "TEST", 45, 48], ["infection", "OBSERVATION_MODIFIER", 4, 13], ["density", "OBSERVATION", 14, 21]]]], "d085451c8e3e03eb1c1833a8a5c97c3aba931a60": [["Introduction (7406)Human immunodeficiency virus type one (HIV-1) is one of the most devastating infectious agents existing worldwide for the past 37 years.", [["Human immunodeficiency virus type one", "DISEASE", 19, 56], ["Human immunodeficiency virus type one", "ORGANISM", 19, 56], ["HIV-1", "ORGANISM", 58, 63], ["Human immunodeficiency virus", "SPECIES", 19, 47], ["HIV-1", "SPECIES", 58, 63], ["Human immunodeficiency virus", "SPECIES", 19, 47], ["HIV-1", "SPECIES", 58, 63], ["Human immunodeficiency virus type", "PROBLEM", 19, 52], ["devastating", "OBSERVATION_MODIFIER", 84, 95], ["infectious", "OBSERVATION", 96, 106]]], ["There were approximately 25.7 million people living with HIV at the end of 2018 with 1.1 million people becoming newly infected in 2017 globally.", [["HIV", "DISEASE", 57, 60], ["people", "ORGANISM", 38, 44], ["people", "ORGANISM", 97, 103], ["people", "SPECIES", 38, 44], ["people", "SPECIES", 97, 103], ["HIV", "SPECIES", 57, 60], ["HIV", "PROBLEM", 57, 60], ["approximately", "OBSERVATION_MODIFIER", 11, 24], ["25.7 million", "OBSERVATION_MODIFIER", 25, 37], ["infected", "OBSERVATION", 119, 127]]], ["The induction of protective T cell immunity is a prerequisite for the durable control of HIV-1 [1, 2] .", [["T cell", "ANATOMY", 28, 34], ["T cell", "CELL", 28, 34], ["HIV-1", "ORGANISM", 89, 94], ["HIV-1", "SPECIES", 89, 94], ["HIV-1", "SPECIES", 89, 94], ["protective T cell immunity", "TREATMENT", 17, 43]]], ["However, host immunosuppression is a hallmark of HIV-1 and other persistent viral infections.", [["viral infections", "DISEASE", 76, 92], ["HIV-1", "ORGANISM", 49, 54], ["HIV-1", "SPECIES", 49, 54], ["HIV-1", "SPECIES", 49, 54], ["host immunosuppression", "TREATMENT", 9, 31], ["HIV", "PROBLEM", 49, 52], ["other persistent viral infections", "PROBLEM", 59, 92], ["host", "OBSERVATION_MODIFIER", 9, 13], ["immunosuppression", "OBSERVATION", 14, 31], ["persistent", "OBSERVATION_MODIFIER", 65, 75], ["viral", "OBSERVATION_MODIFIER", 76, 81], ["infections", "OBSERVATION", 82, 92]]], ["Despite initial antiviral immune activity, persistent viruses eventually evade host immune responses [1, 3] and induce expansion of immune regulatory cells in the host that suppress antiviral T cell immunity [4, 5] , facilitating persistent chronic infection [6] [7] [8] .", [["immune regulatory cells", "ANATOMY", 132, 155], ["T cell", "ANATOMY", 192, 198], ["infection", "DISEASE", 249, 258], ["immune regulatory cells", "CELL", 132, 155], ["T cell", "CELL", 192, 198], ["immune regulatory cells", "CELL_TYPE", 132, 155], ["initial antiviral immune activity", "TREATMENT", 8, 41], ["persistent viruses", "PROBLEM", 43, 61], ["immune regulatory cells", "PROBLEM", 132, 155], ["antiviral T cell immunity", "TREATMENT", 182, 207], ["persistent chronic infection", "PROBLEM", 230, 258], ["antiviral immune activity", "OBSERVATION", 16, 41], ["persistent", "OBSERVATION_MODIFIER", 43, 53], ["viruses", "OBSERVATION", 54, 61], ["immune regulatory cells", "OBSERVATION", 132, 155], ["persistent", "OBSERVATION_MODIFIER", 230, 240], ["chronic", "OBSERVATION_MODIFIER", 241, 248], ["infection", "OBSERVATION", 249, 258]]], ["This immunosuppression is also seen as a host adaptation that enables long-term survival and coexistence with the pathogen, because individuals with genetic ablation of core immunosuppressors often die after infection [9] .", [["infection", "DISEASE", 208, 217], ["This immunosuppression", "TREATMENT", 0, 22], ["long-term survival", "TREATMENT", 70, 88], ["the pathogen", "PROBLEM", 110, 122], ["genetic ablation of core immunosuppressors", "TREATMENT", 149, 191], ["infection", "PROBLEM", 208, 217]]], ["The dynamics of the immunosuppressive response and how this host adaptation affects memory T cell recall responses and function driven by prior vaccination remains largely unclear.", [["memory T cell", "ANATOMY", 84, 97], ["memory T cell", "CELL", 84, 97]]], ["However, understanding these mechanisms will be critical for the design of an effective vaccine or immunotherapy against HIV-1 and other chronic diseases.Introduction (7406)CD8 + T cells play a critical role in vaccine-mediated protection against a number of viral and bacterial pathogens [10, 11] .", [["7406)CD8 + T cells", "ANATOMY", 168, 186], ["HIV-1", "DISEASE", 121, 126], ["chronic diseases", "DISEASE", 137, 153], ["HIV-1", "ORGANISM", 121, 126], ["CD8", "GENE_OR_GENE_PRODUCT", 173, 176], ["CD8", "PROTEIN", 173, 176], ["T cells", "CELL_TYPE", 179, 186], ["HIV", "SPECIES", 121, 124], ["HIV-1", "SPECIES", 121, 126], ["an effective vaccine", "TREATMENT", 75, 95], ["immunotherapy", "TREATMENT", 99, 112], ["HIV", "PROBLEM", 121, 124], ["other chronic diseases", "PROBLEM", 131, 153], ["CD8 + T cells", "TREATMENT", 173, 186], ["vaccine-mediated protection", "TREATMENT", 211, 238], ["viral and bacterial pathogens", "PROBLEM", 259, 288], ["chronic", "OBSERVATION_MODIFIER", 137, 144], ["diseases", "OBSERVATION", 145, 153]]], ["After vaccination, naive CD8 + T cells are primed and undergo a rapid expansion phase to generate large numbers of effector cells for pathogen elimination.", [["CD8 + T cells", "ANATOMY", 25, 38], ["cells", "ANATOMY", 124, 129], ["CD8", "GENE_OR_GENE_PRODUCT", 25, 28], ["cells", "CELL", 124, 129], ["naive CD8 + T cells", "CELL_TYPE", 19, 38], ["effector cells", "CELL_TYPE", 115, 129], ["vaccination", "TREATMENT", 6, 17], ["a rapid expansion phase", "TEST", 62, 85], ["pathogen elimination", "PROBLEM", 134, 154], ["large", "OBSERVATION_MODIFIER", 98, 103], ["effector cells", "OBSERVATION", 115, 129]]], ["Subsequently, a contraction period takes place in which most effector cells are eliminated, leaving a small, long-lived memory cell pool [12] .", [["effector cells", "ANATOMY", 61, 75], ["memory cell", "ANATOMY", 120, 131], ["cells", "CELL", 70, 75], ["memory cell", "CELL", 120, 131], ["effector cells", "CELL_TYPE", 61, 75], ["a contraction period", "TREATMENT", 14, 34], ["small", "OBSERVATION_MODIFIER", 102, 107]]], ["When individuals encounter the vaccine-related pathogen, antigen-specific memory T cells can respond swiftly with robust proliferation and upregulation of effector function.", [["memory T cells", "ANATOMY", 74, 88], ["antigen", "GENE_OR_GENE_PRODUCT", 57, 64], ["memory T cells", "CELL", 74, 88], ["memory T cells", "CELL_TYPE", 74, 88], ["the vaccine", "TREATMENT", 27, 38], ["related pathogen", "PROBLEM", 39, 55], ["antigen", "TEST", 57, 64], ["robust proliferation", "PROBLEM", 114, 134], ["effector function", "OBSERVATION", 155, 172]]], ["Analysis of cellular requirements for generating a memory CD8 + T cell recall response during acute viral infection has suggested a critical role for dendritic cells (DCs) and CD4 + helper T cells.", [["cellular", "ANATOMY", 12, 20], ["memory CD8 + T cell", "ANATOMY", 51, 70], ["dendritic cells", "ANATOMY", 150, 165], ["DCs", "ANATOMY", 167, 170], ["CD4 + helper T cells", "ANATOMY", 176, 196], ["viral infection", "DISEASE", 100, 115], ["cellular", "CELL", 12, 20], ["CD8", "GENE_OR_GENE_PRODUCT", 58, 61], ["dendritic cells", "CELL", 150, 165], ["DCs", "CELL", 167, 170], ["CD4", "GENE_OR_GENE_PRODUCT", 176, 179], ["CD8", "PROTEIN", 58, 61], ["dendritic cells", "CELL_TYPE", 150, 165], ["DCs", "CELL_TYPE", 167, 170], ["CD4 + helper T cells", "CELL_TYPE", 176, 196], ["cellular requirements", "PROBLEM", 12, 33], ["a memory CD8", "TEST", 49, 61], ["acute viral infection", "PROBLEM", 94, 115], ["dendritic cells", "PROBLEM", 150, 165], ["CD4", "TEST", 176, 179], ["cellular requirements", "OBSERVATION", 12, 33], ["acute", "OBSERVATION_MODIFIER", 94, 99], ["viral infection", "OBSERVATION", 100, 115], ["dendritic cells", "OBSERVATION", 150, 165]]], ["Activation of memory T cells in response to systemic or localized infection is predominantly dependent on DCs, and the number of responding memory CD8 + T cells is profoundly decreased during the recall response to various acute infections in DC-depleted mice [13] .", [["memory T cells", "ANATOMY", 14, 28], ["DCs", "ANATOMY", 106, 109], ["memory CD8 + T cells", "ANATOMY", 140, 160], ["DC", "ANATOMY", 243, 245], ["infection", "DISEASE", 66, 75], ["infections", "DISEASE", 229, 239], ["memory T cells", "CELL", 14, 28], ["DCs", "CELL", 106, 109], ["CD8", "GENE_OR_GENE_PRODUCT", 147, 150], ["DC", "CELL", 243, 245], ["mice", "ORGANISM", 255, 259], ["memory T cells", "CELL_TYPE", 14, 28], ["DCs", "CELL_TYPE", 106, 109], ["memory CD8 + T cells", "CELL_TYPE", 140, 160], ["DC", "CELL_TYPE", 243, 245], ["mice", "SPECIES", 255, 259], ["memory T cells", "PROBLEM", 14, 28], ["systemic or localized infection", "PROBLEM", 44, 75], ["various acute infections", "PROBLEM", 215, 239], ["infection", "OBSERVATION", 66, 75], ["predominantly", "OBSERVATION_MODIFIER", 79, 92], ["dependent", "OBSERVATION_MODIFIER", 93, 102], ["decreased", "OBSERVATION_MODIFIER", 175, 184], ["acute", "OBSERVATION_MODIFIER", 223, 228], ["infections", "OBSERVATION", 229, 239]]], ["However, the dependence of CD8 + T cell recall response on CD4 + T cells remains controversial.", [["CD8 + T cell", "ANATOMY", 27, 39], ["CD4 + T cells", "ANATOMY", 59, 72], ["CD8", "GENE_OR_GENE_PRODUCT", 27, 30], ["CD4", "GENE_OR_GENE_PRODUCT", 59, 62], ["CD8", "PROTEIN", 27, 30], ["CD4", "PROTEIN", 59, 62], ["T cells", "CELL_TYPE", 65, 72], ["CD8", "TEST", 27, 30], ["CD4", "TEST", 59, 62], ["T cells", "PROBLEM", 65, 72]]], ["In some cases, CD4 + T cells assist proliferative CD8 + T cell recall responses, whereas in other situations, CD4 + T cells appear to be dispensable for the secondary response [14] [15] [16] .Introduction (7406)During chronic lentiviral infection, both CD4 + and CD8 + T cell responses are suppressed by various mechanisms, and these cells subsequently acquire an exhausted phenotype characterized by upregulation of inhibitory molecules such as PD-1, Tim3 or vista, and reduced production of effector molecules such as IFN-g, TNF, granzymes, and perforin [5, 8, 17] .", [["CD4 + T cells", "ANATOMY", 15, 28], ["CD8 + T cell", "ANATOMY", 50, 62], ["CD4 + T cells", "ANATOMY", 110, 123], ["CD4 + and CD8 + T cell", "ANATOMY", 253, 275], ["cells", "ANATOMY", 334, 339], ["lentiviral infection", "DISEASE", 226, 246], ["CD4", "GENE_OR_GENE_PRODUCT", 15, 18], ["CD8", "GENE_OR_GENE_PRODUCT", 50, 53], ["CD4", "GENE_OR_GENE_PRODUCT", 110, 113], ["lentiviral", "ORGANISM", 226, 236], ["CD4", "GENE_OR_GENE_PRODUCT", 253, 256], ["CD8", "GENE_OR_GENE_PRODUCT", 263, 266], ["cells", "CELL", 334, 339], ["PD-1", "GENE_OR_GENE_PRODUCT", 446, 450], ["Tim3", "GENE_OR_GENE_PRODUCT", 452, 456], ["vista", "GENE_OR_GENE_PRODUCT", 460, 465], ["IFN-g", "GENE_OR_GENE_PRODUCT", 520, 525], ["TNF", "GENE_OR_GENE_PRODUCT", 527, 530], ["granzymes", "GENE_OR_GENE_PRODUCT", 532, 541], ["perforin", "GENE_OR_GENE_PRODUCT", 547, 555], ["CD4", "PROTEIN", 15, 18], ["T cells", "CELL_TYPE", 21, 28], ["CD8", "PROTEIN", 50, 53], ["CD4", "PROTEIN", 110, 113], ["T cells", "CELL_TYPE", 116, 123], ["CD4", "PROTEIN", 253, 256], ["CD8", "PROTEIN", 263, 266], ["inhibitory molecules", "PROTEIN", 417, 437], ["PD-1", "PROTEIN", 446, 450], ["Tim3", "PROTEIN", 452, 456], ["vista", "PROTEIN", 460, 465], ["effector molecules", "PROTEIN", 493, 511], ["IFN", "PROTEIN", 520, 523], ["TNF", "PROTEIN", 527, 530], ["granzymes", "PROTEIN", 532, 541], ["perforin", "PROTEIN", 547, 555], ["CD4", "TEST", 15, 18], ["proliferative CD8", "TEST", 36, 53], ["T cells", "PROBLEM", 116, 123], ["chronic lentiviral infection", "PROBLEM", 218, 246], ["CD4", "TEST", 253, 256], ["CD8", "TEST", 263, 266], ["these cells", "PROBLEM", 328, 339], ["an exhausted phenotype", "PROBLEM", 361, 383], ["inhibitory molecules", "PROBLEM", 417, 437], ["PD", "TEST", 446, 448], ["reduced production of effector molecules", "PROBLEM", 471, 511], ["IFN", "TREATMENT", 520, 523], ["TNF", "TREATMENT", 527, 530], ["granzymes", "TREATMENT", 532, 541], ["chronic", "OBSERVATION_MODIFIER", 218, 225], ["lentiviral infection", "OBSERVATION", 226, 246]]], ["Myeloid-derived suppressor cells (MDSCs) have recently emerged as a major suppressor of immune responses in chronic infection and tumors [18] [19] [20] [21] [22] .", [["Myeloid-derived suppressor cells", "ANATOMY", 0, 32], ["MDSCs", "ANATOMY", 34, 39], ["tumors", "ANATOMY", 130, 136], ["chronic infection", "DISEASE", 108, 125], ["tumors", "DISEASE", 130, 136], ["Myeloid-derived suppressor cells", "CELL", 0, 32], ["MDSCs", "CELL", 34, 39], ["tumors", "CANCER", 130, 136], ["[18] [19] [20] [21] [22]", "SIMPLE_CHEMICAL", 137, 161], ["Myeloid-derived suppressor cells", "CELL_TYPE", 0, 32], ["MDSCs", "CELL_TYPE", 34, 39], ["Myeloid-derived suppressor cells", "TREATMENT", 0, 32], ["immune responses", "PROBLEM", 88, 104], ["chronic infection", "PROBLEM", 108, 125], ["tumors", "PROBLEM", 130, 136], ["suppressor cells", "OBSERVATION", 16, 32], ["chronic", "OBSERVATION_MODIFIER", 108, 115], ["infection", "OBSERVATION", 116, 125]]], ["MDSCs are immature myeloid cells that are induced and accumulated during persistent viral infection [23, 24] , and suppress both innate and adaptive immune responses through many mechanisms.", [["MDSCs", "ANATOMY", 0, 5], ["myeloid cells", "ANATOMY", 19, 32], ["viral infection", "DISEASE", 84, 99], ["MDSCs", "CELL", 0, 5], ["myeloid cells", "CELL", 19, 32], ["MDSCs", "CELL_TYPE", 0, 5], ["immature myeloid cells", "CELL_TYPE", 10, 32], ["immature myeloid cells", "PROBLEM", 10, 32], ["persistent viral infection", "PROBLEM", 73, 99], ["immature myeloid cells", "OBSERVATION", 10, 32], ["persistent", "OBSERVATION_MODIFIER", 73, 83], ["viral", "OBSERVATION_MODIFIER", 84, 89], ["infection", "OBSERVATION", 90, 99]]], ["For example, they produce arginase 1 (ARG1), indoleamine 2,3-dioxygenase (IDO), inducible nitric oxide synthase (NOS2), NADPH oxidase and immunosuppressive cytokines to suppress DC, CTLs and natural killer (NK) cell function, deplete nutrients required by lymphocytes, which causes proliferative arrest of antigen-activated T cells, and expands CD4 + CD25 + FoxP3 + regulatory T cells (Tregs) [19, [25] [26] [27] [28] .Introduction (7406)We recently developed a potent sPD1-p24 fc /EP DNA DC-targeting vaccine, which consistently induces a high frequency of durable HIV-1 GAG-specific CD8 + T lymphocytes [29] .", [["DC", "ANATOMY", 178, 180], ["CTLs", "ANATOMY", 182, 186], ["natural killer (NK) cell", "ANATOMY", 191, 215], ["lymphocytes", "ANATOMY", 256, 267], ["T cells", "ANATOMY", 324, 331], ["CD4 + CD25 + FoxP3 + regulatory T cells", "ANATOMY", 345, 384], ["Tregs", "ANATOMY", 386, 391], ["DC", "ANATOMY", 489, 491], ["CD8 + T lymphocytes", "ANATOMY", 585, 604], ["nitric oxide", "CHEMICAL", 90, 102], ["indoleamine", "CHEMICAL", 45, 56], ["nitric oxide", "CHEMICAL", 90, 102], ["NADPH", "CHEMICAL", 120, 125], ["arginase 1", "GENE_OR_GENE_PRODUCT", 26, 36], ["ARG1", "GENE_OR_GENE_PRODUCT", 38, 42], ["indoleamine 2,3-dioxygenase", "GENE_OR_GENE_PRODUCT", 45, 72], ["IDO", "GENE_OR_GENE_PRODUCT", 74, 77], ["inducible nitric oxide synthase", "GENE_OR_GENE_PRODUCT", 80, 111], ["NOS2", "GENE_OR_GENE_PRODUCT", 113, 117], ["NADPH oxidase", "GENE_OR_GENE_PRODUCT", 120, 133], ["DC", "CELL", 178, 180], ["CTLs", "CELL", 182, 186], ["natural killer (NK) cell", "CELL", 191, 215], ["lymphocytes", "CELL", 256, 267], ["T cells", "CELL", 324, 331], ["CD4", "GENE_OR_GENE_PRODUCT", 345, 348], ["CD25", "GENE_OR_GENE_PRODUCT", 351, 355], ["FoxP3", "GENE_OR_GENE_PRODUCT", 358, 363], ["[25] [26] [27] [28]", "SIMPLE_CHEMICAL", 398, 417], ["sPD1", "GENE_OR_GENE_PRODUCT", 469, 473], ["HIV-1", "ORGANISM", 566, 571], ["GAG", "GENE_OR_GENE_PRODUCT", 572, 575], ["CD8", "GENE_OR_GENE_PRODUCT", 585, 588], ["arginase 1", "PROTEIN", 26, 36], ["ARG1", "PROTEIN", 38, 42], ["indoleamine 2,3-dioxygenase", "PROTEIN", 45, 72], ["IDO", "PROTEIN", 74, 77], ["nitric oxide synthase", "PROTEIN", 90, 111], ["NOS2", "PROTEIN", 113, 117], ["NADPH oxidase", "PROTEIN", 120, 133], ["immunosuppressive cytokines", "PROTEIN", 138, 165], ["DC", "CELL_TYPE", 178, 180], ["CTLs", "CELL_TYPE", 182, 186], ["natural killer (NK) cell", "CELL_TYPE", 191, 215], ["lymphocytes", "CELL_TYPE", 256, 267], ["antigen-activated T cells", "CELL_TYPE", 306, 331], ["CD4", "PROTEIN", 345, 348], ["CD25", "PROTEIN", 351, 355], ["FoxP3", "PROTEIN", 358, 363], ["regulatory T cells", "CELL_TYPE", 366, 384], ["Tregs", "CELL_TYPE", 386, 391], ["sPD1", "PROTEIN", 469, 473], ["p24 fc", "PROTEIN", 474, 480], ["CD8", "PROTEIN", 585, 588], ["T lymphocytes", "CELL_TYPE", 591, 604], ["HIV-1", "SPECIES", 566, 571], ["HIV-1", "SPECIES", 566, 571], ["arginase", "TEST", 26, 34], ["indoleamine", "TEST", 45, 56], ["dioxygenase (IDO)", "TREATMENT", 61, 78], ["inducible nitric oxide synthase (NOS2)", "TREATMENT", 80, 118], ["NADPH oxidase", "TREATMENT", 120, 133], ["immunosuppressive cytokines", "TREATMENT", 138, 165], ["DC", "TEST", 178, 180], ["CTLs", "TEST", 182, 186], ["lymphocytes", "TEST", 256, 267], ["proliferative arrest of antigen", "PROBLEM", 282, 313], ["activated T cells", "PROBLEM", 314, 331], ["CD4", "TEST", 345, 348], ["CD25", "TEST", 351, 355], ["FoxP3", "TEST", 358, 363], ["Tregs", "TEST", 386, 391], ["a potent sPD1", "TEST", 460, 473], ["EP DNA DC", "TREATMENT", 482, 491], ["targeting vaccine", "TREATMENT", 492, 509], ["durable HIV", "TEST", 558, 569], ["arginase", "OBSERVATION", 26, 34], ["proliferative arrest", "OBSERVATION", 282, 302]]], ["Following vaccination, we detected up to 21% of p24 tetramer-positive CD8 + T cells in the mouse spleen, and these exhibited broad reactivity, polyfunctionality and cytotoxicity.", [["CD8 + T cells", "ANATOMY", 70, 83], ["spleen", "ANATOMY", 97, 103], ["p24", "GENE_OR_GENE_PRODUCT", 48, 51], ["CD8", "GENE_OR_GENE_PRODUCT", 70, 73], ["mouse", "ORGANISM", 91, 96], ["spleen", "ORGAN", 97, 103], ["p24 tetramer", "PROTEIN", 48, 60], ["positive CD8 + T cells", "CELL_TYPE", 61, 83], ["mouse", "SPECIES", 91, 96], ["mouse", "SPECIES", 91, 96], ["p24 tetramer", "TEST", 48, 60], ["T cells in the mouse spleen", "PROBLEM", 76, 103], ["broad reactivity", "PROBLEM", 125, 141], ["polyfunctionality", "PROBLEM", 143, 160], ["cytotoxicity", "PROBLEM", 165, 177], ["T cells", "OBSERVATION", 76, 83], ["mouse", "ANATOMY_MODIFIER", 91, 96], ["spleen", "ANATOMY", 97, 103], ["broad reactivity", "OBSERVATION", 125, 141]]], ["This model vaccine was subsequently employed to achieve complete and long-lasting protection against lethal mesothelioma challenge by CD8 + T cells in immunocompetent BALB/c mice [18] .", [["mesothelioma", "ANATOMY", 108, 120], ["CD8 + T cells", "ANATOMY", 134, 147], ["mesothelioma", "DISEASE", 108, 120], ["mesothelioma", "CANCER", 108, 120], ["CD8", "GENE_OR_GENE_PRODUCT", 134, 137], ["BALB/c mice", "ORGANISM", 167, 178], ["CD8", "PROTEIN", 134, 137], ["T cells", "CELL_TYPE", 140, 147], ["mice", "SPECIES", 174, 178], ["mice", "SPECIES", 174, 178], ["This model vaccine", "TREATMENT", 0, 18], ["lethal mesothelioma challenge", "TREATMENT", 101, 130], ["mesothelioma", "OBSERVATION", 108, 120]]], ["We have now utilized this vaccine to analyze the secondary T cell immune response to a persistent lentivirus, and the correlation of the recall responses in prevention and curing of persistent infection.", [["T cell", "ANATOMY", 59, 65], ["infection", "DISEASE", 193, 202], ["T cell", "CELL", 59, 65], ["lentivirus", "ORGANISM", 98, 108], ["this vaccine", "TREATMENT", 21, 33], ["a persistent lentivirus", "PROBLEM", 85, 108], ["persistent infection", "PROBLEM", 182, 202], ["cell immune", "OBSERVATION", 61, 72], ["persistent", "OBSERVATION_MODIFIER", 87, 97], ["lentivirus", "OBSERVATION", 98, 108], ["persistent", "OBSERVATION_MODIFIER", 182, 192], ["infection", "OBSERVATION", 193, 202]]], ["We adopted the lentiviral model of EcoHIV, which establishes persistent infection in immunocompetent BALB/c mice [30, 31] .", [["infection", "DISEASE", 72, 81], ["lentiviral", "ORGANISM", 15, 25], ["EcoHIV", "GENE_OR_GENE_PRODUCT", 35, 41], ["BALB/c mice", "ORGANISM", 101, 112], ["mice", "SPECIES", 108, 112], ["EcoHIV", "SPECIES", 35, 41], ["mice", "SPECIES", 108, 112], ["the lentiviral model of EcoHIV", "TREATMENT", 11, 41], ["persistent infection", "PROBLEM", 61, 81], ["persistent", "OBSERVATION_MODIFIER", 61, 71], ["infection", "OBSERVATION", 72, 81]]], ["Considering that immunosuppression was typically observed during chronic infection [20, 24, 32] , we reasoned that efficient reactivation of large numbers of memory CD8 + T cells with broad reactivity and polyfunctionality might be sufficient to rapidly eliminate infected cells before the induction of immunosuppressive cells, thus preventing persistent infection.", [["memory CD8 + T cells", "ANATOMY", 158, 178], ["cells", "ANATOMY", 273, 278], ["cells", "ANATOMY", 321, 326], ["chronic infection", "DISEASE", 65, 82], ["infection", "DISEASE", 355, 364], ["CD8", "GENE_OR_GENE_PRODUCT", 165, 168], ["cells", "CELL", 273, 278], ["cells", "CELL", 321, 326], ["memory CD8 + T cells", "CELL_TYPE", 158, 178], ["infected cells", "CELL_TYPE", 264, 278], ["immunosuppressive cells", "CELL_TYPE", 303, 326], ["immunosuppression", "TREATMENT", 17, 34], ["chronic infection", "PROBLEM", 65, 82], ["T cells", "PROBLEM", 171, 178], ["broad reactivity and polyfunctionality", "PROBLEM", 184, 222], ["infected cells", "PROBLEM", 264, 278], ["immunosuppressive cells", "TREATMENT", 303, 326], ["persistent infection", "PROBLEM", 344, 364], ["immunosuppression", "OBSERVATION", 17, 34], ["chronic", "OBSERVATION_MODIFIER", 65, 72], ["infection", "OBSERVATION", 73, 82], ["large", "OBSERVATION_MODIFIER", 141, 146], ["numbers", "OBSERVATION_MODIFIER", 147, 154], ["persistent", "OBSERVATION_MODIFIER", 344, 354], ["infection", "OBSERVATION", 355, 364]]], ["However, our results indicated that despite effective initial memory CD8 + T cell reactivation, there was a rapid expansion of MDSCs within 7 days post-infection (dpi), which profoundly subverted the memory CD8 + T cell response both in terms of number and function at a very early stage of infection, resulted in viral persistence.Mice and viruses6-to 8-week-old female BALB/c (Charles River Laboratory), OT-I (Rag1/2+/+) mice were maintained under specific-pathogen-free conditions in the Laboratory Animal Unit.", [["memory CD8 + T cell", "ANATOMY", 62, 81], ["MDSCs", "ANATOMY", 127, 132], ["memory CD8 + T cell", "ANATOMY", 200, 219], ["infection", "DISEASE", 152, 161], ["infection", "DISEASE", 291, 300], ["CD8", "GENE_OR_GENE_PRODUCT", 69, 72], ["MDSCs", "CELL", 127, 132], ["CD8", "GENE_OR_GENE_PRODUCT", 207, 210], ["Mice", "ORGANISM", 332, 336], ["BALB/c", "ORGANISM", 371, 377], ["Charles River Laboratory", "ORGANISM", 379, 403], ["OT-I", "GENE_OR_GENE_PRODUCT", 406, 410], ["Rag1/2", "ORGANISM", 412, 418], ["CD8", "PROTEIN", 69, 72], ["MDSCs", "CELL_TYPE", 127, 132], ["CD8", "PROTEIN", 207, 210], ["Mice", "SPECIES", 332, 336], ["mice", "SPECIES", 423, 427], ["mice", "SPECIES", 423, 427], ["T cell reactivation", "PROBLEM", 75, 94], ["a rapid expansion of MDSCs", "PROBLEM", 106, 132], ["infection", "PROBLEM", 152, 161], ["T cell response", "PROBLEM", 213, 228], ["infection", "PROBLEM", 291, 300], ["viral persistence", "PROBLEM", 314, 331], ["viruses6", "TEST", 341, 349], ["cell reactivation", "OBSERVATION", 77, 94], ["rapid", "OBSERVATION_MODIFIER", 108, 113], ["expansion", "OBSERVATION_MODIFIER", 114, 123], ["MDSCs", "OBSERVATION", 127, 132], ["infection", "OBSERVATION", 152, 161], ["memory CD8", "OBSERVATION", 200, 210], ["T cell response", "OBSERVATION", 213, 228], ["infection", "OBSERVATION", 291, 300], ["viral persistence", "OBSERVATION", 314, 331]]], ["EcoHIV strains from David Volsky of Columbia University were grown and quantified, as described previously [30] .Mouse immunization and challengeConstruction of the DNA vaccines sPD1-p24fc and p24fc and the immunization procedure were previously described [18, 29] .", [["Mouse", "ORGANISM", 113, 118], ["DNA", "CELLULAR_COMPONENT", 165, 168], ["sPD1-p24fc", "GENE_OR_GENE_PRODUCT", 178, 188], ["p24fc", "GENE_OR_GENE_PRODUCT", 193, 198], ["sPD1", "PROTEIN", 178, 182], ["p24fc", "DNA", 183, 188], ["p24fc", "DNA", 193, 198], ["Mouse", "SPECIES", 113, 118], ["EcoHIV", "SPECIES", 0, 6], ["Mouse", "SPECIES", 113, 118], ["Mouse immunization", "TREATMENT", 113, 131], ["the DNA vaccines", "TREATMENT", 161, 177], ["sPD1", "TEST", 178, 182], ["p24fc", "TREATMENT", 193, 198], ["the immunization procedure", "TREATMENT", 203, 229]]], ["Mice received three DNA immunizations by intramuscular injection with EP given every three weeks at a dose of 100 mg per mouse.", [["intramuscular", "ANATOMY", 41, 54], ["EP", "CHEMICAL", 70, 72], ["Mice", "ORGANISM", 0, 4], ["DNA", "CELLULAR_COMPONENT", 20, 23], ["intramuscular", "IMMATERIAL_ANATOMICAL_ENTITY", 41, 54], ["mouse", "ORGANISM", 121, 126], ["Mice", "SPECIES", 0, 4], ["mouse", "SPECIES", 121, 126], ["mouse", "SPECIES", 121, 126], ["three DNA immunizations", "TREATMENT", 14, 37], ["EP", "TREATMENT", 70, 72]]], ["After the final immunization, the mice were challenged with EcoHIV via i.p. route and subsequently sacrificed at 1, 2, 3, or 12 weeks, after which sera and splenocytes were collected for analysis.qPCR quantitation of proviral loadqPCR quantitation of total HIV DNA in EcoHIV-infected mice and DNA standardization was conducted as previously described [33] with forward primer 5 0 -CCCTCAGATGCTGCATATAAGC-3 0 , and reverse primer 5 0 \u00c0GCACTCAAGGCAAGCTTTATTG\u00c03 0 for LTR.", [["sera", "ANATOMY", 147, 151], ["splenocytes", "ANATOMY", 156, 167], ["LTR", "ANATOMY", 465, 468], ["EcoHIV", "CHEMICAL", 60, 66], ["mice", "ORGANISM", 34, 38], ["EcoHIV", "SIMPLE_CHEMICAL", 60, 66], ["sera", "ORGANISM_SUBSTANCE", 147, 151], ["splenocytes", "CELL", 156, 167], ["HIV", "ORGANISM", 257, 260], ["DNA", "CELLULAR_COMPONENT", 261, 264], ["EcoHIV", "GENE_OR_GENE_PRODUCT", 268, 274], ["mice", "ORGANISM", 284, 288], ["DNA", "CELLULAR_COMPONENT", 293, 296], ["LTR", "CELLULAR_COMPONENT", 465, 468], ["splenocytes", "CELL_TYPE", 156, 167], ["total HIV DNA", "DNA", 251, 264], ["forward primer 5 0 -CCCTCAGATGCTGCATATAAGC-3 0", "DNA", 361, 407], ["reverse primer 5 0 \u00c0GCACTCAAGGCAAGCTTTATTG\u00c03 0", "DNA", 414, 460], ["LTR", "DNA", 465, 468], ["mice", "SPECIES", 34, 38], ["HIV", "SPECIES", 257, 260], ["mice", "SPECIES", 284, 288], ["mice", "SPECIES", 34, 38], ["EcoHIV", "SPECIES", 60, 66], ["HIV", "SPECIES", 257, 260], ["EcoHIV", "SPECIES", 268, 274], ["mice", "SPECIES", 284, 288], ["the final immunization", "TREATMENT", 6, 28], ["EcoHIV", "TREATMENT", 60, 66], ["sera and splenocytes", "TEST", 147, 167], ["analysis.qPCR quantitation", "TEST", 187, 213], ["proviral loadqPCR quantitation", "TREATMENT", 217, 247], ["total HIV DNA", "PROBLEM", 251, 264], ["EcoHIV", "TEST", 268, 274], ["infected mice", "TREATMENT", 275, 288], ["DNA standardization", "TEST", 293, 312], ["forward primer", "TEST", 361, 375], ["-CCCTCAGATGCTGCATATAAGC", "TEST", 380, 403], ["LTR", "PROBLEM", 465, 468], ["splenocytes", "ANATOMY", 156, 167]]], ["DNA content was standardized by amplification of murine b globin with forwardResearch in contextEvidence before this study Host immunosuppression is a hallmark of HIV-1 and other persistent viral infections.", [["viral infections", "DISEASE", 190, 206], ["DNA", "CELLULAR_COMPONENT", 0, 3], ["murine", "ORGANISM", 49, 55], ["b globin", "GENE_OR_GENE_PRODUCT", 56, 64], ["HIV-1", "ORGANISM", 163, 168], ["murine b globin", "PROTEIN", 49, 64], ["murine", "SPECIES", 49, 55], ["HIV-1", "SPECIES", 163, 168], ["HIV-1", "SPECIES", 163, 168], ["DNA content", "PROBLEM", 0, 11], ["this study", "TEST", 112, 122], ["Host immunosuppression", "TREATMENT", 123, 145], ["HIV", "PROBLEM", 163, 166], ["other persistent viral infections", "PROBLEM", 173, 206], ["persistent", "OBSERVATION_MODIFIER", 179, 189], ["viral", "OBSERVATION_MODIFIER", 190, 195], ["infections", "OBSERVATION", 196, 206]]], ["Persistent viruses evade host immune responses and induce expansion of immune regulatory cells in the host that suppress antiviral T cell immunity, facilitating persistent chronic infection.", [["immune regulatory cells", "ANATOMY", 71, 94], ["T cell", "ANATOMY", 131, 137], ["chronic infection", "DISEASE", 172, 189], ["immune regulatory cells", "CELL", 71, 94], ["T cell", "CELL", 131, 137], ["immune regulatory cells", "CELL_TYPE", 71, 94], ["Persistent viruses", "PROBLEM", 0, 18], ["immune regulatory cells", "PROBLEM", 71, 94], ["antiviral T cell immunity", "TREATMENT", 121, 146], ["persistent chronic infection", "PROBLEM", 161, 189], ["viruses", "OBSERVATION", 11, 18], ["immune regulatory cells", "OBSERVATION", 71, 94], ["persistent", "OBSERVATION_MODIFIER", 161, 171], ["chronic", "OBSERVATION_MODIFIER", 172, 179], ["infection", "OBSERVATION", 180, 189]]], ["The dynamic of the immunosuppressive response and how this response affects memory T cell recall responses and function driven by prior vaccination remains largely unclear.Added value of this studyThis study provides an overview of the temporal interplay of a persistent virus, DCs, MDSCs, and antigen-specific CD8 + T cells during acute infection.", [["memory T cell", "ANATOMY", 76, 89], ["DCs", "ANATOMY", 278, 281], ["MDSCs", "ANATOMY", 283, 288], ["CD8 + T cells", "ANATOMY", 311, 324], ["acute infection", "DISEASE", 332, 347], ["memory T cell", "CELL", 76, 89], ["DCs", "CELL", 278, 281], ["MDSCs", "CELL", 283, 288], ["antigen", "GENE_OR_GENE_PRODUCT", 294, 301], ["CD8", "GENE_OR_GENE_PRODUCT", 311, 314], ["DCs", "CELL_TYPE", 278, 281], ["MDSCs", "CELL_TYPE", 283, 288], ["antigen-specific CD8 + T cells", "CELL_TYPE", 294, 324], ["this study", "TEST", 187, 197], ["This study", "TEST", 197, 207], ["a persistent virus", "PROBLEM", 258, 276], ["MDSCs", "TEST", 283, 288], ["antigen", "TEST", 294, 301], ["acute infection", "PROBLEM", 332, 347], ["persistent", "OBSERVATION_MODIFIER", 260, 270], ["virus", "OBSERVATION", 271, 276], ["acute", "OBSERVATION_MODIFIER", 332, 337], ["infection", "OBSERVATION", 338, 347]]], ["We demonstrated that despite initial high levels of viral-specific CD8 + T lymphocytes recall response, persistent viruses evade host immune responses through infection of MDSC, and induction of quick MDSC expansion.", [["CD8 + T lymphocytes", "ANATOMY", 67, 86], ["MDSC", "ANATOMY", 172, 176], ["MDSC", "ANATOMY", 201, 205], ["infection", "DISEASE", 159, 168], ["CD8", "GENE_OR_GENE_PRODUCT", 67, 70], ["MDSC", "CELL", 172, 176], ["MDSC", "CELL", 201, 205], ["CD8", "PROTEIN", 67, 70], ["MDSC", "CELL_TYPE", 172, 176], ["MDSC", "CELL_TYPE", 201, 205], ["viral", "TEST", 52, 57], ["persistent viruses", "PROBLEM", 104, 122], ["infection of MDSC", "PROBLEM", 159, 176], ["quick MDSC expansion", "PROBLEM", 195, 215], ["persistent", "OBSERVATION_MODIFIER", 104, 114], ["viruses", "OBSERVATION", 115, 122], ["MDSC", "OBSERVATION", 172, 176], ["MDSC expansion", "OBSERVATION", 201, 215]]], ["MDSCs suppressed T cell function within 7 days post infection and were resistant to CD8 + T cell-mediated apoptosis.", [["MDSCs", "ANATOMY", 0, 5], ["T cell", "ANATOMY", 17, 23], ["CD8 + T cell", "ANATOMY", 84, 96], ["infection", "DISEASE", 52, 61], ["MDSCs", "CELL", 0, 5], ["T cell", "CELL", 17, 23], ["CD8", "GENE_OR_GENE_PRODUCT", 84, 87], ["MDSCs", "CELL_TYPE", 0, 5], ["CD8", "PROTEIN", 84, 87], ["infection", "PROBLEM", 52, 61], ["CD8", "TEST", 84, 87], ["apoptosis", "PROBLEM", 106, 115], ["infection", "OBSERVATION", 52, 61], ["apoptosis", "OBSERVATION", 106, 115]]], ["Depletion of MDSCs reduced infection and boosted T cell function in vivo.Implications of all the available evidenceMDSCs are critical gatekeepers that restrain antiviral T cell memory responses and may serve as an important target for developing effective vaccines against chronic human infections. primer 5 0 \u00c0GGTTTCCTTCCCCTGGCTAT\u00c03 0 and reverse primer 5 0 \u00c0CGCTTCCCCTTTCCTTCTG\u00c03 0 .Evaluation of gag p24-specific t cell responsesEvaluation of IFNg\u00c0producing T cells were conducted by ELISpot assay (Millipore) as previously described [18, 29] .", [["MDSCs", "ANATOMY", 13, 18], ["T cell", "ANATOMY", 49, 55], ["T cell", "ANATOMY", 170, 176], ["t cell", "ANATOMY", 416, 422], ["IFNg\u00c0producing T cells", "ANATOMY", 446, 468], ["infection", "DISEASE", 27, 36], ["chronic human infections", "DISEASE", 273, 297], ["MDSCs", "CELL", 13, 18], ["T cell", "CELL", 49, 55], ["T cell", "CELL", 170, 176], ["human", "ORGANISM", 281, 286], ["gag", "ORGANISM", 399, 402], ["p24", "GENE_OR_GENE_PRODUCT", 403, 406], ["IFNg\u00c0producing T cells", "CELL", 446, 468], ["MDSCs", "CELL_TYPE", 13, 18], ["\u00c0GGTTTCCTTCCCCTGGCTAT\u00c03 0", "DNA", 310, 335], ["reverse primer 5 0 \u00c0CGCTTCCCCTTTCCTTCTG\u00c03 0", "DNA", 340, 383], ["gag p24", "PROTEIN", 399, 406], ["IFNg\u00c0producing T cells", "CELL_LINE", 446, 468], ["human", "SPECIES", 281, 286], ["human", "SPECIES", 281, 286], ["MDSCs reduced infection", "PROBLEM", 13, 36], ["boosted T cell function", "TREATMENT", 41, 64], ["effective vaccines", "TREATMENT", 246, 264], ["chronic human infections", "PROBLEM", 273, 297], ["primer", "TEST", 299, 305], ["reverse primer", "TREATMENT", 340, 354], ["Evaluation of gag p24", "TEST", 385, 406], ["Evaluation", "TEST", 432, 442], ["IFNg\u00c0producing T cells", "PROBLEM", 446, 468], ["ELISpot assay", "TEST", 487, 500], ["MDSCs", "OBSERVATION", 13, 18], ["reduced", "OBSERVATION_MODIFIER", 19, 26], ["infection", "OBSERVATION", 27, 36], ["cell function", "OBSERVATION", 51, 64], ["infections", "OBSERVATION", 287, 297]]], ["Briefly, splenocytes were stimulated with 10 mg/mL of HIV-1 p24 peptide or peptide pools in vitro (NIH, catalog no. 8117).", [["splenocytes", "ANATOMY", 9, 20], ["splenocytes", "CELL", 9, 20], ["HIV-1", "ORGANISM", 54, 59], ["p24", "ORGANISM", 60, 63], ["splenocytes", "CELL_TYPE", 9, 20], ["HIV-1", "SPECIES", 54, 59], ["HIV-1", "SPECIES", 54, 59], ["HIV-1 p24 peptide", "TREATMENT", 54, 71], ["splenocytes", "ANATOMY", 9, 20]]], ["The peptide pools were generated by dividing 59 GAG p24 peptides into three pools.", [["The peptide pools", "TEST", 0, 17]]], ["Each pool contains 19\u00c020 peptides spanning amino acids 1\u00c087 (pool 1), 77\u00c0167 (pool 2), and 157\u00c0231 (pool 3).", [["amino acids", "CHEMICAL", 43, 54], ["amino acids", "CHEMICAL", 43, 54], ["amino acids", "AMINO_ACID", 43, 54], ["amino acids", "TEST", 43, 54]]], ["The final concentration of each peptide in three pools is 2 mg/ml.", [["The final concentration of each peptide in three pools", "TREATMENT", 0, 54]]], ["Peptide GAG A-I (AMQMLKDTI) is specific to CD8+ T cells, whereas peptide GAG 26 (TSNPPIPVGDIYKRWIILGL) is specific to CD4+ T cells.", [["CD8+ T cells", "ANATOMY", 43, 55], ["CD4+ T cells", "ANATOMY", 118, 130], ["GAG A-I", "GENE_OR_GENE_PRODUCT", 8, 15], ["AMQMLKDTI", "GENE_OR_GENE_PRODUCT", 17, 26], ["CD8", "GENE_OR_GENE_PRODUCT", 43, 46], ["peptide GAG 26", "GENE_OR_GENE_PRODUCT", 65, 79], ["CD4", "GENE_OR_GENE_PRODUCT", 118, 121], ["CD8", "PROTEIN", 43, 46], ["T cells", "CELL_TYPE", 48, 55], ["CD4", "PROTEIN", 118, 121], ["T cells", "CELL_TYPE", 123, 130], ["peptide GAG", "TEST", 65, 76]]], ["Cells stimulated with 500 ng/ml phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich) plus 1 mg/ml calcium ionomycin or left in media only served as positive and negative controls, respectively.", [["Cells", "ANATOMY", 0, 5], ["phorbol 12-myristate 13-acetate", "CHEMICAL", 32, 63], ["PMA", "CHEMICAL", 65, 68], ["Sigma-Aldrich", "CHEMICAL", 70, 83], ["calcium", "CHEMICAL", 98, 105], ["ionomycin", "CHEMICAL", 106, 115], ["phorbol 12-myristate 13-acetate", "CHEMICAL", 32, 63], ["PMA", "CHEMICAL", 65, 68], ["calcium", "CHEMICAL", 98, 105], ["ionomycin", "CHEMICAL", 106, 115], ["Cells", "CELL", 0, 5], ["phorbol 12-myristate 13-acetate", "SIMPLE_CHEMICAL", 32, 63], ["PMA", "SIMPLE_CHEMICAL", 65, 68], ["Sigma-Aldrich", "SIMPLE_CHEMICAL", 70, 83], ["calcium", "SIMPLE_CHEMICAL", 98, 105], ["ionomycin", "SIMPLE_CHEMICAL", 106, 115], ["Cells", "TEST", 0, 5], ["phorbol", "TREATMENT", 32, 39], ["myristate", "TREATMENT", 43, 52], ["Sigma-Aldrich)", "TREATMENT", 70, 84], ["calcium ionomycin", "TREATMENT", 98, 115], ["left", "ANATOMY_MODIFIER", 119, 123]]], ["Cells were incubated at 37\u00b0C, and 5% CO2, for 20 h.", [["Cells", "ANATOMY", 0, 5], ["CO2", "CHEMICAL", 37, 40], ["CO2", "CHEMICAL", 37, 40], ["Cells", "CELL", 0, 5], ["CO2", "SIMPLE_CHEMICAL", 37, 40], ["Cells", "TEST", 0, 5]]], ["ImmunoSpot analyzer (Thermo Fisher Scientific) was used to detect the spots.", [["ImmunoSpot analyzer", "TEST", 0, 19], ["the spots", "PROBLEM", 66, 75]]], ["Tetramer-positive CD8 + T cells were detected using MHC class I tetramer H2d-Kd-AMQMLKDTI (Beckman Coulter).T cell proliferation assaySplenocytes isolated from BALB/c mice were labeled with 1 mM CFSE (Invitrogen) at 10 7 cells/ml in PBS for 10 min in a 37\u00b0C water bath, and cultured in the presence of HIV-1 GAG p24 peptide pools (2 mg/ml), or with anti-CD28 (2 mg/ml) and anti-CD3 (0.1 mg/ml) antibodies.", [["Tetramer-positive CD8 + T cells", "ANATOMY", 0, 31], ["T cell", "ANATOMY", 108, 114], ["assaySplenocytes", "ANATOMY", 129, 145], ["cells", "ANATOMY", 221, 226], ["CFSE", "CHEMICAL", 195, 199], ["CFSE", "CHEMICAL", 195, 199], ["Tetramer", "GENE_OR_GENE_PRODUCT", 0, 8], ["CD8", "GENE_OR_GENE_PRODUCT", 18, 21], ["T cell", "CELL", 108, 114], ["BALB/c mice", "ORGANISM", 160, 171], ["CFSE", "SIMPLE_CHEMICAL", 195, 199], ["Invitrogen", "SIMPLE_CHEMICAL", 201, 211], ["anti-CD28", "SIMPLE_CHEMICAL", 349, 358], ["anti-CD3", "SIMPLE_CHEMICAL", 373, 381], ["Tetramer-positive CD8 + T cells", "CELL_LINE", 0, 31], ["MHC class I tetramer H2d", "PROTEIN", 52, 76], ["Kd-AMQMLKDTI", "PROTEIN", 77, 89], ["anti-CD28", "PROTEIN", 349, 358], ["anti-CD3", "PROTEIN", 373, 381], ["mice", "SPECIES", 167, 171], ["HIV-1", "SPECIES", 302, 307], ["mice", "SPECIES", 167, 171], ["HIV-1", "SPECIES", 302, 307], ["Tetramer", "TEST", 0, 8], ["T cells", "PROBLEM", 24, 31], ["T cell proliferation assaySplenocytes", "PROBLEM", 108, 145], ["BALB/c mice", "TREATMENT", 160, 171], ["1 mM CFSE (Invitrogen)", "TREATMENT", 190, 212], ["PBS", "TREATMENT", 233, 236], ["a 37\u00b0C water bath", "TREATMENT", 251, 268], ["HIV", "PROBLEM", 302, 305], ["1 GAG p24 peptide pools", "TREATMENT", 306, 329], ["anti-CD28", "TREATMENT", 349, 358], ["anti-CD3", "TREATMENT", 373, 381], ["cell proliferation", "OBSERVATION", 110, 128]]], ["Cells were collected after five days of coculture, and stained with fluorochrome-conjugated antibodies.", [["Cells", "ANATOMY", 0, 5], ["Cells", "CELL", 0, 5], ["fluorochrome", "SIMPLE_CHEMICAL", 68, 80], ["fluorochrome-conjugated antibodies", "PROTEIN", 68, 102], ["Cells", "TEST", 0, 5], ["coculture", "TEST", 40, 49], ["fluorochrome", "TEST", 68, 80]]], ["Data were acquired using a FACSAria III flow cytometer (BD Biosciences), and analyzed with FlowJo softwarev10 (TreeStar Inc.).Antigen-presenting cell functional assaysTotal DCs and CD8 + T cells were purified from the mice's spleens by anti-CD11c + microbeads (Biolegend) and immunomagnetic beads (Invitrogen), respectively.", [["cell", "ANATOMY", 145, 149], ["DCs", "ANATOMY", 173, 176], ["CD8 + T cells", "ANATOMY", 181, 194], ["spleens", "ANATOMY", 225, 232], ["cell", "CELL", 145, 149], ["Total DCs", "CELL", 167, 176], ["CD8", "GENE_OR_GENE_PRODUCT", 181, 184], ["mice", "ORGANISM", 218, 222], ["spleens", "ORGAN", 225, 232], ["Biolegend", "GENE_OR_GENE_PRODUCT", 261, 270], ["DCs", "CELL_TYPE", 173, 176], ["CD8 + T cells", "CELL_TYPE", 181, 194], ["anti-CD11c", "PROTEIN", 236, 246], ["Biolegend", "PROTEIN", 261, 270], ["mice", "SPECIES", 218, 222], ["mice", "SPECIES", 218, 222], ["a FACSAria III flow cytometer", "TREATMENT", 25, 54], ["Antigen", "TEST", 126, 133], ["Total DCs", "TEST", 167, 176], ["CD8", "TEST", 181, 184], ["T cells", "PROBLEM", 187, 194], ["anti-CD11c + microbeads", "TREATMENT", 236, 259], ["immunomagnetic beads", "TREATMENT", 276, 296], ["spleens", "ANATOMY", 225, 232]]], ["Total DC and CD8 + T cell populations were determined as >95% pure by flow cytometry.", [["DC", "ANATOMY", 6, 8], ["CD8 + T cell", "ANATOMY", 13, 25], ["DC", "CELL", 6, 8], ["CD8", "GENE_OR_GENE_PRODUCT", 13, 16], ["DC", "CELL_TYPE", 6, 8], ["CD8", "PROTEIN", 13, 16], ["Total DC", "TEST", 0, 8], ["CD8 + T cell populations", "TREATMENT", 13, 37], ["flow cytometry", "TEST", 70, 84], ["flow cytometry", "OBSERVATION", 70, 84]]], ["Purified DCs were cultured with 10 5 CFSE-labeled CD8 + OT-I T cells at a ratio of 1:1 with or without the presence of SIINFEKL peptide (GenScript) for 5 days, and then were stained with fluorochrome-conjugated antibodies and analyzed on a BD Aria III flow cytometer (BD Biosciences).T cell suppression assayTotal MDSCs were enriched from the spleens of day 14 EcoHIVinfected mice via MACS beads.", [["DCs", "ANATOMY", 9, 12], ["CD8 + OT-I T cells", "ANATOMY", 50, 68], ["T cell", "ANATOMY", 284, 290], ["MDSCs", "ANATOMY", 314, 319], ["spleens", "ANATOMY", 343, 350], ["CFSE", "CHEMICAL", 37, 41], ["DCs", "CELL", 9, 12], ["CFSE", "SIMPLE_CHEMICAL", 37, 41], ["CD8", "GENE_OR_GENE_PRODUCT", 50, 53], ["fluorochrome", "SIMPLE_CHEMICAL", 187, 199], ["T cell", "CELL", 284, 290], ["assayTotal MDSCs", "CELL", 303, 319], ["spleens", "ORGAN", 343, 350], ["mice", "ORGANISM", 376, 380], ["DCs", "CELL_TYPE", 9, 12], ["CD8", "PROTEIN", 50, 53], ["OT-I T cells", "CELL_TYPE", 56, 68], ["fluorochrome-conjugated antibodies", "PROTEIN", 187, 221], ["assayTotal MDSCs", "CELL_TYPE", 303, 319], ["mice", "SPECIES", 376, 380], ["mice", "SPECIES", 376, 380], ["CD8", "TEST", 50, 53], ["OT", "TEST", 56, 58], ["SIINFEKL peptide", "PROBLEM", 119, 135], ["fluorochrome-conjugated antibodies", "TREATMENT", 187, 221], ["T cell suppression assayTotal MDSCs", "TREATMENT", 284, 319], ["EcoHIVinfected mice via MACS beads", "TREATMENT", 361, 395], ["spleens", "ANATOMY", 343, 350]]], ["The average purity of monocytic populations from three experiments was >90%.", [["monocytic populations", "ANATOMY", 22, 43], ["monocytic populations", "CELL", 22, 43], ["monocytic populations", "CELL_TYPE", 22, 43], ["monocytic populations", "PROBLEM", 22, 43], ["average", "OBSERVATION_MODIFIER", 4, 11], ["purity", "OBSERVATION_MODIFIER", 12, 18], ["monocytic populations", "OBSERVATION", 22, 43]]], ["Myeloid cells were added to 10 5 CFSE-labeled splenocytes from sPD1-p24fc/EP DNA vaccinated and unchallenged mice, and cultured for 5 days with p24 peptide pools or CD28/CD3 antibodies before evaluating proliferation.MDSC isolation and cultureMDSCs were isolated from spleens of EcoHIV-infected BALB/c mice using the Miltenyi Biotech MDSC Isolation Kit, according to the manufacturer's protocols.", [["Myeloid cells", "ANATOMY", 0, 13], ["splenocytes", "ANATOMY", 46, 57], ["MDSC", "ANATOMY", 217, 221], ["cultureMDSCs", "ANATOMY", 236, 248], ["spleens", "ANATOMY", 268, 275], ["CFSE", "CHEMICAL", 33, 37], ["Myeloid cells", "CELL", 0, 13], ["CFSE", "SIMPLE_CHEMICAL", 33, 37], ["splenocytes", "CELL", 46, 57], ["sPD1", "GENE_OR_GENE_PRODUCT", 63, 67], ["DNA", "CELLULAR_COMPONENT", 77, 80], ["mice", "ORGANISM", 109, 113], ["p24", "GENE_OR_GENE_PRODUCT", 144, 147], ["CD28", "GENE_OR_GENE_PRODUCT", 165, 169], ["CD3", "GENE_OR_GENE_PRODUCT", 170, 173], ["MDSC", "CELL", 217, 221], ["cultureMDSCs", "CELL", 236, 248], ["spleens", "ORGAN", 268, 275], ["EcoHIV", "GENE_OR_GENE_PRODUCT", 279, 285], ["BALB/c mice", "ORGANISM", 295, 306], ["Myeloid cells", "CELL_TYPE", 0, 13], ["splenocytes", "CELL_TYPE", 46, 57], ["sPD1", "PROTEIN", 63, 67], ["p24fc", "PROTEIN", 68, 73], ["CD28", "PROTEIN", 165, 169], ["CD3 antibodies", "PROTEIN", 170, 184], ["MDSC", "CELL_TYPE", 217, 221], ["cultureMDSCs", "CELL_TYPE", 236, 248], ["mice", "SPECIES", 109, 113], ["mice", "SPECIES", 302, 306], ["mice", "SPECIES", 109, 113], ["EcoHIV", "SPECIES", 279, 285], ["mice", "SPECIES", 302, 306], ["Myeloid cells", "PROBLEM", 0, 13], ["splenocytes", "TEST", 46, 57], ["sPD1", "TEST", 63, 67], ["EP DNA vaccinated", "TREATMENT", 74, 91], ["p24 peptide pools", "TEST", 144, 161], ["CD28/CD3 antibodies", "TEST", 165, 184], ["proliferation", "PROBLEM", 203, 216], ["MDSC isolation", "TREATMENT", 217, 231], ["cultureMDSCs", "TREATMENT", 236, 248], ["EcoHIV", "TREATMENT", 279, 285], ["the Miltenyi Biotech MDSC Isolation Kit", "TREATMENT", 313, 352], ["the manufacturer's protocols", "TREATMENT", 367, 395], ["spleens", "ANATOMY", 268, 275]]], ["The purity of MDSCs was greater than 95% as determined by flow cytometry.", [["MDSCs", "ANATOMY", 14, 19], ["MDSCs", "CELL", 14, 19], ["MDSCs", "CELL_TYPE", 14, 19], ["flow cytometry", "TEST", 58, 72], ["MDSCs", "OBSERVATION", 14, 19], ["flow cytometry", "OBSERVATION", 58, 72]]], ["To assess CD8 + T cell-mediated apoptosis, MDSCs and freshly isolated CD8 + T cells were co-cultured at MDSC-to-CD8 + T cell ratios of 1:1, 1:2, and 1:5 in a 37\u00b0C incubator for 24 hrs before being subjected to analysis of active caspase-3.Myeloid cell depletion in vivoMice immunized and infected with EcoHIV were given intraperitoneal injections of 100 mg of anti-Gr1 (RB6\u00c08C5) or a rat IgG2b isotype control (LTF-2) (Bio X Cell), at 7, 9, and 11 dpi.", [["CD8 + T cell", "ANATOMY", 10, 22], ["MDSCs", "ANATOMY", 43, 48], ["CD8 + T cells", "ANATOMY", 70, 83], ["MDSC-to-CD8 + T cell", "ANATOMY", 104, 124], ["Myeloid cell", "ANATOMY", 239, 251], ["intraperitoneal", "ANATOMY", 320, 335], ["Cell", "ANATOMY", 425, 429], ["EcoHIV", "CHEMICAL", 302, 308], ["CD8", "GENE_OR_GENE_PRODUCT", 10, 13], ["MDSCs", "CELL", 43, 48], ["CD8", "GENE_OR_GENE_PRODUCT", 70, 73], ["MDSC-to-CD8 + T cell", "CELL", 104, 124], ["caspase-3", "GENE_OR_GENE_PRODUCT", 229, 238], ["Myeloid cell", "CELL", 239, 251], ["intraperitoneal", "IMMATERIAL_ANATOMICAL_ENTITY", 320, 335], ["anti-Gr1", "SIMPLE_CHEMICAL", 360, 368], ["rat", "ORGANISM", 384, 387], ["IgG2b", "GENE_OR_GENE_PRODUCT", 388, 393], ["Bio X Cell", "CELL", 419, 429], ["CD8", "PROTEIN", 10, 13], ["MDSCs", "CELL_TYPE", 43, 48], ["freshly isolated CD8 + T cells", "CELL_TYPE", 53, 83], ["MDSC", "CELL_TYPE", 104, 108], ["to-CD8", "PROTEIN", 109, 115], ["caspase-3", "PROTEIN", 229, 238], ["anti-Gr1", "PROTEIN", 360, 368], ["RB6\u00c08C5", "PROTEIN", 370, 377], ["rat IgG2b isotype", "PROTEIN", 384, 401], ["LTF", "PROTEIN", 411, 414], ["rat", "SPECIES", 384, 387], ["EcoHIV", "SPECIES", 302, 308], ["rat", "SPECIES", 384, 387], ["CD8", "TEST", 10, 13], ["apoptosis", "PROBLEM", 32, 41], ["MDSCs", "TEST", 43, 48], ["T cells", "PROBLEM", 76, 83], ["MDSC", "TEST", 104, 108], ["T cell ratios", "TEST", 118, 131], ["C incubator", "TREATMENT", 161, 172], ["active caspase", "TREATMENT", 222, 236], ["Myeloid cell depletion", "PROBLEM", 239, 261], ["EcoHIV", "TREATMENT", 302, 308], ["intraperitoneal injections", "TREATMENT", 320, 346], ["anti-Gr1 (RB6\u00c08C5)", "TREATMENT", 360, 378], ["a rat IgG2b isotype control", "TREATMENT", 382, 409], ["LTF", "TEST", 411, 414], ["Bio X Cell)", "TEST", 419, 430], ["MDSCs", "ANATOMY", 43, 48], ["cell depletion", "OBSERVATION", 247, 261]]], ["Blood, peritoneum macrophages and spleen were collected on day 14.Double immunofluorescence staining on paraffin sectionsThe samples were de-paraffinized and rehydrated, as previously described [34] .", [["Blood", "ANATOMY", 0, 5], ["peritoneum macrophages", "ANATOMY", 7, 29], ["spleen", "ANATOMY", 34, 40], ["sections", "ANATOMY", 113, 121], ["samples", "ANATOMY", 125, 132], ["paraffin", "CHEMICAL", 104, 112], ["Blood", "ORGANISM_SUBSTANCE", 0, 5], ["peritoneum macrophages", "CELL", 7, 29], ["spleen", "ORGAN", 34, 40], ["peritoneum macrophages", "CELL_TYPE", 7, 29], ["Blood, peritoneum macrophages", "TEST", 0, 29], ["Double immunofluorescence staining", "PROBLEM", 66, 100], ["paraffin sections", "TEST", 104, 121], ["The samples", "TEST", 121, 132], ["peritoneum", "ANATOMY", 7, 17], ["macrophages", "OBSERVATION", 18, 29], ["spleen", "ANATOMY", 34, 40]]], ["After 30 min blocking with normal goat serum at room temperature, samples were incubated with primary antibody at 4\u00b0C overnight, followed by an Alexa448/568/647-conjugated secondary antibody for 1 h at room temperature. primary antibodies used in this study include: p24 (DAKO, M085701\u00c01; 1/5 dilution); CD3 (DAKO, A0452; 1:50 dilution); Gr1 (Abcam); F4/80 (Biolegend, 123,102; 1/50 dilution).", [["serum", "ANATOMY", 39, 44], ["samples", "ANATOMY", 66, 73], ["Alexa448", "CHEMICAL", 144, 152], ["goat", "ORGANISM", 34, 38], ["serum", "ORGANISM_SUBSTANCE", 39, 44], ["Alexa448", "SIMPLE_CHEMICAL", 144, 152], ["p24", "GENE_OR_GENE_PRODUCT", 267, 270], ["DAKO", "GENE_OR_GENE_PRODUCT", 272, 276], ["CD3", "GENE_OR_GENE_PRODUCT", 304, 307], ["DAKO", "GENE_OR_GENE_PRODUCT", 309, 313], ["Abcam", "GENE_OR_GENE_PRODUCT", 343, 348], ["Alexa448/568/647-conjugated secondary antibody", "PROTEIN", 144, 190], ["primary antibodies", "PROTEIN", 220, 238], ["p24", "PROTEIN", 267, 270], ["CD3", "PROTEIN", 304, 307], ["A0452", "PROTEIN", 315, 320], ["Gr1", "PROTEIN", 338, 341], ["Abcam", "PROTEIN", 343, 348], ["goat", "SPECIES", 34, 38], ["goat", "SPECIES", 34, 38], ["primary antibody", "TEST", 94, 110], ["primary antibodies", "TEST", 220, 238], ["this study", "TEST", 247, 257]]], ["To differentiate between individual cells, samples were incubated with 1 mg/ml Hoechst 33,258 (Thermo Fisher Scientific) for 5 min at room temperature, followed by rinsing with water.Confocal microscopyA Carl Zeiss LSM 700 confocal microscope (Carl Zeiss, Oberkochen, Germany) was used to perform Confocal microscopy.", [["cells", "ANATOMY", 36, 41], ["samples", "ANATOMY", 43, 50], ["Hoechst 33,258", "CHEMICAL", 79, 93], ["Hoechst 33,258", "CHEMICAL", 79, 93], ["cells", "CELL", 36, 41], ["Hoechst 33,258", "SIMPLE_CHEMICAL", 79, 93], ["individual cells", "PROBLEM", 25, 41], ["Confocal microscopy", "TEST", 297, 316], ["individual cells", "OBSERVATION", 25, 41]]], ["ZEN (Zeiss) was used to assign colors, which were collected simultaneously: Alexa 568 (Thermo Fisher Scientific) and HNPP/Fast Red, which fluoresce red when excited by a 568-nm laser; Alexa 488 (Thermo Fisher Scientific), which fluoresces green when excited at 488 nm; Alexa 647 (Thermo Fisher Scientific), which fluoresces cyan when excited at 647 nm; and the differential interference contrast (DIC) image, which is in grayscale.Statistical analysisA two-tailed Student t-test was performed to determine statistical significance between different groups.", [["ZEN", "CHEMICAL", 0, 3], ["Alexa 568", "CHEMICAL", 76, 85], ["Alexa 488", "CHEMICAL", 184, 193], ["Alexa 647", "CHEMICAL", 269, 278], ["ZEN", "SIMPLE_CHEMICAL", 0, 3], ["Alexa 568", "SIMPLE_CHEMICAL", 76, 85], ["Alexa 488", "SIMPLE_CHEMICAL", 184, 193], ["Alexa 488", "PROTEIN", 184, 193], ["Alexa 647", "PROTEIN", 269, 278], ["HNPP", "PROBLEM", 117, 121], ["the differential interference contrast (DIC) image", "TEST", 357, 407], ["Student t-test", "TEST", 464, 478]]], ["An additional test using the Bonferroni-Holms method was performed when multiple comparisons being made.", [["An additional test", "TEST", 0, 18], ["the Bonferroni-Holms method", "TREATMENT", 25, 52]]], ["P-value of less than 0.05 was considered to be statistically significant.", [["P-value", "TEST", 0, 7]]], ["Data are presented as the mean values \u00a7 standard error (s.e.m.).Study approvalAll experimental procedures were approved by the University of Hong Kong Committee on the Use of Live Animals in Teaching and Research (CULATR 3638\u00c015).EcoHIV established persistent infection and induced immune suppression in immune competent miceEcoHIV is a chimeric HIV strain that have been modified to infect mice by replacing HIV env (1405 bp) with the coding region of the ecotropic envelope gp80 of ecotropic murine leukemia virus (MLV) in the backbone of HIV-1 clade B (Fig. 1a) .", [["EcoHIV", "CHEMICAL", 230, 236], ["infection", "DISEASE", 260, 269], ["ecotropic murine leukemia virus", "DISEASE", 484, 515], ["miceEcoHIV", "ORGANISM", 321, 331], ["HIV", "ORGANISM", 346, 349], ["mice", "ORGANISM", 391, 395], ["HIV", "ORGANISM", 409, 412], ["ecotropic envelope gp80", "ORGANISM", 457, 480], ["ecotropic murine leukemia virus", "ORGANISM", 484, 515], ["MLV", "ORGANISM", 517, 520], ["HIV-1 clade B", "ORGANISM", 541, 554], ["Fig. 1a", "ORGANISM", 556, 563], ["HIV env", "DNA", 409, 416], ["ecotropic envelope gp80", "PROTEIN", 457, 480], ["HIV", "SPECIES", 346, 349], ["mice", "SPECIES", 391, 395], ["HIV", "SPECIES", 409, 412], ["murine", "SPECIES", 494, 500], ["leukemia virus", "SPECIES", 501, 515], ["HIV-1", "SPECIES", 541, 546], ["EcoHIV", "SPECIES", 230, 236], ["miceEcoHIV", "SPECIES", 321, 331], ["HIV", "SPECIES", 346, 349], ["mice", "SPECIES", 391, 395], ["HIV", "SPECIES", 409, 412], ["murine leukemia virus", "SPECIES", 494, 515], ["MLV", "SPECIES", 517, 520], ["HIV-1", "SPECIES", 541, 546], ["the mean values", "TEST", 22, 37], ["Study approval", "TEST", 64, 78], ["All experimental procedures", "TREATMENT", 78, 105], ["EcoHIV", "TREATMENT", 230, 236], ["persistent infection", "PROBLEM", 249, 269], ["induced immune suppression", "PROBLEM", 274, 300], ["a chimeric HIV strain", "PROBLEM", 335, 356], ["bp", "TEST", 423, 425], ["ecotropic murine leukemia virus", "PROBLEM", 484, 515], ["persistent", "OBSERVATION_MODIFIER", 249, 259], ["infection", "OBSERVATION", 260, 269], ["immune suppression", "OBSERVATION", 282, 300], ["ecotropic envelope", "OBSERVATION", 457, 475], ["ecotropic murine leukemia virus", "OBSERVATION", 484, 515]]], ["All HIV-1 cis-regulatory elements were preserved, and expression of the entire construct was driven by the HIV-1 LTR.", [["LTR", "ANATOMY", 113, 116], ["HIV-1", "ORGANISM", 4, 9], ["HIV-1", "ORGANISM", 107, 112], ["LTR", "ORGANISM", 113, 116], ["HIV-1 cis-regulatory elements", "DNA", 4, 33], ["HIV-1 LTR", "DNA", 107, 116], ["HIV-1", "SPECIES", 4, 9], ["HIV-1", "SPECIES", 107, 112], ["HIV-1", "SPECIES", 4, 9], ["HIV-1", "SPECIES", 107, 112]]], ["It is capable to infect, replicate and persist in macrophages and CD4+ T cells of infected mice [30, 31] , and has been used in several HIV-1 vaccine and therapeutic studies [30, 33, 35, 36] .", [["macrophages", "ANATOMY", 50, 61], ["CD4+ T cells", "ANATOMY", 66, 78], ["macrophages", "CELL", 50, 61], ["CD4", "GENE_OR_GENE_PRODUCT", 66, 69], ["mice", "ORGANISM", 91, 95], ["HIV-1", "ORGANISM", 136, 141], ["macrophages", "CELL_TYPE", 50, 61], ["CD4+ T cells", "CELL_TYPE", 66, 78], ["mice", "SPECIES", 91, 95], ["HIV-1", "SPECIES", 136, 141], ["mice", "SPECIES", 91, 95], ["HIV-1", "SPECIES", 136, 141], ["therapeutic studies", "TEST", 154, 173]]], ["To study if EcoHIV infection leads to an immunosuppressive environment, we injected a group of BALB/c mice with 400 ng p24 EcoHIV intraperitoneally (i.p.), performed kinetic analysis of proviral load in blood for up to 12 weeks, and measured expression of the inhibitory molecules PD-1 and Tim3 on T cells, as well as numbers of Treg cells and MDSCs in the lymph node or spleen at 12 weeks post infection (wpi).", [["blood", "ANATOMY", 203, 208], ["T cells", "ANATOMY", 298, 305], ["Treg cells", "ANATOMY", 329, 339], ["MDSCs", "ANATOMY", 344, 349], ["lymph node", "ANATOMY", 357, 367], ["spleen", "ANATOMY", 371, 377], ["infection", "DISEASE", 19, 28], ["EcoHIV", "CHEMICAL", 123, 129], ["infection", "DISEASE", 395, 404], ["BALB/c mice", "ORGANISM", 95, 106], ["p24", "ORGANISM", 119, 122], ["blood", "ORGANISM_SUBSTANCE", 203, 208], ["PD-1", "GENE_OR_GENE_PRODUCT", 281, 285], ["Tim3", "GENE_OR_GENE_PRODUCT", 290, 294], ["T cells", "CELL", 298, 305], ["Treg cells", "CELL", 329, 339], ["MDSCs", "CELL", 344, 349], ["lymph node", "MULTI-TISSUE_STRUCTURE", 357, 367], ["spleen", "ORGAN", 371, 377], ["p24 EcoHIV", "PROTEIN", 119, 129], ["inhibitory molecules", "PROTEIN", 260, 280], ["PD-1", "PROTEIN", 281, 285], ["Tim3", "PROTEIN", 290, 294], ["T cells", "CELL_TYPE", 298, 305], ["Treg cells", "CELL_TYPE", 329, 339], ["MDSCs", "CELL_TYPE", 344, 349], ["mice", "SPECIES", 102, 106], ["EcoHIV", "SPECIES", 12, 18], ["mice", "SPECIES", 102, 106], ["EcoHIV infection", "PROBLEM", 12, 28], ["an immunosuppressive environment", "TREATMENT", 38, 70], ["a group of BALB/c mice", "TREATMENT", 84, 106], ["kinetic analysis", "TEST", 166, 182], ["proviral load", "PROBLEM", 186, 199], ["the inhibitory molecules PD", "TEST", 256, 283], ["Tim3 on T cells", "PROBLEM", 290, 305], ["Treg cells", "TREATMENT", 329, 339], ["MDSCs in the lymph node", "PROBLEM", 344, 367], ["infection", "PROBLEM", 395, 404], ["infection", "OBSERVATION", 19, 28], ["proviral load", "OBSERVATION", 186, 199], ["Treg cells", "OBSERVATION", 329, 339], ["MDSCs", "OBSERVATION", 344, 349], ["lymph node", "OBSERVATION", 357, 367], ["spleen", "ANATOMY", 371, 377], ["infection", "OBSERVATION", 395, 404]]], ["Successful establishment of persistent infection was consistently confirmed by the presence of provirus in PBMCs, measured every 1 or 2 weeks for 12 weeks (Fig. 1b and 1c) .", [["PBMCs", "ANATOMY", 107, 112], ["infection", "DISEASE", 39, 48], ["provirus", "ORGANISM", 95, 103], ["PBMCs", "CELL", 107, 112], ["PBMCs", "CELL_TYPE", 107, 112], ["persistent infection", "PROBLEM", 28, 48], ["provirus in PBMCs", "TREATMENT", 95, 112], ["persistent", "OBSERVATION_MODIFIER", 28, 38], ["infection", "OBSERVATION", 39, 48], ["provirus", "OBSERVATION", 95, 103]]], ["At week 12, mice were sacrificed, and provirus copies were detectable in spleen and peritoneal macrophages from all mice tested (Fig. 1d ).", [["spleen", "ANATOMY", 73, 79], ["peritoneal macrophages", "ANATOMY", 84, 106], ["mice", "ORGANISM", 12, 16], ["provirus", "ORGANISM", 38, 46], ["spleen", "ORGAN", 73, 79], ["peritoneal macrophages", "CELL", 84, 106], ["mice", "ORGANISM", 116, 120], ["peritoneal macrophages", "CELL_TYPE", 84, 106], ["mice", "SPECIES", 12, 16], ["mice", "SPECIES", 116, 120], ["mice", "SPECIES", 12, 16], ["mice", "SPECIES", 116, 120], ["provirus copies", "TEST", 38, 53], ["spleen", "ANATOMY", 73, 79], ["peritoneal", "ANATOMY", 84, 94], ["macrophages", "OBSERVATION", 95, 106]]], ["Viral replication was determined by detection of viral protein p24 in spleens of EcoHIV-infected mice by immunohistochemistry (IHC) staining using an anti-p24 antibody (Fig. 1e) .", [["spleens", "ANATOMY", 70, 77], ["Viral", "ORGANISM", 0, 5], ["p24", "GENE_OR_GENE_PRODUCT", 63, 66], ["spleens", "ORGAN", 70, 77], ["EcoHIV", "GENE_OR_GENE_PRODUCT", 81, 87], ["mice", "ORGANISM", 97, 101], ["anti-p24", "GENE_OR_GENE_PRODUCT", 150, 158], ["viral protein p24", "PROTEIN", 49, 66], ["anti-p24 antibody", "PROTEIN", 150, 167], ["mice", "SPECIES", 97, 101], ["EcoHIV", "SPECIES", 81, 87], ["mice", "SPECIES", 97, 101], ["Viral replication", "PROBLEM", 0, 17], ["viral protein p24", "TEST", 49, 66], ["EcoHIV", "TEST", 81, 87], ["an anti-p24 antibody", "TEST", 147, 167], ["spleens", "ANATOMY", 70, 77]]], ["Persistent infection induced a p24specific CD8 + T cell response, and up to 1.06% and 1.53% of CD8 + T cells in lymph nodes and spleens, respectively, were positive for H2-Kd-GAG A-I tetramer binding ( Fig. 1f and Fig. S1 ).EcoHIV established persistent infection and induced immune suppression in immune competent miceWe then investigated whether EcoHIV induced immunosuppression at week 12 by measuring proportions of CD4 + and CD8 + T cells, HIV-1 env (1405 bp) was replaced by the coding region of the ecotropic envelope gp80 of MLV.", [["p24specific CD8 + T cell", "ANATOMY", 31, 55], ["CD8 + T cells", "ANATOMY", 95, 108], ["lymph nodes", "ANATOMY", 112, 123], ["spleens", "ANATOMY", 128, 135], ["CD4 + and CD8 + T cells", "ANATOMY", 420, 443], ["infection", "DISEASE", 11, 20], ["EcoHIV", "CHEMICAL", 224, 230], ["infection", "DISEASE", 254, 263], ["EcoHIV", "CHEMICAL", 348, 354], ["CD8", "GENE_OR_GENE_PRODUCT", 43, 46], ["CD8", "GENE_OR_GENE_PRODUCT", 95, 98], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 112, 123], ["spleens", "ORGAN", 128, 135], ["H2-Kd-GAG A-I tetramer", "GENE_OR_GENE_PRODUCT", 169, 191], ["S1", "GENE_OR_GENE_PRODUCT", 219, 221], ["EcoHIV", "SIMPLE_CHEMICAL", 348, 354], ["CD4", "GENE_OR_GENE_PRODUCT", 420, 423], ["CD8", "GENE_OR_GENE_PRODUCT", 430, 433], ["HIV-1", "ORGANISM", 445, 450], ["gp80", "GENE_OR_GENE_PRODUCT", 525, 529], ["MLV", "ORGANISM", 533, 536], ["CD8", "PROTEIN", 43, 46], ["CD8 + T cells", "CELL_TYPE", 95, 108], ["Kd-GAG A", "PROTEIN", 172, 180], ["I tetramer", "PROTEIN", 181, 191], ["S1", "PROTEIN", 219, 221], ["EcoHIV", "PROTEIN", 348, 354], ["CD4", "PROTEIN", 420, 423], ["CD8", "PROTEIN", 430, 433], ["T cells", "CELL_TYPE", 436, 443], ["HIV-1 env", "DNA", 445, 454], ["ecotropic envelope gp80", "PROTEIN", 506, 529], ["HIV-1", "SPECIES", 445, 450], ["EcoHIV", "SPECIES", 224, 230], ["HIV-1", "SPECIES", 445, 450], ["Persistent infection", "PROBLEM", 0, 20], ["a p24specific CD8", "TEST", 29, 46], ["CD8", "TEST", 95, 98], ["lymph nodes", "TEST", 112, 123], ["spleens", "TEST", 128, 135], ["H2-", "TEST", 169, 172], ["EcoHIV", "TREATMENT", 224, 230], ["persistent infection", "PROBLEM", 243, 263], ["induced immune suppression", "PROBLEM", 268, 294], ["EcoHIV induced immunosuppression", "TREATMENT", 348, 380], ["CD4", "TEST", 420, 423], ["CD8 + T cells", "PROBLEM", 430, 443], ["HIV", "TEST", 445, 448], ["bp", "TEST", 461, 463], ["infection", "OBSERVATION", 11, 20], ["T cell response", "OBSERVATION", 49, 64], ["lymph nodes", "OBSERVATION", 112, 123], ["spleens", "ANATOMY", 128, 135], ["persistent", "OBSERVATION_MODIFIER", 243, 253], ["infection", "OBSERVATION", 254, 263], ["immune suppression", "OBSERVATION", 276, 294], ["ecotropic envelope", "OBSERVATION", 506, 524]]], ["All HIV-1 cis-regulatory elements were preserved, and expression of the entire construct was driven by the HIV-1 LTR. b.", [["LTR", "ANATOMY", 113, 116], ["HIV-1", "ORGANISM", 4, 9], ["HIV-1", "ORGANISM", 107, 112], ["LTR", "ORGANISM", 113, 116], ["HIV-1 cis-regulatory elements", "DNA", 4, 33], ["HIV-1 LTR", "DNA", 107, 116], ["HIV-1", "SPECIES", 4, 9], ["HIV-1", "SPECIES", 107, 112], ["HIV-1", "SPECIES", 4, 9], ["HIV-1", "SPECIES", 107, 112]]], ["Mice were inoculated once with EcoHIV, after which blood was collected every 7 to 14 days.", [["blood", "ANATOMY", 51, 56], ["Mice", "ORGANISM", 0, 4], ["blood", "ORGANISM_SUBSTANCE", 51, 56], ["Mice", "SPECIES", 0, 4], ["Mice", "SPECIES", 0, 4], ["EcoHIV", "SPECIES", 31, 37], ["EcoHIV", "TREATMENT", 31, 37]]], ["Mice were sacrificed at 84 days post-infection (dpi). c.", [["infection", "DISEASE", 37, 46], ["Mice", "ORGANISM", 0, 4], ["Mice", "SPECIES", 0, 4], ["infection", "PROBLEM", 37, 46], ["infection", "OBSERVATION", 37, 46]]], ["Viral burden in the blood after EcoHIV infection. d.", [["blood", "ANATOMY", 20, 25], ["infection", "DISEASE", 39, 48], ["Viral", "ORGANISM", 0, 5], ["blood", "ORGANISM_SUBSTANCE", 20, 25], ["EcoHIV", "SPECIES", 32, 38], ["Viral burden in the blood", "PROBLEM", 0, 25], ["EcoHIV infection", "PROBLEM", 32, 48], ["burden", "OBSERVATION", 6, 12], ["blood", "ANATOMY", 20, 25], ["infection", "OBSERVATION", 39, 48]]], ["Comparison of viral burden in splenocytes (SPL) and peritoneal macrophages (Per) at 84 dpi.", [["splenocytes", "ANATOMY", 30, 41], ["SPL", "ANATOMY", 43, 46], ["peritoneal macrophages", "ANATOMY", 52, 74], ["splenocytes", "CELL", 30, 41], ["SPL", "CELL", 43, 46], ["peritoneal macrophages", "CELL", 52, 74], ["Per", "GENE_OR_GENE_PRODUCT", 76, 79], ["splenocytes", "CELL_TYPE", 30, 41], ["SPL", "CELL_TYPE", 43, 46], ["peritoneal macrophages", "CELL_TYPE", 52, 74], ["viral burden in splenocytes (SPL) and peritoneal macrophages", "PROBLEM", 14, 74], ["viral burden", "OBSERVATION", 14, 26], ["splenocytes", "ANATOMY", 30, 41], ["peritoneal", "ANATOMY", 52, 62], ["macrophages", "OBSERVATION", 63, 74]]], ["Viral burdens were determined by qPCR, with data normalized based on cellular b-globin levels. e.", [["cellular", "ANATOMY", 69, 77], ["Viral", "ORGANISM", 0, 5], ["cellular", "CELL", 69, 77], ["Viral burdens", "PROBLEM", 0, 13], ["qPCR", "TEST", 33, 37], ["cellular b-globin levels", "TEST", 69, 93]]], ["Distribution of p24 + (red) cells in spleens at 84 dpi based on immunohistochemistry (IHC) in healthy control (left) and EcoHIV-infected (right) mice. f.", [["p24 + (red) cells", "ANATOMY", 16, 33], ["spleens", "ANATOMY", 37, 44], ["left", "ANATOMY", 111, 115], ["p24", "GENE_OR_GENE_PRODUCT", 16, 19], ["spleens", "ORGAN", 37, 44], ["EcoHIV", "GENE_OR_GENE_PRODUCT", 121, 127], ["mice", "ORGANISM", 145, 149], ["p24 + (red) cells", "CELL_TYPE", 16, 33], ["mice", "SPECIES", 145, 149], ["mice", "SPECIES", 145, 149], ["f.", "SPECIES", 151, 153], ["p24 + (red) cells in spleens", "PROBLEM", 16, 44], ["immunohistochemistry", "TEST", 64, 84], ["EcoHIV", "TEST", 121, 127], ["p24 +", "OBSERVATION", 16, 21], ["spleens", "ANATOMY", 37, 44], ["left", "ANATOMY_MODIFIER", 111, 115], ["infected", "OBSERVATION", 128, 136], ["right", "ANATOMY_MODIFIER", 138, 143]]], ["Similar levels of p24-specific CD8 + T cell responses were detected in the lymph node (LNs) and spleen (SPL) based on H2-Kd-GAG A-I tetramer staining. g.", [["CD8 + T cell", "ANATOMY", 31, 43], ["lymph node", "ANATOMY", 75, 85], ["LNs", "ANATOMY", 87, 90], ["spleen", "ANATOMY", 96, 102], ["p24", "GENE_OR_GENE_PRODUCT", 18, 21], ["CD8", "GENE_OR_GENE_PRODUCT", 31, 34], ["lymph node", "MULTI-TISSUE_STRUCTURE", 75, 85], ["LNs", "MULTI-TISSUE_STRUCTURE", 87, 90], ["spleen", "ORGAN", 96, 102], ["H2-Kd-GAG A-I tetramer", "GENE_OR_GENE_PRODUCT", 118, 140], ["p24", "PROTEIN", 18, 21], ["CD8", "PROTEIN", 31, 34], ["p24", "TEST", 18, 21], ["T cell responses", "TEST", 37, 53], ["lymph node", "OBSERVATION", 75, 85], ["spleen", "ANATOMY", 96, 102], ["SPL", "ANATOMY", 104, 107], ["tetramer staining", "OBSERVATION", 132, 149]]], ["Percentage of PD-1-(left) and Tim3-(right) expressing CD8 + T cells in the spleen at 84 dpi based on flow cytometry analysis. h.", [["left", "ANATOMY", 20, 24], ["Tim3-(right) expressing CD8 + T cells", "ANATOMY", 30, 67], ["spleen", "ANATOMY", 75, 81], ["PD-1", "GENE_OR_GENE_PRODUCT", 14, 18], ["Tim3", "GENE_OR_GENE_PRODUCT", 30, 34], ["CD8", "GENE_OR_GENE_PRODUCT", 54, 57], ["spleen", "ORGAN", 75, 81], ["Tim3", "PROTEIN", 30, 34], ["CD8", "PROTEIN", 54, 57], ["T cells", "CELL_TYPE", 60, 67], ["Percentage", "TEST", 0, 10], ["PD", "TEST", 14, 16], ["Tim3", "TEST", 30, 34], ["T cells in the spleen", "PROBLEM", 60, 81], ["flow cytometry analysis", "TEST", 101, 124], ["left", "ANATOMY_MODIFIER", 20, 24], ["right", "ANATOMY_MODIFIER", 36, 41], ["T cells", "OBSERVATION", 60, 67], ["spleen", "ANATOMY", 75, 81], ["flow cytometry", "OBSERVATION", 101, 115]]], ["Percentage of regulatory CD4 + T cells (Treg) in lymph nodes (left) and MDSC in spleen (right) were determined at 84 dpi by flow cytometry analysis. i.", [["CD4 + T cells", "ANATOMY", 25, 38], ["Treg", "ANATOMY", 40, 44], ["lymph nodes", "ANATOMY", 49, 60], ["left", "ANATOMY", 62, 66], ["MDSC", "ANATOMY", 72, 76], ["spleen", "ANATOMY", 80, 86], ["right", "ANATOMY", 88, 93], ["CD4", "GENE_OR_GENE_PRODUCT", 25, 28], ["Treg", "CELL", 40, 44], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 49, 60], ["MDSC", "CELL", 72, 76], ["spleen", "ORGAN", 80, 86], ["right", "ORGAN", 88, 93], ["regulatory CD4 + T cells", "CELL_TYPE", 14, 38], ["Treg", "CELL_TYPE", 40, 44], ["MDSC", "CELL_TYPE", 72, 76], ["Percentage", "TEST", 0, 10], ["lymph nodes", "TEST", 49, 60], ["flow cytometry analysis", "TEST", 124, 147], ["CD4 + T cells", "OBSERVATION", 25, 38], ["lymph nodes", "OBSERVATION", 49, 60], ["left", "ANATOMY_MODIFIER", 62, 66], ["MDSC", "ANATOMY", 72, 76], ["spleen", "ANATOMY", 80, 86], ["right", "ANATOMY_MODIFIER", 88, 93], ["flow cytometry", "OBSERVATION", 124, 138]]], ["IHC shows T lymphopenia in EcoHIV-infected spleens compared to healthy controls at 84 dpi.", [["spleens", "ANATOMY", 43, 50], ["lymphopenia", "DISEASE", 12, 23], ["T", "GENE_OR_GENE_PRODUCT", 10, 11], ["EcoHIV", "GENE_OR_GENE_PRODUCT", 27, 33], ["spleens", "ORGAN", 43, 50], ["IHC", "TEST", 0, 3], ["T lymphopenia in EcoHIV", "PROBLEM", 10, 33], ["infected spleens", "PROBLEM", 34, 50], ["T lymphopenia", "OBSERVATION", 10, 23], ["infected", "OBSERVATION_MODIFIER", 34, 42], ["spleens", "ANATOMY", 43, 50]]], ["Data represent three independent experiments with three mice per group and with error bars representing the SEM.", [["mice", "ORGANISM", 56, 60], ["mice", "SPECIES", 56, 60], ["mice", "SPECIES", 56, 60]]], ["A two-tailed Student t-test was used to determine statistical significance between different groups.", [["Student t-test", "TEST", 13, 27]]], ["Treg cells (CD4 + CD25 + Foxp3 + ) and MDSCs (CD11b + Gr-1 + ) and expression of PD-1 and Tim-3 on CD8 + T cells in mouse lymph nodes and spleens.", [["Treg cells", "ANATOMY", 0, 10], ["CD4 + CD25 + Foxp3 + )", "ANATOMY", 12, 34], ["MDSCs", "ANATOMY", 39, 44], ["CD11b + Gr-1 +", "ANATOMY", 46, 60], ["CD8 + T cells", "ANATOMY", 99, 112], ["lymph nodes", "ANATOMY", 122, 133], ["spleens", "ANATOMY", 138, 145], ["Treg cells", "CELL", 0, 10], ["CD4", "GENE_OR_GENE_PRODUCT", 12, 15], ["CD25", "GENE_OR_GENE_PRODUCT", 18, 22], ["Foxp3", "GENE_OR_GENE_PRODUCT", 25, 30], ["MDSCs", "CELL", 39, 44], ["CD11b", "GENE_OR_GENE_PRODUCT", 46, 51], ["Gr-1", "GENE_OR_GENE_PRODUCT", 54, 58], ["PD-1", "GENE_OR_GENE_PRODUCT", 81, 85], ["Tim-3", "GENE_OR_GENE_PRODUCT", 90, 95], ["CD8", "GENE_OR_GENE_PRODUCT", 99, 102], ["mouse", "ORGANISM", 116, 121], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 122, 133], ["spleens", "ORGAN", 138, 145], ["Treg cells", "CELL_TYPE", 0, 10], ["CD4", "PROTEIN", 12, 15], ["CD25", "PROTEIN", 18, 22], ["Foxp3", "PROTEIN", 25, 30], ["MDSCs", "CELL_TYPE", 39, 44], ["CD11b", "PROTEIN", 46, 51], ["Gr", "PROTEIN", 54, 56], ["Tim", "PROTEIN", 90, 93], ["CD8", "PROTEIN", 99, 102], ["T cells", "CELL_TYPE", 105, 112], ["mouse", "SPECIES", 116, 121], ["mouse", "SPECIES", 116, 121], ["Treg cells", "TEST", 0, 10], ["CD4", "TEST", 12, 15], ["CD25", "TEST", 18, 22], ["Foxp3", "TEST", 25, 30], ["MDSCs", "TEST", 39, 44], ["CD11", "TEST", 46, 50], ["Gr", "TEST", 54, 56], ["PD", "TEST", 81, 83], ["Tim", "TEST", 90, 93], ["CD8", "TEST", 99, 102], ["MDSCs", "ANATOMY", 39, 44], ["lymph nodes", "OBSERVATION", 122, 133], ["spleens", "ANATOMY", 138, 145]]], ["We did not observe significant decrease of frequencies of the CD4 + or CD8 + T cells.", [["CD4 +", "ANATOMY", 62, 67], ["CD8 + T cells", "ANATOMY", 71, 84], ["CD4", "GENE_OR_GENE_PRODUCT", 62, 65], ["CD8", "GENE_OR_GENE_PRODUCT", 71, 74], ["CD4", "PROTEIN", 62, 65], ["CD8 + T cells", "CELL_TYPE", 71, 84], ["significant decrease of frequencies", "PROBLEM", 19, 54], ["the CD4", "TEST", 58, 65], ["CD8 + T cells", "PROBLEM", 71, 84]]], ["However, EcoHIV infection led to up-regulation of PD-1 and Tim-3 on CD8 + T cells (Fig. 1g) , and expansion of MDSCs in the spleen and Treg cells in the lymph nodes ( Fig. 1h and Fig. S1 ).", [["CD8 + T cells", "ANATOMY", 68, 81], ["MDSCs", "ANATOMY", 111, 116], ["spleen", "ANATOMY", 124, 130], ["Treg cells", "ANATOMY", 135, 145], ["lymph nodes", "ANATOMY", 153, 164], ["EcoHIV", "CHEMICAL", 9, 15], ["infection", "DISEASE", 16, 25], ["PD-1", "GENE_OR_GENE_PRODUCT", 50, 54], ["Tim-3", "GENE_OR_GENE_PRODUCT", 59, 64], ["CD8", "GENE_OR_GENE_PRODUCT", 68, 71], ["MDSCs", "CELL", 111, 116], ["spleen", "ORGAN", 124, 130], ["Treg cells", "CELL", 135, 145], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 153, 164], ["S1", "GENE_OR_GENE_PRODUCT", 184, 186], ["PD-1", "PROTEIN", 50, 54], ["Tim-3", "PROTEIN", 59, 64], ["CD8", "PROTEIN", 68, 71], ["T cells", "CELL_TYPE", 74, 81], ["MDSCs", "CELL_TYPE", 111, 116], ["Treg cells", "CELL_TYPE", 135, 145], ["S1", "PROTEIN", 184, 186], ["EcoHIV infection", "PROBLEM", 9, 25], ["PD", "TEST", 50, 52], ["Tim", "TEST", 59, 62], ["CD8", "TEST", 68, 71], ["T cells", "PROBLEM", 74, 81], ["Fig.", "TEST", 83, 87], ["expansion of MDSCs in the spleen", "PROBLEM", 98, 130], ["infection", "OBSERVATION", 16, 25], ["expansion", "OBSERVATION_MODIFIER", 98, 107], ["MDSCs", "OBSERVATION", 111, 116], ["spleen", "ANATOMY", 124, 130], ["Treg cells", "OBSERVATION", 135, 145], ["lymph nodes", "OBSERVATION", 153, 164]]], ["Lymphoid architecture is integral to induction and maintenance of immune responses, and EcoHIV infection resulted in slight splenic disorganization at 12 wpi, with a higher proportion of F4/80 + myeloid cells and a corresponding loss of T cells (Fig. 1i) , consistent with previous reports of other chronic infection, such as lymphocytic choriomeningitis virus (LCMV) [24] .", [["Lymphoid", "ANATOMY", 0, 8], ["splenic", "ANATOMY", 124, 131], ["F4/80 + myeloid cells", "ANATOMY", 187, 208], ["T cells", "ANATOMY", 237, 244], ["infection", "DISEASE", 95, 104], ["chronic infection", "DISEASE", 299, 316], ["lymphocytic choriomeningitis virus", "DISEASE", 326, 360], ["Lymphoid architecture", "MULTI-TISSUE_STRUCTURE", 0, 21], ["splenic", "ORGAN", 124, 131], ["F4/80", "CELL", 187, 192], ["myeloid cells", "CELL", 195, 208], ["T cells", "CELL", 237, 244], ["lymphocytic choriomeningitis virus", "ORGANISM", 326, 360], ["LCMV", "ORGANISM", 362, 366], ["myeloid cells", "CELL_TYPE", 195, 208], ["T cells", "CELL_TYPE", 237, 244], ["lymphocytic choriomeningitis virus", "SPECIES", 326, 360], ["EcoHIV", "SPECIES", 88, 94], ["lymphocytic choriomeningitis virus", "SPECIES", 326, 360], ["LCMV", "SPECIES", 362, 366], ["Lymphoid architecture", "PROBLEM", 0, 21], ["immune responses", "PROBLEM", 66, 82], ["EcoHIV infection", "PROBLEM", 88, 104], ["slight splenic disorganization", "PROBLEM", 117, 147], ["myeloid cells", "PROBLEM", 195, 208], ["a corresponding loss of T cells", "PROBLEM", 213, 244], ["other chronic infection", "PROBLEM", 293, 316], ["lymphocytic choriomeningitis virus", "PROBLEM", 326, 360], ["infection", "OBSERVATION", 95, 104], ["slight", "OBSERVATION_MODIFIER", 117, 123], ["splenic", "ANATOMY", 124, 131], ["disorganization", "OBSERVATION", 132, 147], ["myeloid cells", "OBSERVATION", 195, 208], ["loss", "OBSERVATION_MODIFIER", 229, 233], ["consistent with", "UNCERTAINTY", 257, 272], ["chronic", "OBSERVATION_MODIFIER", 299, 306], ["infection", "OBSERVATION", 307, 316], ["lymphocytic choriomeningitis", "OBSERVATION", 326, 354]]], ["These results suggest that although EcoHIV does not induce canonical immunosuppression as shown in patients with AIDS with significant loss of CD4 T-cells, it establishes persistent infection and induces immune suppression in chronically infected mice.Prophylactic vaccination-mediated virus clearance was restrained by day 7After establishing the EcoHIV model, we aimed to study the role of memory CD8 + T cell recall responses in prevention of persistent infection.", [["CD4 T-cells", "ANATOMY", 143, 154], ["memory CD8 + T cell", "ANATOMY", 392, 411], ["AIDS", "DISEASE", 113, 117], ["infection", "DISEASE", 182, 191], ["chronically infected", "DISEASE", 226, 246], ["infection", "DISEASE", 457, 466], ["EcoHIV", "ORGANISM", 36, 42], ["patients", "ORGANISM", 99, 107], ["CD4", "GENE_OR_GENE_PRODUCT", 143, 146], ["mice", "ORGANISM", 247, 251], ["virus", "ORGANISM", 286, 291], ["CD8", "GENE_OR_GENE_PRODUCT", 399, 402], ["CD4 T-cells", "CELL_TYPE", 143, 154], ["CD8", "PROTEIN", 399, 402], ["patients", "SPECIES", 99, 107], ["mice", "SPECIES", 247, 251], ["HIV", "SPECIES", 39, 42], ["mice", "SPECIES", 247, 251], ["EcoHIV", "PROBLEM", 36, 42], ["canonical immunosuppression", "TREATMENT", 59, 86], ["AIDS", "PROBLEM", 113, 117], ["significant loss of CD4 T-cells", "PROBLEM", 123, 154], ["persistent infection", "PROBLEM", 171, 191], ["immune suppression", "PROBLEM", 204, 222], ["Prophylactic vaccination-mediated virus clearance", "TREATMENT", 252, 301], ["persistent infection", "PROBLEM", 446, 466], ["persistent", "OBSERVATION_MODIFIER", 171, 181], ["infection", "OBSERVATION", 182, 191], ["immune suppression", "OBSERVATION", 204, 222], ["chronically", "OBSERVATION_MODIFIER", 226, 237], ["infected", "OBSERVATION", 238, 246], ["persistent", "OBSERVATION_MODIFIER", 446, 456], ["infection", "OBSERVATION", 457, 466]]], ["For this purpose, we used the sPD1-p24 fc /EP DNA vaccine [29] .", [["sPD1", "GENE_OR_GENE_PRODUCT", 30, 34], ["sPD1", "PROTEIN", 30, 34], ["p24 fc", "PROTEIN", 35, 41], ["the sPD1-p24 fc /EP DNA vaccine", "TREATMENT", 26, 57]]], ["This vaccine exploits the binding of PD-1 to ligands expressed on DCs by fusing soluble PD-1 with HIV-1 GAG p24 antigen.", [["DCs", "ANATOMY", 66, 69], ["PD-1", "GENE_OR_GENE_PRODUCT", 37, 41], ["DCs", "CELL", 66, 69], ["PD-1", "GENE_OR_GENE_PRODUCT", 88, 92], ["HIV-1", "ORGANISM", 98, 103], ["GAG p24 antigen", "GENE_OR_GENE_PRODUCT", 104, 119], ["DCs", "CELL_TYPE", 66, 69], ["HIV-1 GAG p24 antigen", "PROTEIN", 98, 119], ["HIV-1", "SPECIES", 98, 103], ["HIV-1", "SPECIES", 98, 103], ["This vaccine", "TREATMENT", 0, 12], ["fusing soluble PD", "TEST", 73, 90], ["HIV", "TEST", 98, 101]]], ["In previous studies, this vaccine consistently elicited up to 21.2% of p24 tetramer-positive CD8 + T cells in the spleen, with broad reactivity, polyfunctionality and cytotoxicity [29] .", [["CD8 + T cells", "ANATOMY", 93, 106], ["spleen", "ANATOMY", 114, 120], ["p24", "GENE_OR_GENE_PRODUCT", 71, 74], ["CD8", "GENE_OR_GENE_PRODUCT", 93, 96], ["spleen", "ORGAN", 114, 120], ["p24 tetramer", "PROTEIN", 71, 83], ["positive CD8 + T cells", "CELL_TYPE", 84, 106], ["previous studies", "TEST", 3, 19], ["this vaccine", "TEST", 21, 33], ["p24 tetramer", "TEST", 71, 83], ["T cells in the spleen", "PROBLEM", 99, 120], ["broad reactivity", "PROBLEM", 127, 143], ["polyfunctionality", "PROBLEM", 145, 162], ["cytotoxicity", "TEST", 167, 179], ["T cells", "OBSERVATION", 99, 106], ["spleen", "ANATOMY", 114, 120], ["broad reactivity", "OBSERVATION_MODIFIER", 127, 143]]], ["We also included a non-DC-targeting vaccine, p24 fc /EP, as a control.", [["p24", "ORGANISM", 45, 48], ["p24 fc", "PROTEIN", 45, 51], ["EP", "PROTEIN", 53, 55], ["a non-DC-targeting vaccine", "TREATMENT", 17, 43], ["EP", "TREATMENT", 53, 55]]], ["Using the same immunization schedule from that work, we immunized groups of BALB/c mice (n = 5) with 100 mg DNA intramuscularly via electroporation (EP) three times at 3-week intervals (Fig. 2a) .", [["BALB/c mice", "ORGANISM", 76, 87], ["DNA", "CELLULAR_COMPONENT", 108, 111], ["mice", "SPECIES", 83, 87], ["mice", "SPECIES", 83, 87], ["the same immunization schedule", "TREATMENT", 6, 36], ["BALB/c mice (n", "TREATMENT", 76, 90]]], ["T cell responses to vaccination were measured at 2 weeks after the final vaccination.", [["T cell", "ANATOMY", 0, 6], ["T cell", "CELL", 0, 6], ["vaccination", "TEST", 20, 31], ["the final vaccination", "TREATMENT", 63, 84]]], ["Subsequently, mice were challenged EcoHIV infection.", [["EcoHIV", "CHEMICAL", 35, 41], ["infection", "DISEASE", 42, 51], ["mice", "ORGANISM", 14, 18], ["mice", "SPECIES", 14, 18], ["mice", "SPECIES", 14, 18], ["EcoHIV", "SPECIES", 35, 41], ["EcoHIV infection", "PROBLEM", 35, 51], ["infection", "OBSERVATION", 42, 51]]], ["Groups of BALB/c mice (n = 15 in each group) were vaccinated with 100 mg sPD1-p24fc/EP or p24fc/EP DNA, or with PBS as a control, intramuscularly at weeks 0, 3, and 6, followed by intraperitoneal challenge with EcoHIV (400 ng p24) 6 weeks after the third vaccination.", [["intraperitoneal", "ANATOMY", 180, 195], ["EcoHIV", "CHEMICAL", 211, 217], ["BALB/c mice", "ORGANISM", 10, 21], ["EP", "SIMPLE_CHEMICAL", 84, 86], ["p24fc", "ORGANISM", 90, 95], ["DNA", "CELLULAR_COMPONENT", 99, 102], ["intraperitoneal", "IMMATERIAL_ANATOMICAL_ENTITY", 180, 195], ["EcoHIV", "SIMPLE_CHEMICAL", 211, 217], ["p24fc", "PROTEIN", 90, 95], ["mice", "SPECIES", 17, 21], ["mice", "SPECIES", 17, 21], ["EcoHIV", "SPECIES", 211, 217], ["EP", "TREATMENT", 84, 86], ["EP DNA", "TREATMENT", 96, 102], ["PBS", "TREATMENT", 112, 115], ["intraperitoneal challenge", "TREATMENT", 180, 205], ["EcoHIV", "TREATMENT", 211, 217], ["the third vaccination", "TREATMENT", 245, 266], ["intraperitoneal", "ANATOMY", 180, 195]]], ["HIV-1 p24-specific H2-Kd-GAG A-I-PE tetramer staining of CD8 + T cell populations two weeks after final immunization and before EcoHIV challenge. c.", [["CD8 + T cell", "ANATOMY", 57, 69], ["HIV-1", "ORGANISM", 0, 5], ["p24", "GENE_OR_GENE_PRODUCT", 6, 9], ["CD8", "GENE_OR_GENE_PRODUCT", 57, 60], ["p24", "PROTEIN", 6, 9], ["CD8", "PROTEIN", 57, 60], ["HIV-1", "SPECIES", 0, 5], ["HIV-1", "SPECIES", 0, 5], ["HIV", "TEST", 0, 3], ["p24", "TEST", 6, 9], ["specific H2-Kd-GAG", "TEST", 10, 28], ["CD8", "PROBLEM", 57, 60], ["T cell populations", "PROBLEM", 63, 81], ["final immunization", "TREATMENT", 98, 116], ["EcoHIV challenge", "TREATMENT", 128, 144], ["PE", "OBSERVATION", 33, 35], ["tetramer staining", "OBSERVATION", 36, 53]]], ["HIV-1 p24-specific T cell ELISpot responses were determined using three non-overlapping peptide pools. d.", [["T cell", "ANATOMY", 19, 25], ["HIV-1", "ORGANISM", 0, 5], ["p24", "ORGANISM", 6, 9], ["T cell", "CELL", 19, 25], ["p24", "PROTEIN", 6, 9], ["HIV-1", "SPECIES", 0, 5], ["HIV-1", "SPECIES", 0, 5], ["HIV", "TEST", 0, 3], ["p24", "TEST", 6, 9]]], ["Proviral load in the spleen, peritoneal macrophages, and blood were evaluated by examining HIV LTR copy number per million cells by qPCR at 7 dp.i. e.", [["spleen", "ANATOMY", 21, 27], ["peritoneal macrophages", "ANATOMY", 29, 51], ["blood", "ANATOMY", 57, 62], ["LTR", "ANATOMY", 95, 98], ["cells", "ANATOMY", 123, 128], ["spleen", "ORGAN", 21, 27], ["peritoneal macrophages", "CELL", 29, 51], ["blood", "ORGANISM_SUBSTANCE", 57, 62], ["HIV", "ORGANISM", 91, 94], ["cells", "CELL", 123, 128], ["peritoneal macrophages", "CELL_TYPE", 29, 51], ["HIV LTR", "DNA", 91, 98], ["HIV", "SPECIES", 91, 94], ["Proviral load", "TEST", 0, 13], ["peritoneal macrophages", "PROBLEM", 29, 51], ["spleen", "ANATOMY", 21, 27], ["peritoneal", "ANATOMY", 29, 39], ["macrophages", "OBSERVATION", 40, 51]]], ["Reduction of proviral loads in the peritoneal macrophages (peritoneum) and spleen for vaccinated mice presented as percentage compared to unimmunized mice data at 7 dp.i. f.", [["peritoneal macrophages", "ANATOMY", 35, 57], ["peritoneum", "ANATOMY", 59, 69], ["spleen", "ANATOMY", 75, 81], ["peritoneal macrophages", "MULTI-TISSUE_STRUCTURE", 35, 57], ["peritoneum", "MULTI-TISSUE_STRUCTURE", 59, 69], ["spleen", "ORGAN", 75, 81], ["mice", "ORGANISM", 97, 101], ["mice", "ORGANISM", 150, 154], ["peritoneal macrophages", "CELL_TYPE", 35, 57], ["mice", "SPECIES", 97, 101], ["mice", "SPECIES", 150, 154], ["mice", "SPECIES", 97, 101], ["mice", "SPECIES", 150, 154], ["proviral loads in the peritoneal macrophages", "TREATMENT", 13, 57], ["vaccinated mice", "TREATMENT", 86, 101], ["proviral loads", "OBSERVATION", 13, 27], ["peritoneal", "ANATOMY", 35, 45], ["macrophages", "OBSERVATION", 46, 57], ["peritoneum", "ANATOMY", 59, 69], ["spleen", "ANATOMY", 75, 81]]], ["Proviral load in the spleen, peritoneal macrophages, and blood based on HIV LTR copy number per million cells as determined by qPCR at 14 and 21 dp.i. g.", [["spleen", "ANATOMY", 21, 27], ["peritoneal macrophages", "ANATOMY", 29, 51], ["blood", "ANATOMY", 57, 62], ["LTR", "ANATOMY", 76, 79], ["cells", "ANATOMY", 104, 109], ["spleen", "ORGAN", 21, 27], ["peritoneal macrophages", "CELL", 29, 51], ["blood", "ORGANISM_SUBSTANCE", 57, 62], ["cells", "CELL", 104, 109], ["peritoneal macrophages", "CELL_TYPE", 29, 51], ["HIV LTR", "DNA", 72, 79], ["HIV", "SPECIES", 72, 75], ["Proviral load", "TEST", 0, 13], ["peritoneal macrophages", "TREATMENT", 29, 51], ["HIV LTR", "TREATMENT", 72, 79], ["qPCR", "TEST", 127, 131], ["spleen", "ANATOMY", 21, 27], ["peritoneal", "ANATOMY", 29, 39], ["macrophages", "OBSERVATION", 40, 51]]], ["Reduction of proviral loads in the peritoneal macrophages (peritoneum) and spleen for vaccinated mice presented as percentage compared to unimmunized mice data at 14 and 21 dp.i.", [["peritoneal macrophages", "ANATOMY", 35, 57], ["peritoneum", "ANATOMY", 59, 69], ["spleen", "ANATOMY", 75, 81], ["peritoneal macrophages", "MULTI-TISSUE_STRUCTURE", 35, 57], ["peritoneum", "MULTI-TISSUE_STRUCTURE", 59, 69], ["spleen", "ORGAN", 75, 81], ["mice", "ORGANISM", 97, 101], ["mice", "ORGANISM", 150, 154], ["peritoneal macrophages", "CELL_TYPE", 35, 57], ["mice", "SPECIES", 97, 101], ["mice", "SPECIES", 150, 154], ["mice", "SPECIES", 97, 101], ["mice", "SPECIES", 150, 154], ["proviral loads in the peritoneal macrophages", "TREATMENT", 13, 57], ["vaccinated mice", "TREATMENT", 86, 101], ["unimmunized mice data", "TEST", 138, 159], ["proviral loads", "OBSERVATION", 13, 27], ["peritoneal", "ANATOMY", 35, 45], ["macrophages", "OBSERVATION", 46, 57], ["peritoneum", "ANATOMY", 59, 69], ["spleen", "ANATOMY", 75, 81]]], ["Data represent two independent experiments with three (b and c) or five mice (d, e, f, g) per group and with error bars representing the SEM. *, P < 0.05; **, P<0.0001.", [["mice", "ORGANISM", 72, 76], ["mice", "SPECIES", 72, 76]]], ["A two-tailed Student t-test and Bonferroni-Holms method was used. h.", [["Bonferroni-Holms method", "TREATMENT", 32, 55]]], ["Strong positive correlation between percentage of PD1 + CD8 + Tem and p24 + MDSC (left) and CD11b + myeloid cells in blood at day 7 after anti-Gr1 treatment.", [["PD1 + CD8 + Tem", "ANATOMY", 50, 65], ["p24 + MDSC", "ANATOMY", 70, 80], ["left", "ANATOMY", 82, 86], ["CD11b + myeloid cells", "ANATOMY", 92, 113], ["blood", "ANATOMY", 117, 122], ["Gr1", "CHEMICAL", 143, 146], ["PD1", "GENE_OR_GENE_PRODUCT", 50, 53], ["CD8", "GENE_OR_GENE_PRODUCT", 56, 59], ["p24 + MDSC", "GENE_OR_GENE_PRODUCT", 70, 80], ["CD11b", "GENE_OR_GENE_PRODUCT", 92, 97], ["blood", "ORGANISM_SUBSTANCE", 117, 122], ["Gr1", "GENE_OR_GENE_PRODUCT", 143, 146], ["PD1", "PROTEIN", 50, 53], ["CD8", "PROTEIN", 56, 59], ["Tem", "PROTEIN", 62, 65], ["p24", "PROTEIN", 70, 73], ["MDSC", "CELL_TYPE", 76, 80], ["CD11b + myeloid cells", "CELL_TYPE", 92, 113], ["Gr1", "PROTEIN", 143, 146], ["percentage", "TEST", 36, 46], ["PD1", "TEST", 50, 53], ["CD8", "TEST", 56, 59], ["Tem", "TEST", 62, 65], ["p24", "TEST", 70, 73], ["MDSC", "TEST", 76, 80], ["CD11", "TEST", 92, 96], ["myeloid cells", "PROBLEM", 100, 113], ["blood", "TEST", 117, 122], ["anti-Gr1 treatment", "TREATMENT", 138, 156], ["MDSC", "ANATOMY", 76, 80], ["left", "ANATOMY_MODIFIER", 82, 86], ["myeloid cells", "OBSERVATION", 100, 113]]], ["Liner regression was used.Antibody depletion of mdsc enhances clearance of eohiv-infected cells in vivoPD1 on blood Tem is positively correlated with frequency of p24 + MDSC and CD11b + myeloid cells (Fig. 8h) .", [["cells", "ANATOMY", 90, 95], ["blood", "ANATOMY", 110, 115], ["p24 + MDSC", "ANATOMY", 163, 173], ["CD11b + myeloid cells", "ANATOMY", 178, 199], ["mdsc", "GENE_OR_GENE_PRODUCT", 48, 52], ["eohiv", "GENE_OR_GENE_PRODUCT", 75, 80], ["cells", "CELL", 90, 95], ["vivoPD1", "SIMPLE_CHEMICAL", 99, 106], ["blood", "ORGANISM_SUBSTANCE", 110, 115], ["p24", "GENE_OR_GENE_PRODUCT", 163, 166], ["MDSC", "CELL", 169, 173], ["CD11b", "GENE_OR_GENE_PRODUCT", 178, 183], ["mdsc", "PROTEIN", 48, 52], ["eohiv-infected cells", "CELL_LINE", 75, 95], ["vivoPD1", "PROTEIN", 99, 106], ["p24", "PROTEIN", 163, 166], ["MDSC", "CELL_TYPE", 169, 173], ["CD11b", "PROTEIN", 178, 183], ["myeloid cells", "CELL_TYPE", 186, 199], ["Liner regression", "TREATMENT", 0, 16], ["Antibody depletion", "PROBLEM", 26, 44], ["eohiv", "TEST", 75, 80], ["infected cells", "PROBLEM", 81, 95], ["blood Tem", "TEST", 110, 119], ["p24", "TEST", 163, 166], ["MDSC", "TEST", 169, 173], ["CD11", "TEST", 178, 182], ["myeloid cells", "PROBLEM", 186, 199], ["mdsc", "OBSERVATION", 48, 52], ["infected cells", "OBSERVATION", 81, 95], ["MDSC", "ANATOMY", 169, 173], ["myeloid cells", "OBSERVATION", 186, 199]]], ["In the spleen, only Mo-DC were significantly reduced in anti-Gr1 treated mice (Fig. S8A) .", [["spleen", "ANATOMY", 7, 13], ["DC", "ANATOMY", 23, 25], ["Gr1", "CHEMICAL", 61, 64], ["spleen", "ORGAN", 7, 13], ["Mo-DC", "CELL", 20, 25], ["Gr1", "GENE_OR_GENE_PRODUCT", 61, 64], ["mice", "ORGANISM", 73, 77], ["Mo-DC", "CELL_TYPE", 20, 25], ["Gr1", "PROTEIN", 61, 64], ["mice", "SPECIES", 73, 77], ["Mo-DC", "TREATMENT", 20, 25], ["spleen", "ANATOMY", 7, 13], ["significantly", "OBSERVATION_MODIFIER", 31, 44], ["reduced", "OBSERVATION_MODIFIER", 45, 52]]], ["Moreover, depleted mice tended to have an increase in interferon g-producing p24-specific T cells (Fig. S8b, 8c and 8d) , reduced proviral loads in the spleen (Fig. 8f) .", [["T cells", "ANATOMY", 90, 97], ["spleen", "ANATOMY", 152, 158], ["mice", "ORGANISM", 19, 23], ["interferon g", "GENE_OR_GENE_PRODUCT", 54, 66], ["p24", "GENE_OR_GENE_PRODUCT", 77, 80], ["T cells", "CELL", 90, 97], ["spleen", "ORGAN", 152, 158], ["interferon g", "PROTEIN", 54, 66], ["p24", "PROTEIN", 77, 80], ["T cells", "CELL_TYPE", 90, 97], ["mice", "SPECIES", 19, 23], ["mice", "SPECIES", 19, 23], ["an increase", "PROBLEM", 39, 50], ["interferon g", "TEST", 54, 66], ["Fig. S8b", "TEST", 99, 107], ["8c", "TEST", 109, 111], ["reduced proviral loads in the spleen", "PROBLEM", 122, 158], ["increase", "OBSERVATION_MODIFIER", 42, 50], ["proviral loads", "OBSERVATION", 130, 144], ["spleen", "ANATOMY", 152, 158]]], ["However, these differences were not statistically significant, suggesting a limited effect of anti-Gr1 antibody on depletion of MDSCs and reduction of EcoHIV infection there.", [["MDSCs", "ANATOMY", 128, 133], ["infection", "DISEASE", 158, 167], ["anti-Gr1 antibody", "GENE_OR_GENE_PRODUCT", 94, 111], ["MDSCs", "CELL", 128, 133], ["EcoHIV", "GENE_OR_GENE_PRODUCT", 151, 157], ["anti-Gr1 antibody", "PROTEIN", 94, 111], ["MDSCs", "CELL_TYPE", 128, 133], ["EcoHIV", "SPECIES", 151, 157], ["anti-Gr1 antibody", "TREATMENT", 94, 111], ["depletion of MDSCs", "TREATMENT", 115, 133], ["EcoHIV infection", "PROBLEM", 151, 167], ["MDSCs", "OBSERVATION", 128, 133], ["EcoHIV", "OBSERVATION_MODIFIER", 151, 157], ["infection", "OBSERVATION", 158, 167]]], ["Our data suggest that by reducing the numbers of ly6c + cells, we were able to enhance elimination of infected cells in vivo, and likely boosted CD8 + T cell function to clear infected ly6c negative cells.DiscussionHere we have identified an unexpected role of myeloid cells in facilitating viral evasion of memory CD8 + T cell response at very early stage of viral infection.", [["ly6c + cells", "ANATOMY", 49, 61], ["cells", "ANATOMY", 111, 116], ["CD8 + T cell", "ANATOMY", 145, 157], ["ly6c negative cells", "ANATOMY", 185, 204], ["myeloid cells", "ANATOMY", 261, 274], ["memory CD8 + T cell", "ANATOMY", 308, 327], ["viral infection", "DISEASE", 360, 375], ["ly6c + cells", "CELL", 49, 61], ["cells", "CELL", 111, 116], ["CD8", "GENE_OR_GENE_PRODUCT", 145, 148], ["cells", "CELL", 199, 204], ["myeloid cells", "CELL", 261, 274], ["CD8", "GENE_OR_GENE_PRODUCT", 315, 318], ["ly6c + cells", "CELL_LINE", 49, 61], ["infected cells", "CELL_TYPE", 102, 116], ["CD8", "PROTEIN", 145, 148], ["ly6c negative cells", "CELL_TYPE", 185, 204], ["myeloid cells", "CELL_TYPE", 261, 274], ["CD8", "PROTEIN", 315, 318], ["Our data", "TEST", 0, 8], ["infected cells", "PROBLEM", 102, 116], ["myeloid cells", "PROBLEM", 261, 274], ["T cell response", "PROBLEM", 321, 336], ["viral infection", "PROBLEM", 360, 375], ["infected cells", "OBSERVATION", 102, 116], ["likely", "UNCERTAINTY", 130, 136], ["infected", "OBSERVATION_MODIFIER", 176, 184], ["ly6c negative cells", "OBSERVATION", 185, 204], ["myeloid cells", "OBSERVATION", 261, 274], ["viral", "OBSERVATION_MODIFIER", 360, 365], ["infection", "OBSERVATION", 366, 375]]], ["We present an extensive analysis of innate cell activation and memory CD8 + T cell response following virus challenge of vaccinated, immunocompetent BALB/c mice.", [["cell", "ANATOMY", 43, 47], ["memory CD8 + T cell", "ANATOMY", 63, 82], ["innate cell", "CELL", 36, 47], ["CD8", "GENE_OR_GENE_PRODUCT", 70, 73], ["BALB/c mice", "ORGANISM", 149, 160], ["CD8", "PROTEIN", 70, 73], ["mice", "SPECIES", 156, 160], ["mice", "SPECIES", 156, 160], ["an extensive analysis", "TEST", 11, 32], ["innate cell activation", "TREATMENT", 36, 58], ["T cell response", "PROBLEM", 76, 91], ["virus challenge", "TREATMENT", 102, 117], ["innate cell activation", "OBSERVATION", 36, 58]]], ["Our results indicate that EcoHIV activates DCs and myeloid cells during the first week of infection, and initiates both effective CD8 + T cell priming in na\u00efve mice and recall of memory T cells response and effector function in vaccinated mice.", [["DCs", "ANATOMY", 43, 46], ["myeloid cells", "ANATOMY", 51, 64], ["CD8 + T cell", "ANATOMY", 130, 142], ["memory T cells", "ANATOMY", 179, 193], ["infection", "DISEASE", 90, 99], ["EcoHIV", "GENE_OR_GENE_PRODUCT", 26, 32], ["DCs", "CELL", 43, 46], ["myeloid cells", "CELL", 51, 64], ["CD8", "GENE_OR_GENE_PRODUCT", 130, 133], ["mice", "ORGANISM", 160, 164], ["memory T cells", "CELL", 179, 193], ["mice", "ORGANISM", 239, 243], ["EcoHIV", "PROTEIN", 26, 32], ["DCs", "CELL_TYPE", 43, 46], ["myeloid cells", "CELL_TYPE", 51, 64], ["CD8", "PROTEIN", 130, 133], ["memory T cells", "CELL_TYPE", 179, 193], ["mice", "SPECIES", 160, 164], ["mice", "SPECIES", 239, 243], ["EcoHIV", "SPECIES", 26, 32], ["mice", "SPECIES", 160, 164], ["mice", "SPECIES", 239, 243], ["myeloid cells", "PROBLEM", 51, 64], ["infection", "PROBLEM", 90, 99], ["myeloid cells", "OBSERVATION", 51, 64], ["infection", "OBSERVATION", 90, 99]]], ["However, myeloid cells serve as shelters to provide a mechanism for the virus to escape CTL-mediated apoptosis, and infection led to rapid expansion and accumulation of myeloid cells with T cell-suppressive function, resulting in diminished virusspecific CD8 + T cell numbers and function, and reduced vaccinemediated virus clearance within 7 dpi.", [["myeloid cells", "ANATOMY", 9, 22], ["myeloid cells", "ANATOMY", 169, 182], ["T cell", "ANATOMY", 188, 194], ["virusspecific CD8 + T cell", "ANATOMY", 241, 267], ["infection", "DISEASE", 116, 125], ["myeloid cells", "CELL", 9, 22], ["CTL", "GENE_OR_GENE_PRODUCT", 88, 91], ["myeloid cells", "CELL", 169, 182], ["T cell", "CELL", 188, 194], ["CD8", "GENE_OR_GENE_PRODUCT", 255, 258], ["myeloid cells", "CELL_TYPE", 9, 22], ["myeloid cells", "CELL_TYPE", 169, 182], ["CD8", "PROTEIN", 255, 258], ["myeloid cells", "PROBLEM", 9, 22], ["the virus", "PROBLEM", 68, 77], ["mediated apoptosis", "PROBLEM", 92, 110], ["infection", "PROBLEM", 116, 125], ["rapid expansion", "PROBLEM", 133, 148], ["accumulation of myeloid cells", "PROBLEM", 153, 182], ["reduced vaccinemediated virus clearance", "PROBLEM", 294, 333], ["myeloid cells", "OBSERVATION", 9, 22], ["infection", "OBSERVATION", 116, 125], ["accumulation of myeloid cells", "OBSERVATION", 153, 182], ["diminished", "OBSERVATION_MODIFIER", 230, 240]]], ["These data provide not only a detailed picture of DC, myeloid cell, and memory CD8 + T cell reactivation in response to persistent viral infection, but also new insight into the mechanisms that underlie lentiviral evasion of vaccine-induced T cell immunity to establish persistent infection.DiscussionThus far, it has remained unclear when and to what extent persistent infection suppresses CD8 + memory T cell reactivation during recall response.", [["DC", "ANATOMY", 50, 52], ["myeloid cell", "ANATOMY", 54, 66], ["memory CD8 + T cell", "ANATOMY", 72, 91], ["T cell", "ANATOMY", 241, 247], ["CD8 + memory T cell", "ANATOMY", 391, 410], ["viral infection", "DISEASE", 131, 146], ["infection", "DISEASE", 281, 290], ["infection", "DISEASE", 370, 379], ["DC", "CELL", 50, 52], ["myeloid cell", "CELL", 54, 66], ["CD8", "GENE_OR_GENE_PRODUCT", 79, 82], ["lentiviral", "ORGANISM", 203, 213], ["T cell", "CELL", 241, 247], ["CD8", "GENE_OR_GENE_PRODUCT", 391, 394], ["DC", "CELL_TYPE", 50, 52], ["memory CD8 + T cell", "CELL_TYPE", 72, 91], ["CD8", "PROTEIN", 391, 394], ["myeloid cell", "PROBLEM", 54, 66], ["T cell reactivation", "PROBLEM", 85, 104], ["persistent viral infection", "PROBLEM", 120, 146], ["lentiviral evasion of vaccine", "TREATMENT", 203, 232], ["persistent infection", "PROBLEM", 270, 290], ["persistent infection", "PROBLEM", 359, 379], ["memory T cell reactivation", "PROBLEM", 397, 423], ["myeloid cell", "OBSERVATION", 54, 66], ["cell reactivation", "OBSERVATION", 87, 104], ["persistent", "OBSERVATION_MODIFIER", 120, 130], ["viral", "OBSERVATION_MODIFIER", 131, 136], ["infection", "OBSERVATION", 137, 146], ["persistent", "OBSERVATION_MODIFIER", 270, 280], ["infection", "OBSERVATION", 281, 290], ["persistent", "OBSERVATION_MODIFIER", 359, 369], ["infection", "OBSERVATION", 370, 379], ["memory T cell reactivation", "OBSERVATION", 397, 423]]], ["Data are currently only available regarding the role of MDSCs in suppressing CD8 + T cell function during primary infection [20, 24, 32] .", [["MDSCs", "ANATOMY", 56, 61], ["CD8 + T cell", "ANATOMY", 77, 89], ["primary infection", "DISEASE", 106, 123], ["MDSCs", "CELL", 56, 61], ["CD8", "GENE_OR_GENE_PRODUCT", 77, 80], ["MDSCs", "CELL_TYPE", 56, 61], ["CD8", "PROTEIN", 77, 80], ["primary infection", "PROBLEM", 106, 123]]], ["We recently developed a sPD1-p24 fc /EP DNA DC-targeting vaccine, which induces a strong and durable HIV-1 GAGspecific CD8 + T lymphocyte response, with broad reactivity, polyfunctionality and cytotoxicity [29] .", [["DC", "ANATOMY", 44, 46], ["CD8 + T lymphocyte", "ANATOMY", 119, 137], ["sPD1", "GENE_OR_GENE_PRODUCT", 24, 28], ["HIV-1", "ORGANISM", 101, 106], ["CD8", "GENE_OR_GENE_PRODUCT", 119, 122], ["sPD1", "PROTEIN", 24, 28], ["CD8", "PROTEIN", 119, 122], ["HIV-1", "SPECIES", 101, 106], ["HIV-1", "SPECIES", 101, 106], ["a sPD1", "TEST", 22, 28], ["EP DNA DC", "TREATMENT", 37, 46], ["targeting vaccine", "TREATMENT", 47, 64], ["durable HIV", "TEST", 93, 104], ["T lymphocyte response", "PROBLEM", 125, 146], ["broad reactivity", "PROBLEM", 153, 169], ["polyfunctionality", "PROBLEM", 171, 188], ["cytotoxicity", "TEST", 193, 205], ["lymphocyte response", "OBSERVATION", 127, 146]]], ["We have now utilized this model vaccine to investigate its potential to confer complete protection against persistent lentiviral infection.", [["lentiviral infection", "DISEASE", 118, 138], ["lentiviral", "ORGANISM", 118, 128], ["lentiviral", "SPECIES", 118, 128], ["this model vaccine", "TREATMENT", 21, 39], ["persistent lentiviral infection", "PROBLEM", 107, 138], ["lentiviral infection", "OBSERVATION", 118, 138]]], ["We have analyzed the secondary T cell immune response to EcoHIV, a persistent lentivirus that induces immunosuppression during infection, and the role of the recall responses in preventing persistent infection.", [["T cell", "ANATOMY", 31, 37], ["EcoHIV", "CHEMICAL", 57, 63], ["infection", "DISEASE", 127, 136], ["infection", "DISEASE", 200, 209], ["T cell", "CELL", 31, 37], ["EcoHIV", "GENE_OR_GENE_PRODUCT", 57, 63], ["lentivirus", "ORGANISM", 78, 88], ["lentivirus", "SPECIES", 78, 88], ["EcoHIV", "TREATMENT", 57, 63], ["a persistent lentivirus", "PROBLEM", 65, 88], ["immunosuppression", "TREATMENT", 102, 119], ["infection", "PROBLEM", 127, 136], ["persistent infection", "PROBLEM", 189, 209], ["cell immune", "OBSERVATION", 33, 44], ["persistent", "OBSERVATION_MODIFIER", 67, 77], ["lentivirus", "OBSERVATION", 78, 88], ["persistent", "OBSERVATION_MODIFIER", 189, 199], ["infection", "OBSERVATION", 200, 209]]], ["We found that after Eco-HIV challenge, there was robust proliferation of antigen-specific CD8 + T cells, which reduced the number of virus-infected cells in spleen and Peritoneum macrophages before day 7.", [["CD8 + T cells", "ANATOMY", 90, 103], ["cells", "ANATOMY", 148, 153], ["spleen", "ANATOMY", 157, 163], ["Peritoneum macrophages", "ANATOMY", 168, 190], ["Eco-HIV", "ORGANISM", 20, 27], ["antigen", "GENE_OR_GENE_PRODUCT", 73, 80], ["CD8", "GENE_OR_GENE_PRODUCT", 90, 93], ["cells", "CELL", 148, 153], ["spleen", "ORGAN", 157, 163], ["Peritoneum macrophages", "CELL", 168, 190], ["CD8 + T cells", "CELL_TYPE", 90, 103], ["virus-infected cells", "CELL_TYPE", 133, 153], ["Peritoneum macrophages", "CELL_TYPE", 168, 190], ["HIV", "SPECIES", 24, 27], ["Eco", "TEST", 20, 23], ["HIV challenge", "TREATMENT", 24, 37], ["robust proliferation of antigen", "PROBLEM", 49, 80], ["T cells", "PROBLEM", 96, 103], ["virus", "PROBLEM", 133, 138], ["infected cells in spleen and Peritoneum macrophages", "PROBLEM", 139, 190], ["robust", "OBSERVATION_MODIFIER", 49, 55], ["proliferation", "OBSERVATION_MODIFIER", 56, 69], ["infected cells", "OBSERVATION", 139, 153], ["spleen", "ANATOMY", 157, 163], ["Peritoneum", "ANATOMY", 168, 178]]], ["However, EcoHIV also infected MDSCs, which are resistant to CD8 + T cell-mediated killing, while also inducing a rapid expansion of this cell population ( Fig. 6 and Fig. 7) .", [["MDSCs", "ANATOMY", 30, 35], ["CD8 + T cell", "ANATOMY", 60, 72], ["cell", "ANATOMY", 137, 141], ["EcoHIV", "GENE_OR_GENE_PRODUCT", 9, 15], ["MDSCs", "CELL", 30, 35], ["CD8", "GENE_OR_GENE_PRODUCT", 60, 63], ["cell population", "CELL", 137, 152], ["EcoHIV", "PROTEIN", 9, 15], ["MDSCs", "CELL_TYPE", 30, 35], ["CD8", "PROTEIN", 60, 63], ["EcoHIV", "SPECIES", 9, 15], ["infected MDSCs", "PROBLEM", 21, 35], ["CD8", "TEST", 60, 63], ["a rapid expansion of this cell population", "PROBLEM", 111, 152], ["infected MDSCs", "OBSERVATION", 21, 35], ["rapid", "OBSERVATION_MODIFIER", 113, 118], ["expansion", "OBSERVATION", 119, 128]]], ["The expanded MDSCs profoundly subverted the memory CD8 + T cell response in terms of both number and function at a very early stage of infection, resulting in persistent viral infection.", [["MDSCs", "ANATOMY", 13, 18], ["memory CD8 + T cell", "ANATOMY", 44, 63], ["infection", "DISEASE", 135, 144], ["viral infection", "DISEASE", 170, 185], ["MDSCs", "CELL", 13, 18], ["CD8", "GENE_OR_GENE_PRODUCT", 51, 54], ["MDSCs", "CELL_TYPE", 13, 18], ["CD8", "PROTEIN", 51, 54], ["infection", "PROBLEM", 135, 144], ["persistent viral infection", "PROBLEM", 159, 185], ["expanded", "OBSERVATION_MODIFIER", 4, 12], ["MDSCs", "OBSERVATION", 13, 18], ["memory CD8", "OBSERVATION", 44, 54], ["cell response", "OBSERVATION", 59, 72], ["infection", "OBSERVATION", 135, 144], ["persistent", "OBSERVATION_MODIFIER", 159, 169], ["viral", "OBSERVATION_MODIFIER", 170, 175], ["infection", "OBSERVATION", 176, 185]]], ["Our data have revealed the time-course of this process, and the important role of myeloid cells in subverting memory recall responses to virus and thereby facilitating viral persistence.", [["myeloid cells", "ANATOMY", 82, 95], ["myeloid cells", "CELL", 82, 95], ["myeloid cells", "CELL_TYPE", 82, 95], ["Our data", "TEST", 0, 8], ["myeloid cells", "PROBLEM", 82, 95], ["virus", "TREATMENT", 137, 142], ["myeloid cells", "OBSERVATION", 82, 95], ["viral persistence", "OBSERVATION", 168, 185]]], ["We did not observe significant reduction of proviral load in PBMC in sPD1-p24 fc vaccinated and challenged mice, which might be due to the higher frequency of MDSCs in the blood compared to spleen (Fig. 8b and Fig. 1h) , and the resistance of infected MDSC to CD8 + T cell-mediated killing.DiscussionOur description of the expansion of Gr1 + myeloid cells following EcoHIV challenge in vaccinated mice is similar to the phenomenon observed in chronic LCMV [24, 41] .", [["PBMC", "ANATOMY", 61, 65], ["MDSCs", "ANATOMY", 159, 164], ["blood", "ANATOMY", 172, 177], ["spleen", "ANATOMY", 190, 196], ["MDSC", "ANATOMY", 252, 256], ["CD8 + T cell", "ANATOMY", 260, 272], ["Gr1 + myeloid cells", "ANATOMY", 336, 355], ["EcoHIV", "CHEMICAL", 366, 372], ["PBMC", "CELL", 61, 65], ["sPD1", "GENE_OR_GENE_PRODUCT", 69, 73], ["p24", "GENE_OR_GENE_PRODUCT", 74, 77], ["mice", "ORGANISM", 107, 111], ["MDSCs", "CELL", 159, 164], ["blood", "ORGANISM_SUBSTANCE", 172, 177], ["spleen", "ORGAN", 190, 196], ["MDSC", "CELL", 252, 256], ["CD8", "GENE_OR_GENE_PRODUCT", 260, 263], ["Gr1 + myeloid cells", "CELL", 336, 355], ["mice", "ORGANISM", 397, 401], ["LCMV", "ORGANISM", 451, 455], ["PBMC", "CELL_TYPE", 61, 65], ["sPD1", "PROTEIN", 69, 73], ["MDSCs", "CELL_TYPE", 159, 164], ["MDSC", "CELL_TYPE", 252, 256], ["CD8", "PROTEIN", 260, 263], ["Gr1 + myeloid cells", "CELL_TYPE", 336, 355], ["mice", "SPECIES", 107, 111], ["mice", "SPECIES", 397, 401], ["mice", "SPECIES", 107, 111], ["mice", "SPECIES", 397, 401], ["LCMV", "SPECIES", 451, 455], ["proviral load", "PROBLEM", 44, 57], ["PBMC", "TEST", 61, 65], ["sPD1", "TEST", 69, 73], ["Gr1 + myeloid cells", "PROBLEM", 336, 355], ["EcoHIV challenge in vaccinated mice", "TREATMENT", 366, 401], ["the phenomenon", "PROBLEM", 416, 430], ["chronic LCMV", "PROBLEM", 443, 455], ["proviral load", "OBSERVATION", 44, 57], ["MDSCs", "OBSERVATION", 159, 164], ["spleen", "ANATOMY", 190, 196], ["infected", "OBSERVATION_MODIFIER", 243, 251], ["MDSC", "OBSERVATION", 252, 256], ["Gr1", "ANATOMY", 336, 339], ["myeloid cells", "OBSERVATION", 342, 355], ["chronic", "OBSERVATION_MODIFIER", 443, 450], ["LCMV", "OBSERVATION", 451, 455]]], ["Previous studies using models of acute and chronic LCMV infection, the ARM and C13 strains [42, 43] , respectively, induced accumulation of Ly6C hi monocytes and Gr1 hi neutrophils in lymphoid organs and blood during the first three days [24] .", [["Ly6C hi monocytes", "ANATOMY", 140, 157], ["Gr1 hi neutrophils", "ANATOMY", 162, 180], ["lymphoid organs", "ANATOMY", 184, 199], ["blood", "ANATOMY", 204, 209], ["LCMV infection", "DISEASE", 51, 65], ["LCMV", "ORGANISM", 51, 55], ["Ly6C hi monocytes", "CELL", 140, 157], ["Gr1 hi neutrophils", "CELL", 162, 180], ["lymphoid organs", "MULTI-TISSUE_STRUCTURE", 184, 199], ["blood", "ORGANISM_SUBSTANCE", 204, 209], ["Ly6C hi monocytes", "CELL_TYPE", 140, 157], ["Gr1 hi neutrophils", "CELL_LINE", 162, 180], ["LCMV", "SPECIES", 51, 55], ["Previous studies", "TEST", 0, 16], ["acute and chronic LCMV infection", "PROBLEM", 33, 65], ["the ARM and C13 strains", "TEST", 67, 90], ["Ly6C hi monocytes", "TEST", 140, 157], ["lymphoid organs", "TEST", 184, 199], ["blood", "TEST", 204, 209], ["acute", "OBSERVATION_MODIFIER", 33, 38], ["chronic", "OBSERVATION_MODIFIER", 43, 50], ["LCMV infection", "OBSERVATION", 51, 65], ["ARM", "ANATOMY", 71, 74], ["Ly6C hi monocytes", "OBSERVATION", 140, 157], ["hi neutrophils", "OBSERVATION", 166, 180], ["lymphoid organs", "OBSERVATION", 184, 199]]], ["However, the expansion of myeloid cells was only enhanced and sustained over time after peaking at 14 dpi in persistent C13 virus infection, but not in the ARM strain [24] .", [["myeloid cells", "ANATOMY", 26, 39], ["infection", "DISEASE", 130, 139], ["myeloid cells", "CELL", 26, 39], ["C13 virus", "ORGANISM", 120, 129], ["myeloid cells", "CELL_TYPE", 26, 39], ["C13 virus", "SPECIES", 120, 129], ["the expansion of myeloid cells", "PROBLEM", 9, 39], ["persistent C13 virus infection", "PROBLEM", 109, 139], ["expansion", "OBSERVATION_MODIFIER", 13, 22], ["myeloid cells", "OBSERVATION", 26, 39], ["enhanced", "OBSERVATION_MODIFIER", 49, 57], ["persistent", "OBSERVATION_MODIFIER", 109, 119], ["C13 virus infection", "OBSERVATION", 120, 139], ["ARM", "ANATOMY", 156, 159]]], ["In our study, accumulation of MDSCs in vaccinated and EcoHIV-challenged mice started before 7 dpi and likewise peaked at 14 dpi.", [["MDSCs", "ANATOMY", 30, 35], ["EcoHIV", "CHEMICAL", 54, 60], ["MDSCs", "CELL", 30, 35], ["EcoHIV", "ORGANISM", 54, 60], ["mice", "ORGANISM", 72, 76], ["MDSCs", "CELL_TYPE", 30, 35], ["mice", "SPECIES", 72, 76], ["mice", "SPECIES", 72, 76], ["our study", "TEST", 3, 12], ["MDSCs in vaccinated", "TREATMENT", 30, 49], ["EcoHIV", "TREATMENT", 54, 60], ["MDSCs", "OBSERVATION", 30, 35]]], ["In C13 infection, both DCs and myeloid cells are capable of stimulating T cell proliferation during the first few days of infection, and CD11b + myeloid cells only begin actively suppressing the priming of T cells at 14 dpi [44, 45] .", [["DCs", "ANATOMY", 23, 26], ["myeloid cells", "ANATOMY", 31, 44], ["T cell", "ANATOMY", 72, 78], ["CD11b + myeloid cells", "ANATOMY", 137, 158], ["T cells", "ANATOMY", 206, 213], ["infection", "DISEASE", 7, 16], ["infection", "DISEASE", 122, 131], ["DCs", "CELL", 23, 26], ["myeloid cells", "CELL", 31, 44], ["T cell", "CELL", 72, 78], ["CD11", "GENE_OR_GENE_PRODUCT", 137, 141], ["myeloid cells", "CELL", 145, 158], ["T cells", "CELL", 206, 213], ["DCs", "CELL_TYPE", 23, 26], ["myeloid cells", "CELL_TYPE", 31, 44], ["CD11b + myeloid cells", "CELL_TYPE", 137, 158], ["T cells", "CELL_TYPE", 206, 213], ["C13 infection", "PROBLEM", 3, 16], ["myeloid cells", "PROBLEM", 31, 44], ["stimulating T cell proliferation", "PROBLEM", 60, 92], ["infection", "PROBLEM", 122, 131], ["CD11", "TEST", 137, 141], ["myeloid cells", "PROBLEM", 145, 158], ["C13", "ANATOMY", 3, 6], ["infection", "OBSERVATION", 7, 16], ["myeloid cells", "OBSERVATION", 31, 44], ["cell proliferation", "OBSERVATION", 74, 92], ["infection", "OBSERVATION", 122, 131], ["myeloid cells", "OBSERVATION", 145, 158]]], ["But in EcoHIV-infected mice, only DCs are functional in T cell priming (Fig. 5) .", [["DCs", "ANATOMY", 34, 37], ["T cell", "ANATOMY", 56, 62], ["EcoHIV", "GENE_OR_GENE_PRODUCT", 7, 13], ["mice", "ORGANISM", 23, 27], ["DCs", "CELL", 34, 37], ["T cell", "CELL", 56, 62], ["DCs", "CELL_TYPE", 34, 37], ["mice", "SPECIES", 23, 27], ["mice", "SPECIES", 23, 27], ["infected mice", "OBSERVATION", 14, 27]]], ["Myeloid cells from EcoHIV-infected mice were not able to stimulate T cell proliferation before 7 dpi (data not shown).", [["Myeloid cells", "ANATOMY", 0, 13], ["T cell", "ANATOMY", 67, 73], ["Myeloid cells", "CELL", 0, 13], ["EcoHIV", "GENE_OR_GENE_PRODUCT", 19, 25], ["mice", "ORGANISM", 35, 39], ["T cell", "CELL", 67, 73], ["Myeloid cells", "CELL_TYPE", 0, 13], ["T cell", "CELL_TYPE", 67, 73], ["mice", "SPECIES", 35, 39], ["mice", "SPECIES", 35, 39], ["Myeloid cells", "PROBLEM", 0, 13], ["EcoHIV", "TEST", 19, 25], ["infected mice", "PROBLEM", 26, 39]]], ["Instead, Gr1 + cells suppressed memory CD8 + T cells proliferation during this time period in vaccinated and EcoHIV-challenged mice (Fig. 6) , suggesting earlier induction of MDSCs during secondary response.", [["Gr1 + cells", "ANATOMY", 9, 20], ["memory CD8 + T cells", "ANATOMY", 32, 52], ["MDSCs", "ANATOMY", 175, 180], ["Gr1 + cells", "CELL", 9, 20], ["CD8", "GENE_OR_GENE_PRODUCT", 39, 42], ["EcoHIV", "ORGANISM", 109, 115], ["mice", "ORGANISM", 127, 131], ["MDSCs", "CELL", 175, 180], ["Gr1", "PROTEIN", 9, 12], ["memory CD8 + T cells", "CELL_TYPE", 32, 52], ["MDSCs", "CELL_TYPE", 175, 180], ["mice", "SPECIES", 127, 131], ["mice", "SPECIES", 127, 131], ["T cells proliferation", "PROBLEM", 45, 66], ["earlier induction of MDSCs", "TREATMENT", 154, 180]]], ["This might be because memory T cells response employ different mechanisms from those involved in the priming of na\u00efve T cells.", [["memory T cells", "ANATOMY", 22, 36], ["na\u00efve T cells", "ANATOMY", 112, 125], ["memory T cells", "CELL", 22, 36], ["na\u00efve T cells", "CELL", 112, 125], ["memory T cells", "CELL_TYPE", 22, 36], ["na\u00efve T cells", "CELL_TYPE", 112, 125], ["memory T cells", "PROBLEM", 22, 36]]], ["It is also possible that a robust memory CD8 + T cell response during the first few days of EcoHIV infection accelerated MDSC induction.", [["memory CD8 + T cell", "ANATOMY", 34, 53], ["MDSC", "ANATOMY", 121, 125], ["infection", "DISEASE", 99, 108], ["CD8", "GENE_OR_GENE_PRODUCT", 41, 44], ["EcoHIV", "ORGANISM", 92, 98], ["MDSC", "CELL", 121, 125], ["CD8", "PROTEIN", 41, 44], ["MDSC", "CELL_TYPE", 121, 125], ["EcoHIV", "SPECIES", 92, 98], ["T cell response", "PROBLEM", 47, 62], ["EcoHIV infection", "PROBLEM", 92, 108], ["accelerated MDSC induction", "TREATMENT", 109, 135], ["also possible", "UNCERTAINTY", 6, 19], ["cell response", "OBSERVATION", 49, 62], ["infection", "OBSERVATION", 99, 108], ["MDSC induction", "OBSERVATION", 121, 135]]], ["Consistent with this, it has previously been reported that interferon g produced by effector T cells upon recognition of viral antigens can induce iNOS production in monocytic cells, which in turn inhibits T cell function [46] .", [["effector T cells", "ANATOMY", 84, 100], ["monocytic cells", "ANATOMY", 166, 181], ["T cell", "ANATOMY", 206, 212], ["interferon g", "GENE_OR_GENE_PRODUCT", 59, 71], ["effector T cells", "CELL", 84, 100], ["iNOS", "GENE_OR_GENE_PRODUCT", 147, 151], ["monocytic cells", "CELL", 166, 181], ["T cell", "CELL", 206, 212], ["interferon g", "PROTEIN", 59, 71], ["effector T cells", "CELL_TYPE", 84, 100], ["viral antigens", "PROTEIN", 121, 135], ["iNOS", "PROTEIN", 147, 151], ["monocytic cells", "CELL_TYPE", 166, 181], ["interferon g", "TREATMENT", 59, 71], ["effector T cells", "PROBLEM", 84, 100], ["viral antigens", "PROBLEM", 121, 135], ["iNOS production in monocytic cells", "PROBLEM", 147, 181], ["monocytic cells", "OBSERVATION", 166, 181]]], ["Interestingly, there is a slight recovery of CD4 + T cell proliferation at 3 wpi, coincide with the slightly drop of MDSC frequency (Fig. 3) .DiscussionOf note, persistent LCMV infection has been linked to increased susceptibility of DCs and myeloid derived cells to infection [47, 48] .", [["CD4 + T cell", "ANATOMY", 45, 57], ["MDSC", "ANATOMY", 117, 121], ["DCs", "ANATOMY", 234, 237], ["myeloid derived cells", "ANATOMY", 242, 263], ["LCMV infection", "DISEASE", 172, 186], ["infection", "DISEASE", 267, 276], ["CD4", "GENE_OR_GENE_PRODUCT", 45, 48], ["MDSC", "CELL", 117, 121], ["LCMV", "ORGANISM", 172, 176], ["DCs", "CELL", 234, 237], ["myeloid derived cells", "CELL", 242, 263], ["CD4", "PROTEIN", 45, 48], ["MDSC", "CELL_TYPE", 117, 121], ["DCs", "CELL_TYPE", 234, 237], ["myeloid derived cells", "CELL_TYPE", 242, 263], ["LCMV", "SPECIES", 172, 176], ["CD4", "TEST", 45, 48], ["T cell proliferation", "PROBLEM", 51, 71], ["the slightly drop of MDSC frequency", "PROBLEM", 96, 131], ["persistent LCMV infection", "PROBLEM", 161, 186], ["DCs", "PROBLEM", 234, 237], ["myeloid derived cells", "PROBLEM", 242, 263], ["infection", "PROBLEM", 267, 276], ["slight", "OBSERVATION_MODIFIER", 26, 32], ["recovery", "OBSERVATION_MODIFIER", 33, 41], ["cell proliferation", "OBSERVATION", 53, 71], ["slightly", "OBSERVATION_MODIFIER", 100, 108], ["drop", "OBSERVATION_MODIFIER", 109, 113], ["MDSC frequency", "OBSERVATION", 117, 131], ["persistent", "OBSERVATION_MODIFIER", 161, 171], ["LCMV", "OBSERVATION_MODIFIER", 172, 176], ["infection", "OBSERVATION", 177, 186], ["increased", "OBSERVATION_MODIFIER", 206, 215], ["myeloid", "OBSERVATION", 242, 249]]], ["Their faster replication in DCs and myeloid cells outpaces the ability of the adaptive immune response to contain the infection, while also driving excessive immune activation, and inducing MDSC expansion [43, 48] .", [["DCs", "ANATOMY", 28, 31], ["myeloid cells", "ANATOMY", 36, 49], ["MDSC", "ANATOMY", 190, 194], ["infection", "DISEASE", 118, 127], ["DCs", "CELL", 28, 31], ["myeloid cells", "CELL", 36, 49], ["MDSC", "CELL", 190, 194], ["DCs", "CELL_TYPE", 28, 31], ["myeloid cells", "CELL_TYPE", 36, 49], ["MDSC", "CELL_TYPE", 190, 194], ["myeloid cells", "PROBLEM", 36, 49], ["the infection", "PROBLEM", 114, 127], ["myeloid cells", "OBSERVATION", 36, 49], ["infection", "OBSERVATION", 118, 127]]], ["MDSCs repress T cell function, and consequently hinder viral clearance [46] .", [["MDSCs", "ANATOMY", 0, 5], ["T cell", "ANATOMY", 14, 20], ["MDSCs", "CELL", 0, 5], ["T cell", "CELL", 14, 20], ["MDSCs", "CELL_TYPE", 0, 5]]], ["Although the frequency of EcoHIV infected cells is lower in mice overall, it also infects DCs and myeloid cells ( Fig. 6 and Fig. 8) , and induces MDSC expansion.", [["cells", "ANATOMY", 42, 47], ["DCs", "ANATOMY", 90, 93], ["myeloid cells", "ANATOMY", 98, 111], ["MDSC", "ANATOMY", 147, 151], ["cells", "CELL", 42, 47], ["mice", "ORGANISM", 60, 64], ["DCs", "CELL", 90, 93], ["myeloid cells", "CELL", 98, 111], ["Fig. 6", "CELL", 114, 120], ["MDSC", "CELL", 147, 151], ["EcoHIV infected cells", "CELL_LINE", 26, 47], ["DCs", "CELL_TYPE", 90, 93], ["myeloid cells", "CELL_TYPE", 98, 111], ["MDSC", "CELL_TYPE", 147, 151], ["mice", "SPECIES", 60, 64], ["EcoHIV", "SPECIES", 26, 32], ["mice", "SPECIES", 60, 64], ["EcoHIV infected cells", "PROBLEM", 26, 47], ["myeloid cells", "TEST", 98, 111], ["Fig.", "TEST", 114, 118], ["MDSC expansion", "PROBLEM", 147, 161], ["infected cells", "OBSERVATION", 33, 47], ["lower", "OBSERVATION_MODIFIER", 51, 56], ["myeloid cells", "OBSERVATION", 98, 111], ["MDSC expansion", "OBSERVATION", 147, 161]]], ["Unlike C13-infected mice, in which the majority of MDSCs are neutrophils, EcoHIV induced ly6c hi monocytic myeloid cell expansion, with continuous reduction of Gr1 hi neutrophils.", [["MDSCs", "ANATOMY", 51, 56], ["neutrophils", "ANATOMY", 61, 72], ["ly6c hi monocytic myeloid cell", "ANATOMY", 89, 119], ["Gr1 hi neutrophils", "ANATOMY", 160, 178], ["mice", "ORGANISM", 20, 24], ["MDSCs", "CELL", 51, 56], ["neutrophils", "CELL", 61, 72], ["EcoHIV", "CELL", 74, 80], ["ly6c hi monocytic myeloid cell", "CELL", 89, 119], ["Gr1 hi neutrophils", "CELL", 160, 178], ["MDSCs", "CELL_TYPE", 51, 56], ["neutrophils", "CELL_TYPE", 61, 72], ["Gr1 hi neutrophils", "CELL_TYPE", 160, 178], ["mice", "SPECIES", 20, 24], ["mice", "SPECIES", 20, 24], ["neutrophils", "TEST", 61, 72], ["EcoHIV", "TEST", 74, 80], ["monocytic myeloid cell expansion", "PROBLEM", 97, 129], ["infected mice", "OBSERVATION", 11, 24], ["MDSCs", "ANATOMY", 51, 56], ["ly6c hi monocytic myeloid cell expansion", "OBSERVATION", 89, 129], ["Gr1 hi neutrophils", "OBSERVATION", 160, 178]]], ["Further investigation revealed that both monocytes and neutrophils are infected.", [["monocytes", "ANATOMY", 41, 50], ["neutrophils", "ANATOMY", 55, 66], ["monocytes", "CELL", 41, 50], ["neutrophils", "CELL", 55, 66], ["monocytes", "CELL_TYPE", 41, 50], ["neutrophils", "CELL_TYPE", 55, 66], ["Further investigation", "TEST", 0, 21], ["infected", "PROBLEM", 71, 79], ["both monocytes", "OBSERVATION", 36, 50], ["neutrophils", "OBSERVATION_MODIFIER", 55, 66], ["infected", "OBSERVATION", 71, 79]]], ["However, MDSCs from EcoHIVinfected mice were more resistant to CTL-mediated apoptosis compared to MDSCs from our malignant mesothelioma model (Fig. 7) , in which most MDSCs are Gr1 hi MDSCs [18] , suggesting that EcoHIV induced monocytes might be more resistant to CTL-mediated apoptosis, while infected neutrophils were eliminated by virus-specific CD8 + T cells.DiscussionSimilarly, induction of myeloid cells expansion was demonstrated in blood of SIV infected macaques after two weeks of virus inoculation [32] .", [["MDSCs", "ANATOMY", 9, 14], ["MDSCs", "ANATOMY", 98, 103], ["malignant mesothelioma", "ANATOMY", 113, 135], ["MDSCs", "ANATOMY", 167, 172], ["MDSCs", "ANATOMY", 184, 189], ["monocytes", "ANATOMY", 228, 237], ["neutrophils", "ANATOMY", 304, 315], ["CD8 + T cells", "ANATOMY", 350, 363], ["myeloid cells", "ANATOMY", 398, 411], ["blood", "ANATOMY", 442, 447], ["malignant mesothelioma", "DISEASE", 113, 135], ["SIV infected", "DISEASE", 451, 463], ["MDSCs", "CELL", 9, 14], ["EcoHIVinfected mice", "ORGANISM", 20, 39], ["CTL", "CELL", 63, 66], ["MDSCs", "CELL", 98, 103], ["malignant mesothelioma", "CANCER", 113, 135], ["MDSCs", "CELL", 167, 172], ["Gr1 hi MDSCs", "CELL", 177, 189], ["EcoHIV", "GENE_OR_GENE_PRODUCT", 213, 219], ["monocytes", "CELL", 228, 237], ["CTL", "GENE_OR_GENE_PRODUCT", 265, 268], ["neutrophils", "CELL", 304, 315], ["CD8", "GENE_OR_GENE_PRODUCT", 350, 353], ["myeloid cells", "CELL", 398, 411], ["blood", "ORGANISM_SUBSTANCE", 442, 447], ["SIV", "ORGANISM", 451, 454], ["macaques", "ORGANISM", 464, 472], ["MDSCs", "CELL_TYPE", 9, 14], ["MDSCs", "CELL_TYPE", 98, 103], ["MDSCs", "CELL_TYPE", 167, 172], ["MDSCs", "CELL_TYPE", 184, 189], ["monocytes", "CELL_TYPE", 228, 237], ["infected neutrophils", "CELL_TYPE", 295, 315], ["CD8 + T cells", "CELL_TYPE", 350, 363], ["myeloid cells", "CELL_TYPE", 398, 411], ["mice", "SPECIES", 35, 39], ["macaques", "SPECIES", 464, 472], ["mice", "SPECIES", 35, 39], ["SIV", "SPECIES", 451, 454], ["MDSCs", "PROBLEM", 9, 14], ["CTL", "TEST", 63, 66], ["apoptosis", "PROBLEM", 76, 85], ["MDSCs", "PROBLEM", 98, 103], ["our malignant mesothelioma model", "PROBLEM", 109, 141], ["EcoHIV induced monocytes", "PROBLEM", 213, 237], ["CTL", "TEST", 265, 268], ["apoptosis", "PROBLEM", 278, 287], ["infected neutrophils", "PROBLEM", 295, 315], ["virus", "TEST", 335, 340], ["myeloid cells expansion", "PROBLEM", 398, 421], ["SIV infected macaques", "TREATMENT", 451, 472], ["virus inoculation", "TREATMENT", 492, 509], ["malignant", "OBSERVATION_MODIFIER", 113, 122], ["mesothelioma", "OBSERVATION", 123, 135], ["monocytes", "OBSERVATION", 228, 237], ["myeloid cells", "OBSERVATION", 398, 411]]], ["Expansion of MDSC in blood of HIV patients have also been observed in recent years [49] .", [["MDSC", "ANATOMY", 13, 17], ["blood", "ANATOMY", 21, 26], ["MDSC", "CELL", 13, 17], ["blood", "ORGANISM_SUBSTANCE", 21, 26], ["HIV", "ORGANISM", 30, 33], ["patients", "ORGANISM", 34, 42], ["MDSC", "CELL_TYPE", 13, 17], ["HIV", "SPECIES", 30, 33], ["patients", "SPECIES", 34, 42], ["HIV", "SPECIES", 30, 33], ["MDSC", "PROBLEM", 13, 17], ["HIV", "PROBLEM", 30, 33], ["MDSC", "OBSERVATION", 13, 17]]], ["However, infection of MDSCs during HIV/SIV infection has not been reported.", [["MDSCs", "ANATOMY", 22, 27], ["infection", "DISEASE", 9, 18], ["HIV/SIV infection", "DISEASE", 35, 52], ["MDSCs", "CELL", 22, 27], ["HIV", "ORGANISM", 35, 38], ["SIV", "ORGANISM", 39, 42], ["MDSCs", "CELL_TYPE", 22, 27], ["HIV", "SPECIES", 35, 38], ["HIV", "SPECIES", 35, 38], ["SIV", "SPECIES", 39, 42], ["infection of MDSCs", "PROBLEM", 9, 27], ["HIV/SIV infection", "PROBLEM", 35, 52], ["infection", "OBSERVATION", 9, 18], ["MDSCs", "OBSERVATION", 22, 27]]], ["Moreover, the impact of MDSC on HIV vaccine strategies, in particular on HIV therapeutic vaccine remains unknown.", [["MDSC", "ANATOMY", 24, 28], ["MDSC", "CELL", 24, 28], ["HIV", "ORGANISM", 32, 35], ["HIV", "ORGANISM", 73, 76], ["MDSC", "CELL_TYPE", 24, 28], ["HIV", "SPECIES", 32, 35], ["HIV", "SPECIES", 73, 76], ["MDSC", "TREATMENT", 24, 28], ["HIV vaccine strategies", "TREATMENT", 32, 54], ["HIV therapeutic vaccine", "TREATMENT", 73, 96], ["MDSC", "ANATOMY", 24, 28]]], ["Our data suggests that MDSCs was induced and suppressed T cell recall response as early as 7 dpi in vaccinated and EcoHIV-challenged mice.", [["MDSCs", "ANATOMY", 23, 28], ["T cell", "ANATOMY", 56, 62], ["EcoHIV", "CHEMICAL", 115, 121], ["MDSCs", "CELL", 23, 28], ["T cell", "CELL", 56, 62], ["EcoHIV", "SIMPLE_CHEMICAL", 115, 121], ["mice", "ORGANISM", 133, 137], ["MDSCs", "CELL_TYPE", 23, 28], ["mice", "SPECIES", 133, 137], ["mice", "SPECIES", 133, 137], ["Our data", "TEST", 0, 8], ["MDSCs", "OBSERVATION", 23, 28]]], ["In EcoHIV-challenged na\u00efve mice, repeated therapeutic vaccination elicited only low levels of p24-specific CD8 + T cell response (Fig. 4d) .", [["CD8 + T cell", "ANATOMY", 107, 119], ["EcoHIV", "CHEMICAL", 3, 9], ["EcoHIV", "SIMPLE_CHEMICAL", 3, 9], ["mice", "ORGANISM", 27, 31], ["p24", "GENE_OR_GENE_PRODUCT", 94, 97], ["CD8", "GENE_OR_GENE_PRODUCT", 107, 110], ["p24", "PROTEIN", 94, 97], ["CD8", "PROTEIN", 107, 110], ["mice", "SPECIES", 27, 31], ["mice", "SPECIES", 27, 31], ["repeated therapeutic vaccination", "TREATMENT", 33, 65], ["p24", "TEST", 94, 97]]], ["It is unclear whether EcoHIV infection suppressed CD8 + T cell priming by therapeutic vaccination, or first immunization-primed, antigen-specific CD8 + T cells quickly became exhausted in infected mice.", [["CD8 + T cell", "ANATOMY", 50, 62], ["CD8 + T cells", "ANATOMY", 146, 159], ["infection", "DISEASE", 29, 38], ["EcoHIV", "GENE_OR_GENE_PRODUCT", 22, 28], ["CD8", "GENE_OR_GENE_PRODUCT", 50, 53], ["CD8", "GENE_OR_GENE_PRODUCT", 146, 149], ["mice", "ORGANISM", 197, 201], ["CD8", "PROTEIN", 50, 53], ["antigen-specific CD8 + T cells", "CELL_TYPE", 129, 159], ["mice", "SPECIES", 197, 201], ["mice", "SPECIES", 197, 201], ["EcoHIV infection", "PROBLEM", 22, 38], ["T cell priming", "TREATMENT", 56, 70], ["therapeutic vaccination", "TREATMENT", 74, 97], ["first immunization", "TREATMENT", 102, 120], ["antigen", "TEST", 129, 136], ["unclear whether", "UNCERTAINTY", 6, 21], ["infection", "OBSERVATION", 29, 38], ["infected mice", "OBSERVATION", 188, 201]]], ["Testing earlier timepoints post vaccination would reveal whether these T cells quickly became exhausted or were never elicited.", [["T cells", "ANATOMY", 71, 78], ["T cells", "CELL", 71, 78], ["T cells", "CELL_TYPE", 71, 78], ["vaccination", "TREATMENT", 32, 43], ["these T cells", "PROBLEM", 65, 78], ["exhausted", "PROBLEM", 94, 103]]], ["The role of MDSCs on antiviral T cell memory recall responses in HIV vaccine clinical trial or macaque model of SIV/SHIV infection might be important to investigate for developing effective vaccines.DiscussionWe depleted myeloid cells during EcoHIV infection using an antibody (RB6\u00c08C5) that recognizes Gr1.", [["MDSCs", "ANATOMY", 12, 17], ["T cell", "ANATOMY", 31, 37], ["myeloid cells", "ANATOMY", 221, 234], ["SHIV infection", "DISEASE", 116, 130], ["infection", "DISEASE", 249, 258], ["MDSCs", "CELL", 12, 17], ["T cell", "CELL", 31, 37], ["HIV", "ORGANISM", 65, 68], ["macaque", "ORGANISM", 95, 102], ["SIV", "ORGANISM", 112, 115], ["SHIV", "ORGANISM", 116, 120], ["myeloid cells", "CELL", 221, 234], ["EcoHIV", "ORGANISM", 242, 248], ["RB6\u00c08C5", "GENE_OR_GENE_PRODUCT", 278, 285], ["Gr1", "GENE_OR_GENE_PRODUCT", 303, 306], ["MDSCs", "CELL_TYPE", 12, 17], ["myeloid cells", "CELL_TYPE", 221, 234], ["RB6\u00c08C5", "PROTEIN", 278, 285], ["Gr1", "PROTEIN", 303, 306], ["HIV", "SPECIES", 65, 68], ["HIV", "SPECIES", 65, 68], ["SIV", "SPECIES", 112, 115], ["SHIV", "SPECIES", 116, 120], ["EcoHIV", "SPECIES", 242, 248], ["antiviral T cell memory", "TREATMENT", 21, 44], ["HIV vaccine clinical trial", "TREATMENT", 65, 91], ["SIV/SHIV infection", "TREATMENT", 112, 130], ["depleted myeloid cells", "PROBLEM", 212, 234], ["EcoHIV infection", "PROBLEM", 242, 258], ["an antibody", "TEST", 265, 276], ["myeloid cells", "OBSERVATION", 221, 234], ["infection", "OBSERVATION", 249, 258]]], ["Gr1 is a marker predominantly expressed by MDSCs, and has been used in many studies to deplete neutrophils, monocytes, and MDSCs [24, 50] .", [["MDSCs", "ANATOMY", 43, 48], ["neutrophils", "ANATOMY", 95, 106], ["monocytes", "ANATOMY", 108, 117], ["MDSCs", "ANATOMY", 123, 128], ["Gr1", "GENE_OR_GENE_PRODUCT", 0, 3], ["MDSCs", "CELL", 43, 48], ["neutrophils", "CELL", 95, 106], ["monocytes", "CELL", 108, 117], ["MDSCs", "CELL", 123, 128], ["Gr1", "PROTEIN", 0, 3], ["MDSCs", "CELL_TYPE", 43, 48], ["neutrophils", "CELL_TYPE", 95, 106], ["monocytes", "CELL_TYPE", 108, 117], ["MDSCs", "CELL_TYPE", 123, 128], ["neutrophils", "TEST", 95, 106], ["monocytes", "TEST", 108, 117], ["MDSCs", "TEST", 123, 128], ["MDSCs", "OBSERVATION", 43, 48]]], ["We tested the dose of antibody delivery that could reduce MDSCs in the blood by > 90% (Fig. S7) , and subsequently used the same dose and regimen of antibody to deplete MDSCs in vaccinated and infected mice.", [["MDSCs", "ANATOMY", 58, 63], ["blood", "ANATOMY", 71, 76], ["MDSCs", "ANATOMY", 169, 174], ["MDSCs", "CELL", 58, 63], ["blood", "ORGANISM_SUBSTANCE", 71, 76], ["MDSCs", "CELL", 169, 174], ["mice", "ORGANISM", 202, 206], ["MDSCs", "CELL_TYPE", 58, 63], ["MDSCs", "CELL_TYPE", 169, 174], ["mice", "SPECIES", 202, 206], ["mice", "SPECIES", 202, 206], ["antibody delivery", "TREATMENT", 22, 39], ["MDSCs", "PROBLEM", 58, 63], ["the blood", "TEST", 67, 76], ["regimen", "TREATMENT", 138, 145], ["antibody to deplete MDSCs", "TREATMENT", 149, 174]]], ["We found significant decrease of total myeloid cells, MDSCs and ly6c + pDCs and Mo-DCs at day 1 after antibody injection.", [["myeloid cells", "ANATOMY", 39, 52], ["MDSCs", "ANATOMY", 54, 59], ["ly6c + pDCs", "ANATOMY", 64, 75], ["Mo-DCs", "ANATOMY", 80, 86], ["myeloid cells", "CELL", 39, 52], ["MDSCs", "CELL", 54, 59], ["ly6c + pDCs", "CELL", 64, 75], ["Mo-DCs", "CELL", 80, 86], ["total myeloid cells", "CELL_TYPE", 33, 52], ["MDSCs", "CELL_TYPE", 54, 59], ["ly6c", "CELL_TYPE", 64, 68], ["pDCs", "CELL_TYPE", 71, 75], ["Mo-DCs", "CELL_TYPE", 80, 86], ["significant decrease of total myeloid cells", "PROBLEM", 9, 52], ["pDCs", "PROBLEM", 71, 75], ["antibody injection", "TREATMENT", 102, 120], ["significant", "OBSERVATION_MODIFIER", 9, 20], ["decrease", "OBSERVATION_MODIFIER", 21, 29], ["total myeloid cells", "OBSERVATION", 33, 52]]], ["Moreover, the loss of myeloid cells and pDCs correlated with decreased PD1 expression on CD8 + Tem cells, and significantly lowered frequency of p24 + cells and proviral load in peritoneal macrophages (Fig. 8) .", [["myeloid cells", "ANATOMY", 22, 35], ["pDCs", "ANATOMY", 40, 44], ["CD8 + Tem cells", "ANATOMY", 89, 104], ["p24 + cells", "ANATOMY", 145, 156], ["peritoneal macrophages", "ANATOMY", 178, 200], ["myeloid cells", "CELL", 22, 35], ["pDCs", "CELL", 40, 44], ["PD1", "GENE_OR_GENE_PRODUCT", 71, 74], ["CD8", "GENE_OR_GENE_PRODUCT", 89, 92], ["p24", "GENE_OR_GENE_PRODUCT", 145, 148], ["peritoneal macrophages", "CELL", 178, 200], ["myeloid cells", "CELL_TYPE", 22, 35], ["pDCs", "CELL_TYPE", 40, 44], ["PD1", "PROTEIN", 71, 74], ["CD8", "PROTEIN", 89, 92], ["Tem cells", "CELL_TYPE", 95, 104], ["p24", "PROTEIN", 145, 148], ["peritoneal macrophages", "CELL_TYPE", 178, 200], ["the loss of myeloid cells", "PROBLEM", 10, 35], ["decreased PD1 expression", "PROBLEM", 61, 85], ["CD8", "TEST", 89, 92], ["Tem cells", "TEST", 95, 104], ["p24 + cells", "PROBLEM", 145, 156], ["proviral load in peritoneal macrophages", "PROBLEM", 161, 200], ["myeloid cells", "OBSERVATION", 22, 35], ["p24 + cells", "OBSERVATION", 145, 156], ["proviral load", "OBSERVATION", 161, 174], ["peritoneal", "ANATOMY", 178, 188], ["macrophages", "OBSERVATION", 189, 200]]], ["Surprisingly, we did not observe a significant impact on proviral loads in the spleen.", [["spleen", "ANATOMY", 79, 85], ["spleen", "ORGAN", 79, 85], ["a significant impact on proviral loads in the spleen", "PROBLEM", 33, 85], ["significant", "OBSERVATION_MODIFIER", 35, 46], ["impact", "OBSERVATION", 47, 53], ["proviral loads", "OBSERVATION", 57, 71], ["spleen", "ANATOMY", 79, 85]]], ["The failure to reduce provirus in spleen significantly may be due to multiple factors.", [["spleen", "ANATOMY", 34, 40], ["provirus", "ORGANISM", 22, 30], ["spleen", "ORGAN", 34, 40], ["The failure", "PROBLEM", 0, 11], ["provirus in spleen", "PROBLEM", 22, 40], ["multiple factors", "PROBLEM", 69, 85], ["failure", "OBSERVATION", 4, 11], ["provirus", "OBSERVATION", 22, 30], ["spleen", "ANATOMY", 34, 40], ["may be due to", "UNCERTAINTY", 55, 68], ["multiple", "OBSERVATION_MODIFIER", 69, 77], ["factors", "OBSERVATION", 78, 85]]], ["Although myeloid cells are infected by EcoHIV, the frequency of these cells in the spleen is relatively low (Fig. 1) , and were not effectively depleted (Fig. S8) .", [["myeloid cells", "ANATOMY", 9, 22], ["cells", "ANATOMY", 70, 75], ["spleen", "ANATOMY", 83, 89], ["myeloid cells", "CELL", 9, 22], ["EcoHIV", "GENE_OR_GENE_PRODUCT", 39, 45], ["cells", "CELL", 70, 75], ["spleen", "ORGAN", 83, 89], ["S8", "GENE_OR_GENE_PRODUCT", 159, 161], ["myeloid cells", "CELL_TYPE", 9, 22], ["EcoHIV", "PROTEIN", 39, 45], ["S8", "PROTEIN", 159, 161], ["myeloid cells", "PROBLEM", 9, 22], ["myeloid cells", "OBSERVATION", 9, 22], ["infected", "OBSERVATION_MODIFIER", 27, 35], ["cells", "OBSERVATION", 70, 75], ["spleen", "ANATOMY", 83, 89], ["relatively", "OBSERVATION_MODIFIER", 93, 103], ["low", "OBSERVATION_MODIFIER", 104, 107]]], ["Moreover, they are but one of many cell types infected by EcoHIV at 2 wpi, including DCs (Fig. 8) and CD4 + T cells (Fig. 7) .", [["cell", "ANATOMY", 35, 39], ["DCs", "ANATOMY", 85, 88], ["CD4 + T cells", "ANATOMY", 102, 115], ["cell", "CELL", 35, 39], ["EcoHIV", "GENE_OR_GENE_PRODUCT", 58, 64], ["DCs", "CELL", 85, 88], ["CD4", "GENE_OR_GENE_PRODUCT", 102, 105], ["EcoHIV", "PROTEIN", 58, 64], ["DCs", "CELL_TYPE", 85, 88], ["CD4", "PROTEIN", 102, 105], ["T cells", "CELL_TYPE", 108, 115], ["DCs (Fig.", "TEST", 85, 94], ["CD4 + T cells", "PROBLEM", 102, 115], ["cell types", "OBSERVATION_MODIFIER", 35, 45], ["infected", "OBSERVATION", 46, 54]]], ["We did not observe a significant increase in memory CD8 + T cell response, which is likely because MDSCs are just one of several factors involved in the suppression of T cell responses during chronic infection.", [["memory CD8 + T cell", "ANATOMY", 45, 64], ["MDSCs", "ANATOMY", 99, 104], ["T cell", "ANATOMY", 168, 174], ["chronic infection", "DISEASE", 192, 209], ["CD8", "GENE_OR_GENE_PRODUCT", 52, 55], ["MDSCs", "CELL", 99, 104], ["T cell", "CELL", 168, 174], ["CD8", "PROTEIN", 52, 55], ["MDSCs", "CELL_TYPE", 99, 104], ["a significant increase", "PROBLEM", 19, 41], ["MDSCs", "PROBLEM", 99, 104], ["T cell responses", "PROBLEM", 168, 184], ["chronic infection", "PROBLEM", 192, 209], ["significant", "OBSERVATION_MODIFIER", 21, 32], ["increase", "OBSERVATION_MODIFIER", 33, 41], ["memory CD8", "OBSERVATION", 45, 55], ["cell response", "OBSERVATION", 60, 73], ["is likely", "UNCERTAINTY", 81, 90], ["chronic", "OBSERVATION_MODIFIER", 192, 199], ["infection", "OBSERVATION", 200, 209]]], ["Other factors, such as Treg cells, and PD1-PDL1 pathway, IL-10, and TGF-b, might suppress T cell response in MDSCs depleted mice.", [["Treg cells", "ANATOMY", 23, 33], ["T cell", "ANATOMY", 90, 96], ["MDSCs", "ANATOMY", 109, 114], ["Treg cells", "CELL", 23, 33], ["PD1", "GENE_OR_GENE_PRODUCT", 39, 42], ["PDL1", "GENE_OR_GENE_PRODUCT", 43, 47], ["IL-10", "GENE_OR_GENE_PRODUCT", 57, 62], ["TGF-b", "GENE_OR_GENE_PRODUCT", 68, 73], ["T cell", "CELL", 90, 96], ["MDSCs", "CELL", 109, 114], ["mice", "ORGANISM", 124, 128], ["Treg cells", "CELL_TYPE", 23, 33], ["PD1", "PROTEIN", 39, 42], ["PDL1", "PROTEIN", 43, 47], ["TGF-b", "PROTEIN", 68, 73], ["MDSCs", "CELL_TYPE", 109, 114], ["mice", "SPECIES", 124, 128], ["mice", "SPECIES", 124, 128], ["Other factors", "PROBLEM", 0, 13], ["Treg cells", "TEST", 23, 33], ["PD1", "TEST", 39, 42], ["IL", "TEST", 57, 59], ["TGF", "TEST", 68, 71], ["MDSCs depleted", "OBSERVATION", 109, 123]]], ["Moreover, Mo-DCs and pDCs also express ly6c, and were depleted by anti-Gr1 antibody.", [["Mo-DCs", "ANATOMY", 10, 16], ["pDCs", "ANATOMY", 21, 25], ["Mo-DCs", "CELL", 10, 16], ["pDCs", "CELL", 21, 25], ["ly6c", "GENE_OR_GENE_PRODUCT", 39, 43], ["anti-Gr1 antibody", "GENE_OR_GENE_PRODUCT", 66, 83], ["Mo-DCs", "CELL_TYPE", 10, 16], ["pDCs", "CELL_TYPE", 21, 25], ["ly6c", "PROTEIN", 39, 43], ["anti-Gr1 antibody", "PROTEIN", 66, 83]]], ["The depletion of Mo-DCs and pDC might compromise the T cell response in vivo.", [["Mo-DCs", "ANATOMY", 17, 23], ["pDC", "ANATOMY", 28, 31], ["T cell", "ANATOMY", 53, 59], ["Mo-DCs", "GENE_OR_GENE_PRODUCT", 17, 23], ["pDC", "CELL", 28, 31], ["T cell", "CELL", 53, 59], ["Mo-DCs", "PROTEIN", 17, 23], ["pDC", "CELL_TYPE", 28, 31], ["The depletion of Mo-DCs", "TREATMENT", 0, 23], ["pDC", "TREATMENT", 28, 31], ["depletion", "OBSERVATION", 4, 13], ["cell response", "OBSERVATION", 55, 68]]], ["In summary, we demonstrated that depletion of MDSC can enhance viral clearance in vaccinated mice.", [["MDSC", "ANATOMY", 46, 50], ["MDSC", "CELL", 46, 50], ["mice", "ORGANISM", 93, 97], ["MDSC", "CELL_TYPE", 46, 50], ["mice", "SPECIES", 93, 97], ["mice", "SPECIES", 93, 97], ["depletion of MDSC", "PROBLEM", 33, 50], ["MDSC", "ANATOMY", 46, 50]]], ["We believe that strategies that counteract the effects of MDSCs during acute infection could be highly valuable for the development of effective vaccines against chronic human infections like HIV and other persistent virus.", [["MDSCs", "ANATOMY", 58, 63], ["acute infection", "DISEASE", 71, 86], ["chronic human infections", "DISEASE", 162, 186], ["MDSCs", "CELL", 58, 63], ["human", "ORGANISM", 170, 175], ["HIV", "ORGANISM", 192, 195], ["MDSCs", "CELL_TYPE", 58, 63], ["human", "SPECIES", 170, 175], ["HIV", "SPECIES", 192, 195], ["human", "SPECIES", 170, 175], ["HIV", "SPECIES", 192, 195], ["MDSCs", "PROBLEM", 58, 63], ["acute infection", "PROBLEM", 71, 86], ["effective vaccines", "TREATMENT", 135, 153], ["chronic human infections", "PROBLEM", 162, 186], ["HIV", "PROBLEM", 192, 195], ["other persistent virus", "PROBLEM", 200, 222], ["infections", "OBSERVATION", 176, 186], ["persistent", "OBSERVATION_MODIFIER", 206, 216], ["virus", "OBSERVATION", 217, 222]]], ["The funding sources of this study had not involved in the study design, the collection, analysis and interpretation of the data, in the writing of the manuscript or in the decision to submit the paper for publication.Author contributionsZC, HW and LL are the principal investigator and co-principal investigators with overall responsibility for the design of the study.", [["this study", "TEST", 23, 33], ["the study", "TEST", 54, 63], ["the collection, analysis", "TEST", 72, 96], ["the data", "TEST", 119, 127], ["the study", "TEST", 359, 368]]], ["LL, QL and JP analyzed the data.", [["JP analyzed the data", "TEST", 11, 31], ["JP", "ANATOMY", 11, 13]]], ["LL, ZC, WH and KY contributed to drafting the manuscript.", [["ZC", "OBSERVATION_MODIFIER", 4, 6]]], ["LL, QL, PJ, ZD and JS extracted plasmid DNA and/or generated virus.", [["plasmid", "ANATOMY", 32, 39], ["DNA", "CELLULAR_COMPONENT", 40, 43], ["LL, QL, PJ, ZD and JS extracted plasmid DNA", "DNA", 0, 43], ["PJ", "TREATMENT", 8, 10], ["ZD", "TREATMENT", 12, 14], ["JS extracted plasmid DNA", "TREATMENT", 19, 43], ["generated virus", "PROBLEM", 51, 66], ["QL", "ANATOMY", 4, 6], ["PJ", "ANATOMY", 8, 10], ["ZD", "OBSERVATION", 12, 14]]], ["LQ, PJ, LL, TZ, HK and TH coordinated the viral inoculation, autopsy organization, and collection of autopsy materials of mice.", [["TZ", "CHEMICAL", 12, 14], ["TZ", "SIMPLE_CHEMICAL", 12, 14], ["HK", "GENE_OR_GENE_PRODUCT", 16, 18], ["TH", "GENE_OR_GENE_PRODUCT", 23, 25], ["mice", "ORGANISM", 122, 126], ["mice", "SPECIES", 122, 126], ["mice", "SPECIES", 122, 126], ["the viral inoculation", "PROBLEM", 38, 59], ["autopsy organization", "TEST", 61, 81], ["PJ", "ANATOMY", 4, 6], ["LL", "ANATOMY", 8, 10], ["TZ", "ANATOMY_MODIFIER", 12, 14], ["viral inoculation", "OBSERVATION", 42, 59]]], ["LL, KN, QL and JL was involved in the development and performance of the q-PCR assay.", [["the q-PCR assay", "TEST", 69, 84], ["KN", "OBSERVATION", 4, 6], ["JL", "ANATOMY", 15, 17]]], ["LL and KH were involved in the development and conduct of the H&E and IHC assays.", [["the H&E", "TEST", 58, 65], ["IHC assays", "TEST", 70, 80]]], ["LL, QL, PJ, TZ, TH, KL and FJ conducted T cell proliferation, ELISpot and FACS analyses.", [["T cell", "ANATOMY", 40, 46], ["TZ", "SIMPLE_CHEMICAL", 12, 14], ["TH", "GENE_OR_GENE_PRODUCT", 16, 18], ["T cell", "CELL", 40, 46], ["LL", "TEST", 0, 2], ["PJ", "TEST", 8, 10], ["ELISpot and FACS analyses", "TEST", 62, 87], ["QL", "ANATOMY", 4, 6], ["PJ", "ANATOMY", 8, 10], ["KL", "ANATOMY", 20, 22], ["FJ", "ANATOMY", 27, 29], ["cell proliferation", "OBSERVATION", 42, 60]]]], "713009d93eb4281b0e8aed1fea8b21c174175d64": [["(COVID-19) were reported worldwide.", [["COVID", "TEST", 1, 6]]], ["In Italy, no epidemiological study has been done yet to verify how many people have been infected.", [["people", "ORGANISM", 72, 78], ["people", "SPECIES", 72, 78], ["epidemiological study", "TEST", 13, 34], ["infected", "PROBLEM", 89, 97], ["infected", "OBSERVATION", 89, 97]]], ["Therefore, the real prevalence and mortality rate are not known.", [["mortality rate", "TEST", 35, 49]]], ["Since several doubts currently persist regarding the virus transmission dynamics, principally concerning the influence of asymptomatic subjects on the virus's spread, this article discusses the necessity of an epidemiological study on COVID-19 to estimate the number of infected people through a probability sample representing the population.", [["people", "ORGANISM", 279, 285], ["people", "SPECIES", 279, 285], ["the virus transmission dynamics", "PROBLEM", 49, 80], ["asymptomatic subjects", "PROBLEM", 122, 143], ["the virus's spread", "PROBLEM", 147, 165], ["an epidemiological study", "TEST", 207, 231], ["COVID", "TEST", 235, 240], ["infected", "OBSERVATION", 270, 278]]], ["Furthermore, the single use of serological tests to evaluate the prevalence of subjects with COVID-19 infection produces a significant reduced sensitivity in detecting these subjects.", [["COVID-19", "CHEMICAL", 93, 101], ["infection", "DISEASE", 102, 111], ["COVID-19", "ORGANISM", 93, 101], ["COVID-19", "SPECIES", 93, 101], ["serological tests", "TEST", 31, 48], ["COVID-19 infection", "PROBLEM", 93, 111], ["a significant reduced sensitivity", "PROBLEM", 121, 154], ["infection", "OBSERVATION", 102, 111]]], ["The authors suggest to combine the serological test and the pharyngeal swab RT-PCR together to improve the reliability of an epidemiological analysis on the spread of COVID-19.", [["pharyngeal swab", "ANATOMY", 60, 75], ["COVID-19", "DNA", 167, 175], ["the serological test", "TEST", 31, 51], ["the pharyngeal swab RT-PCR", "TEST", 56, 82], ["an epidemiological analysis", "TEST", 122, 149], ["COVID", "TEST", 167, 172], ["pharyngeal", "ANATOMY", 60, 70]]], ["A descriptive, analytical, clinical epidemiological research based on a significant statistical sample is necessary to understand the real impact of COVID-19 infection on our country and to have clear indications on which to base the definition of swab and serological testing policies, health practices and protocols, methods of managing economics and social activities.", [["COVID-19", "CHEMICAL", 149, 157], ["infection", "DISEASE", 158, 167], ["a significant statistical sample", "PROBLEM", 70, 102], ["COVID-19 infection", "PROBLEM", 149, 167], ["swab", "TEST", 248, 252], ["serological testing", "TEST", 257, 276]]], ["In Italy, no epidemiological study has been done to verify how many people have been infected.", [["people", "ORGANISM", 68, 74], ["people", "SPECIES", 68, 74], ["epidemiological study", "TEST", 13, 34], ["infected", "PROBLEM", 85, 93], ["infected", "OBSERVATION", 85, 93]]], ["We know that to date we have had 246,488 cases with 35,123 deaths, numbers highlighted by pharyngeal swabs RT-PCR performed on subjects suspected of COVID-19 and their close contacts excluding asymptomatic and paucysymptomatic individuals.", [["pharyngeal swabs", "ANATOMY", 90, 106], ["deaths", "DISEASE", 59, 65], ["pharyngeal swabs RT-PCR", "TEST", 90, 113], ["COVID", "TEST", 149, 154], ["asymptomatic and paucysymptomatic individuals", "PROBLEM", 193, 238], ["pharyngeal", "ANATOMY", 90, 100]]], ["Only in Vo'(Padua, Italy), nasopharyngeal swabs from 2,812 subjects were collected, corresponding to 85.9% of the entire Vo' population, a total of 73 individuals were positive and 30 of them (41.1%; 95% CI 29.7-53.2%) who tested positive were asymptomatic [1] .", [["nasopharyngeal swabs", "ANATOMY", 27, 47], ["nasopharyngeal swabs", "CANCER", 27, 47], ["subjects", "ORGANISM", 59, 67], ["individuals", "ORGANISM", 151, 162], ["nasopharyngeal swabs", "TEST", 27, 47], ["CI", "TEST", 204, 206], ["nasopharyngeal", "ANATOMY", 27, 41]]], ["The actual prevalence was 2.6% which would be decreased to 1.5% without asymptomatic cases.", [["asymptomatic cases", "PROBLEM", 72, 90]]], ["In Italy, only people with symptoms have been mainly tested so far, therefore official data greatly underestimate SARS-CoV-2 occurrence in all the population.J o u r n a l P r e -p r o o fSince several doubts currently persist regarding the virus transmission dynamics, principally concerning the influence of asymptomatic subjects on the virus's spread [2] , it would be vital to know their number, especially now that people's mobility restrictions are over.", [["SARS", "DISEASE", 114, 118], ["people", "ORGANISM", 15, 21], ["people", "ORGANISM", 420, 426], ["people", "SPECIES", 15, 21], ["people", "SPECIES", 420, 426], ["symptoms", "PROBLEM", 27, 35], ["official data", "TEST", 78, 91], ["fSince", "PROBLEM", 187, 193], ["the virus transmission dynamics", "PROBLEM", 237, 268], ["asymptomatic subjects", "PROBLEM", 310, 331], ["the virus's spread", "PROBLEM", 335, 353]]], ["This would let us know the real impact of the virus, control its spread and, at the same time, allow the population to maintain public and economic activities.J o u r n a l P r e -p r o o fWe should probably estimate the number of infected people through a probability sample representing the population obtained by randomly selecting people from the municipal civil record list, following a sampling strategy.", [["people", "ORGANISM", 240, 246], ["people", "ORGANISM", 335, 341], ["people", "SPECIES", 240, 246], ["people", "SPECIES", 335, 341], ["the virus", "PROBLEM", 42, 51], ["fWe", "PROBLEM", 188, 191], ["a sampling strategy", "TREATMENT", 390, 409], ["infected", "OBSERVATION", 231, 239]]], ["By carrying out the RT-PCR test in association with serology tests we could estimate quite correctly the prevalence of SARS-CoV-2 in the target population.", [["SARS", "DISEASE", 119, 123], ["SARS-CoV-2", "ORGANISM", 119, 129], ["SARS-CoV", "SPECIES", 119, 127], ["the RT-PCR test", "TEST", 16, 31], ["serology tests", "TEST", 52, 66], ["SARS", "PROBLEM", 119, 123], ["CoV", "TEST", 124, 127]]], ["In fact, the gold standard for COVID-19 diagnosis was nucleic acid testing for SARS-CoV-2 by RT-PCR.J o u r n a l P r e -p r o o fHowever, false-negative results may occur due to the presence of amplification inhibitors in the sample or insufficient organisms rising from inappropriate collection, transportation, or handling.", [["sample", "ANATOMY", 227, 233], ["nucleic acid", "CHEMICAL", 54, 66], ["SARS", "DISEASE", 79, 83], ["nucleic acid", "SIMPLE_CHEMICAL", 54, 66], ["SARS-CoV", "SPECIES", 79, 87], ["COVID", "TEST", 31, 36], ["nucleic acid testing", "TEST", 54, 74], ["SARS", "TEST", 79, 83], ["CoV", "TEST", 84, 87], ["RT", "TEST", 93, 95], ["PCR", "TEST", 96, 99], ["fHowever", "TEST", 129, 137], ["false", "TEST", 139, 144], ["amplification inhibitors", "PROBLEM", 195, 219], ["the sample", "TEST", 223, 233], ["insufficient organisms", "PROBLEM", 237, 259], ["inappropriate collection", "PROBLEM", 272, 296]]], ["On the other hand, serological tests could also lead to several cases of false negatives therefore there might be no evidence of their reliability on asymptomatic patients.", [["patients", "ORGANISM", 163, 171], ["patients", "SPECIES", 163, 171], ["serological tests", "TEST", 19, 36], ["false negatives", "PROBLEM", 73, 88], ["no evidence of", "UNCERTAINTY", 114, 128]]], ["There are many serological tests and each of them is differently reliable.", [["many serological tests", "TEST", 10, 32]]], ["An analysis of various serological tests has concluded that both IgM and IgG tests' sensitivity ranges between 72.7% and 100%, while specificity varies between 98.7% to 100% [3] .", [["IgM", "GENE_OR_GENE_PRODUCT", 65, 68], ["IgG", "GENE_OR_GENE_PRODUCT", 73, 76], ["IgM", "PROTEIN", 65, 68], ["IgG", "PROTEIN", 73, 76], ["An analysis", "TEST", 0, 11], ["various serological tests", "TEST", 15, 40], ["IgM", "TEST", 65, 68], ["IgG tests' sensitivity", "TEST", 73, 95], ["specificity", "TEST", 133, 144]]], ["Furthermore, these tests may give false negative responses in COVID-19 infection's early phase.", [["infection", "DISEASE", 71, 80], ["COVID-19", "CELL", 62, 70], ["COVID-19", "SPECIES", 62, 70], ["these tests", "TEST", 13, 24], ["COVID", "TEST", 62, 67]]], ["In fact, the seroconversion of specific IgM and IgG antibodies was observed as early as the 4th day after J o u r n a l P r e -p r o o f symptom onset [4] or even after 9 days [5] .", [["IgM", "GENE_OR_GENE_PRODUCT", 40, 43], ["IgG antibodies", "GENE_OR_GENE_PRODUCT", 48, 62], ["IgM", "PROTEIN", 40, 43], ["IgG antibodies", "PROTEIN", 48, 62], ["specific IgM", "TEST", 31, 43], ["IgG antibodies", "TEST", 48, 62], ["symptom onset", "PROBLEM", 137, 150]]], ["This can lead to low sensitivity of serological tests.", [["serological tests", "TEST", 36, 53]]], ["Actually, in confirmed COVID-19 patients, sensitivity and specificity percentages of IgM to detect disease were 77.3% (51/66) and 100%, while those of IgG were 83.3% (55/66) and 95.0% respectively [4] .", [["patients", "ORGANISM", 32, 40], ["IgM", "GENE_OR_GENE_PRODUCT", 85, 88], ["IgG", "GENE_OR_GENE_PRODUCT", 151, 154], ["IgM", "PROTEIN", 85, 88], ["IgG", "PROTEIN", 151, 154], ["patients", "SPECIES", 32, 40], ["COVID", "TEST", 23, 28], ["sensitivity", "TEST", 42, 53], ["IgM", "TEST", 85, 88], ["disease", "PROBLEM", 99, 106], ["IgG", "TEST", 151, 154]]], ["In patients with suspected COVID-19, sensitivity and specificity of IgM were 87.5% (21/24) and 100% and those of IgG were 70.8% (17/24) and 96.6% [4] .", [["patients", "ORGANISM", 3, 11], ["IgM", "GENE_OR_GENE_PRODUCT", 68, 71], ["IgG", "GENE_OR_GENE_PRODUCT", 113, 116], ["IgM", "PROTEIN", 68, 71], ["IgG", "PROTEIN", 113, 116], ["patients", "SPECIES", 3, 11], ["suspected COVID", "TEST", 17, 32], ["sensitivity", "TEST", 37, 48], ["IgM", "TEST", 68, 71], ["IgG", "TEST", 113, 116]]], ["Therefore, antibodies against SARS-CoV-2 can be detected from mid to late stages of the disease significantly reducing its sensitivity during its early stages.", [["SARS-CoV-2", "ORGANISM", 30, 40], ["antibodies", "PROTEIN", 11, 21], ["SARS-CoV", "SPECIES", 30, 38], ["antibodies", "TEST", 11, 21], ["SARS", "PROBLEM", 30, 34], ["CoV", "TEST", 35, 38], ["the disease", "PROBLEM", 84, 95], ["late stages", "OBSERVATION_MODIFIER", 69, 80], ["disease", "OBSERVATION", 88, 95]]], ["Carrying out the pharyngeal swab RT-PCR and serological tests together could reduce the sensitivity gap of the latter.", [["pharyngeal swab", "ANATOMY", 17, 32], ["the pharyngeal swab RT-PCR", "TEST", 13, 39], ["serological tests", "TEST", 44, 61], ["pharyngeal", "ANATOMY", 17, 27]]], ["Other authors agree with the combined use of the two tests since, as already mentioned, viral nucleic acid and antibody concentrations fluctuate in different infection stages.", [["nucleic acid", "CHEMICAL", 94, 106], ["infection", "DISEASE", 158, 167], ["the two tests", "TEST", 45, 58], ["viral nucleic acid", "TEST", 88, 106], ["antibody concentrations", "PROBLEM", 111, 134], ["different infection stages", "PROBLEM", 148, 174], ["different", "OBSERVATION_MODIFIER", 148, 157], ["infection", "OBSERVATION", 158, 167]]], ["Consequently, using a combination of molecular and serological assays may permit to determine SARS-CoV-2 infection more effectively [6] .", [["infection", "DISEASE", 105, 114], ["SARS-CoV-2", "ORGANISM", 94, 104], ["SARS-CoV-2", "SPECIES", 94, 104], ["molecular and serological assays", "TEST", 37, 69], ["SARS", "PROBLEM", 94, 98], ["CoV-2 infection", "PROBLEM", 99, 114]]], ["In fact, in patients with undetectable RNA in their respiratory tract samplesFundingThis work received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.", [["respiratory tract samples", "ANATOMY", 52, 77], ["patients", "ORGANISM", 12, 20], ["patients", "SPECIES", 12, 20], ["undetectable RNA in their respiratory tract samples", "PROBLEM", 26, 77], ["respiratory tract", "ANATOMY", 52, 69]]]], "43c7ba111ae18ffa359129e252428f3dcc260b14": [["Introduction 9 early as day 1 in both BAL and peripheral blood, similar to previous reports from humans 161 infected with SARS-CoV-2 (Liao et al., 2020 , Ravindra et al., 2020 , Xiong et al., 2020 .", [["BAL", "ANATOMY", 38, 41], ["peripheral blood", "ANATOMY", 46, 62], ["SARS", "DISEASE", 122, 126], ["BAL", "CELL", 38, 41], ["peripheral blood", "ORGANISM_SUBSTANCE", 46, 62], ["humans", "ORGANISM", 97, 103], ["SARS-CoV-2", "ORGANISM", 122, 132], ["humans", "SPECIES", 97, 103], ["humans", "SPECIES", 97, 103], ["SARS-CoV", "SPECIES", 122, 130], ["peripheral blood", "TEST", 46, 62], ["SARS", "PROBLEM", 122, 126], ["peripheral", "ANATOMY_MODIFIER", 46, 56], ["blood", "ANATOMY", 57, 62]]], ["GSEA 162 (Subramanian et al., 2005) showed significant increase of pathways of interferon alpha (IFN\u03b1), 163 interferon gamma (IFN\u03b3), TNF\u03b1 and inflammatory signaling on days 1-4 in BAL and peripheral 164 blood of infected macaques ( Figure 3A) .", [["BAL", "ANATOMY", 180, 183], ["peripheral 164 blood", "ANATOMY", 188, 208], ["interferon alpha", "GENE_OR_GENE_PRODUCT", 79, 95], ["IFN\u03b1", "GENE_OR_GENE_PRODUCT", 97, 101], ["163 interferon gamma", "GENE_OR_GENE_PRODUCT", 104, 124], ["IFN\u03b3", "GENE_OR_GENE_PRODUCT", 126, 130], ["TNF\u03b1", "GENE_OR_GENE_PRODUCT", 133, 137], ["BAL", "CELL", 180, 183], ["blood", "ORGANISM_SUBSTANCE", 203, 208], ["macaques", "ORGANISM", 221, 229], ["interferon alpha", "PROTEIN", 79, 95], ["IFN\u03b1", "PROTEIN", 97, 101], ["interferon gamma", "PROTEIN", 108, 124], ["IFN\u03b3", "PROTEIN", 126, 130], ["TNF\u03b1", "PROTEIN", 133, 137], ["macaques", "SPECIES", 221, 229], ["GSEA", "TEST", 0, 4], ["significant increase of pathways", "PROBLEM", 43, 75], ["interferon alpha (IFN\u03b1", "TREATMENT", 79, 101], ["interferon gamma", "TEST", 108, 124], ["TNF", "PROBLEM", 133, 136], ["inflammatory signaling", "PROBLEM", 142, 164], ["BAL", "TEST", 180, 183], ["significant", "OBSERVATION_MODIFIER", 43, 54], ["increase", "OBSERVATION_MODIFIER", 55, 63], ["interferon gamma", "OBSERVATION", 108, 124], ["inflammatory", "OBSERVATION_MODIFIER", 142, 154], ["peripheral", "ANATOMY", 188, 198], ["infected macaques", "OBSERVATION", 212, 229]]], ["165 We observed a significant upregulation of ISGs and antiviral genes, including MX1, 166 MX2, IFIT1-3, ISG15, IRF7, IFTM1, IFTM2, OAS1/2/3, DDX58 and IDO1 in BAL ( Figure 167 3B) and peripheral blood ( Figure 3C ) as well as upregulation of inflammasome pathway, TLRs 168 (TLR2/5/7), TNF\u03b1, CSF, and NF-\u03baB.", [["BAL", "ANATOMY", 160, 163], ["peripheral blood", "ANATOMY", 185, 201], ["ISGs", "GENE_OR_GENE_PRODUCT", 46, 50], ["MX1", "GENE_OR_GENE_PRODUCT", 82, 85], ["MX2", "GENE_OR_GENE_PRODUCT", 91, 94], ["IFIT1-3", "GENE_OR_GENE_PRODUCT", 96, 103], ["ISG15", "GENE_OR_GENE_PRODUCT", 105, 110], ["IRF7", "GENE_OR_GENE_PRODUCT", 112, 116], ["IFTM1", "GENE_OR_GENE_PRODUCT", 118, 123], ["IFTM2", "GENE_OR_GENE_PRODUCT", 125, 130], ["OAS1", "GENE_OR_GENE_PRODUCT", 132, 136], ["2/3", "GENE_OR_GENE_PRODUCT", 137, 140], ["DDX58", "GENE_OR_GENE_PRODUCT", 142, 147], ["IDO1", "GENE_OR_GENE_PRODUCT", 152, 156], ["Figure 167 3B", "GENE_OR_GENE_PRODUCT", 166, 179], ["peripheral", "ORGANISM_SUBSTANCE", 185, 195], ["blood", "ORGANISM_SUBSTANCE", 196, 201], ["Figure 3C", "GENE_OR_GENE_PRODUCT", 204, 213], ["TLRs 168", "GENE_OR_GENE_PRODUCT", 265, 273], ["TLR2", "GENE_OR_GENE_PRODUCT", 275, 279], ["5/7", "GENE_OR_GENE_PRODUCT", 280, 283], ["TNF\u03b1", "GENE_OR_GENE_PRODUCT", 286, 290], ["CSF", "GENE_OR_GENE_PRODUCT", 292, 295], ["NF-\u03baB.", "GENE_OR_GENE_PRODUCT", 301, 307], ["ISGs", "DNA", 46, 50], ["antiviral genes", "DNA", 55, 70], ["MX1", "DNA", 82, 85], ["MX2", "DNA", 91, 94], ["IFIT1", "DNA", 96, 101], ["ISG15", "DNA", 105, 110], ["IRF7", "DNA", 112, 116], ["IFTM1", "DNA", 118, 123], ["IFTM2", "DNA", 125, 130], ["OAS1", "DNA", 132, 136], ["2/3", "DNA", 137, 140], ["DDX58", "DNA", 142, 147], ["IDO1", "DNA", 152, 156], ["TLRs 168", "PROTEIN", 265, 273], ["TLR2", "PROTEIN", 275, 279], ["TNF\u03b1", "PROTEIN", 286, 290], ["CSF", "PROTEIN", 292, 295], ["NF", "PROTEIN", 301, 303], ["a significant upregulation of ISGs", "PROBLEM", 16, 50], ["antiviral genes", "TREATMENT", 55, 70], ["IFIT1", "TEST", 96, 101], ["ISG15", "TEST", 105, 110], ["IRF7", "TEST", 112, 116], ["IFTM1", "TEST", 118, 123], ["IFTM2", "TEST", 125, 130], ["OAS1", "TEST", 132, 136], ["DDX58", "TEST", 142, 147], ["IDO1 in BAL", "TEST", 152, 163], ["Figure", "TEST", 166, 172], ["peripheral blood ( Figure 3C", "TREATMENT", 185, 213], ["upregulation of inflammasome pathway", "TREATMENT", 227, 263], ["TLRs", "TEST", 265, 269], ["TLR2", "TEST", 275, 279], ["TNF", "TEST", 286, 289], ["CSF", "TEST", 292, 295], ["NF", "TEST", 301, 303], ["significant", "OBSERVATION_MODIFIER", 18, 29], ["upregulation", "OBSERVATION", 30, 42], ["ISGs", "OBSERVATION", 46, 50], ["antiviral genes", "OBSERVATION", 55, 70], ["peripheral", "ANATOMY_MODIFIER", 185, 195], ["blood", "ANATOMY", 196, 201], ["CSF", "ANATOMY", 292, 295]]], ["Of note, RNA levels of IFN\u03b1 genes including IFNA8, 169 IFNA2, IFNA4, and IFNA10 were increased by SARS-CoV-2 in BAL ( Figure 3B ), while these 170", [["BAL", "ANATOMY", 112, 115], ["IFN\u03b1", "GENE_OR_GENE_PRODUCT", 23, 27], ["IFNA8", "GENE_OR_GENE_PRODUCT", 44, 49], ["169", "GENE_OR_GENE_PRODUCT", 51, 54], ["IFNA2", "GENE_OR_GENE_PRODUCT", 55, 60], ["IFNA4", "GENE_OR_GENE_PRODUCT", 62, 67], ["IFNA10", "GENE_OR_GENE_PRODUCT", 73, 79], ["BAL", "CELL", 112, 115], ["IFN\u03b1 genes", "DNA", 23, 33], ["IFNA8", "DNA", 44, 49], ["IFNA2", "DNA", 55, 60], ["IFNA4", "DNA", 62, 67], ["IFNA10", "DNA", 73, 79], ["SARS-CoV", "SPECIES", 98, 106], ["RNA levels", "TEST", 9, 19], ["IFN", "TEST", 23, 26], ["IFNA8", "TEST", 44, 49], ["IFNA2", "TEST", 55, 60], ["IFNA4", "TEST", 62, 67], ["IFNA10", "TEST", 73, 79], ["SARS", "TEST", 98, 102], ["CoV", "TEST", 103, 106]]]], "0cbef8e0d916f8355fa2423d91360fc14b09124a": [["IntroductionBilingual lexicons have been a key building block for effective Machine Translation systems for the last few decades [1, 2, 3] .", [["effective Machine Translation systems", "TREATMENT", 66, 103]]], ["Several prominent recent lines of work on bilingual lexicon induction [4, 5, 6, 7, 8, 2, 3] involve training embeddings on two monolingual corpora and learning a mapping between the two embeddings.IntroductionIn this widely studied NLP problem, primary focus areas are (1) methods (e.g., joint training [6] versus separate training [9] ; incorporating adversarial approaches [10, 11, 3] ) (2) performance and (3) alleviating resource requirements (e.g., seed lexicon, parallel data).", [["corpora", "MULTI-TISSUE_STRUCTURE", 139, 146], ["bilingual lexicon induction", "TREATMENT", 42, 69], ["IntroductionIn", "TREATMENT", 197, 211], ["joint training", "TREATMENT", 288, 302], ["prominent", "OBSERVATION_MODIFIER", 8, 17], ["lines", "OBSERVATION_MODIFIER", 25, 30], ["joint", "ANATOMY", 288, 293]]], ["With a combined language base of more than 500 million Hindi speakers in India and Pakistan, and prior studies reporting that more than 90% of Indian language texts found on the web are Romanized [12] , rich bilingual lexicons would help in the under-explored task of analyzing Romanized Hindi web content.IntroductionIn this paper, we describe a surprisingly simple technique to retrieve bilingual lexicons.", [["prior studies", "TEST", 97, 110]]], ["We find that by (1) training a single Skip-gram model on the whole multilingual corpus, and (2) conducting a constrained nearest neighbor sampling on the resulting polyglot word embedding space for a given source word, we can retrieve substantial bilingual lexicons even in harsh social media multilingual data sets.", [["corpus", "ANATOMY", 80, 86], ["corpus", "MULTI-TISSUE_STRUCTURE", 80, 86], ["the resulting polyglot word embedding space", "TREATMENT", 150, 193]]], ["On two data sets found in the literature [13, 14] and one data set first introduced in this paper, we demonstrate that without any parallel data, monolingual corpora or seed lexicon, our method Figure 1 : A t-SNE [16] 2D visualization of Skip-gram polyglot embeddings trained on (a) a data set of 2.04 million YouTube comments relevant to the 2019 India-Pakistan conflict [13] and (b) en-es Europarl corpus [17] .", [["2D visualization", "TEST", 218, 234], ["Skip", "TEST", 238, 242]]], ["These results indicate that naive nearest neighbor sampling of a word yields other words with similar meaning in the same language. retrieves substantial lexicons.", [["substantial", "OBSERVATION_MODIFIER", 142, 153], ["lexicons", "OBSERVATION", 154, 162]]], ["We then demonstrate practical benefits of our bilingual lexicon through a cross-lingual sampling task defined in [15] .", [["a cross-lingual sampling task", "TREATMENT", 72, 101]]], ["Our method obtains a 45% improvement over previously reported results.IntroductionWhile our performance numbers are encouraging, we see our paper primarily as a discovery paper where we are intrigued by the observation that polyglot Skip-gram embeddings trained on a multilingual corpus learn a rich semantic representation that captures word meanings across languages.", [["corpus", "ORGAN", 280, 286]]], ["Our experiments reveal that our method can retrieve bilingual lexicons even across European language pairs.", [["Our experiments", "TEST", 0, 15], ["bilingual lexicons", "TREATMENT", 52, 70]]], ["(3) Release the resulting lexicons of 1,100 word pairs.", [["1,100 word pairs", "DNA", 38, 54]]], ["(4) Provide a purely unsupervised cross-lingual sampling technique for an important humanitarian domain.", [["a purely unsupervised cross-lingual sampling technique", "TREATMENT", 12, 66]]], ["(5) Provide insights into our finding on polyglot word embeddings with a broad study across several language pairs.Our ApproachThe Skip-gram objective predicts an input word's context [9] .", [["a broad study", "TEST", 71, 84]]], ["When two separate Skip-gram models are trained on two monolingual corpora, it is observed that the trained embeddings exhibit isomorphism [4] and using a seed lexicon, a linear projection can be learned to construct a bilingual lexicon.Our ApproachWhat happens when we train a single Skip-gram model on a bilingual corpus ?", [["corpus", "ANATOMY", 315, 321], ["corpora", "MULTI-TISSUE_STRUCTURE", 66, 73], ["corpus", "ORGAN", 315, 321], ["a linear projection", "TREATMENT", 168, 187]]], ["Intuitively, sampling a word's nearest neighbors in a polyglot embedding space trained on a bilingual corpus would still yield semantically similar words in the same language of the probe word.", [["corpus", "CANCER", 102, 108], ["a polyglot embedding space", "TREATMENT", 52, 78]]], ["Or, in Skip-gram polyglot word-embeddings trained on a noisy social media English-Romanized Hindi corpus of YouTube video comments relevant to the 2019 India-Pakistan conflict [13] , we notice that nearest neighbors of a word include spelling variations and incorrect spellings of a word along with words with similar meanings.Our ApproachDo these polyglot word embeddings capture richer semantic structures that tell us lucha and fight or religion and mazhab are related, in fact, synonymous to each other?", [["mazhab", "GENE_OR_GENE_PRODUCT", 453, 459], ["Skip-gram polyglot word", "DNA", 7, 30], ["spelling variations", "PROBLEM", 234, 253]]], ["In this paper, we describe a surprisingly simple constrained nearest neighbor sampling that allows us to retrieve substantial bilingual lexicon that requires (1) no seed lexicon (2) no parallel data and even (3) no monolingual corpora.", [["corpora", "MULTI-TISSUE_STRUCTURE", 227, 234], ["parallel data", "TEST", 185, 198]]], ["Recent analyses of polyglot embedding spaces have shown that tokens and documents are grouped together based on their language -i.e., the monolingual components are grouped together.", [["Recent analyses of polyglot embedding spaces", "PROBLEM", 0, 44], ["polyglot embedding", "OBSERVATION", 19, 37]]], ["A resulting algorithm L polyglot exploits this phenomenon to perform document [13] and token [15] level language identification with minimal supervision.", [["A resulting algorithm L polyglot exploits", "TREATMENT", 0, 41]]], ["In fact, neither lucha nor fight features in each others top 1,000 naively sampled nearest neighbors.Our ApproachWhat happens when nearest neighbor searches are restricted to words in the corpus written in a different language than the input word?", [["corpus", "ANATOMY", 188, 194], ["corpus", "ORGANISM_SUBDIVISION", 188, 194]]], ["We discover that this simple constrained nearest neighbor sampling is capable of retrieving substantial bilingual lexicons and this phenomenon is observed in multiple language pairs.", [["this phenomenon", "PROBLEM", 127, 142]]], ["Formally, in a bilingual corpus D of two languages L source and L target , let V source and V target denote the vocabularies of the two languages, respectively.", [["let V", "GENE_OR_GENE_PRODUCT", 75, 80]]], ["The translation scheme L source \u2192 L target takes a word w source \u2208 V source as input and outputs a single word translation, w target , such that w target \u2208 V target and \u2200w \u2208 V target , dist(w source , w) \u2265 dist(w source , w target ).", [["L target", "RNA", 34, 42], ["dist", "ANATOMY", 185, 189]]], ["Note that, our method involves no explicit attempt to achieve alignment; a single Skip-gram model is trained on a bilingual corpus and lexicons are retrieved using this simple constrained nearest neighbor sampling.", [["corpus", "ANATOMY", 124, 130], ["corpus", "MULTI-TISSUE_STRUCTURE", 124, 130], ["a single Skip-gram model", "TEST", 73, 97]]], ["Further, noisy estimations of vocabularies are obtained using L polyglot .", [["L polyglot", "TREATMENT", 62, 72]]], ["Using our technique, we retrieve substantial bilingual lexicons across three different Indian social media corpora, and several (synthetically induced) bilingual corpora of European language pairs.NotationWe denote English, Spanish, German, Romanized Hindi as en, es, de, and hi e , respectively.", [["corpora", "MULTI-TISSUE_STRUCTURE", 107, 114], ["our technique", "TREATMENT", 6, 19], ["substantial bilingual lexicons", "TREATMENT", 33, 63], ["media corpora", "ANATOMY", 101, 114]]], ["When we use L polyglot to estimate the language label or vocabulary, we indicate that by L (.) and V .", [["L polyglot", "GENE_OR_GENE_PRODUCT", 12, 22], ["L polyglot", "PROTEIN", 12, 22], ["L polyglot", "TREATMENT", 12, 22]]], ["In our work, we perform several frequency-based analyses to understand our method's strengths and weaknesses.", [["weaknesses", "PROBLEM", 98, 108]]], ["We denote the top 5% of words by frequency in the vocabulary as VRelated WorkBilingual lexicon induction has a rich line of prior literature [18, 19, 20, 21, 22, 23, 24, 25] with modern methods [4, 26, 27, 6, 28, 29, 30, 31, 2, 3, 11, 32, 33] leveraging continuous representation of words [9, 34, 35] .", [["modern methods", "TEST", 179, 193]]], ["While this list is far from exhaustive, several of these focus on alleviating resource requirements like seed lexicon, or parallel data.", [["alleviating resource requirements", "TREATMENT", 66, 99], ["parallel data", "TEST", 122, 135]]], ["For example, [30] aligned two monolingual embeddings trained on distinct monolingual corpora using digits to address the requirement of large seed lexicons; [3] aligned monolingual embeddings using a Cross-Domain Local Scaling measure that requires no seed lexicon, or parallel data.", [["large seed lexicons", "TREATMENT", 136, 155], ["a Cross-Domain Local Scaling measure", "TREATMENT", 198, 234], ["no", "UNCERTAINTY", 249, 251]]], ["Our method does not require clean, monolingual corpora; we learn a single Skip-gram embedding on a bilingual corpus and present a novel finding that constrained nearest neighbor sampling can retrieve substantial bilingual lexicons without any explicit attempt to align.", [["corpus", "ORGAN", 109, 115]]], ["Recent work in unsupervised machine translation [36] utilizes monolingual language models and alignment steps to learn a phrase-level translation model.", [["monolingual language models", "TREATMENT", 62, 89]]], ["While polyglot word-embeddings and polyglot training in particular have received attention recently for demonstrating performance improvements across a variety of NLP tasks [37, 38, 39, 13, 15] , to the best of our knowledge, no previous work has explored their effectiveness in retrieving bilingual lexicons.Related WorkOur work is related to [15] in two key ways: (1) use of L polyglot to perform token-level language identification and (2) a shared task of cross-lingual sampling in the domain of hope speech.", [["L polyglot", "GENE_OR_GENE_PRODUCT", 377, 387], ["L polyglot", "PROTEIN", 377, 387], ["polyglot training", "TREATMENT", 35, 52], ["L polyglot", "TREATMENT", 377, 387]]], ["However, unlike [15] who use vocabulary estimates to measure the extent of code mixing, we use the vocabulary estimates for our constrained nearest neighbor sampling.", [["vocabulary estimates", "TEST", 29, 49]]], ["Moreover, our approach to perform cross-lingual sampling is different.", [["cross-lingual sampling", "TEST", 34, 56]]], ["Finally, we obtain a 45% performance improvement over the best-performing method reported by [15] .Sampled hope speechLoose translation kaash dono mulko me dosti ho jaye dono mil kr Europe ke desho ki tra developed ho skte hai piece love I wish two countries make friendship and together prosper and develop like European countries; peace, love. kaash dono desho mein shanti k rishte kayam ho sake I wish both countries can forge a relationship of peace. jung talti rhe to bahtar he ap or ham sabhi k anagan me shama jalti rhe to bahatr he jung to khud hi ek masla he jung kiya maslo ka hal de gi It is better if war is avoided.", [["ham sabhi k anagan me shama jalti rhe to bahatr he jung to khud hi ek masla he jung kiya maslo ka hal de gi", "SPECIES", 489, 596]]], ["In addition, we construct a new data set.Data Sets\u2022 D hope consists of 2.04 million comments posted by 791,289 user on 2,890 YouTube videos relevant to the 2019 India-Pakistan conflict [13] .Data Sets\u2022 D election consists of 6.18 million comments on 130,067 videos by 1,518,077 users posted in a 100 day period leading up to the 2019 Indian General Election [14] .Data Sets\u2022 D covid consists of 4,511,355 comments by 1,359,638 users on 71,969 videos from fourteen Indian news outlets (see, Appendix for details) posted between 30 th January, 2020 2 and 7 th May, 2020.Data set challengesAs documented in [13, 14, 15] , typical to most noisy, short social media texts generated in linguistically diverse regions, the data sets we consider exhibit a considerable presence of code mixing, and grammar and spelling disfluencies.", [["Data set challengesAs", "TEST", 568, 589], ["code mixing", "TREATMENT", 773, 784], ["spelling disfluencies", "PROBLEM", 802, 823]]], ["On top of these, D hope and D election involve two additional challenges.", [["D", "SIMPLE_CHEMICAL", 28, 29], ["D election", "TREATMENT", 28, 38]]], ["First, due to a strong presence of content contributors who do not speak English as their first language, varying levels of English proficiency in the corpus with a substantial incidence of phonetic spelling errors were reported.", [["corpus", "ANATOMY", 151, 157], ["corpus", "ORGAN", 151, 157], ["phonetic spelling errors", "PROBLEM", 190, 214]]], ["For example, 32% of times, the word liar was misspelled as lier [14] , or consider the following example comment -[pak pm godblashu my ind pailat thanksh you cantri] that possibly intended to express Pak PM God bless you; my Ind pilot, thank you country.", [["Pak", "GENE_OR_GENE_PRODUCT", 200, 203], ["Pak", "PROTEIN", 200, 203]]], ["Second, since Romanized Hindi does not have any standard spelling rules [12] (e.g., the word nuksaan meaning damage is spelled in the corpus as nuksaan, nuqsaan and nuksan), a high level of spelling variations added to the challenges.PreprocessingFor each of these three data sets as input, we conduct the following preprocessing and output the en and hi e vocabularies.Preprocessing\u2022 We first clean the multilingual corpus with the same steps (e.g., removing emojis, lower casing words written in Roman script, removing punctuations) described in [14] .Preprocessing\u2022 Following [13] , we train 100 dimensional FastText embeddings [35] (full training configuration presented in Appendix).", [["corpus", "ANATOMY", 134, 140], ["corpus", "ORGANISM_SUBDIVISION", 134, 140], ["corpus", "ORGAN", 417, 423], ["meaning damage", "PROBLEM", 101, 115], ["spelling variations", "PROBLEM", 190, 209], ["output", "TEST", 334, 340], ["full training configuration", "TREATMENT", 637, 664], ["Appendix", "ANATOMY", 678, 686]]], ["Following [15] , we construct the hi e and en vocabularies.PreprocessingNote that, while our constrained nearest neighbor sampling restricts the vocabulary of the target word based on our obtained (noisy) vocabularies from L polyglot , we perform no explicit monolingual corpus extraction or removal of any other language expressed in Roman script or traditional script (e.g., Hindi in Devanagari constitutes a small fraction of all corpora, see Appendix for visualizations). source and are mapped to target words in V target that are present in the corpus for at least 100 or more times. p@K indicates top-K accuracy.", [["corpus", "ANATOMY", 550, 556], ["corpus", "ORGAN", 550, 556], ["V target", "DNA", 517, 525], ["explicit monolingual corpus extraction", "TREATMENT", 250, 288], ["removal", "TREATMENT", 292, 299], ["p@K", "TEST", 589, 592], ["Appendix", "ANATOMY", 446, 454], ["corpus", "ANATOMY_MODIFIER", 550, 556]]], ["Following standard practice [2, 3] , we report p@1, p@5 and p@10 performance. p@K is defined as the top-K accuracy [4] , i.e., an accurate translation of the source word is present in the retrieved top K target words.", [["p@K", "GENE_OR_GENE_PRODUCT", 78, 81], ["p@K", "PROTEIN", 78, 81], ["p@K", "TEST", 78, 81]]], ["We restrict V source to V 0\u22125 source and V target to words that have appeared at least 100 times in the corpus (Appendix contains hyperparameter sensitivity analysis).", [["corpus", "ANATOMY", 104, 110], ["corpus", "MULTI-TISSUE_STRUCTURE", 104, 110], ["V 0\u22125 source", "DNA", 24, 36], ["hyperparameter sensitivity analysis", "TEST", 130, 165], ["Appendix", "ANATOMY", 112, 120]]], ["Table 2 , we observe that substantial bilingual lexicons can be retrieved using our unsupervised method.", [["substantial bilingual lexicons", "PROBLEM", 26, 56]]], ["Even on multilingual, challenging social media data sets, a p@5 performance as high as 0.5 was achieved on multiple occasions.", [["p@5", "DNA", 60, 63]]], ["Romanized Hindi does not have standard spelling rules; a larger volume of data could be useful in learning embeddings robust to spelling variations.As shown inThe three data sets we looked into have wildly different topical focus: international conflict, general election and a global pandemic.", [["standard spelling rules", "PROBLEM", 30, 53], ["a global pandemic", "PROBLEM", 276, 293]]], ["In contrast, from D election we obtained words focusing on national priorities and issues (e.g., corruption, population, unemployment), while our method when applied on D covid retrieved words focusing on disease symptoms, preventive measures and treatment terms (e.g., fever, cough, wash, distance, treatment, medicine).", [["fever", "DISEASE", 270, 275], ["cough", "DISEASE", 277, 282], ["disease symptoms", "PROBLEM", 205, 221], ["preventive measures", "TREATMENT", 223, 242], ["treatment terms", "TREATMENT", 247, 262], ["fever", "PROBLEM", 270, 275], ["cough", "PROBLEM", 277, 282], ["treatment", "TREATMENT", 300, 309], ["medicine", "TREATMENT", 311, 319]]], ["Our obtained lexicons had non-overlapping regions which indicate the possibility of growing the lexicon through combining multiple corpora focusing on topics with minimal overlap.", [["growing the lexicon", "PROBLEM", 84, 103], ["indicate the possibility of", "UNCERTAINTY", 56, 83], ["growing", "OBSERVATION_MODIFIER", 84, 91], ["lexicon", "OBSERVATION", 96, 103], ["multiple", "OBSERVATION_MODIFIER", 122, 130], ["corpora", "OBSERVATION", 131, 138], ["minimal", "OBSERVATION_MODIFIER", 163, 170], ["overlap", "OBSERVATION", 171, 178]]], ["We will release this bilingual lexicon (consensus label by two annotators, annotator details are present in the Appendix) of 1,100 unique word pairs as a resource.", [["Appendix", "ANATOMY", 112, 120]]], ["For a given source word, multiple valid synonymous target words were often among the top translations produced by our method (e.g., aman and shanti for peace; dharam, mazhab and jaat for religion).", [["multiple valid synonymous target words", "PROBLEM", 25, 63]]], ["Stylistic choices like contraction were reflected in the translation (e.g., kyki (kyuki) mapped to bcz (because), and shi (sahi) mapped to ryt (right)).", [["kyuki", "DNA", 82, 87], ["bcz", "DNA", 99, 102], ["shi", "DNA", 118, 121], ["sahi", "DNA", 123, 127], ["ryt", "DNA", 139, 142], ["contraction", "OBSERVATION", 23, 34], ["right", "ANATOMY_MODIFIER", 144, 149]]], ["Verbs are conjugated differently in Hindi and English and word-for-word translations don't typically exist -for instance help him translates to uska \"him\" madad \"help\" karo \"do\", thus words like karo were rarely successfully translated.Qualitative AnalysisPolysemy: Our system performs single word translation.", [["karo", "PROTEIN", 195, 199]]], ["During translation, without context, detecting polysemy and resolving it to the true meaning w.r.t. the context is not possible.", [["polysemy", "PROBLEM", 47, 55], ["without", "UNCERTAINTY", 20, 27], ["not possible", "UNCERTAINTY", 115, 127]]], ["For example, the word cold can mean both low temperature or a common viral infection.Qualitative AnalysisIn D covid , both these meanings were captured in the top translations while translations in D hope and D election only reflected the meaning of low temperature.", [["viral infection", "DISEASE", 69, 84], ["both low temperature", "PROBLEM", 36, 56], ["a common viral infection", "PROBLEM", 60, 84], ["low temperature", "PROBLEM", 250, 265], ["low temperature", "OBSERVATION_MODIFIER", 41, 56], ["viral", "OBSERVATION_MODIFIER", 69, 74], ["infection", "OBSERVATION", 75, 84], ["low temperature", "OBSERVATION_MODIFIER", 250, 265]]], ["It is unlikely that cold in the sense of viral infection would be highly discussed in the latter two corpora, while it is understandable that common cold and associated symptoms would be heavily discussed in D covid .Qualitative AnalysisNativization of loanwords: Lexical borrowing across language pairs in the context of loanwords (or borrowed words) has been studied in linguistics [40, 41, 42] and computational linguistics [43, 44] .", [["viral infection", "DISEASE", 41, 56], ["D covid", "CELL", 208, 215], ["cold", "PROBLEM", 20, 24], ["viral infection", "PROBLEM", 41, 56], ["common cold and associated symptoms", "PROBLEM", 142, 177], ["unlikely", "UNCERTAINTY", 6, 14], ["cold", "OBSERVATION", 20, 24], ["viral", "OBSERVATION_MODIFIER", 41, 46], ["infection", "OBSERVATION", 47, 56]]], ["We noticed nativized loanwords, i.e., borrowed words that underwent phonological repairs to adapt to a foreign language, translate back to their English donor counterpart (e.g., rashan and angrezi translate to donor words ration and English, respectively).Digging deeperWe conduct a detailed ablation study to understand this phenomenon.", [["phonological repairs", "TREATMENT", 68, 88], ["a detailed ablation study", "TEST", 281, 306], ["this phenomenon", "PROBLEM", 321, 336]]], ["In what follows, we summarize our findings (see, Appendix for details).Digging deeper\u2022 Disabling numbers: In prior literature, [30] showed that digits can be used as seed lexicons to align monolingual embeddings.", [["digits", "ANATOMY", 144, 150]]], ["We replaced all numbers with a specific randomly chosen string that does not occur in the original corpus and evaluated the retrieval performance of our previously successful p@1 translations.", [["corpus", "ANATOMY", 99, 105], ["corpus", "ORGAN", 99, 105], ["p@1", "PROTEIN", 175, 178]]], ["We observed a performance dip of 28% which indicates that numeric literals may contribute to this phenomenon.Digging deeper\u2022 Loanwords: We observe that in most cases, in successfully translated word pairs (e.g., madad, help , ilaj, treatment ), at least one of the words is borrowed and used in the other language (e.g., humein help chahiye \"we need help\").", [["a performance dip", "TEST", 12, 29], ["numeric literals", "PROBLEM", 58, 74], ["this phenomenon", "PROBLEM", 93, 108], ["treatment", "TREATMENT", 232, 241]]], ["These loanwords thus result in similar contexts for word pairs from different languages -which are possibly reflected in the obtained word embeddings facilitating translation.Digging deeper\u2022 Frequency preserving corpus transformation: We perform a frequency preserving loanword exchange (see, Appendix) to modify the corpus where translated word pairs are interchanged to diminish the extent of borrowing of these loanwords (e.g., phrases like humein help chahiye is rewritten as humein madad chahiye).", [["corpus", "ANATOMY", 212, 218], ["corpus", "ANATOMY", 317, 323], ["corpus", "MULTI-TISSUE_STRUCTURE", 212, 218], ["a frequency preserving loanword exchange", "TREATMENT", 246, 286], ["corpus transformation", "OBSERVATION", 212, 233], ["Appendix", "ANATOMY", 293, 301], ["corpus", "ANATOMY", 317, 323]]], ["We observe that the p@1 performance dipped by 33% after this corpus modification indicating that loanwords are possibly major contributors to this phenomenon.Cross-lingual samplingIn our previous section, we have demonstrated that our unsupervised constrained nearest neighbor sampling method is able to retrieve substantial bilingual lexicons across three different en-hi e data sets.", [["corpus", "ANATOMY", 61, 67], ["p@1", "DNA", 20, 23], ["the p@1 performance", "TEST", 16, 35], ["this corpus modification", "PROBLEM", 56, 80], ["this phenomenon", "PROBLEM", 142, 157], ["Cross-lingual sampling", "TEST", 158, 180]]], ["We now demonstrate a practical benefit of our method.Cross-lingual samplingWe focus on the task of detecting hostility-diffusing hope speech first introduced in [13] .", [["our method", "TREATMENT", 42, 52]]], ["While the authors present an important study of a modern conflict, much of the focus was centered around the English sub-corpus.", [["corpus", "TISSUE", 121, 127], ["corpus", "ANATOMY", 121, 127]]], ["In a recent study, [15] widened the analysis with a cross-lingual sampling technique to detect hope speech content authored in Romanized Hindi.", [["a recent study", "TEST", 3, 17], ["the analysis", "TEST", 32, 44], ["a cross-lingual sampling technique", "TREATMENT", 50, 84]]], ["Using the English hope speech classifier and leveraging L polyglot to perform token-level language identification, their proposed method first detects highly code mixed hope speech, then uses it to sample hi e hope speech using nearest-neighbor sampling (NN-sampling) in the comment embedding space of the hi e sub-corpus, D hie hope .Cross-lingual samplingBaselines: We include both methods proposed in [15] and their baseline (random sampling) for performance comparison.", [["L polyglot", "DNA", 56, 66], ["performance comparison", "TEST", 450, 472], ["corpus", "ANATOMY", 315, 321]]], ["Performing a naive translation using our translation scheme runs into the well-studied hubness problem observed in high-dimensional spaces [45, 46, 47] .", [["a naive translation", "TREATMENT", 11, 30]]], ["Essentially, the hubness problem arises when a small subset of words are \"universal\" neighbors and hence attract several many-to-one mappings.", [["the hubness problem", "PROBLEM", 13, 32]]], ["For an input document, we obtain the noisy word-for-word translation and compute the resulting document's embeddingthe average of the normalized word embeddings.Cross-lingual samplingIn our earlier analyses, we noticed that our translation scheme found several synonyms in its top choices (e.g., religion has mazhab, dharam and jaat in its top translated choices).", [["Cross-lingual sampling", "TEST", 161, 183], ["word embeddings", "OBSERVATION", 145, 160]]], ["To account for this noise in translation and to induce more diversity, for each word, we randomly sample a mutually nearest neighbor.", [["this noise", "PROBLEM", 15, 25]]], ["Table 4 compares the performance of our sampling method against existing approaches.", [["our sampling method", "TREATMENT", 36, 55]]], ["In order to shed light into influence of different design choices on performance, we present our main method and ablation studies after disabling random sampling from top choices and back-translation to address the hubness problem.", [["ablation studies", "TEST", 113, 129], ["disabling random sampling", "PROBLEM", 136, 161], ["the hubness problem", "PROBLEM", 211, 230]]], ["V target is restricted to words that appeared more than 100 times in the corpus.Cross-lingual samplingthe hubness problem appears to be the primary performance bottleneck.", [["corpus", "ANATOMY", 73, 79], ["V", "GENE_OR_GENE_PRODUCT", 0, 1], ["corpus", "ORGAN", 73, 79], ["V target", "DNA", 0, 8], ["corpus", "ANATOMY", 73, 79]]], ["On a highly challenging task of mining rare positives (random sampling only yields 1.8% hope speech), we obtained a 45% improvement over the previously reported best result.", [["random sampling", "TEST", 55, 70]]], ["Table 1 lists a random sample of hope speech obtained using our method.", [["our method", "TREATMENT", 60, 70]]], ["A 2D visualization of the obtained comments indicate (see, Figure 2 ) that our method retrieved comments reasonably distributed across the Hindi region.Analyzing other language pairsWe were curious to learn if our approach works with other language pairs.", [["Analyzing other language pairs", "PROBLEM", 152, 182], ["Hindi", "ANATOMY", 139, 144], ["region", "ANATOMY_MODIFIER", 145, 151]]], ["On two European language pairs, en, es and en, de , we observed that our simple approach of constrained nearest neighbor sampling retrieves reasonable bilingual lexicons even when trained on a single, multilingual corpus (synthetically induced) without any explicit attempt to align.", [["corpus", "ANATOMY", 214, 220], ["corpus", "ORGAN", 214, 220]]], ["We acknowledge that prior art with supervision and seed lexicon (e.g., [4] ) and recent unsupervised approaches (e.g., [3] ) achieve considerably better performance on our test data set introduced in [3] .", [["our test data", "TEST", 168, 181]]], ["For instance, compared to our p@1 performance on en \u2192 es of 0.25, [4] and [3] achieved performance of 0.33, and 0.82 respectively.", [["p@1", "PROTEIN", 30, 33]]], ["Our focus is not on competing with the rich research conducted so far, rather, we are interested in reporting the generalizability of our approach.Analyzing other language pairsData sets: We conduct experiments using Europarl [17] and Wikipedia data sets.", [["Analyzing other language pairs", "PROBLEM", 147, 177], ["Wikipedia data sets", "TEST", 235, 254]]], ["We synthetically induce a multilingual corpus by combining two monolingual corpora and then randomly shuffling at the sentence level.", [["corpus", "ANATOMY", 39, 45], ["corpus", "CANCER", 39, 45]]], ["We find that our overall performance improved with Wikipedia data especially for de \u2192 en and es \u2192 en.Analyzing other language pairs[3] also reported a performance boost with Wikipedia data.Analyzing other language pairsIn addition to an English-Italian translation retrieval task, we present an ablation study in the Appendix.", [["Analyzing other language pairs", "PROBLEM", 189, 219], ["an ablation study", "TEST", 292, 309], ["ablation", "OBSERVATION", 295, 303], ["Appendix", "ANATOMY", 317, 325]]], ["A fine-grained look at the performance based on the frequency of the source word reveals that we perform substantially better on high-frequency words belonging to V 0\u22125 source (e.g., en \u2192 es performance jumps from 0.25 to 0.61 when we consider words in V 0\u22125 source ). \u2022 Topical cohesion: When we sample the en part of the corpus from Europarl and the es (or de) part from Wikipedia, we remove the topical cohesion between the en and es (de) components.", [["corpus", "ANATOMY", 323, 329], ["corpus", "ORGAN", 323, 329], ["V 0\u22125 source", "DNA", 163, 175], ["the topical cohesion between the en and es (de) components", "TREATMENT", 394, 452]]], ["We observe that performance dips slightly.Conclusions and Future WorkIn this paper, we explore the word embedding space resulting from training a single Skip-gram model on several bilingual corpora.", [["corpora", "MULTI-TISSUE_STRUCTURE", 190, 197]]], ["Our detailed experiments reveal a rich and expressive embedding space across several language pairs that allows simple methods to retrieve substantial bilingual lexicons.", [["expressive embedding space", "PROBLEM", 43, 69]]], ["The (relatively) poorly resourced Romanized Hindi, and consequently the difficulty in obtaining monolingual corpora in this language pair make our observations and methods particularly well-suited for this setting.", [["corpora", "MULTI-TISSUE_STRUCTURE", 108, 115], ["monolingual corpora", "TREATMENT", 96, 115]]], ["Future directions include exploring the presence of this phenomenon in settings like contextual embeddings, and alternate models such as the highly successful transformer based methods.", [["this phenomenon", "PROBLEM", 52, 67]]], ["Each cell summarizes the p@K performance for a given translation direction on a data set as a / b / c, where a (top) is the performance observed when the source vocabulary is restricted to V source , 100 source words are randomly selected.", [["cell", "ANATOMY", 5, 9], ["cell", "CELL", 5, 9], ["p@K", "DNA", 25, 28]]], ["The selected words are mapped to target words in V target that are present in the corpus for at least 100 or more times. p@K indicates top-K accuracy.", [["corpus", "ANATOMY", 82, 88], ["corpus", "ORGAN", 82, 88], ["V target", "DNA", 49, 57], ["p@K", "TEST", 121, 124]]], ["Table 7 : Performance summary of our approach with training data set Europarl [17] ; test data set (denoted by D test ) introduced in [3] .", [["training data", "TEST", 51, 64], ["test data", "TEST", 85, 94]]], ["V target is restricted to words that appeared more than 100 times in the training data set.", [["V", "GENE_OR_GENE_PRODUCT", 0, 1], ["V target", "DNA", 0, 8]]], ["Each cell summarizes the p@K performance for a given translation direction asD covid data setWe used the publicly available YouTube API to crawl our comments.", [["cell", "ANATOMY", 5, 9], ["cell", "CELL", 5, 9], ["the p@K performance", "TEST", 21, 40], ["asD covid data", "TEST", 75, 89]]], ["Our data set consists of 4,511,355 comments by 1,359,638 users on 71,969 videos from fourteen Indian news outlets listed in Table 9 .", [["Our data", "TEST", 0, 8]]], ["Figure 3 presents a 2D visualization of the word embeddings obtained using L polyglot .", [["L polyglot", "PROTEIN", 75, 85], ["a 2D visualization", "TEST", 18, 36], ["L polyglot", "TREATMENT", 75, 85]]], ["The visualization indicates that apart from Romanized Hindi and English, our data set also demonstrates substantial presence of Hindi written in Devanagari script further establishing the challenges associated to our task.", [["The visualization", "TEST", 0, 17], ["substantial", "OBSERVATION_MODIFIER", 104, 115]]], ["The size of the estimated vocabularies is presented in Table 8 .", [["size", "OBSERVATION_MODIFIER", 4, 8], ["estimated", "OBSERVATION_MODIFIER", 16, 25], ["vocabularies", "OBSERVATION", 26, 38]]], ["Table 9 : National channels.Embedding HyperparametersAll the models discussed in this paper are obtained by training Fasttext Skip-gram models with the following parameters unless stated otherwise:Hyperparameter sensitivity analysisRecall that, we restricted V source and V target to prevalence criteria that (1) V source is restricted to V 0\u22125 source (2) V target contains words that have appeared at least 100 or more times in the corpus.", [["corpus", "ANATOMY", 433, 439], ["corpus", "ORGAN", 433, 439], ["V 0\u22125 source (2) V target", "DNA", 339, 364], ["Hyperparameter sensitivity analysisRecall", "TEST", 197, 238], ["corpus", "ANATOMY", 433, 439]]], ["In Table 6 , we relax the prevalence criterion on V source and observe that as we move towards more infrequent words, the translation performance degrades.Hyperparameter sensitivity analysisThe performance drop is more visible with V 10\u2212100 source .", [["Hyperparameter sensitivity analysis", "TEST", 155, 190], ["The performance drop", "PROBLEM", 190, 210]]], ["Our annotators informed that poor quality of spelling and increased prevalence of contraction made the annotation task particularly challenging for rare words.Hyperparameter sensitivity analysisWe next analyze the effect of the frequency threshold of 100 on V target .", [["poor quality of spelling", "PROBLEM", 29, 53], ["the annotation task", "TEST", 99, 118], ["the frequency threshold", "TEST", 224, 247]]], ["Hence, although for 91% or the source words we found a translation within the top 10 translations, our p@1 performance took a considerable hit.", [["p@1", "DNA", 103, 106]]], ["Our annotators reported that with a lowered frequency threshold, the retrieved translations contained higher degree of misspellings.", [["a lowered frequency threshold", "PROBLEM", 34, 63], ["higher degree of misspellings", "PROBLEM", 102, 131], ["higher degree", "OBSERVATION_MODIFIER", 102, 115]]], ["Our conclusion from this experiment is 100 is a reasonable threshold given the noisy nature of our corpora.Hyperparameter sensitivity analysisWe conducted a similar analysis on our word translation tasks using European language pairs.", [["corpora", "MULTI-TISSUE_STRUCTURE", 99, 106]]], ["Table 10 lists an extended bilingual lexicon containing 90 words pairs (30 from each corpus) obtained using our method.", [["corpus", "ANATOMY", 85, 91], ["corpus", "CANCER", 85, 91]]], ["We will release the complete lexicon of 1,100 word pairs upon acceptance.LoanwordWe now slightly abuse the definition of a loanword and consider a word is a loanword if it appears in a context of words written in a different language, and define a simple measure to quantify to what extent this occurs in a two-language setting.", [["slightly", "OBSERVATION_MODIFIER", 88, 96], ["abuse", "OBSERVATION", 97, 102]]], ["Let c denote the context (single word left and right) of a word w.", [["Let c", "GENE_OR_GENE_PRODUCT", 0, 5], ["right", "ANATOMY_MODIFIER", 47, 52]]], ["Let this number be denoted as N not-borrowed .", [["Let", "GENE_OR_GENE_PRODUCT", 0, 3]]], ["A high LWI indicates substantial lexical borrowing of the word outside its language.LoanwordSince we use L polyglot to estimate language labels, we indicate LWI(.) as LWI (.).", [["L polyglot", "PROTEIN", 105, 115], ["A high LWI", "PROBLEM", 0, 10], ["substantial", "OBSERVATION_MODIFIER", 21, 32], ["lexical borrowing", "OBSERVATION", 33, 50]]], ["For example, if the LWI is high for the pair help, madad , it indicates that at least one of these words was substantially borrowed.", [["LWI", "DNA", 20, 23], ["high", "OBSERVATION", 27, 31]]], ["Our hypothesis is that successfully translated word pairs would have a high LWI indicating at least one of the pair was used as a loanword facilitating translation.", [["LWI", "DNA", 76, 79]]], ["The average Loan Word Index of all successfully translated word pairs in our test data sets across all three corpora is 0.15.", [["our test data", "TEST", 73, 86]]], ["We next performed a frequency preserving loan word exchange to modify the corpus where translated word pairs are interchanged to diminish the extent to which words are borrowed (e.g., phrases like humein help chahiye is rewritten as humein madad chahiye).", [["corpus", "ANATOMY", 74, 80], ["a frequency preserving loan word exchange", "TREATMENT", 18, 59]]], ["We thus preserve word frequencies while diminishing the loanword phenomenon.", [["diminishing the loanword phenomenon", "PROBLEM", 40, 75]]], ["We observed that the retrieval performance of our p@1 set dipped by 33% after this corpus modification indicating that frequent borrowing of words possibly positively contributed to our method's translation performance.NN-sampleAlgorithm 2 reproduces the NN-Sample (we refer to this as NN-Sampling in our paper) method as presented in [15] .", [["corpus", "ANATOMY", 83, 89], ["p@1", "DNA", 50, 53], ["this corpus modification", "TREATMENT", 78, 102]]], ["Initially, E is an empty set and at each step, E is expanded with nearest neighbors that are not present in the expanded set or the seed set.", [["E", "DNA", 11, 12], ["E", "DNA", 47, 48], ["empty", "OBSERVATION", 19, 24]]], ["Consistent with [15] , the parameter size is set to 5, and U is set to D hie hope .Topical cohesionWe break topical cohesion by sampling en and es (de) from Europarl and Wikipedia respectively.", [["[15]", "SIMPLE_CHEMICAL", 16, 20], ["the parameter size", "TEST", 23, 41], ["Topical cohesionWe break topical cohesion", "TREATMENT", 83, 124], ["size", "OBSERVATION_MODIFIER", 37, 41], ["break", "OBSERVATION_MODIFIER", 102, 107], ["topical cohesion", "OBSERVATION", 108, 124]]], ["Our results show that bilingual lexicons are still retrieved albeit with marginally lower performance.", [["bilingual lexicons", "TREATMENT", 22, 40]]], ["We conclude that topical cohesion possibly helps but may not be a prerequisite for retrieving a reasonably sized bilingual lexicon.", [["topical cohesion", "TREATMENT", 17, 33]]], ["Table 11 : Evaluating the importance of topical cohesion.", [["topical cohesion", "TREATMENT", 40, 56]]], ["Blue, red and gray denote Europarl, Wikipedia and a mixed corpus where English is sampled from Europarl and the other language (Spanish or German) is sampled from Wikipedia, respectively.", [["red", "OBSERVATION", 6, 9], ["mixed", "OBSERVATION_MODIFIER", 52, 57], ["corpus", "OBSERVATION_MODIFIER", 58, 64]]], ["However, in spite of reduced topical cohesion, our method still retrieves bilingual lexicons of reasonable size.Translation retrieval taskWe evaluated our approach on a task of translation retrieval.", [["reduced topical cohesion", "PROBLEM", 21, 45], ["our method", "TEST", 47, 57], ["translation retrieval", "TREATMENT", 177, 198], ["reduced", "OBSERVATION_MODIFIER", 21, 28], ["topical cohesion", "OBSERVATION", 29, 45], ["reasonable", "OBSERVATION_MODIFIER", 96, 106], ["size", "OBSERVATION_MODIFIER", 107, 111]]], ["The translation retrieval task involves mapping 2k sentences from a source language to 2k in the target language out of a pool of 200K sentences in the target language.", [["2k", "DNA", 87, 89], ["The translation retrieval task", "TREATMENT", 0, 30]]], ["For a sentence in the source language, Method 2 uses the translateEmbeddings algorithm as described in Algorithm 1 and obtains an equivalent (noisy) embedding in the target language.", [["the translateEmbeddings algorithm", "TREATMENT", 53, 86]]], ["Next, using the obtained embedding, it finds the nearest neighbor(s) in the 200K sentences in target language ranked by cosine distance in the ascending order.", [["200K sentences", "DNA", 76, 90], ["ascending", "ANATOMY", 143, 152]]], ["In en \u2192it it \u2192en Methods p@1 p@5 p@10 p@1 p@5 p@10 [4] 0.11 0.19 0.23 0.12 0.22 0.27 [45] 0.45 0.72 0.81 0.49 0.71 0.78 [2] 0.55 0.73 0.78 0.43 0.62 0.69 [3] 0 Table 12 : Evaluating translation retrieval performance.", [["Evaluating translation retrieval performance", "TEST", 171, 215]]], ["We follow the evaluation task as presented in [3] .", [["the evaluation task", "TEST", 10, 29]]], ["The translation task involves mapping 2K randomly sampled sentences in a source language to 200K sentences in the target language.Translation retrieval taskMethod 1, we perform a minor modification in translateEmbeddings.", [["a minor modification in translateEmbeddings", "TREATMENT", 177, 220]]]], "PMC7537947": [["1 INTRODUCTIONBy March 2013, 89 003 experimentally determined protein structures were deposited in the Protein Data Bank (Berman et al., 2007).", [["protein structures", "PROBLEM", 62, 80]]], ["However, this number is only about one-sixth of 539 616, the number of protein sequences held in the UniProtKB/Swiss-Prot database (Wu et al., 2006).", [["protein sequences", "TEST", 71, 88]]], ["To timely use such vast amount of structure-unknown protein sequences for basic research and drug development, it is highly desired to determine their 3D structures and functions by means of homology approaches (Chou, 2004).", [["basic research", "TEST", 74, 88]]], ["Unfortunately, protein remote homology detection is still a challenging problem in bioinformatics.1 INTRODUCTIONThe early methods in dealing with this problem were based on the pairwise sequence comparison approaches, such as BLAST (Altschul et al., 1990) and Smith\u2013Waterman local alignment algorithm (Smith and Waterman, 1981).", [["protein remote homology detection", "TEST", 15, 48], ["this problem", "PROBLEM", 146, 158], ["early", "OBSERVATION_MODIFIER", 116, 121]]], ["However, in many cases, this kind of sequence alignment method failed to detect remote homologies due to the low sequence similarities.", [["sequence alignment method", "TEST", 37, 62], ["remote homologies", "PROBLEM", 80, 97], ["the low sequence similarities", "PROBLEM", 105, 134]]], ["Later methods to challenge this problem were based on the generative models to induce a probability distribution over the protein family, and then to generate the unknown proteins as new members of the family from the stochastic model.", [["protein family", "PROTEIN", 122, 136]]], ["For example, the hidden Markov model (HMM) (Karplus et al., 1998) can be trained iteratively in a semi-supervised manner by using both positively labeled and unlabeled samples of a particular family to generate the positive set (Qian and Goldstein, 2004).1 INTRODUCTIONRecently, the discriminative methods, such as support vector machine (SVM) (Vapnik, 1998), were used to address this problem by focusing on the differences between protein families.", [["samples", "ANATOMY", 168, 175], ["protein families", "PROTEIN", 433, 449]]], ["The key of the SVM methods is the kernel function by which to compute the inner product between two samples in the feature space.", [["samples", "ANATOMY", 100, 107]]], ["The most straightforward approach to generate the kernels was based on the features extracted from protein sequences.", [["protein sequences", "TEST", 99, 116]]], ["SVM-Ngram (Dong et al., 2006), SVM-pairwise (Liao and Noble, 2003) and SVM-LA (Saigo et al., 2004) were three of the most successful sequence-based kernels.", [["LA", "CHEMICAL", 75, 77], ["SVM", "TEST", 0, 3], ["SVM", "TEST", 71, 74], ["LA", "ANATOMY", 75, 77]]], ["SVM-Ngram (Dong et al., 2006) was based on the feature space that contains all short subsequence of length N. In SVM-pairwise (Liao and Noble, 2003), a protein sequence was represented as a vector of pairwise similarities to all protein sequences in the training set, and then inner product between these vector-space representations was taken as the kernel.", [["SVM", "TEST", 0, 3], ["a protein sequence", "TEST", 150, 168], ["all", "OBSERVATION_MODIFIER", 75, 78], ["short", "OBSERVATION_MODIFIER", 79, 84]]], ["SVM-LA (Saigo et al., 2004) measured the similarity between a pair of proteins by taking all the optimal local alignment scores with gaps between all possible subsequences into account.", [["LA", "CHEMICAL", 4, 6], ["SVM", "TEST", 0, 3], ["a pair of proteins", "TREATMENT", 60, 78], ["LA", "ANATOMY_MODIFIER", 4, 6]]], ["Besides these kernels, several other sequence-based kernels were also proposed, such as Mismatch (Leslie et al., 2004) and SVM-BALSA (Webb-Robertson et al., 2005).", [["SVM", "TEST", 123, 126]]], ["For example, Top-n-grams (Liu et al., 2008) extracted the profile-based patterns by considering the most frequent elements in the profiles; profile kernel (Kuang et al., 2005) extracted the short substrings according to the profile-based ungapped alignment scores; some profile-based methods improved the predictive performance by developing more sensitive profiles.", [["Top", "TEST", 13, 16], ["the short substrings", "PROBLEM", 186, 206]]], ["In COMPASS (Sadreyev et al., 2009), numerical profiles were generated to construct optimal profile\u2013profile alignments and to estimate the statistical significance of the corresponding alignment scores.1 INTRODUCTIONIn the meantime, some other features and techniques have been applied to this field to further improve the predictive performance.", [["profile\u2013profile alignments", "DNA", 91, 117], ["numerical profiles", "TEST", 36, 54]]], ["For instance, the kernel combination methodology (VBKC) (Damoulas and Girolami, 2008) used a single multi-class kernel machine to combine various kernels based on different feature spaces; SVM-physicochemical distance transformation (PDT) (Liu et al., 2012) combined the amino acid physicochemical properties and the profile features via PDT to incorporate the local sequence-order information of the entire protein sequences.", [["amino acid", "CHEMICAL", 271, 281], ["amino acid", "CHEMICAL", 271, 281], ["amino acid", "AMINO_ACID", 271, 281], ["protein sequences", "PROTEIN", 408, 425], ["a single multi-class kernel machine", "TREATMENT", 91, 126], ["different feature spaces", "PROBLEM", 163, 187], ["the amino acid physicochemical properties", "TREATMENT", 267, 308], ["PDT", "TREATMENT", 338, 341], ["the local sequence", "TEST", 357, 375], ["the entire protein sequences", "TEST", 397, 425]]], ["Also, based on the similarities between protein sequences and natural languages, the natural language processing techniques were applied to this field.", [["protein sequences", "DNA", 40, 57], ["protein sequences", "TEST", 40, 57]]], ["It was shown that the performance of building-block-based methods could be improved by using the latent semantic analysis (LSA) (Dong et al., 2006).", [["building-block-based methods", "TREATMENT", 37, 65], ["the latent semantic analysis", "TEST", 93, 121]]], ["Moreover, PROTEMBED (Melvin et al., 2011) detected protein remote homology by embedding protein sequences into a low-dimensional semantic space.1 INTRODUCTIONAs we can see from the aforementioned introduction, most of the top-performing methods were developed based on the features extracted from profiles.", [["protein sequences", "DNA", 88, 105], ["embedding protein sequences", "TEST", 78, 105], ["semantic space", "OBSERVATION", 129, 143]]], ["This is consistent with the fact that a profile is much richer than an individual sequence in encoding information.", [["consistent with", "UNCERTAINTY", 8, 23]]], ["All biological species have developed beginning from a limited number of ancestral species.", [["All biological species", "PROBLEM", 0, 22], ["ancestral species", "PROBLEM", 73, 90], ["biological species", "OBSERVATION", 4, 22], ["ancestral species", "OBSERVATION", 73, 90]]], ["It is true for protein sequence as well (Chou, 2004).", [["protein sequence", "TEST", 15, 31]]], ["Their evolution involves changes of single residues, insertions and deletions of several residues, gene doubling and gene fusion (Chou, 1995).", [["single residues", "PROBLEM", 36, 51], ["insertions and deletions", "TREATMENT", 53, 77], ["several residues", "PROBLEM", 81, 97], ["gene doubling and gene fusion", "TREATMENT", 99, 128]]], ["With these changes accumulated for a long period, many similarities between initial and resultant amino acid sequences are gradually eliminated, but the corresponding proteins may still share many common features, such as having basically the same biological function (Loewenstein et al., 2009), folding topology, subcellular location and other attributes (Chou, 2013).1 INTRODUCTIONAccordingly, the key to improve the performance of these methods is to find a suitable approach to extract the evolutionary information from the profiles.", [["subcellular", "ANATOMY", 314, 325], ["amino acid", "CHEMICAL", 98, 108], ["amino acid", "CHEMICAL", 98, 108], ["amino acid", "AMINO_ACID", 98, 108], ["resultant amino acid sequences", "TEST", 88, 118]]], ["In view of this, the current study was initiated in an attempt to propose a profile-based protein representation by extracting the evolutionary information from the frequency profiles.2.1 SCOP benchmark ::: 2 MATERIALS AND METHODSSuppose is a remote homology system investigated in the current study that contains 4352 protein sequences, which were taken from (Liao and Noble, 2003) at http://noble.gs.washington.edu/proj/svm-pairwise/.", [["4352 protein sequences", "DNA", 314, 336], ["the current study", "TEST", 17, 34], ["a profile-based protein representation", "PROBLEM", 74, 112], ["the current study", "TEST", 282, 299], ["protein sequences", "TEST", 319, 336]]], ["These proteins were selected from SCOP version 1.53 and extracted from the Astral database (Brenner et al., 2000).", [["These proteins", "TEST", 0, 14], ["SCOP version", "TEST", 34, 46]]], ["None of the 4352 proteins has sequence pairwise similarity to any other with higher than in the E-value [for more about the E-value and its implication in reducing homology bias and redundancy, see (Brenner et al., 2000)].", [["4352 proteins", "PROTEIN", 12, 25]]], ["These proteins were also used by others (Dong et al., 2006; Lingner and Meinicke, 2006; Saigo et al., 2004) to study remote homology detection.", [["remote homology detection", "TEST", 117, 142]]], ["The 4352 proteins in can be classified into 853 superfamilies and 1356 families; i.e.(1)where is the superfamily, is the family and the symbol represents the \u2018union\u2019 in the set theory.", [["4352 proteins", "PROTEIN", 4, 17]]], ["For readers\u2019 convenience, the codes of the 4352 proteins and their sequence as well as the attributes of their families and superfamilies are given in Supplementary Material S1.2.1 SCOP benchmark ::: 2 MATERIALS AND METHODSBecause some families and superfamilies in do not contain significant number of protein sequences, and also because the negative dataset for each protein family can be any proteins except those belonging to its own superfamily, it is not so straightforward but a little more complicated and subtle for how to select protein samples from to define the training and testing datasets.", [["4352 proteins", "PROTEIN", 43, 56], ["protein sequences", "PROTEIN", 303, 320], ["protein family", "PROTEIN", 369, 383], ["protein sequences", "TEST", 303, 320], ["the training", "TREATMENT", 570, 582], ["testing datasets", "TEST", 587, 603]]], ["As demonstrated by many previous studies on a series of important biological topics, such as enzyme-catalyzed reactions (Zhou and Deng, 1984), inhibition of human immunodeficiency virus-1 reverse transcriptase (Althaus et al., 1993), drug metabolism systems (Chou, 2010) and applying wenxiang diagram or graph (Chou et al., 2011) to study protein\u2013protein interactions (Zhou, 2011; Zhou and Huang, 2013), using graphical approaches to study complicated problems can provide an intuitive picture and useful insights for in-depth studying and analyzing various complicated relations in these systems (Lin and Lapointe, 2013).", [["human immunodeficiency virus", "DISEASE", 157, 185], ["human immunodeficiency virus-1", "ORGANISM", 157, 187], ["reverse transcriptase", "PROTEIN", 188, 209], ["human immunodeficiency virus-1", "SPECIES", 157, 187], ["human immunodeficiency virus-1", "SPECIES", 157, 187], ["enzyme", "TEST", 93, 99], ["catalyzed reactions", "PROBLEM", 100, 119], ["human immunodeficiency virus", "PROBLEM", 157, 185], ["complicated problems", "PROBLEM", 440, 460]]], ["In view of this, let us also use graphic approach to describe the feature and relation of the families and superfamilies in , as shown in Figure 1, where the open circles denote the families or superfamilies that have significant number of protein sequences and the gray circles denote those that do not.", [["protein sequences", "PROTEIN", 240, 257], ["graphic approach", "TREATMENT", 33, 49]]]], "PMC7522621": [], "b876f335e81e4725ca185a59a1b9d320a558d5fe": [["IntroductionIn 1972, a group of investigators observed the presence of modified cytosine, 5-hydroxymethylcytosine (5hmC), which accounted for about 15% of the total cytosine residues in rat and mouse brain DNA [1] .", [["brain", "ANATOMY", 200, 205], ["cytosine", "CHEMICAL", 80, 88], ["5-hydroxymethylcytosine", "CHEMICAL", 90, 113], ["5hmC", "CHEMICAL", 115, 119], ["cytosine", "CHEMICAL", 165, 173], ["cytosine", "CHEMICAL", 80, 88], ["5-hydroxymethylcytosine", "CHEMICAL", 90, 113], ["5hmC", "CHEMICAL", 115, 119], ["cytosine", "CHEMICAL", 165, 173], ["cytosine", "SIMPLE_CHEMICAL", 80, 88], ["5-hydroxymethylcytosine", "SIMPLE_CHEMICAL", 90, 113], ["5hmC", "SIMPLE_CHEMICAL", 115, 119], ["cytosine", "SIMPLE_CHEMICAL", 165, 173], ["rat", "ORGANISM", 186, 189], ["mouse", "ORGANISM", 194, 199], ["brain DNA", "TISSUE", 200, 209], ["rat", "SPECIES", 186, 189], ["mouse", "SPECIES", 194, 199], ["rat", "SPECIES", 186, 189], ["mouse", "SPECIES", 194, 199], ["modified cytosine", "TREATMENT", 71, 88], ["hydroxymethylcytosine", "TREATMENT", 92, 113], ["the total cytosine residues", "TREATMENT", 155, 182], ["mouse brain DNA", "PROBLEM", 194, 209]]], ["Further attempts to reproduce these results failed for a long time, the biological role of 5hmC remaining unknown for roughly the next 40 years.", [["5hmC", "CELLULAR_COMPONENT", 91, 95]]], ["In 2009, however, 5hmC was repeatedly detected in mouse brain cells [2] and mouse embryonic stem cells (mESCs) [3] .", [["brain cells", "ANATOMY", 56, 67], ["embryonic stem cells", "ANATOMY", 82, 102], ["mESCs", "ANATOMY", 104, 109], ["5hmC", "CELLULAR_COMPONENT", 18, 22], ["mouse", "ORGANISM", 50, 55], ["brain cells [2]", "CELL", 56, 71], ["mouse", "ORGANISM", 76, 81], ["embryonic stem cells", "CELL", 82, 102], ["mESCs", "CELL", 104, 109], ["5hmC", "PROTEIN", 18, 22], ["mouse brain cells", "CELL_TYPE", 50, 67], ["mouse embryonic stem cells", "CELL_LINE", 76, 102], ["mESCs", "CELL_LINE", 104, 109], ["mouse", "SPECIES", 50, 55], ["mouse", "SPECIES", 76, 81], ["mouse", "SPECIES", 50, 55], ["mouse", "SPECIES", 76, 81], ["mouse embryonic stem cells", "PROBLEM", 76, 102], ["embryonic stem cells", "OBSERVATION", 82, 102]]], ["Moreover, 5hmC was identified as the oxidation product of methylated cytosine, 5-methylcytosine (5mC) [3] , which is a major player in epigenetic regulation and genome reprogramming in mammalian development [4] [5] [6] [7] .", [["5hmC", "CHEMICAL", 10, 14], ["cytosine", "CHEMICAL", 69, 77], ["5-methylcytosine", "CHEMICAL", 79, 95], ["5mC", "CHEMICAL", 97, 100], ["cytosine", "CHEMICAL", 69, 77], ["5-methylcytosine", "CHEMICAL", 79, 95], ["5mC", "CHEMICAL", 97, 100], ["5hmC", "CELLULAR_COMPONENT", 10, 14], ["cytosine", "SIMPLE_CHEMICAL", 69, 77], ["5-methylcytosine", "SIMPLE_CHEMICAL", 79, 95], ["5mC", "SIMPLE_CHEMICAL", 97, 100], [") [3]", "SIMPLE_CHEMICAL", 100, 105], ["[4] [5] [6] [7]", "SIMPLE_CHEMICAL", 207, 222], ["5hmC", "PROTEIN", 10, 14], ["the oxidation product", "TREATMENT", 33, 54], ["methylated cytosine", "TREATMENT", 58, 77]]], ["5mC oxidation is mediated by the enzymatic activity of TET (Ten-Eleven-Translocation) family proteins and consistently yields three oxidative derivatives: 5-hydroxymethylcytosine, 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC).", [["5mC", "CHEMICAL", 0, 3], ["TET", "CHEMICAL", 55, 58], ["5-hydroxymethylcytosine", "CHEMICAL", 155, 178], ["5-formylcytosine", "CHEMICAL", 180, 196], ["5fC", "CHEMICAL", 198, 201], ["5-carboxylcytosine", "CHEMICAL", 208, 226], ["5caC", "CHEMICAL", 228, 232], ["5mC", "CHEMICAL", 0, 3], ["TET", "CHEMICAL", 55, 58], ["5-hydroxymethylcytosine", "CHEMICAL", 155, 178], ["5-formylcytosine", "CHEMICAL", 180, 196], ["5fC", "CHEMICAL", 198, 201], ["5-carboxylcytosine", "CHEMICAL", 208, 226], ["5caC", "CHEMICAL", 228, 232], ["5mC", "SIMPLE_CHEMICAL", 0, 3], ["TET", "SIMPLE_CHEMICAL", 55, 58], ["5-hydroxymethylcytosine", "SIMPLE_CHEMICAL", 155, 178], ["5-formylcytosine", "SIMPLE_CHEMICAL", 180, 196], ["5fC", "SIMPLE_CHEMICAL", 198, 201], ["5-carboxylcytosine", "SIMPLE_CHEMICAL", 208, 226], ["5caC", "SIMPLE_CHEMICAL", 228, 232], ["Ten-Eleven-Translocation) family proteins", "PROTEIN", 60, 101], ["5mC oxidation", "TREATMENT", 0, 13], ["three oxidative derivatives", "TREATMENT", 126, 153], ["hydroxymethylcytosine", "TREATMENT", 157, 178], ["formylcytosine (5fC", "TREATMENT", 182, 201], ["carboxylcytosine", "TREATMENT", 210, 226]]], ["Once targeted by base excision repair enzymes, 5fC and 5caC are excised from the DNA and replaced with unmodified cytosine [3, 8] .", [["cytosine", "CHEMICAL", 114, 122], ["cytosine", "CHEMICAL", 114, 122], ["5fC", "GENE_OR_GENE_PRODUCT", 47, 50], ["5caC", "GENE_OR_GENE_PRODUCT", 55, 59], ["DNA", "CELLULAR_COMPONENT", 81, 84], ["cytosine", "SIMPLE_CHEMICAL", 114, 122], ["base excision repair enzymes", "PROTEIN", 17, 45], ["5fC", "PROTEIN", 47, 50], ["5caC", "PROTEIN", 55, 59], ["base excision repair enzymes", "TREATMENT", 17, 45], ["5fC", "TREATMENT", 47, 50], ["5caC", "TREATMENT", 55, 59], ["unmodified cytosine", "TREATMENT", 103, 122]]], ["TET-mediated 5mC oxidation apparently promotes active (enzymatic) DNA demethylation which is a key event of epigenetic reprogramming in germ cells and mammalian embryos.IntroductionResearch demonstrated that 5mC oxidation products serve as intermediates in active DNA demethylation and likewise function in genome regulation.", [["germ cells", "ANATOMY", 136, 146], ["embryos", "ANATOMY", 161, 168], ["TET", "CHEMICAL", 0, 3], ["5mC", "CHEMICAL", 13, 16], ["TET", "CHEMICAL", 0, 3], ["5mC", "CHEMICAL", 13, 16], ["5mC", "CHEMICAL", 208, 211], ["TET", "SIMPLE_CHEMICAL", 0, 3], ["5mC", "SIMPLE_CHEMICAL", 13, 16], ["DNA", "CELLULAR_COMPONENT", 66, 69], ["germ cells", "CELL", 136, 146], ["mammalian", "CELL", 151, 160], ["embryos", "DEVELOPING_ANATOMICAL_STRUCTURE", 161, 168], ["5mC", "SIMPLE_CHEMICAL", 208, 211], ["DNA", "CELLULAR_COMPONENT", 264, 267], ["germ cells", "CELL_TYPE", 136, 146], ["5mC oxidation products", "PROTEIN", 208, 230], ["TET-mediated 5mC oxidation", "TREATMENT", 0, 26], ["active (enzymatic) DNA demethylation", "PROBLEM", 47, 83], ["epigenetic reprogramming in germ cells", "TREATMENT", 108, 146], ["mammalian embryos", "PROBLEM", 151, 168], ["5mC oxidation products", "TREATMENT", 208, 230], ["active DNA demethylation", "TREATMENT", 257, 281], ["active", "OBSERVATION_MODIFIER", 47, 53], ["germ cells", "OBSERVATION", 136, 146], ["mammalian embryos", "OBSERVATION", 151, 168], ["active", "OBSERVATION_MODIFIER", 257, 263], ["DNA demethylation", "OBSERVATION", 264, 281]]], ["This is particularly true for 5hmC as a predominantly stable oxidation product of 5mC.", [["5hmC", "CHEMICAL", 30, 34], ["5hmC", "CHEMICAL", 30, 34], ["5mC", "CHEMICAL", 82, 85], ["5hmC", "SIMPLE_CHEMICAL", 30, 34], ["5mC", "SIMPLE_CHEMICAL", 82, 85], ["5mC", "PROTEIN", 82, 85], ["predominantly", "OBSERVATION_MODIFIER", 40, 53], ["stable", "OBSERVATION_MODIFIER", 54, 60], ["oxidation product", "OBSERVATION", 61, 78]]], ["Thus, 5hmC is specifically recognized by some protein regulators of cell metabolism, including RPL26, PRP8, MHS6, MeCP2, UHRF, and Thy28 [9] [10] [11] .", [["cell", "ANATOMY", 68, 72], ["5hmC", "CHEMICAL", 6, 10], ["5hmC", "GENE_OR_GENE_PRODUCT", 6, 10], ["cell", "CELL", 68, 72], ["RPL26", "GENE_OR_GENE_PRODUCT", 95, 100], ["PRP8", "GENE_OR_GENE_PRODUCT", 102, 106], ["MHS6", "GENE_OR_GENE_PRODUCT", 108, 112], ["MeCP2", "GENE_OR_GENE_PRODUCT", 114, 119], ["UHRF", "GENE_OR_GENE_PRODUCT", 121, 125], ["5hmC", "PROTEIN", 6, 10], ["protein regulators", "PROTEIN", 46, 64], ["RPL26", "PROTEIN", 95, 100], ["PRP8", "PROTEIN", 102, 106], ["MHS6", "PROTEIN", 108, 112], ["MeCP2", "PROTEIN", 114, 119], ["UHRF", "PROTEIN", 121, 125], ["cell metabolism", "TEST", 68, 83], ["RPL26", "TEST", 95, 100], ["PRP8", "TEST", 102, 106], ["MHS6", "TEST", 108, 112], ["MeCP2", "TEST", 114, 119], ["UHRF", "TEST", 121, 125], ["cell metabolism", "OBSERVATION", 68, 83]]], ["Typically, 5hmC would exhibit specific genomic localization-in enhancers, sites flanking promoters (or CpG-islands), and in gene bodies.", [["5hmC", "CHEMICAL", 11, 15], ["5hmC", "CELLULAR_COMPONENT", 11, 15], ["5hmC", "PROTEIN", 11, 15], ["enhancers", "DNA", 63, 72], ["sites flanking promoters", "DNA", 74, 98], ["CpG-islands", "DNA", 103, 114], ["specific", "OBSERVATION_MODIFIER", 30, 38], ["genomic localization", "OBSERVATION", 39, 59], ["gene", "ANATOMY", 124, 128], ["bodies", "ANATOMY_MODIFIER", 129, 135]]], ["Furthermore, abundance of 5hmC at enhancers is positively correlated with enhancer activity [12] [13] [14] .", [["5hmC", "GENE_OR_GENE_PRODUCT", 26, 30], ["5hmC", "PROTEIN", 26, 30], ["enhancers", "DNA", 34, 43], ["5hmC at enhancers", "PROBLEM", 26, 43]]], ["At CpG-islands, 5hmC is vital to maintain promoters in the unmethylated state, whereas in intragenic sequences, 5hmC is suggested to have an inhibitory action on antisense transcription initiation [15, 16] .", [["5hmC", "CHEMICAL", 112, 116], ["CpG", "CHEMICAL", 3, 6], ["5hmC", "CELLULAR_COMPONENT", 16, 20], ["5hmC", "CELLULAR_COMPONENT", 112, 116], ["CpG-islands", "DNA", 3, 14], ["5hmC", "DNA", 16, 20], ["promoters", "DNA", 42, 51], ["intragenic sequences", "DNA", 90, 110], ["5hmC", "PROTEIN", 112, 116], ["antisense transcription initiation", "TREATMENT", 162, 196]]], ["5hmC can be thus recognized as a stable cytosine modification which has its own function [17] [18] [19] [20] [21] .IntroductionOn the one hand, in the course of ontogenesis, specific epigenetic profiles that act to initiate gene expression programs and direct cell differentiation are established, maintained, and altered in a strictly determined way [22] [23] [24] .", [["cell", "ANATOMY", 260, 264], ["5hmC", "CHEMICAL", 0, 4], ["cytosine", "CHEMICAL", 40, 48], ["cytosine", "CHEMICAL", 40, 48], ["5hmC", "SIMPLE_CHEMICAL", 0, 4], ["cytosine", "SIMPLE_CHEMICAL", 40, 48], ["[17] [18] [19] [20] [21]", "SIMPLE_CHEMICAL", 89, 113], ["cell", "CELL", 260, 264], ["5hmC", "PROTEIN", 0, 4], ["a stable cytosine modification", "TREATMENT", 31, 61], ["gene expression programs", "TREATMENT", 224, 248], ["direct cell differentiation", "TEST", 253, 280]]], ["Reversible cytosine modification, on the other hand, provides a source of epigenomic plasticity-the ability of the epigenome to change in response to external factors.", [["cytosine", "CHEMICAL", 11, 19], ["cytosine", "CHEMICAL", 11, 19], ["cytosine", "SIMPLE_CHEMICAL", 11, 19], ["Reversible cytosine modification", "TREATMENT", 0, 32], ["epigenomic plasticity", "PROBLEM", 74, 95], ["external factors", "TREATMENT", 150, 166], ["cytosine modification", "OBSERVATION", 11, 32]]], ["Today, there is well-established evidence that aberrant DNA methylation patterns generally associated with some pathological conditions including genome structural variation and complex rearrangements can be provoked by endogenous and environmental factors [25] [26] [27] [28] [29] .", [["DNA", "CELLULAR_COMPONENT", 56, 59], ["[25] [26] [27] [28] [29]", "SIMPLE_CHEMICAL", 257, 281], ["aberrant DNA methylation patterns", "PROBLEM", 47, 80], ["some pathological conditions", "PROBLEM", 107, 135], ["genome structural variation", "PROBLEM", 146, 173], ["aberrant", "OBSERVATION_MODIFIER", 47, 55], ["DNA methylation", "OBSERVATION", 56, 71]]], ["Folic acid deficiency during pregnancy can induce a deficiency of S-adenosylmethionine (SAM), a methyl group donor, resulting in elevated homocysteine and abnormal DNA methylation.", [["Folic acid", "CHEMICAL", 0, 10], ["S-adenosylmethionine", "CHEMICAL", 66, 86], ["SAM", "CHEMICAL", 88, 91], ["methyl", "CHEMICAL", 96, 102], ["homocysteine", "CHEMICAL", 138, 150], ["Folic acid", "CHEMICAL", 0, 10], ["S-adenosylmethionine", "CHEMICAL", 66, 86], ["SAM", "CHEMICAL", 88, 91], ["methyl", "CHEMICAL", 96, 102], ["homocysteine", "CHEMICAL", 138, 150], ["Folic acid", "SIMPLE_CHEMICAL", 0, 10], ["S-adenosylmethionine", "SIMPLE_CHEMICAL", 66, 86], ["SAM", "SIMPLE_CHEMICAL", 88, 91], ["methyl", "SIMPLE_CHEMICAL", 96, 102], ["homocysteine", "SIMPLE_CHEMICAL", 138, 150], ["DNA", "CELLULAR_COMPONENT", 164, 167], ["Folic acid deficiency", "PROBLEM", 0, 21], ["a deficiency of S-adenosylmethionine (SAM)", "PROBLEM", 50, 92], ["a methyl group donor", "TREATMENT", 94, 114], ["elevated homocysteine", "PROBLEM", 129, 150], ["abnormal DNA methylation", "PROBLEM", 155, 179], ["acid deficiency", "OBSERVATION", 6, 21], ["elevated homocysteine", "OBSERVATION", 129, 150], ["DNA methylation", "OBSERVATION", 164, 179]]], ["This leads to gene deregulation, including abnormal biallelic expression of imprinted genes, which are normally characterized by a monoallelic expression [30] .", [["imprinted genes", "DNA", 76, 91], ["gene deregulation", "PROBLEM", 14, 31], ["abnormal biallelic expression of imprinted genes", "PROBLEM", 43, 91], ["gene deregulation", "OBSERVATION", 14, 31], ["abnormal", "OBSERVATION_MODIFIER", 43, 51], ["biallelic expression", "OBSERVATION", 52, 72], ["imprinted genes", "OBSERVATION", 76, 91]]], ["Metals such as nickel, cadmium, and arsenic perturb DNA methylation patterns and damage epigenetic regulation of proto-oncogenes and oncosuppressors, thus increasing the risk of malignization [31] .", [["Metals", "CHEMICAL", 0, 6], ["nickel", "CHEMICAL", 15, 21], ["cadmium", "CHEMICAL", 23, 30], ["arsenic", "CHEMICAL", 36, 43], ["malignization", "DISEASE", 178, 191], ["nickel", "CHEMICAL", 15, 21], ["cadmium", "CHEMICAL", 23, 30], ["arsenic", "CHEMICAL", 36, 43], ["Metals", "SIMPLE_CHEMICAL", 0, 6], ["nickel", "SIMPLE_CHEMICAL", 15, 21], ["cadmium", "SIMPLE_CHEMICAL", 23, 30], ["arsenic", "SIMPLE_CHEMICAL", 36, 43], ["DNA", "CELLULAR_COMPONENT", 52, 55], ["proto-oncogenes", "GENE_OR_GENE_PRODUCT", 113, 128], ["proto-oncogenes", "DNA", 113, 128], ["Metals", "TREATMENT", 0, 6], ["nickel, cadmium", "TREATMENT", 15, 30], ["arsenic perturb DNA methylation patterns", "TREATMENT", 36, 76], ["damage epigenetic regulation of proto-oncogenes", "TREATMENT", 81, 128], ["oncosuppressors", "TREATMENT", 133, 148]]], ["Research has shown that disrupted DNA methylation can be induced by synthetic nonsteroidal estrogen-diethylstilbestrol [32] [33] [34] .", [["estrogen-diethylstilbestrol", "CHEMICAL", 91, 118], ["estrogen", "CHEMICAL", 91, 99], ["diethylstilbestrol", "CHEMICAL", 100, 118], ["DNA", "CELLULAR_COMPONENT", 34, 37], ["nonsteroidal estrogen-diethylstilbestrol [32] [33] [34]", "SIMPLE_CHEMICAL", 78, 133], ["disrupted DNA methylation", "PROBLEM", 24, 49], ["synthetic nonsteroidal estrogen", "TREATMENT", 68, 99]]], ["Ample studies suggest evidence of DNA methylation damage due to exposure to chromium, mercury, trichloroethylene, dichloroacetic and trichloroacetic acid, bisphenol A (BPA), and many other substances [35] [36] [37] [38] [39] [40] [41] [42] .IntroductionWhile DNA methylation has been extensively investigated, knowledge about how 5hmC patterns change in response to adverse environmental factors is so far scarce [43] .", [["chromium", "CHEMICAL", 76, 84], ["mercury", "CHEMICAL", 86, 93], ["trichloroethylene", "CHEMICAL", 95, 112], ["dichloroacetic and trichloroacetic acid", "CHEMICAL", 114, 153], ["bisphenol A", "CHEMICAL", 155, 166], ["BPA", "CHEMICAL", 168, 171], ["[35] [36] [37] [38] [39] [40] [41", "CHEMICAL", 200, 233], ["chromium", "CHEMICAL", 76, 84], ["mercury", "CHEMICAL", 86, 93], ["trichloroethylene", "CHEMICAL", 95, 112], ["dichloroacetic", "CHEMICAL", 114, 128], ["trichloroacetic acid", "CHEMICAL", 133, 153], ["bisphenol A", "CHEMICAL", 155, 166], ["BPA", "CHEMICAL", 168, 171], ["[35] [36] [37] [38] [39] [40] [41]", "CHEMICAL", 200, 234], ["DNA", "CELLULAR_COMPONENT", 34, 37], ["chromium", "SIMPLE_CHEMICAL", 76, 84], ["mercury", "SIMPLE_CHEMICAL", 86, 93], ["trichloroethylene", "SIMPLE_CHEMICAL", 95, 112], ["dichloroacetic", "SIMPLE_CHEMICAL", 114, 128], ["trichloroacetic acid", "SIMPLE_CHEMICAL", 133, 153], ["bisphenol A", "SIMPLE_CHEMICAL", 155, 166], ["BPA", "SIMPLE_CHEMICAL", 168, 171], ["[35] [36] [37] [38] [39] [40] [41] [42]", "SIMPLE_CHEMICAL", 200, 239], ["DNA", "CELLULAR_COMPONENT", 259, 262], ["5hmC", "GENE_OR_GENE_PRODUCT", 330, 334], ["Ample studies", "TEST", 0, 13], ["DNA methylation damage", "PROBLEM", 34, 56], ["chromium", "TREATMENT", 76, 84], ["trichloroethylene", "TREATMENT", 95, 112], ["dichloroacetic", "TREATMENT", 114, 128], ["trichloroacetic acid", "TREATMENT", 133, 153], ["adverse environmental factors", "PROBLEM", 366, 395], ["suggest evidence of", "UNCERTAINTY", 14, 33]]], ["Up-to-date information is focused on brain-related 5hmC changes upon external exposures [44] or has been reviewed in terms of the link between environmental cues and DNA hydroxymethylation, lacking discussion of the underlying molecular mechanisms [45] .", [["brain", "ANATOMY", 37, 42], ["brain", "ORGAN", 37, 42], ["5hmC", "GENE_OR_GENE_PRODUCT", 51, 55], ["DNA", "CELLULAR_COMPONENT", 166, 169], ["5hmC changes", "PROBLEM", 51, 63], ["DNA hydroxymethylation", "TREATMENT", 166, 188]]], ["The present paper consolidates current evidence on 5hmC pattern alterations induced by environmental factors in different organs, tissues, and cell lines and analyzes how they affect genome function.", [["organs", "ANATOMY", 122, 128], ["tissues", "ANATOMY", 130, 137], ["cell lines", "ANATOMY", 143, 153], ["5hmC", "SIMPLE_CHEMICAL", 51, 55], ["organs", "ORGAN", 122, 128], ["tissues", "TISSUE", 130, 137], ["cell lines", "CELL", 143, 153], ["5hmC pattern alterations", "PROBLEM", 51, 75], ["cell lines", "TREATMENT", 143, 153], ["cell lines", "OBSERVATION", 143, 153]]], ["Along with DNA hydroxymethylation changes, the associated alterations of major components for 5hmC production (5mC, TETs, DNA methylases, co-substrates, and co-factors) are reviewed to place special emphasis on the molecular mechanisms providing epigenetic responses to adverse external effectors.", [["DNA", "CELLULAR_COMPONENT", 11, 14], ["5hmC", "SIMPLE_CHEMICAL", 94, 98], ["5mC", "SIMPLE_CHEMICAL", 111, 114], ["DNA", "CELLULAR_COMPONENT", 122, 125], ["5hmC", "PROTEIN", 94, 98], ["5mC", "PROTEIN", 111, 114], ["TETs", "PROTEIN", 116, 120], ["DNA methylases", "PROTEIN", 122, 136], ["co-substrates", "PROTEIN", 138, 151], ["DNA hydroxymethylation changes", "PROBLEM", 11, 41], ["5hmC production", "PROBLEM", 94, 109], ["TETs, DNA methylases", "TREATMENT", 116, 136], ["adverse external effectors", "PROBLEM", 270, 296], ["DNA hydroxymethylation", "OBSERVATION", 11, 33]]], ["The reviewed data strongly suggest that environmentally induced genome-wide and gene-specific hydroxymethylation alterations are driven by various metabolic pathways due to effector-specific changes in 5hmC biochemistry.", [["5hmC", "SIMPLE_CHEMICAL", 202, 206], ["The reviewed data", "TEST", 0, 17], ["environmentally induced genome", "PROBLEM", 40, 70], ["specific hydroxymethylation alterations", "PROBLEM", 85, 124]]], ["The associated transcriptional changes point towards the role of environmentally induced 5hmC alterations in epigenetically mediated genome flexibility.Factors Associated with 5hmC Biochemical Pathways in Mammalian DNA5hmC biochemical pathways in mammalian DNA are shown in Figure 1 .", [["5hmC", "GENE_OR_GENE_PRODUCT", 89, 93], ["DNA5hmC", "GENE_OR_GENE_PRODUCT", 215, 222], ["DNA", "CELLULAR_COMPONENT", 257, 260], ["5hmC", "PROTEIN", 176, 180], ["mammalian DNA", "DNA", 247, 260], ["The associated transcriptional changes", "PROBLEM", 0, 38], ["5hmC alterations", "PROBLEM", 89, 105], ["5hmC Biochemical Pathways", "PROBLEM", 176, 201], ["transcriptional changes", "OBSERVATION", 15, 38], ["genome flexibility", "OBSERVATION", 133, 151], ["mammalian DNA", "OBSERVATION", 247, 260]]], ["5hmC in mammalian DNA is the product of 5mC oxidation.", [["5hmC", "CHEMICAL", 0, 4], ["5mC", "CHEMICAL", 40, 43], ["5hmC", "CELLULAR_COMPONENT", 0, 4], ["DNA", "CELLULAR_COMPONENT", 18, 21], ["5mC", "SIMPLE_CHEMICAL", 40, 43], ["5hmC", "DNA", 0, 4], ["mammalian DNA", "DNA", 8, 21], ["5hmC in mammalian DNA", "TREATMENT", 0, 21], ["5mC oxidation", "TREATMENT", 40, 53], ["mammalian DNA", "OBSERVATION", 8, 21]]], ["Although several studies provided evidence for the production of 5hmC by a random hydroxyl radical attack on 5mC under oxidative stress conditions [46] [47] [48] , basically, hydroxylation of methylated DNA is driven by TET proteins [3] .", [["5hmC", "CHEMICAL", 65, 69], ["hydroxyl", "CHEMICAL", 82, 90], ["5mC", "CHEMICAL", 109, 112], ["[46] [47] [48]", "CHEMICAL", 147, 161], ["TET", "CHEMICAL", 220, 223], ["5hmC", "CHEMICAL", 65, 69], ["hydroxyl", "CHEMICAL", 82, 90], ["5mC", "CHEMICAL", 109, 112], ["5hmC", "SIMPLE_CHEMICAL", 65, 69], ["hydroxyl radical", "SIMPLE_CHEMICAL", 82, 98], ["5mC", "SIMPLE_CHEMICAL", 109, 112], ["[46] [47] [48]", "SIMPLE_CHEMICAL", 147, 161], ["DNA", "CELLULAR_COMPONENT", 203, 206], ["TET proteins", "GENE_OR_GENE_PRODUCT", 220, 232], ["TET proteins", "PROTEIN", 220, 232], ["several studies", "TEST", 9, 24], ["the production of 5hmC", "PROBLEM", 47, 69], ["a random hydroxyl radical attack", "TREATMENT", 73, 105], ["hydroxylation of methylated DNA", "TREATMENT", 175, 206]]], ["The TET family consists of three proteins-TET1, TET2, and TET3; all of them are dioxygenases that can catalyze the oxidation of 5mC to produce 5hmC both in vivo and in vitro [8] .", [["TET", "CHEMICAL", 4, 7], ["5mC", "CHEMICAL", 128, 131], ["TET", "CANCER", 4, 7], ["TET1", "GENE_OR_GENE_PRODUCT", 42, 46], ["TET2", "GENE_OR_GENE_PRODUCT", 48, 52], ["TET3", "GENE_OR_GENE_PRODUCT", 58, 62], ["5mC", "SIMPLE_CHEMICAL", 128, 131], ["5hmC", "SIMPLE_CHEMICAL", 143, 147], ["TET family", "PROTEIN", 4, 14], ["TET1", "PROTEIN", 42, 46], ["TET2", "PROTEIN", 48, 52], ["TET3", "PROTEIN", 58, 62], ["dioxygenases", "PROTEIN", 80, 92], ["5mC", "PROTEIN", 128, 131], ["5hmC", "PROTEIN", 143, 147], ["TET3", "TREATMENT", 58, 62]]], ["Apart from 5mC, TET proteins utilize alpha-ketoglutarate and oxygen as co-substrates and require co-factors Fe(II) and ascorbate to yield the reaction end products: 5hmC, CO 2 , and succinate [3] .", [["TET", "CHEMICAL", 16, 19], ["alpha-ketoglutarate", "CHEMICAL", 37, 56], ["oxygen", "CHEMICAL", 61, 67], ["Fe(II", "CHEMICAL", 108, 113], ["ascorbate", "CHEMICAL", 119, 128], ["succinate", "CHEMICAL", 182, 191], ["alpha-ketoglutarate", "CHEMICAL", 37, 56], ["oxygen", "CHEMICAL", 61, 67], ["Fe(II)", "CHEMICAL", 108, 114], ["ascorbate", "CHEMICAL", 119, 128], ["CO 2", "CHEMICAL", 171, 175], ["succinate", "CHEMICAL", 182, 191], ["5mC", "SIMPLE_CHEMICAL", 11, 14], ["TET proteins", "GENE_OR_GENE_PRODUCT", 16, 28], ["alpha-ketoglutarate", "SIMPLE_CHEMICAL", 37, 56], ["oxygen", "SIMPLE_CHEMICAL", 61, 67], ["Fe(II)", "SIMPLE_CHEMICAL", 108, 114], ["ascorbate", "SIMPLE_CHEMICAL", 119, 128], ["hmC", "SIMPLE_CHEMICAL", 166, 169], ["CO 2", "SIMPLE_CHEMICAL", 171, 175], ["succinate [3]", "SIMPLE_CHEMICAL", 182, 195], ["5mC", "PROTEIN", 11, 14], ["TET proteins", "PROTEIN", 16, 28], ["alpha-ketoglutarate", "TREATMENT", 37, 56], ["oxygen", "TREATMENT", 61, 67], ["co-factors Fe(II)", "TREATMENT", 97, 114], ["ascorbate", "TREATMENT", 119, 128], ["CO", "TEST", 171, 173]]], ["It is therefore apparent that the mechanism of reaction depends on TET enzymatic activity, availability of substrate, and co-factors. suggest that environmentally induced genome-wide and gene-specific hydroxymethylation alterations are driven by various metabolic pathways due to effector-specific changes in 5hmC biochemistry.", [["TET", "CHEMICAL", 67, 70], ["TET", "SIMPLE_CHEMICAL", 67, 70], ["5hmC", "SIMPLE_CHEMICAL", 309, 313], ["reaction", "PROBLEM", 47, 55], ["specific hydroxymethylation alterations", "PROBLEM", 192, 231], ["5hmC biochemistry", "TEST", 309, 326]]], ["The associated transcriptional changes point towards the role of environmentally induced 5hmC alterations in epigenetically mediated genome flexibility.Factors Associated with 5hmC Biochemical Pathways in Mammalian DNA5hmC biochemical pathways in mammalian DNA are shown in Figure 1 .", [["5hmC", "GENE_OR_GENE_PRODUCT", 89, 93], ["DNA5hmC", "GENE_OR_GENE_PRODUCT", 215, 222], ["DNA", "CELLULAR_COMPONENT", 257, 260], ["5hmC", "PROTEIN", 176, 180], ["mammalian DNA", "DNA", 247, 260], ["The associated transcriptional changes", "PROBLEM", 0, 38], ["5hmC alterations", "PROBLEM", 89, 105], ["5hmC Biochemical Pathways", "PROBLEM", 176, 201], ["transcriptional changes", "OBSERVATION", 15, 38], ["genome flexibility", "OBSERVATION", 133, 151], ["mammalian DNA", "OBSERVATION", 247, 260]]], ["5hmC in mammalian DNA is the product of 5mC oxidation.", [["5hmC", "CHEMICAL", 0, 4], ["5mC", "CHEMICAL", 40, 43], ["5hmC", "CELLULAR_COMPONENT", 0, 4], ["DNA", "CELLULAR_COMPONENT", 18, 21], ["5mC", "SIMPLE_CHEMICAL", 40, 43], ["5hmC", "DNA", 0, 4], ["mammalian DNA", "DNA", 8, 21], ["5hmC in mammalian DNA", "TREATMENT", 0, 21], ["5mC oxidation", "TREATMENT", 40, 53], ["mammalian DNA", "OBSERVATION", 8, 21]]], ["Although several studies provided evidence for the production of 5hmC by a random hydroxyl radical attack on 5mC under oxidative stress conditions [46] [47] [48] , basically, hydroxylation of methylated DNA is driven by \u0422\u0415\u0422 proteins [3] .", [["5hmC", "CHEMICAL", 65, 69], ["hydroxyl", "CHEMICAL", 82, 90], ["5mC", "CHEMICAL", 109, 112], ["[46] [47] [48]", "CHEMICAL", 147, 161], ["5hmC", "CHEMICAL", 65, 69], ["hydroxyl", "CHEMICAL", 82, 90], ["5mC", "CHEMICAL", 109, 112], ["5hmC", "SIMPLE_CHEMICAL", 65, 69], ["hydroxyl radical", "SIMPLE_CHEMICAL", 82, 98], ["5mC", "SIMPLE_CHEMICAL", 109, 112], ["[46] [47] [48]", "SIMPLE_CHEMICAL", 147, 161], ["DNA", "CELLULAR_COMPONENT", 203, 206], ["\u0422\u0415\u0422 proteins", "PROTEIN", 220, 232], ["several studies", "TEST", 9, 24], ["the production of 5hmC", "PROBLEM", 47, 69], ["a random hydroxyl radical attack", "TREATMENT", 73, 105], ["hydroxylation of methylated DNA", "TREATMENT", 175, 206]]], ["The TET family consists of three proteins-TET1, TET2, and TET3; all of them are dioxygenases that can catalyze the oxidation of 5mC to produce 5hmC both in vivo and in vitro [8] .", [["TET", "CHEMICAL", 4, 7], ["5mC", "CHEMICAL", 128, 131], ["TET", "CANCER", 4, 7], ["TET1", "GENE_OR_GENE_PRODUCT", 42, 46], ["TET2", "GENE_OR_GENE_PRODUCT", 48, 52], ["TET3", "GENE_OR_GENE_PRODUCT", 58, 62], ["5mC", "SIMPLE_CHEMICAL", 128, 131], ["5hmC", "SIMPLE_CHEMICAL", 143, 147], ["TET family", "PROTEIN", 4, 14], ["TET1", "PROTEIN", 42, 46], ["TET2", "PROTEIN", 48, 52], ["TET3", "PROTEIN", 58, 62], ["dioxygenases", "PROTEIN", 80, 92], ["5mC", "PROTEIN", 128, 131], ["5hmC", "PROTEIN", 143, 147], ["TET3", "TREATMENT", 58, 62]]], ["Apart from 5mC, TET proteins utilize alpha-ketoglutarate and oxygen as co-substrates and require co-factors Fe(II) and ascorbate to yield the reaction end products: 5hmC, \u0421\u041e2, and succinate [3] .", [["TET", "CHEMICAL", 16, 19], ["alpha-ketoglutarate", "CHEMICAL", 37, 56], ["oxygen", "CHEMICAL", 61, 67], ["Fe", "CHEMICAL", 108, 110], ["ascorbate", "CHEMICAL", 119, 128], ["succinate", "CHEMICAL", 180, 189], ["alpha-ketoglutarate", "CHEMICAL", 37, 56], ["oxygen", "CHEMICAL", 61, 67], ["Fe(II)", "CHEMICAL", 108, 114], ["ascorbate", "CHEMICAL", 119, 128], ["\u0421\u041e2", "CHEMICAL", 171, 174], ["succinate", "CHEMICAL", 180, 189], ["5mC", "SIMPLE_CHEMICAL", 11, 14], ["TET proteins", "GENE_OR_GENE_PRODUCT", 16, 28], ["alpha-ketoglutarate", "SIMPLE_CHEMICAL", 37, 56], ["oxygen", "SIMPLE_CHEMICAL", 61, 67], ["Fe(II)", "SIMPLE_CHEMICAL", 108, 114], ["ascorbate", "SIMPLE_CHEMICAL", 119, 128], ["hmC", "SIMPLE_CHEMICAL", 166, 169], ["\u0421\u041e2", "SIMPLE_CHEMICAL", 171, 174], ["succinate [3]", "SIMPLE_CHEMICAL", 180, 193], ["5mC", "PROTEIN", 11, 14], ["TET proteins", "PROTEIN", 16, 28], ["alpha-ketoglutarate", "TREATMENT", 37, 56], ["oxygen", "TREATMENT", 61, 67], ["co-factors Fe(II)", "TREATMENT", 97, 114], ["ascorbate", "TREATMENT", 119, 128], ["the reaction end products", "TREATMENT", 138, 163]]], ["It is therefore apparent that the mechanism of reaction depends on TET enzymatic activity, availability of substrate, and co-factors.", [["TET", "CHEMICAL", 67, 70], ["TET", "SIMPLE_CHEMICAL", 67, 70], ["reaction", "PROBLEM", 47, 55]]], ["5-hydroxymethylcytosine (5hmC) biochemical pathways in mammalian DNA.", [["5-hydroxymethylcytosine", "CHEMICAL", 0, 23], ["5hmC", "CHEMICAL", 25, 29], ["5-hydroxymethylcytosine", "CHEMICAL", 0, 23], ["5hmC", "CHEMICAL", 25, 29], ["5-hydroxymethylcytosine", "SIMPLE_CHEMICAL", 0, 23], ["5hmC", "SIMPLE_CHEMICAL", 25, 29], ["DNA", "CELLULAR_COMPONENT", 65, 68], ["mammalian DNA", "DNA", 55, 68], ["hydroxymethylcytosine (5hmC)", "TREATMENT", 2, 30], ["mammalian DNA", "OBSERVATION", 55, 68]]], ["5hmC is produced by TET protein-mediated oxidation (hydroxylation) of 5-methylcytosine (5mC).", [["5hmC", "CHEMICAL", 0, 4], ["TET", "CHEMICAL", 20, 23], ["5-methylcytosine", "CHEMICAL", 70, 86], ["5mC", "CHEMICAL", 88, 91], ["5-methylcytosine", "CHEMICAL", 70, 86], ["5mC", "CHEMICAL", 88, 91], ["5hmC", "SIMPLE_CHEMICAL", 0, 4], ["TET protein", "GENE_OR_GENE_PRODUCT", 20, 31], ["5-methylcytosine", "SIMPLE_CHEMICAL", 70, 86], ["5mC", "SIMPLE_CHEMICAL", 88, 91], ["5hmC", "PROTEIN", 0, 4], ["TET protein", "PROTEIN", 20, 31], ["TET protein-mediated oxidation (hydroxylation)", "TREATMENT", 20, 66], ["methylcytosine", "TREATMENT", 72, 86]]], ["TET proteins utilize alpha-ketoglutarate (\u03b1-KG) and oxygen (\u041e2) as co-substrates and require co-factors Fe(II) and ascorbate to yield 5hmC, \u0421\u041e2, and succinate.", [["TET", "CHEMICAL", 0, 3], ["alpha-ketoglutarate", "CHEMICAL", 21, 40], ["\u03b1-KG", "CHEMICAL", 42, 46], ["oxygen", "CHEMICAL", 52, 58], ["Fe", "CHEMICAL", 104, 106], ["ascorbate", "CHEMICAL", 115, 124], ["5hmC", "CHEMICAL", 134, 138], ["succinate", "CHEMICAL", 149, 158], ["alpha-ketoglutarate", "CHEMICAL", 21, 40], ["\u03b1-KG", "CHEMICAL", 42, 46], ["oxygen", "CHEMICAL", 52, 58], ["Fe(II)", "CHEMICAL", 104, 110], ["ascorbate", "CHEMICAL", 115, 124], ["5hmC", "CHEMICAL", 134, 138], ["\u0421\u041e2", "CHEMICAL", 140, 143], ["succinate", "CHEMICAL", 149, 158], ["TET proteins", "GENE_OR_GENE_PRODUCT", 0, 12], ["alpha-ketoglutarate", "SIMPLE_CHEMICAL", 21, 40], ["\u03b1-KG", "SIMPLE_CHEMICAL", 42, 46], ["oxygen", "SIMPLE_CHEMICAL", 52, 58], ["\u041e2", "SIMPLE_CHEMICAL", 60, 62], ["Fe(II)", "SIMPLE_CHEMICAL", 104, 110], ["ascorbate", "SIMPLE_CHEMICAL", 115, 124], ["5hmC", "SIMPLE_CHEMICAL", 134, 138], ["\u0421\u041e2", "SIMPLE_CHEMICAL", 140, 143], ["succinate", "SIMPLE_CHEMICAL", 149, 158], ["TET proteins", "PROTEIN", 0, 12], ["TET proteins", "TREATMENT", 0, 12], ["alpha-ketoglutarate (\u03b1-KG)", "TREATMENT", 21, 47], ["oxygen (\u041e2)", "TREATMENT", 52, 63], ["co-factors Fe(II)", "TREATMENT", 93, 110], ["ascorbate", "TREATMENT", 115, 124], ["\u0421\u041e2", "TREATMENT", 140, 143], ["succinate", "TREATMENT", 149, 158]]], ["Succinate, fumarate, and 2-hydroxyglutarate are inhibitors of TET activity.", [["Succinate", "CHEMICAL", 0, 9], ["fumarate", "CHEMICAL", 11, 19], ["2-hydroxyglutarate", "CHEMICAL", 25, 43], ["TET", "CHEMICAL", 62, 65], ["Succinate", "CHEMICAL", 0, 9], ["fumarate", "CHEMICAL", 11, 19], ["2-hydroxyglutarate", "CHEMICAL", 25, 43], ["Succinate", "SIMPLE_CHEMICAL", 0, 9], ["fumarate", "SIMPLE_CHEMICAL", 11, 19], ["2-hydroxyglutarate", "SIMPLE_CHEMICAL", 25, 43], ["TET", "SIMPLE_CHEMICAL", 62, 65], ["Succinate", "TREATMENT", 0, 9], ["fumarate", "TREATMENT", 11, 19], ["hydroxyglutarate", "TREATMENT", 27, 43], ["inhibitors", "TREATMENT", 48, 58], ["TET activity", "TREATMENT", 62, 74]]], ["Further TET-driven oxidation of 5hmC consistently produces 5formylcytosine (5fC) and 5-carboxylcytosine (5caC), which are replaced with cytosine (C) by thymine-DNA glycosylase (TDG)-mediated base excision repair (BER).", [["TET", "CHEMICAL", 8, 11], ["5hmC", "CHEMICAL", 32, 36], ["5formylcytosine", "CHEMICAL", 59, 74], ["5fC", "CHEMICAL", 76, 79], ["5-carboxylcytosine", "CHEMICAL", 85, 103], ["5caC", "CHEMICAL", 105, 109], ["cytosine", "CHEMICAL", 136, 144], ["thymine", "CHEMICAL", 152, 159], ["TET", "CHEMICAL", 8, 11], ["5hmC", "CHEMICAL", 32, 36], ["formylcytosine", "CHEMICAL", 60, 74], ["5fC", "CHEMICAL", 76, 79], ["5-carboxylcytosine", "CHEMICAL", 85, 103], ["5caC", "CHEMICAL", 105, 109], ["cytosine", "CHEMICAL", 136, 144], ["thymine", "CHEMICAL", 152, 159], ["TET", "SIMPLE_CHEMICAL", 8, 11], ["5hmC", "SIMPLE_CHEMICAL", 32, 36], ["5formylcytosine", "SIMPLE_CHEMICAL", 59, 74], ["5fC", "SIMPLE_CHEMICAL", 76, 79], ["5-carboxylcytosine", "SIMPLE_CHEMICAL", 85, 103], ["5caC", "SIMPLE_CHEMICAL", 105, 109], ["cytosine (C", "SIMPLE_CHEMICAL", 136, 147], ["thymine-DNA glycosylase", "GENE_OR_GENE_PRODUCT", 152, 175], ["TDG", "SIMPLE_CHEMICAL", 177, 180], ["5hmC", "PROTEIN", 32, 36], ["DNA glycosylase", "PROTEIN", 160, 175], ["TDG", "PROTEIN", 177, 180], ["Further TET-driven oxidation of 5hmC", "TREATMENT", 0, 36], ["5formylcytosine (5fC", "TREATMENT", 59, 79], ["carboxylcytosine (5caC)", "TREATMENT", 87, 110], ["cytosine (C)", "TREATMENT", 136, 148], ["DNA glycosylase (TDG)", "TREATMENT", 160, 181], ["mediated base excision repair", "TREATMENT", 182, 211], ["excision", "OBSERVATION_MODIFIER", 196, 204], ["repair", "OBSERVATION", 205, 211]]], ["DNA methyltransferases I and III (DNMTs I and III) transfer methyl group from S-adenosylmethionine (SAM) to cytosine producing 5mC and S-adenosylhomocysteine (SAH).Factors Associated with 5hmC Biochemical Pathways in Mammalian DNAThe main substrate 5mC is derived from DNA methylation: the transfer of methyl group from SAM to the fifth carbon of cytosine in CpG dinucleotide [49] .", [["methyl", "CHEMICAL", 60, 66], ["S-adenosylmethionine", "CHEMICAL", 78, 98], ["SAM", "CHEMICAL", 100, 103], ["cytosine", "CHEMICAL", 108, 116], ["5mC", "CHEMICAL", 127, 130], ["S-adenosylhomocysteine", "CHEMICAL", 135, 157], ["SAH", "DISEASE", 159, 162], ["methyl", "CHEMICAL", 302, 308], ["cytosine", "CHEMICAL", 347, 355], ["CpG dinucleotide", "CHEMICAL", 359, 375], ["methyl", "CHEMICAL", 60, 66], ["S-adenosylmethionine", "CHEMICAL", 78, 98], ["SAM", "CHEMICAL", 100, 103], ["cytosine", "CHEMICAL", 108, 116], ["5mC", "CHEMICAL", 127, 130], ["S-adenosylhomocysteine", "CHEMICAL", 135, 157], ["SAH", "CHEMICAL", 159, 162], ["methyl", "CHEMICAL", 302, 308], ["SAM", "CHEMICAL", 320, 323], ["carbon", "CHEMICAL", 337, 343], ["cytosine", "CHEMICAL", 347, 355], ["CpG dinucleotide", "CHEMICAL", 359, 375], ["DNA methyltransferases I and III", "GENE_OR_GENE_PRODUCT", 0, 32], ["DNMTs I", "GENE_OR_GENE_PRODUCT", 34, 41], ["methyl group", "SIMPLE_CHEMICAL", 60, 72], ["S-adenosylmethionine", "SIMPLE_CHEMICAL", 78, 98], ["SAM", "SIMPLE_CHEMICAL", 100, 103], ["cytosine", "SIMPLE_CHEMICAL", 108, 116], ["5mC", "SIMPLE_CHEMICAL", 127, 130], ["S-adenosylhomocysteine", "SIMPLE_CHEMICAL", 135, 157], ["SAH", "SIMPLE_CHEMICAL", 159, 162], ["DNA", "CELLULAR_COMPONENT", 269, 272], ["methyl", "SIMPLE_CHEMICAL", 302, 308], ["SAM", "SIMPLE_CHEMICAL", 320, 323], ["cytosine", "SIMPLE_CHEMICAL", 347, 355], ["DNA methyltransferases I and III", "PROTEIN", 0, 32], ["DNMTs I and III", "PROTEIN", 34, 49], ["5hmC", "PROTEIN", 188, 192], ["Mammalian DNAThe main substrate 5mC", "PROTEIN", 217, 252], ["DNA methyltransferases I and III (DNMTs I and III) transfer methyl group from S-adenosylmethionine (SAM)", "TREATMENT", 0, 104], ["cytosine producing 5mC and S-adenosylhomocysteine (SAH)", "TREATMENT", 108, 163], ["5hmC Biochemical Pathways", "TREATMENT", 188, 213], ["Mammalian DNAThe main substrate 5mC", "TREATMENT", 217, 252], ["the fifth carbon of cytosine in CpG dinucleotide", "TREATMENT", 327, 375]]], ["DNA methylation is catalyzed by a group of specific enzymes-type I and III DNA methyltransferases (or methylases).", [["DNA", "CELLULAR_COMPONENT", 0, 3], ["type I and III DNA methyltransferases", "GENE_OR_GENE_PRODUCT", 60, 97], ["enzymes", "PROTEIN", 52, 59], ["type I and III DNA methyltransferases", "PROTEIN", 60, 97], ["methylases", "PROTEIN", 102, 112], ["DNA methylation", "PROBLEM", 0, 15], ["specific enzymes", "TEST", 43, 59], ["type I and III DNA methyltransferases", "PROBLEM", 60, 97]]], ["Type I DNA methyltransferase (DNMT1) is specific to hemimethylated DNA which is produced after replication and contains a methylated template strand and an unmethylated newly synthesized strand.", [["Type I DNA methyltransferase", "GENE_OR_GENE_PRODUCT", 0, 28], ["DNMT1", "GENE_OR_GENE_PRODUCT", 30, 35], ["DNA", "CELLULAR_COMPONENT", 67, 70], ["strand", "CELLULAR_COMPONENT", 187, 193], ["Type I DNA methyltransferase", "PROTEIN", 0, 28], ["DNMT1", "PROTEIN", 30, 35], ["hemimethylated DNA", "DNA", 52, 70], ["methylated template strand", "DNA", 122, 148], ["unmethylated newly synthesized strand", "DNA", 156, 193], ["Type I DNA methyltransferase (DNMT1)", "TREATMENT", 0, 36], ["hemimethylated DNA", "PROBLEM", 52, 70], ["a methylated template strand", "TREATMENT", 120, 148], ["an unmethylated newly synthesized strand", "TREATMENT", 153, 193], ["hemimethylated DNA", "OBSERVATION", 52, 70]]], ["DNMT1 methylation of the new strand mediates reproduction of the template strand methylation pattern and thus enables its inheritance by daughter cells during divisions.", [["daughter cells", "ANATOMY", 137, 151], ["DNMT1", "GENE_OR_GENE_PRODUCT", 0, 5], ["daughter cells", "CELL", 137, 151], ["DNMT1", "PROTEIN", 0, 5], ["daughter cells", "CELL_TYPE", 137, 151], ["the new strand mediates reproduction", "TREATMENT", 21, 57], ["the template strand methylation pattern", "PROBLEM", 61, 100], ["new", "OBSERVATION_MODIFIER", 25, 28], ["strand", "OBSERVATION_MODIFIER", 29, 35]]], ["Conversely, type III DNA Figure 1 .", [["DNA", "CELLULAR_COMPONENT", 21, 24]]], ["5-hydroxymethylcytosine (5hmC) biochemical pathways in mammalian DNA.", [["5-hydroxymethylcytosine", "CHEMICAL", 0, 23], ["5hmC", "CHEMICAL", 25, 29], ["5-hydroxymethylcytosine", "CHEMICAL", 0, 23], ["5hmC", "CHEMICAL", 25, 29], ["5-hydroxymethylcytosine", "SIMPLE_CHEMICAL", 0, 23], ["5hmC", "SIMPLE_CHEMICAL", 25, 29], ["DNA", "CELLULAR_COMPONENT", 65, 68], ["mammalian DNA", "DNA", 55, 68], ["hydroxymethylcytosine (5hmC)", "TREATMENT", 2, 30], ["mammalian DNA", "OBSERVATION", 55, 68]]], ["5hmC is produced by TET protein-mediated oxidation (hydroxylation) of 5-methylcytosine (5mC).", [["5hmC", "CHEMICAL", 0, 4], ["TET", "CHEMICAL", 20, 23], ["5-methylcytosine", "CHEMICAL", 70, 86], ["5mC", "CHEMICAL", 88, 91], ["5-methylcytosine", "CHEMICAL", 70, 86], ["5mC", "CHEMICAL", 88, 91], ["5hmC", "SIMPLE_CHEMICAL", 0, 4], ["TET protein", "GENE_OR_GENE_PRODUCT", 20, 31], ["5-methylcytosine", "SIMPLE_CHEMICAL", 70, 86], ["5mC", "SIMPLE_CHEMICAL", 88, 91], ["5hmC", "PROTEIN", 0, 4], ["TET protein", "PROTEIN", 20, 31], ["TET protein-mediated oxidation (hydroxylation)", "TREATMENT", 20, 66], ["methylcytosine", "TREATMENT", 72, 86]]], ["TET proteins utilize alpha-ketoglutarate (\u03b1-KG) and oxygen (O 2 ) as co-substrates and require co-factors Fe(II) and ascorbate to yield 5hmC, CO 2 , and succinate.", [["TET", "CHEMICAL", 0, 3], ["alpha-ketoglutarate", "CHEMICAL", 21, 40], ["\u03b1-KG", "CHEMICAL", 42, 46], ["oxygen", "CHEMICAL", 52, 58], ["Fe(II", "CHEMICAL", 106, 111], ["ascorbate", "CHEMICAL", 117, 126], ["5hmC", "CHEMICAL", 136, 140], ["succinate", "CHEMICAL", 153, 162], ["alpha-ketoglutarate", "CHEMICAL", 21, 40], ["\u03b1-KG", "CHEMICAL", 42, 46], ["oxygen", "CHEMICAL", 52, 58], ["O 2", "CHEMICAL", 60, 63], ["Fe(II)", "CHEMICAL", 106, 112], ["ascorbate", "CHEMICAL", 117, 126], ["5hmC", "CHEMICAL", 136, 140], ["CO 2", "CHEMICAL", 142, 146], ["succinate", "CHEMICAL", 153, 162], ["TET proteins", "GENE_OR_GENE_PRODUCT", 0, 12], ["alpha-ketoglutarate", "SIMPLE_CHEMICAL", 21, 40], ["\u03b1-KG", "SIMPLE_CHEMICAL", 42, 46], ["oxygen", "SIMPLE_CHEMICAL", 52, 58], ["O 2", "SIMPLE_CHEMICAL", 60, 63], ["Fe(II)", "SIMPLE_CHEMICAL", 106, 112], ["ascorbate", "SIMPLE_CHEMICAL", 117, 126], ["5hmC", "SIMPLE_CHEMICAL", 136, 140], ["CO 2", "SIMPLE_CHEMICAL", 142, 146], ["succinate", "SIMPLE_CHEMICAL", 153, 162], ["TET proteins", "PROTEIN", 0, 12], ["TET proteins", "TREATMENT", 0, 12], ["alpha-ketoglutarate (\u03b1-KG)", "TREATMENT", 21, 47], ["oxygen", "TREATMENT", 52, 58], ["ascorbate", "TREATMENT", 117, 126], ["5hmC", "TEST", 136, 140], ["CO", "TEST", 142, 144], ["succinate", "TREATMENT", 153, 162]]], ["Succinate, fumarate, and 2-hydroxyglutarate are inhibitors of TET activity.", [["Succinate", "CHEMICAL", 0, 9], ["fumarate", "CHEMICAL", 11, 19], ["2-hydroxyglutarate", "CHEMICAL", 25, 43], ["TET", "CHEMICAL", 62, 65], ["Succinate", "CHEMICAL", 0, 9], ["fumarate", "CHEMICAL", 11, 19], ["2-hydroxyglutarate", "CHEMICAL", 25, 43], ["Succinate", "SIMPLE_CHEMICAL", 0, 9], ["fumarate", "SIMPLE_CHEMICAL", 11, 19], ["2-hydroxyglutarate", "SIMPLE_CHEMICAL", 25, 43], ["TET", "SIMPLE_CHEMICAL", 62, 65], ["Succinate", "TREATMENT", 0, 9], ["fumarate", "TREATMENT", 11, 19], ["hydroxyglutarate", "TREATMENT", 27, 43], ["inhibitors", "TREATMENT", 48, 58], ["TET activity", "TREATMENT", 62, 74]]], ["Further TET-driven oxidation of 5hmC consistently produces 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC), which are replaced with cytosine (C) by thymine-DNA glycosylase (TDG)-mediated base excision repair (BER).", [["TET", "CHEMICAL", 8, 11], ["5hmC", "CHEMICAL", 32, 36], ["5-formylcytosine", "CHEMICAL", 59, 75], ["5fC", "CHEMICAL", 77, 80], ["5-carboxylcytosine", "CHEMICAL", 86, 104], ["5caC", "CHEMICAL", 106, 110], ["cytosine", "CHEMICAL", 137, 145], ["thymine", "CHEMICAL", 153, 160], ["TET", "CHEMICAL", 8, 11], ["5hmC", "CHEMICAL", 32, 36], ["5-formylcytosine", "CHEMICAL", 59, 75], ["5fC", "CHEMICAL", 77, 80], ["5-carboxylcytosine", "CHEMICAL", 86, 104], ["5caC", "CHEMICAL", 106, 110], ["cytosine", "CHEMICAL", 137, 145], ["thymine", "CHEMICAL", 153, 160], ["TET", "SIMPLE_CHEMICAL", 8, 11], ["5hmC", "SIMPLE_CHEMICAL", 32, 36], ["5-formylcytosine", "SIMPLE_CHEMICAL", 59, 75], ["5fC", "SIMPLE_CHEMICAL", 77, 80], ["5-carboxylcytosine", "SIMPLE_CHEMICAL", 86, 104], ["5caC", "SIMPLE_CHEMICAL", 106, 110], ["cytosine (C", "SIMPLE_CHEMICAL", 137, 148], ["thymine-DNA glycosylase", "GENE_OR_GENE_PRODUCT", 153, 176], ["TDG", "SIMPLE_CHEMICAL", 178, 181], ["5hmC", "PROTEIN", 32, 36], ["DNA glycosylase", "PROTEIN", 161, 176], ["TDG", "PROTEIN", 178, 181], ["Further TET", "TEST", 0, 11], ["formylcytosine (5fC", "TREATMENT", 61, 80], ["carboxylcytosine (5caC)", "TREATMENT", 88, 111], ["cytosine (C)", "TREATMENT", 137, 149], ["DNA glycosylase (TDG)", "TREATMENT", 161, 182], ["mediated base excision repair", "TREATMENT", 183, 212], ["excision", "OBSERVATION_MODIFIER", 197, 205], ["repair", "OBSERVATION", 206, 212]]], ["DNA methyltransferases I and III (DNMTs I and III) transfer methyl group from S-adenosylmethionine (SAM) to cytosine producing 5mC and S-adenosylhomocysteine (SAH).Factors Associated with 5hmC Biochemical Pathways in Mammalian DNAThe main substrate 5mC is derived from DNA methylation: the transfer of methyl group from SAM to the fifth carbon of cytosine in CpG dinucleotide [49] .", [["methyl", "CHEMICAL", 60, 66], ["S-adenosylmethionine", "CHEMICAL", 78, 98], ["SAM", "CHEMICAL", 100, 103], ["cytosine", "CHEMICAL", 108, 116], ["5mC", "CHEMICAL", 127, 130], ["S-adenosylhomocysteine", "CHEMICAL", 135, 157], ["SAH", "DISEASE", 159, 162], ["methyl", "CHEMICAL", 302, 308], ["cytosine", "CHEMICAL", 347, 355], ["CpG dinucleotide", "CHEMICAL", 359, 375], ["methyl", "CHEMICAL", 60, 66], ["S-adenosylmethionine", "CHEMICAL", 78, 98], ["SAM", "CHEMICAL", 100, 103], ["cytosine", "CHEMICAL", 108, 116], ["5mC", "CHEMICAL", 127, 130], ["S-adenosylhomocysteine", "CHEMICAL", 135, 157], ["SAH", "CHEMICAL", 159, 162], ["methyl", "CHEMICAL", 302, 308], ["SAM", "CHEMICAL", 320, 323], ["carbon", "CHEMICAL", 337, 343], ["cytosine", "CHEMICAL", 347, 355], ["CpG dinucleotide", "CHEMICAL", 359, 375], ["DNA methyltransferases I and III", "GENE_OR_GENE_PRODUCT", 0, 32], ["DNMTs I", "GENE_OR_GENE_PRODUCT", 34, 41], ["methyl group", "SIMPLE_CHEMICAL", 60, 72], ["S-adenosylmethionine", "SIMPLE_CHEMICAL", 78, 98], ["SAM", "SIMPLE_CHEMICAL", 100, 103], ["cytosine", "SIMPLE_CHEMICAL", 108, 116], ["5mC", "SIMPLE_CHEMICAL", 127, 130], ["S-adenosylhomocysteine", "SIMPLE_CHEMICAL", 135, 157], ["SAH", "SIMPLE_CHEMICAL", 159, 162], ["DNA", "CELLULAR_COMPONENT", 269, 272], ["methyl", "SIMPLE_CHEMICAL", 302, 308], ["SAM", "SIMPLE_CHEMICAL", 320, 323], ["cytosine", "SIMPLE_CHEMICAL", 347, 355], ["DNA methyltransferases I and III", "PROTEIN", 0, 32], ["DNMTs I and III", "PROTEIN", 34, 49], ["5hmC", "PROTEIN", 188, 192], ["Mammalian DNAThe main substrate 5mC", "PROTEIN", 217, 252], ["DNA methyltransferases I and III (DNMTs I and III) transfer methyl group from S-adenosylmethionine (SAM)", "TREATMENT", 0, 104], ["cytosine producing 5mC and S-adenosylhomocysteine (SAH)", "TREATMENT", 108, 163], ["5hmC Biochemical Pathways", "TREATMENT", 188, 213], ["Mammalian DNAThe main substrate 5mC", "TREATMENT", 217, 252], ["the fifth carbon of cytosine in CpG dinucleotide", "TREATMENT", 327, 375]]], ["DNA methylation is catalyzed by a group of specific enzymes-type I and III DNA methyltransferases (or methylases).", [["DNA", "CELLULAR_COMPONENT", 0, 3], ["type I and III DNA methyltransferases", "GENE_OR_GENE_PRODUCT", 60, 97], ["enzymes", "PROTEIN", 52, 59], ["type I and III DNA methyltransferases", "PROTEIN", 60, 97], ["methylases", "PROTEIN", 102, 112], ["DNA methylation", "PROBLEM", 0, 15], ["specific enzymes", "TEST", 43, 59], ["type I and III DNA methyltransferases", "PROBLEM", 60, 97]]], ["Type I DNA methyltransferase (DNMT1) is specific to hemimethylated DNA which is produced after replication and contains a methylated template strand and an unmethylated newly synthesized strand.", [["Type I DNA methyltransferase", "GENE_OR_GENE_PRODUCT", 0, 28], ["DNMT1", "GENE_OR_GENE_PRODUCT", 30, 35], ["DNA", "CELLULAR_COMPONENT", 67, 70], ["strand", "CELLULAR_COMPONENT", 187, 193], ["Type I DNA methyltransferase", "PROTEIN", 0, 28], ["DNMT1", "PROTEIN", 30, 35], ["hemimethylated DNA", "DNA", 52, 70], ["methylated template strand", "DNA", 122, 148], ["unmethylated newly synthesized strand", "DNA", 156, 193], ["Type I DNA methyltransferase (DNMT1)", "TREATMENT", 0, 36], ["hemimethylated DNA", "PROBLEM", 52, 70], ["a methylated template strand", "TREATMENT", 120, 148], ["an unmethylated newly synthesized strand", "TREATMENT", 153, 193], ["hemimethylated DNA", "OBSERVATION", 52, 70]]], ["DNMT1 methylation of the new strand mediates reproduction of the template strand methylation pattern and thus enables its inheritance by daughter cells during divisions.", [["daughter cells", "ANATOMY", 137, 151], ["DNMT1", "GENE_OR_GENE_PRODUCT", 0, 5], ["daughter cells", "CELL", 137, 151], ["DNMT1", "PROTEIN", 0, 5], ["daughter cells", "CELL_TYPE", 137, 151], ["the new strand mediates reproduction", "TREATMENT", 21, 57], ["the template strand methylation pattern", "PROBLEM", 61, 100], ["new", "OBSERVATION_MODIFIER", 25, 28], ["strand", "OBSERVATION_MODIFIER", 29, 35]]], ["Conversely, type III DNA methyltransferases DNMT3A and DNMT3B are specific to unmethylated DNA and can drive methylation de novo [50] .Factors Associated with 5hmC Biochemical Pathways in Mammalian DNAAlpha-ketoglutarate is enzymatically produced from isocitrate.", [["DNAAlpha-ketoglutarate", "CHEMICAL", 198, 220], ["isocitrate", "CHEMICAL", 252, 262], ["DNAAlpha-ketoglutarate", "CHEMICAL", 198, 220], ["isocitrate", "CHEMICAL", 252, 262], ["type III", "GENE_OR_GENE_PRODUCT", 12, 20], ["DNA", "CELLULAR_COMPONENT", 21, 24], ["DNMT3A", "GENE_OR_GENE_PRODUCT", 44, 50], ["DNMT3B", "GENE_OR_GENE_PRODUCT", 55, 61], ["DNA", "CELLULAR_COMPONENT", 91, 94], ["DNAAlpha-ketoglutarate", "SIMPLE_CHEMICAL", 198, 220], ["isocitrate", "SIMPLE_CHEMICAL", 252, 262], ["type III DNA methyltransferases", "PROTEIN", 12, 43], ["DNMT3A", "PROTEIN", 44, 50], ["DNMT3B", "PROTEIN", 55, 61], ["unmethylated DNA", "DNA", 78, 94], ["type III DNA methyltransferases DNMT3A", "PROBLEM", 12, 50], ["unmethylated DNA", "PROBLEM", 78, 94], ["5hmC Biochemical Pathways", "PROBLEM", 159, 184], ["Mammalian DNAAlpha", "TREATMENT", 188, 206], ["methyltransferases DNMT3A", "OBSERVATION", 25, 50], ["Biochemical Pathways", "OBSERVATION", 164, 184], ["Mammalian DNAAlpha", "OBSERVATION", 188, 206]]], ["The reaction is catalyzed by isocitrate dehydrogenases IDH1, IDH2, and IDH3 [51] .", [["isocitrate", "CHEMICAL", 29, 39], ["isocitrate dehydrogenases", "GENE_OR_GENE_PRODUCT", 29, 54], ["IDH1", "GENE_OR_GENE_PRODUCT", 55, 59], ["IDH2", "GENE_OR_GENE_PRODUCT", 61, 65], ["isocitrate dehydrogenases", "PROTEIN", 29, 54], ["IDH1", "PROTEIN", 55, 59], ["IDH2", "PROTEIN", 61, 65], ["IDH3", "PROTEIN", 71, 75], ["The reaction", "PROBLEM", 0, 12], ["isocitrate dehydrogenases IDH1", "PROBLEM", 29, 59], ["IDH2", "PROBLEM", 61, 65], ["IDH3", "PROBLEM", 71, 75]]], ["IDH2 dysfunction in gastric cancer cells results in 5hmC depletion [52] .", [["gastric cancer cells", "ANATOMY", 20, 40], ["gastric cancer", "DISEASE", 20, 34], ["5hmC", "CHEMICAL", 52, 56], ["5hmC", "CHEMICAL", 52, 56], ["IDH2", "GENE_OR_GENE_PRODUCT", 0, 4], ["gastric cancer cells", "CELL", 20, 40], ["5hmC", "SIMPLE_CHEMICAL", 52, 56], ["IDH2", "PROTEIN", 0, 4], ["gastric cancer cells", "CELL_TYPE", 20, 40], ["IDH2 dysfunction in gastric cancer cells", "PROBLEM", 0, 40], ["5hmC depletion", "PROBLEM", 52, 66], ["gastric", "ANATOMY", 20, 27], ["cancer", "OBSERVATION", 28, 34], ["5hmC depletion", "OBSERVATION", 52, 66]]], ["In melanoma cells, IDH2 down-regulation is also associated with decreased 5hmC levels [53] .", [["melanoma cells", "ANATOMY", 3, 17], ["melanoma", "DISEASE", 3, 11], ["melanoma cells", "CELL", 3, 17], ["IDH2", "GENE_OR_GENE_PRODUCT", 19, 23], ["5hmC", "SIMPLE_CHEMICAL", 74, 78], ["melanoma cells", "CELL_TYPE", 3, 17], ["IDH2", "PROTEIN", 19, 23], ["5hmC", "PROTEIN", 74, 78], ["melanoma cells", "PROBLEM", 3, 17], ["IDH2", "PROBLEM", 19, 23], ["decreased 5hmC levels", "PROBLEM", 64, 85], ["melanoma cells", "OBSERVATION", 3, 17]]], ["The latter is induced by 2-hydroxyglutarate accumulation-an oncometabolite that competitively inhibits TET enzymes [54] .", [["2-hydroxyglutarate", "CHEMICAL", 25, 43], ["TET", "CHEMICAL", 103, 106], ["2-hydroxyglutarate", "CHEMICAL", 25, 43], ["2-hydroxyglutarate", "SIMPLE_CHEMICAL", 25, 43], ["TET enzymes", "GENE_OR_GENE_PRODUCT", 103, 114], ["TET enzymes", "PROTEIN", 103, 114], ["hydroxyglutarate accumulation", "PROBLEM", 27, 56], ["TET enzymes", "TEST", 103, 114]]], ["Fumarate and succinate, generally accumulated by cancer cells that are exposed to fumarate hydratase and succinate dehydrogenase deficiency, also show inhibitory action on TET proteins and prevent their binding with alpha-ketoglutarate [55, 56] .", [["cancer cells", "ANATOMY", 49, 61], ["Fumarate", "CHEMICAL", 0, 8], ["succinate", "CHEMICAL", 13, 22], ["cancer", "DISEASE", 49, 55], ["fumarate", "CHEMICAL", 82, 90], ["succinate", "CHEMICAL", 105, 114], ["TET", "CHEMICAL", 172, 175], ["alpha-ketoglutarate", "CHEMICAL", 216, 235], ["Fumarate", "CHEMICAL", 0, 8], ["succinate", "CHEMICAL", 13, 22], ["fumarate", "CHEMICAL", 82, 90], ["succinate", "CHEMICAL", 105, 114], ["alpha-ketoglutarate", "CHEMICAL", 216, 235], ["Fumarate", "SIMPLE_CHEMICAL", 0, 8], ["succinate", "SIMPLE_CHEMICAL", 13, 22], ["cancer cells", "CELL", 49, 61], ["fumarate hydratase", "GENE_OR_GENE_PRODUCT", 82, 100], ["succinate dehydrogenase", "GENE_OR_GENE_PRODUCT", 105, 128], ["TET proteins", "GENE_OR_GENE_PRODUCT", 172, 184], ["alpha-ketoglutarate", "SIMPLE_CHEMICAL", 216, 235], ["cancer cells", "CELL_TYPE", 49, 61], ["fumarate hydratase", "PROTEIN", 82, 100], ["succinate dehydrogenase", "PROTEIN", 105, 128], ["TET proteins", "PROTEIN", 172, 184], ["Fumarate", "TREATMENT", 0, 8], ["succinate", "TREATMENT", 13, 22], ["cancer cells", "PROBLEM", 49, 61], ["fumarate hydratase", "TEST", 82, 100], ["succinate dehydrogenase deficiency", "PROBLEM", 105, 139], ["TET proteins", "TREATMENT", 172, 184], ["alpha-ketoglutarate", "TEST", 216, 235], ["cancer cells", "OBSERVATION", 49, 61]]], ["Conversely, excess of IDH1 and IDH2 facilitates the increase of DNA hydroxymethylation [53, 54] .", [["IDH1", "GENE_OR_GENE_PRODUCT", 22, 26], ["IDH2", "GENE_OR_GENE_PRODUCT", 31, 35], ["DNA", "CELLULAR_COMPONENT", 64, 67], ["IDH1", "PROTEIN", 22, 26], ["IDH2", "PROTEIN", 31, 35], ["IDH1", "PROBLEM", 22, 26], ["IDH2", "PROBLEM", 31, 35], ["DNA hydroxymethylation", "TREATMENT", 64, 86]]], ["Elevated alpha-ketoglutarate in mouse liver cells induces a surge in 5hmC levels [57] .Factors Associated with 5hmC Biochemical Pathways in Mammalian DNAIn different cell types, oxygen can affect 5mC hydroxylation in various ways.", [["liver cells", "ANATOMY", 38, 49], ["cell", "ANATOMY", 166, 170], ["alpha-ketoglutarate", "CHEMICAL", 9, 28], ["oxygen", "CHEMICAL", 178, 184], ["5mC", "CHEMICAL", 196, 199], ["alpha-ketoglutarate", "CHEMICAL", 9, 28], ["oxygen", "CHEMICAL", 178, 184], ["5mC", "CHEMICAL", 196, 199], ["alpha-ketoglutarate", "SIMPLE_CHEMICAL", 9, 28], ["mouse", "ORGANISM", 32, 37], ["liver cells", "CELL", 38, 49], ["5hmC", "SIMPLE_CHEMICAL", 69, 73], ["cell", "CELL", 166, 170], ["oxygen", "SIMPLE_CHEMICAL", 178, 184], ["5mC", "SIMPLE_CHEMICAL", 196, 199], ["mouse liver cells", "CELL_TYPE", 32, 49], ["mouse", "SPECIES", 32, 37], ["mouse", "SPECIES", 32, 37], ["Elevated alpha-ketoglutarate in mouse liver cells", "PROBLEM", 0, 49], ["5hmC levels", "TEST", 69, 80], ["5hmC Biochemical Pathways", "PROBLEM", 111, 136], ["Mammalian DNAIn different cell types", "TREATMENT", 140, 176], ["oxygen", "TREATMENT", 178, 184], ["5mC hydroxylation", "TREATMENT", 196, 213], ["alpha-ketoglutarate", "OBSERVATION", 9, 28], ["liver", "ANATOMY", 38, 43], ["different cell types", "OBSERVATION", 156, 176]]], ["Throughout embryogenesis, oxygen gradients differentially regulate TET activity and thus determine cellular differentiation [58] .", [["cellular", "ANATOMY", 99, 107], ["oxygen", "CHEMICAL", 26, 32], ["TET", "CHEMICAL", 67, 70], ["oxygen", "CHEMICAL", 26, 32], ["oxygen", "SIMPLE_CHEMICAL", 26, 32], ["TET", "GENE_OR_GENE_PRODUCT", 67, 70], ["cellular", "CELL", 99, 107], ["TET", "PROTEIN", 67, 70], ["oxygen gradients", "PROBLEM", 26, 42], ["TET activity", "PROBLEM", 67, 79], ["oxygen gradients", "OBSERVATION", 26, 42]]], ["Under hypoxia, human glioblastoma cells exhibit a decrease in 5hmC levels which is associated with hypermethylation and loss of TET activity [59] .", [["glioblastoma cells", "ANATOMY", 21, 39], ["hypoxia", "DISEASE", 6, 13], ["glioblastoma", "DISEASE", 21, 33], ["TET", "CHEMICAL", 128, 131], ["human", "ORGANISM", 15, 20], ["glioblastoma cells", "CELL", 21, 39], ["5hmC", "GENE_OR_GENE_PRODUCT", 62, 66], ["TET", "GENE_OR_GENE_PRODUCT", 128, 131], ["human glioblastoma cells", "CELL_TYPE", 15, 39], ["5hmC", "PROTEIN", 62, 66], ["TET", "PROTEIN", 128, 131], ["human", "SPECIES", 15, 20], ["human", "SPECIES", 15, 20], ["hypoxia", "PROBLEM", 6, 13], ["human glioblastoma cells", "PROBLEM", 15, 39], ["a decrease in 5hmC levels", "PROBLEM", 48, 73], ["hypermethylation and loss of TET activity", "PROBLEM", 99, 140], ["hypoxia", "OBSERVATION", 6, 13], ["glioblastoma cells", "OBSERVATION", 21, 39], ["decrease", "OBSERVATION_MODIFIER", 50, 58], ["5hmC levels", "OBSERVATION", 62, 73]]], ["On the contrary, human embryonic stem cells (hESCs) show hypoxia-induced TET up-regulation which leads to elevated DNA hydroxymethylation [60] .", [["embryonic stem cells", "ANATOMY", 23, 43], ["hESCs", "ANATOMY", 45, 50], ["TET", "CHEMICAL", 73, 76], ["human", "ORGANISM", 17, 22], ["embryonic stem cells", "CELL", 23, 43], ["hESCs", "CELL", 45, 50], ["hypoxia-", "GENE_OR_GENE_PRODUCT", 57, 65], ["TET", "GENE_OR_GENE_PRODUCT", 73, 76], ["DNA", "CELLULAR_COMPONENT", 115, 118], ["human embryonic stem cells", "CELL_TYPE", 17, 43], ["hESCs", "CELL_TYPE", 45, 50], ["TET", "PROTEIN", 73, 76], ["human", "SPECIES", 17, 22], ["human", "SPECIES", 17, 22], ["hypoxia-", "PROBLEM", 57, 65], ["elevated DNA hydroxymethylation", "PROBLEM", 106, 137], ["embryonic stem cells", "OBSERVATION", 23, 43]]], ["Similarly, hypoxic neuroblastoma cells demonstrate elevated 5hmC levels induced by hypoxia-inducible factor (HIF) activation that in turn enhances TET activity [61] .Factors Associated with 5hmC Biochemical Pathways in Mammalian DNAAscorbate (l-ascorbic acid or vitamin C) promotes 5hmC increase in the genome [62] .", [["hypoxic neuroblastoma cells", "ANATOMY", 11, 38], ["neuroblastoma", "DISEASE", 19, 32], ["TET", "CHEMICAL", 147, 150], ["DNAAscorbate", "CHEMICAL", 229, 241], ["l-ascorbic acid", "CHEMICAL", 243, 258], ["vitamin C", "CHEMICAL", 262, 271], ["5hmC", "CHEMICAL", 282, 286], ["DNAAscorbate", "CHEMICAL", 229, 241], ["l-ascorbic acid", "CHEMICAL", 243, 258], ["vitamin C", "CHEMICAL", 262, 271], ["hypoxic neuroblastoma cells", "CELL", 11, 38], ["5hmC", "SIMPLE_CHEMICAL", 60, 64], ["hypoxia-inducible factor", "GENE_OR_GENE_PRODUCT", 83, 107], ["HIF", "GENE_OR_GENE_PRODUCT", 109, 112], ["TET", "GENE_OR_GENE_PRODUCT", 147, 150], ["DNAAscorbate", "SIMPLE_CHEMICAL", 229, 241], ["l-ascorbic acid", "SIMPLE_CHEMICAL", 243, 258], ["vitamin C", "SIMPLE_CHEMICAL", 262, 271], ["5hmC", "SIMPLE_CHEMICAL", 282, 286], ["hypoxic neuroblastoma cells", "CELL_TYPE", 11, 38], ["5hmC", "PROTEIN", 60, 64], ["inducible factor", "PROTEIN", 91, 107], ["HIF", "PROTEIN", 109, 112], ["TET", "PROTEIN", 147, 150], ["hypoxic neuroblastoma cells", "PROBLEM", 11, 38], ["elevated 5hmC levels", "PROBLEM", 51, 71], ["hypoxia", "PROBLEM", 83, 90], ["inducible factor (HIF) activation", "PROBLEM", 91, 124], ["5hmC Biochemical Pathways", "TREATMENT", 190, 215], ["Mammalian DNAAscorbate (l-ascorbic acid", "TREATMENT", 219, 258], ["vitamin C)", "TREATMENT", 262, 272], ["hypoxic neuroblastoma cells", "OBSERVATION", 11, 38], ["elevated", "OBSERVATION_MODIFIER", 51, 59], ["5hmC levels", "OBSERVATION", 60, 71], ["hypoxia", "OBSERVATION", 83, 90], ["increase", "OBSERVATION_MODIFIER", 287, 295]]], ["This effect is neither Fe(II)-dependent nor related to changes in Tet or IDH expression and subsequent alpha-ketoglutarate production [63] .", [["Fe(II", "CHEMICAL", 23, 28], ["alpha-ketoglutarate", "CHEMICAL", 103, 122], ["Fe(II)", "CHEMICAL", 23, 29], ["alpha-ketoglutarate", "CHEMICAL", 103, 122], ["Fe(II)", "SIMPLE_CHEMICAL", 23, 29], ["Tet", "GENE_OR_GENE_PRODUCT", 66, 69], ["IDH", "GENE_OR_GENE_PRODUCT", 73, 76], ["alpha-ketoglutarate", "SIMPLE_CHEMICAL", 103, 122], ["IDH", "PROTEIN", 73, 76], ["changes in Tet or IDH expression", "PROBLEM", 55, 87], ["subsequent alpha-ketoglutarate production", "PROBLEM", 92, 133]]], ["Ascorbate directly interacts with the catalytic domain of TET proteins, reducing Fe(III) to Fe(II) and enhancing TET-mediated 5mC oxidation [64] .", [["Ascorbate", "CHEMICAL", 0, 9], ["TET", "CHEMICAL", 58, 61], ["Fe", "CHEMICAL", 81, 83], ["Fe", "CHEMICAL", 92, 94], ["TET", "CHEMICAL", 113, 116], ["5mC", "CHEMICAL", 126, 129], ["Ascorbate", "CHEMICAL", 0, 9], ["Fe(III)", "CHEMICAL", 81, 88], ["Fe(II)", "CHEMICAL", 92, 98], ["TET", "CHEMICAL", 113, 116], ["5mC", "CHEMICAL", 126, 129], ["Ascorbate", "SIMPLE_CHEMICAL", 0, 9], ["TET proteins", "GENE_OR_GENE_PRODUCT", 58, 70], ["Fe(II", "SIMPLE_CHEMICAL", 92, 97], ["TET", "SIMPLE_CHEMICAL", 113, 116], ["5mC", "SIMPLE_CHEMICAL", 126, 129], ["catalytic domain", "PROTEIN", 38, 54], ["TET proteins", "PROTEIN", 58, 70], ["Fe(III)", "PROTEIN", 81, 88], ["Fe(II)", "PROTEIN", 92, 98], ["TET proteins", "TREATMENT", 58, 70], ["reducing Fe(III)", "TREATMENT", 72, 88], ["enhancing TET-mediated 5mC oxidation", "TREATMENT", 103, 139]]], ["Considering that most, if not all, malignant lesions exhibit decreased 5hmC levels [65] , ascorbic acid's potential as an anti-cancer therapy is currently intensively investigated.", [["malignant lesions", "ANATOMY", 35, 52], ["ascorbic acid", "CHEMICAL", 90, 103], ["ascorbic acid", "CHEMICAL", 90, 103], ["malignant lesions", "CANCER", 35, 52], ["5hmC", "SIMPLE_CHEMICAL", 71, 75], ["ascorbic acid", "SIMPLE_CHEMICAL", 90, 103], ["anti-cancer", "CANCER", 122, 133], ["5hmC", "PROTEIN", 71, 75], ["malignant lesions", "PROBLEM", 35, 52], ["decreased 5hmC levels", "PROBLEM", 61, 82], ["ascorbic acid", "TREATMENT", 90, 103], ["an anti-cancer therapy", "TREATMENT", 119, 141], ["malignant", "OBSERVATION_MODIFIER", 35, 44], ["lesions", "OBSERVATION", 45, 52], ["decreased", "OBSERVATION_MODIFIER", 61, 70], ["anti-cancer therapy", "OBSERVATION", 122, 141]]], ["Evidence suggests that ascorbate-mediated 5hmC increase in melanoma cells suppresses their metastatic capabilities and detains tumor growth [66] .Factors Associated with 5hmC Biochemical Pathways in Mammalian DNAThe presence of Fe(II) as another co-factor for 5mC hydroxylation also appears to enhance the activity of TET to generate 5hmC [67] .", [["melanoma cells", "ANATOMY", 59, 73], ["tumor", "ANATOMY", 127, 132], ["ascorbate", "CHEMICAL", 23, 32], ["5hmC", "CHEMICAL", 42, 46], ["melanoma", "DISEASE", 59, 67], ["tumor", "DISEASE", 127, 132], ["Fe", "CHEMICAL", 228, 230], ["5mC", "CHEMICAL", 260, 263], ["TET", "CHEMICAL", 318, 321], ["ascorbate", "CHEMICAL", 23, 32], ["Fe(II)", "CHEMICAL", 228, 234], ["5mC", "CHEMICAL", 260, 263], ["TET", "CHEMICAL", 318, 321], ["5hmC", "CHEMICAL", 334, 338], ["ascorbate", "SIMPLE_CHEMICAL", 23, 32], ["5hmC", "CELLULAR_COMPONENT", 42, 46], ["melanoma cells", "CELL", 59, 73], ["tumor", "CANCER", 127, 132], ["Fe(II", "SIMPLE_CHEMICAL", 228, 233], ["5mC", "SIMPLE_CHEMICAL", 260, 263], ["TET", "SIMPLE_CHEMICAL", 318, 321], ["melanoma cells", "CELL_TYPE", 59, 73], ["Fe(II)", "PROTEIN", 228, 234], ["TET", "PROTEIN", 318, 321], ["ascorbate", "TEST", 23, 32], ["melanoma cells", "PROBLEM", 59, 73], ["their metastatic capabilities", "PROBLEM", 85, 114], ["detains tumor growth", "PROBLEM", 119, 139], ["5mC hydroxylation", "TREATMENT", 260, 277], ["5hmC", "OBSERVATION_MODIFIER", 42, 46], ["increase", "OBSERVATION_MODIFIER", 47, 55], ["melanoma cells", "OBSERVATION", 59, 73], ["metastatic", "OBSERVATION_MODIFIER", 91, 101]]], ["Mutation-induced modifications at the Fe(II)-binding domain of TET proteins lead to a decrease/loss of enzymatic activity [3] .Factors Associated with 5hmC Biochemical Pathways in Mammalian DNAOverall, 5hmC production in the mammalian genome predominantly depends on the presence and level of major components for 5mC oxidation: 5mC itself, TET enzymes, alpha-ketoglutarate, oxygen, Fe(II), and ascorbate.PhenobarbitalPhenobarbital is a barbituric acid derivative with antiseizure, hypnotic, and sedative properties.", [["Fe", "CHEMICAL", 38, 40], ["TET", "CHEMICAL", 63, 66], ["5hmC", "CHEMICAL", 202, 206], ["5mC", "CHEMICAL", 314, 317], ["5mC", "CHEMICAL", 329, 332], ["TET", "CHEMICAL", 341, 344], ["alpha-ketoglutarate", "CHEMICAL", 354, 373], ["oxygen", "CHEMICAL", 375, 381], ["Fe(II", "CHEMICAL", 383, 388], ["ascorbate", "CHEMICAL", 395, 404], ["Phenobarbital", "CHEMICAL", 405, 418], ["Phenobarbital", "CHEMICAL", 418, 431], ["barbituric acid", "CHEMICAL", 437, 452], ["Fe(II)", "CHEMICAL", 38, 44], ["5mC", "CHEMICAL", 314, 317], ["5mC", "CHEMICAL", 329, 332], ["alpha-ketoglutarate", "CHEMICAL", 354, 373], ["oxygen", "CHEMICAL", 375, 381], ["Fe(II)", "CHEMICAL", 383, 389], ["ascorbate", "CHEMICAL", 395, 404], ["Phenobarbital", "CHEMICAL", 405, 418], ["Phenobarbital", "CHEMICAL", 418, 431], ["barbituric acid", "CHEMICAL", 437, 452], ["TET proteins", "GENE_OR_GENE_PRODUCT", 63, 75], ["5hmC", "CELLULAR_COMPONENT", 202, 206], ["5mC", "SIMPLE_CHEMICAL", 314, 317], ["5mC", "SIMPLE_CHEMICAL", 329, 332], ["TET enzymes", "SIMPLE_CHEMICAL", 341, 352], ["alpha-ketoglutarate", "SIMPLE_CHEMICAL", 354, 373], ["oxygen", "SIMPLE_CHEMICAL", 375, 381], ["Fe(II)", "SIMPLE_CHEMICAL", 383, 389], ["ascorbate", "SIMPLE_CHEMICAL", 395, 404], ["Phenobarbital", "SIMPLE_CHEMICAL", 405, 418], ["Phenobarbital", "SIMPLE_CHEMICAL", 418, 431], ["barbituric acid", "SIMPLE_CHEMICAL", 437, 452], ["Fe(II)-binding domain", "PROTEIN", 38, 59], ["TET proteins", "PROTEIN", 63, 75], ["mammalian genome", "DNA", 225, 241], ["TET enzymes", "PROTEIN", 341, 352], ["Mutation", "PROBLEM", 0, 8], ["TET proteins", "TREATMENT", 63, 75], ["a decrease/loss of enzymatic activity", "PROBLEM", 84, 121], ["5mC oxidation", "TEST", 314, 327], ["TET enzymes", "TEST", 341, 352], ["alpha", "TEST", 354, 359], ["ascorbate", "TREATMENT", 395, 404], ["PhenobarbitalPhenobarbital", "TREATMENT", 405, 431], ["a barbituric acid derivative", "TREATMENT", 435, 463], ["antiseizure", "TREATMENT", 469, 480], ["hypnotic", "TREATMENT", 482, 490], ["sedative properties", "TREATMENT", 496, 515], ["5hmC production", "OBSERVATION", 202, 217], ["mammalian genome", "OBSERVATION", 225, 241]]], ["In rodents, chronic exposure to phenobarbital demonstrated hepatocancerogenic action [68] ; there is no evidence of hepatocancerogenic hazard of phenobarbital in humans.", [["phenobarbital", "CHEMICAL", 32, 45], ["phenobarbital", "CHEMICAL", 145, 158], ["phenobarbital", "CHEMICAL", 32, 45], ["phenobarbital", "CHEMICAL", 145, 158], ["phenobarbital", "SIMPLE_CHEMICAL", 32, 45], ["phenobarbital", "SIMPLE_CHEMICAL", 145, 158], ["humans", "ORGANISM", 162, 168], ["humans", "SPECIES", 162, 168], ["humans", "SPECIES", 162, 168], ["phenobarbital", "TREATMENT", 32, 45], ["hepatocancerogenic hazard of phenobarbital in humans", "PROBLEM", 116, 168], ["chronic", "OBSERVATION_MODIFIER", 12, 19], ["no evidence of", "UNCERTAINTY", 101, 115], ["phenobarbital", "OBSERVATION", 145, 158]]], ["Mice that had been treated with phenobarbital in drinking water for 28 days showed elevated 5hmC levels in promoters of tumor-related genes of liver tissue.", [["tumor", "ANATOMY", 120, 125], ["liver tissue", "ANATOMY", 143, 155], ["phenobarbital", "CHEMICAL", 32, 45], ["tumor", "DISEASE", 120, 125], ["phenobarbital", "CHEMICAL", 32, 45], ["Mice", "ORGANISM", 0, 4], ["phenobarbital", "SIMPLE_CHEMICAL", 32, 45], ["5hmC", "SIMPLE_CHEMICAL", 92, 96], ["tumor", "CANCER", 120, 125], ["liver tissue", "TISSUE", 143, 155], ["5hmC", "PROTEIN", 92, 96], ["promoters", "DNA", 107, 116], ["Mice", "SPECIES", 0, 4], ["phenobarbital", "TREATMENT", 32, 45], ["elevated 5hmC levels", "PROBLEM", 83, 103], ["tumor", "PROBLEM", 120, 125], ["liver tissue", "PROBLEM", 143, 155], ["tumor", "OBSERVATION", 120, 125], ["liver", "ANATOMY", 143, 148], ["tissue", "ANATOMY_MODIFIER", 149, 155]]], ["Elevated 5hmC is associated with decreased DNA methylation and up-regulation of these genes, suggesting the initiation of active DNA demethylation [69, 70] .", [["5hmC", "CHEMICAL", 9, 13], ["5hmC", "GENE_OR_GENE_PRODUCT", 9, 13], ["DNA", "CELLULAR_COMPONENT", 43, 46], ["DNA", "CELLULAR_COMPONENT", 129, 132], ["5hmC", "PROTEIN", 9, 13], ["Elevated 5hmC", "PROBLEM", 0, 13], ["decreased DNA methylation", "PROBLEM", 33, 58], ["active DNA demethylation", "PROBLEM", 122, 146], ["5hmC", "OBSERVATION", 9, 13], ["decreased", "OBSERVATION_MODIFIER", 33, 42], ["DNA methylation", "OBSERVATION", 43, 58]]], ["Prolonged exposure to phenobarbital of up to 91 days significantly promotes DNA hydroxymethylation [70] .", [["phenobarbital", "CHEMICAL", 22, 35], ["phenobarbital", "CHEMICAL", 22, 35], ["phenobarbital", "SIMPLE_CHEMICAL", 22, 35], ["DNA", "CELLULAR_COMPONENT", 76, 79], ["phenobarbital", "TREATMENT", 22, 35], ["DNA hydroxymethylation", "TREATMENT", 76, 98]]], ["Experimental data on phenobarbital-induced hepatocellular adenomas demonstrated changes of hydroxymethylation and gene expression levels, including carcinogenic genes, especially those regulated through the constitutive androstane receptor (CAR) signaling pathways [71] .", [["hepatocellular adenomas", "ANATOMY", 43, 66], ["phenobarbital", "CHEMICAL", 21, 34], ["hepatocellular adenomas", "DISEASE", 43, 66], ["phenobarbital", "CHEMICAL", 21, 34], ["androstane", "CHEMICAL", 220, 230], ["phenobarbital", "SIMPLE_CHEMICAL", 21, 34], ["hepatocellular adenomas", "CANCER", 43, 66], ["constitutive androstane receptor", "GENE_OR_GENE_PRODUCT", 207, 239], ["CAR", "GENE_OR_GENE_PRODUCT", 241, 244], ["carcinogenic genes", "DNA", 148, 166], ["constitutive androstane receptor", "PROTEIN", 207, 239], ["CAR", "PROTEIN", 241, 244], ["Experimental data", "PROBLEM", 0, 17], ["phenobarbital", "TREATMENT", 21, 34], ["hepatocellular adenomas", "PROBLEM", 43, 66], ["hydroxymethylation and gene expression levels", "PROBLEM", 91, 136], ["carcinogenic genes", "PROBLEM", 148, 166], ["hepatocellular", "ANATOMY", 43, 57], ["adenomas", "OBSERVATION", 58, 66], ["carcinogenic genes", "OBSERVATION", 148, 166]]], ["This evidence suggests that changes in 5hmC levels related to the initiation of active DNA demethylation indicate hepatic cell response to phenobarbital, associated with carcinogenicity and other effects.DiethylstilbestrolDiethylstilbestrol is a synthetic nonsteroidal estrogen that was prescribed to pregnant women until 1971 to support pregnancy and prevent miscarriage or other pregnancy complications.", [["hepatic cell", "ANATOMY", 114, 126], ["phenobarbital", "CHEMICAL", 139, 152], ["Diethylstilbestrol", "CHEMICAL", 204, 222], ["Diethylstilbestrol", "CHEMICAL", 222, 240], ["estrogen", "CHEMICAL", 269, 277], ["miscarriage", "DISEASE", 360, 371], ["phenobarbital", "CHEMICAL", 139, 152], ["Diethylstilbestrol", "CHEMICAL", 204, 222], ["Diethylstilbestrol", "CHEMICAL", 222, 240], ["estrogen", "CHEMICAL", 269, 277], ["5hmC", "GENE_OR_GENE_PRODUCT", 39, 43], ["DNA", "CELLULAR_COMPONENT", 87, 90], ["hepatic cell", "CELL", 114, 126], ["phenobarbital", "SIMPLE_CHEMICAL", 139, 152], ["Diethylstilbestrol", "SIMPLE_CHEMICAL", 204, 222], ["Diethylstilbestrol", "SIMPLE_CHEMICAL", 222, 240], ["estrogen", "SIMPLE_CHEMICAL", 269, 277], ["women", "ORGANISM", 310, 315], ["5hmC", "PROTEIN", 39, 43], ["women", "SPECIES", 310, 315], ["changes in 5hmC levels", "PROBLEM", 28, 50], ["active DNA demethylation", "TREATMENT", 80, 104], ["hepatic cell response", "PROBLEM", 114, 135], ["phenobarbital", "TREATMENT", 139, 152], ["carcinogenicity", "PROBLEM", 170, 185], ["DiethylstilbestrolDiethylstilbestrol", "TREATMENT", 204, 240], ["a synthetic nonsteroidal estrogen", "TREATMENT", 244, 277], ["miscarriage", "PROBLEM", 360, 371], ["other pregnancy complications", "PROBLEM", 375, 404], ["hepatic", "ANATOMY", 114, 121], ["cell response", "OBSERVATION", 122, 135], ["carcinogenicity", "OBSERVATION", 170, 185]]], ["The drug was banned after the American Cancer Society provided evidence of carcinogenicity [72] .", [["Cancer", "DISEASE", 39, 45]]], ["In mice, neonatal exposure to diethylstilbestrol induces alterations in histone modification pattern and a significant reduction in Tet1 expression; this correlates with a decrease in 5hmC levels in adults [73] .", [["diethylstilbestrol", "CHEMICAL", 30, 48], ["diethylstilbestrol", "CHEMICAL", 30, 48], ["mice", "ORGANISM", 3, 7], ["diethylstilbestrol", "SIMPLE_CHEMICAL", 30, 48], ["histone", "GENE_OR_GENE_PRODUCT", 72, 79], ["Tet1", "GENE_OR_GENE_PRODUCT", 132, 136], ["5hmC", "GENE_OR_GENE_PRODUCT", 184, 188], ["histone", "PROTEIN", 72, 79], ["Tet1", "PROTEIN", 132, 136], ["5hmC", "PROTEIN", 184, 188], ["mice", "SPECIES", 3, 7], ["mice", "SPECIES", 3, 7], ["neonatal exposure to diethylstilbestrol", "TREATMENT", 9, 48], ["alterations in histone modification pattern", "PROBLEM", 57, 100], ["a significant reduction in Tet1 expression", "PROBLEM", 105, 147], ["a decrease in 5hmC levels", "PROBLEM", 170, 195], ["histone modification", "OBSERVATION", 72, 92], ["significant", "OBSERVATION_MODIFIER", 107, 118], ["reduction", "OBSERVATION_MODIFIER", 119, 128], ["Tet1 expression", "OBSERVATION", 132, 147], ["decrease", "OBSERVATION_MODIFIER", 172, 180]]], ["Considering these results, the authors assumed that it is diethylstilbestrol-induced epigenetic alterations that are responsible for modifications in female reproductive tract gene expression, infertility, and uterine cancer [73] .", [["uterine cancer", "ANATOMY", 210, 224], ["diethylstilbestrol", "CHEMICAL", 58, 76], ["infertility", "DISEASE", 193, 204], ["uterine cancer", "DISEASE", 210, 224], ["diethylstilbestrol", "CHEMICAL", 58, 76], ["diethylstilbestrol", "SIMPLE_CHEMICAL", 58, 76], ["tract", "ORGANISM_SUBDIVISION", 170, 175], ["uterine cancer", "CANCER", 210, 224], ["epigenetic alterations", "PROBLEM", 85, 107], ["infertility", "PROBLEM", 193, 204], ["uterine cancer", "PROBLEM", 210, 224], ["uterine", "ANATOMY", 210, 217], ["cancer", "OBSERVATION", 218, 224]]], ["First-trimester diethylstilbestrol exposure is associated with an increased risk of benign tumors-uterine leiomyomas [74] .", [["benign tumors", "ANATOMY", 84, 97], ["uterine leiomyomas", "ANATOMY", 98, 116], ["diethylstilbestrol", "CHEMICAL", 16, 34], ["tumors", "DISEASE", 91, 97], ["uterine leiomyomas", "DISEASE", 98, 116], ["diethylstilbestrol", "CHEMICAL", 16, 34], ["diethylstilbestrol", "SIMPLE_CHEMICAL", 16, 34], ["benign tumors", "CANCER", 84, 97], ["uterine leiomyomas", "CANCER", 98, 116], ["First-trimester diethylstilbestrol exposure", "TREATMENT", 0, 43], ["benign tumors", "PROBLEM", 84, 97], ["uterine leiomyomas", "PROBLEM", 98, 116], ["increased", "OBSERVATION_MODIFIER", 66, 75], ["benign", "OBSERVATION_MODIFIER", 84, 90], ["tumors", "OBSERVATION", 91, 97], ["uterine", "ANATOMY", 98, 105], ["leiomyomas", "OBSERVATION", 106, 116]]], ["Based on detected 5hmC imbalance in uterine leiomyoma tissue [75] and the dependence of the hydroxymethylation pattern on the hormonal status [76] , it can be assumed that diethylstilbestrol-induced benign tumorigenesis also involves alterations in 5hmC.CocaineCocaine is a highly addictive alkaloid of the shrub Erythroxylum coca.", [["uterine leiomyoma tissue", "ANATOMY", 36, 60], ["uterine leiomyoma", "DISEASE", 36, 53], ["diethylstilbestrol", "CHEMICAL", 172, 190], ["CocaineCocaine", "CHEMICAL", 254, 268], ["alkaloid of the shrub Erythroxylum coca", "CHEMICAL", 291, 330], ["diethylstilbestrol", "CHEMICAL", 172, 190], ["CocaineCocaine", "CHEMICAL", 254, 268], ["5hmC", "GENE_OR_GENE_PRODUCT", 18, 22], ["uterine leiomyoma tissue", "TISSUE", 36, 60], ["diethylstilbestrol", "SIMPLE_CHEMICAL", 172, 190], ["5hmC", "CELLULAR_COMPONENT", 249, 253], ["CocaineCocaine", "SIMPLE_CHEMICAL", 254, 268], ["Erythroxylum coca", "ORGANISM", 313, 330], ["Erythroxylum coca", "SPECIES", 313, 330], ["Erythroxylum coca", "SPECIES", 313, 330], ["5hmC imbalance in uterine leiomyoma tissue", "PROBLEM", 18, 60], ["the hydroxymethylation pattern", "PROBLEM", 88, 118], ["diethylstilbestrol", "TREATMENT", 172, 190], ["benign tumorigenesis", "PROBLEM", 199, 219], ["CocaineCocaine", "TREATMENT", 254, 268], ["uterine", "ANATOMY", 36, 43], ["leiomyoma", "OBSERVATION", 44, 53], ["highly", "OBSERVATION_MODIFIER", 274, 280], ["addictive alkaloid", "OBSERVATION", 281, 299], ["shrub", "OBSERVATION_MODIFIER", 307, 312], ["Erythroxylum coca", "OBSERVATION", 313, 330]]], ["Mice receiving cocaine intraperitoneal injections for 14 days showed decreased 5hmC levels in liver cells without any alterations in global DNA methylation; meanwhile in brain cells, hydroxymethylation level remained unchanged [77] .", [["intraperitoneal", "ANATOMY", 23, 38], ["liver cells", "ANATOMY", 94, 105], ["brain cells", "ANATOMY", 170, 181], ["cocaine", "CHEMICAL", 15, 22], ["cocaine", "CHEMICAL", 15, 22], ["Mice", "ORGANISM", 0, 4], ["cocaine", "SIMPLE_CHEMICAL", 15, 22], ["intraperitoneal", "IMMATERIAL_ANATOMICAL_ENTITY", 23, 38], ["5hmC", "SIMPLE_CHEMICAL", 79, 83], ["liver cells", "CELL", 94, 105], ["DNA", "CELLULAR_COMPONENT", 140, 143], ["brain cells", "CELL", 170, 181], ["5hmC", "PROTEIN", 79, 83], ["liver cells", "CELL_TYPE", 94, 105], ["brain cells", "CELL_TYPE", 170, 181], ["Mice", "SPECIES", 0, 4], ["cocaine intraperitoneal injections", "TREATMENT", 15, 49], ["decreased 5hmC levels in liver cells", "PROBLEM", 69, 105], ["any alterations", "PROBLEM", 114, 129], ["global DNA methylation", "PROBLEM", 133, 155], ["hydroxymethylation level", "TEST", 183, 207], ["liver", "ANATOMY", 94, 99], ["without", "UNCERTAINTY", 106, 113], ["brain cells", "ANATOMY", 170, 181], ["unchanged", "OBSERVATION_MODIFIER", 217, 226]]], ["Another research also reports the absence of alterations in global DNA methylation and hydroxymethylation in mouse nucleus accumbens in response to cocaine administration [78] .", [["nucleus accumbens", "ANATOMY", 115, 132], ["cocaine", "CHEMICAL", 148, 155], ["cocaine", "CHEMICAL", 148, 155], ["DNA", "CELLULAR_COMPONENT", 67, 70], ["mouse", "ORGANISM", 109, 114], ["nucleus accumbens", "ORGANISM", 115, 132], ["cocaine", "SIMPLE_CHEMICAL", 148, 155], ["mouse", "SPECIES", 109, 114], ["mouse", "SPECIES", 109, 114], ["global DNA methylation", "TREATMENT", 60, 82], ["hydroxymethylation in mouse nucleus accumbens", "TREATMENT", 87, 132]]], ["The authors observed significant down-regulation of Tet1 mRNA and a concomitant decrease in TET1 protein [78] .", [["Tet1", "GENE_OR_GENE_PRODUCT", 52, 56], ["TET1", "GENE_OR_GENE_PRODUCT", 92, 96], ["Tet1 mRNA", "RNA", 52, 61], ["TET1 protein", "PROTEIN", 92, 104], ["Tet1 mRNA", "PROBLEM", 52, 61], ["a concomitant decrease in TET1 protein", "PROBLEM", 66, 104], ["significant", "OBSERVATION_MODIFIER", 21, 32], ["decrease", "OBSERVATION_MODIFIER", 80, 88]]], ["A~40% decrease in TET1 mRNA was observed in the nucleus accumbens of human cocaine addicts examined postmortem [78] .", [["nucleus accumbens", "ANATOMY", 48, 65], ["cocaine", "CHEMICAL", 75, 82], ["cocaine", "CHEMICAL", 75, 82], ["TET1", "GENE_OR_GENE_PRODUCT", 18, 22], ["nucleus accumbens", "CELLULAR_COMPONENT", 48, 65], ["human", "ORGANISM", 69, 74], ["TET1 mRNA", "RNA", 18, 27], ["human", "SPECIES", 69, 74], ["human", "SPECIES", 69, 74], ["A~40% decrease in TET1 mRNA", "PROBLEM", 0, 27], ["nucleus", "ANATOMY", 48, 55]]], ["This evidence suggests that cocaine can induce locus-specific 5hmC alterations, while a greater abundance of Tet2 and Tet3 mRNAs, characteristic of nucleus accumbens, can presumably compensate for TET1 decrease [78] .", [["nucleus accumbens", "ANATOMY", 148, 165], ["cocaine", "CHEMICAL", 28, 35], ["cocaine", "CHEMICAL", 28, 35], ["cocaine", "SIMPLE_CHEMICAL", 28, 35], ["5hmC", "GENE_OR_GENE_PRODUCT", 62, 66], ["Tet2", "GENE_OR_GENE_PRODUCT", 109, 113], ["Tet3", "GENE_OR_GENE_PRODUCT", 118, 122], ["nucleus accumbens", "GENE_OR_GENE_PRODUCT", 148, 165], ["TET1", "GENE_OR_GENE_PRODUCT", 197, 201], ["Tet2 and Tet3 mRNAs", "RNA", 109, 128], ["TET1", "PROTEIN", 197, 201], ["specific 5hmC alterations", "PROBLEM", 53, 78], ["Tet2 and Tet3 mRNAs", "PROBLEM", 109, 128], ["nucleus accumbens", "PROBLEM", 148, 165], ["TET1 decrease", "PROBLEM", 197, 210], ["nucleus accumbens", "OBSERVATION", 148, 165]]], ["Selective chemical labeling for 5hmC followed by deep sequencing allowed identification of 11511 differentially hydroxymethylated regions, distributed primarily in gene bodies (~55%) and intergenic regions (~34%) [78] .", [["5hmC", "CELLULAR_COMPONENT", 32, 36], ["5hmC", "PROTEIN", 32, 36], ["11511 differentially hydroxymethylated regions", "DNA", 91, 137], ["intergenic regions", "DNA", 187, 205], ["deep sequencing", "TEST", 49, 64], ["intergenic regions", "TEST", 187, 205], ["gene bodies", "OBSERVATION", 164, 175]]], ["In rat prefrontal cortex exposed to cocaine self-administration, both DNA methylation and hydroxymethylation are decreased within the Homer2 promoter, a glutamate receptor-related scaffolding protein [79] ; all Tet genes and Dnmt3b are down-regulated while Dnmt3a is up-regulated [80] .", [["prefrontal cortex", "ANATOMY", 7, 24], ["cocaine", "CHEMICAL", 36, 43], ["glutamate", "CHEMICAL", 153, 162], ["cocaine", "CHEMICAL", 36, 43], ["glutamate", "CHEMICAL", 153, 162], ["rat", "ORGANISM", 3, 6], ["prefrontal cortex", "MULTI-TISSUE_STRUCTURE", 7, 24], ["cocaine", "SIMPLE_CHEMICAL", 36, 43], ["DNA", "CELLULAR_COMPONENT", 70, 73], ["Homer2", "GENE_OR_GENE_PRODUCT", 134, 140], ["glutamate receptor-related scaffolding protein [79", "GENE_OR_GENE_PRODUCT", 153, 203], ["Tet", "GENE_OR_GENE_PRODUCT", 211, 214], ["Dnmt3b", "GENE_OR_GENE_PRODUCT", 225, 231], ["Dnmt3a", "GENE_OR_GENE_PRODUCT", 257, 263], ["Homer2 promoter", "DNA", 134, 149], ["glutamate receptor", "PROTEIN", 153, 171], ["scaffolding protein", "PROTEIN", 180, 199], ["Tet genes", "DNA", 211, 220], ["Dnmt3b", "DNA", 225, 231], ["Dnmt3a", "PROTEIN", 257, 263], ["rat", "SPECIES", 3, 6], ["both DNA methylation and hydroxymethylation", "TREATMENT", 65, 108], ["a glutamate receptor", "TEST", 151, 171], ["scaffolding protein", "TEST", 180, 199], ["all Tet genes", "TREATMENT", 207, 220], ["Dnmt3b", "TEST", 225, 231], ["cocaine self", "OBSERVATION", 36, 48]]], ["Combined with the effect on brain structures, there is indirect evidence of cocaine-induced alterations in DNA hydroxymethylation patterns in mouse spermatogenic cells: authors observed decreased Dnmt3b and Tet1 mRNAs and increased Dnmt3a and DNA methylation [81] .MethamphetamineMethamphetamine is a synthetic neurotoxic psychostimulant.", [["brain structures", "ANATOMY", 28, 44], ["spermatogenic cells", "ANATOMY", 148, 167], ["cocaine", "CHEMICAL", 76, 83], ["Methamphetamine", "CHEMICAL", 265, 280], ["Methamphetamine", "CHEMICAL", 280, 295], ["neurotoxic", "DISEASE", 311, 321], ["cocaine", "CHEMICAL", 76, 83], ["Methamphetamine", "CHEMICAL", 265, 280], ["Methamphetamine", "CHEMICAL", 280, 295], ["brain structures", "MULTI-TISSUE_STRUCTURE", 28, 44], ["cocaine", "SIMPLE_CHEMICAL", 76, 83], ["DNA", "CELLULAR_COMPONENT", 107, 110], ["mouse", "ORGANISM", 142, 147], ["spermatogenic cells", "CELL", 148, 167], ["Dnmt3b", "GENE_OR_GENE_PRODUCT", 196, 202], ["Tet1", "GENE_OR_GENE_PRODUCT", 207, 211], ["Dnmt3a", "GENE_OR_GENE_PRODUCT", 232, 238], ["DNA", "CELLULAR_COMPONENT", 243, 246], ["Methamphetamine", "SIMPLE_CHEMICAL", 265, 280], ["Methamphetamine", "SIMPLE_CHEMICAL", 280, 295], ["mouse spermatogenic cells", "CELL_TYPE", 142, 167], ["Dnmt3b and Tet1 mRNAs", "RNA", 196, 217], ["Dnmt3a", "PROTEIN", 232, 238], ["mouse", "SPECIES", 142, 147], ["mouse", "SPECIES", 142, 147], ["the effect on brain structures", "PROBLEM", 14, 44], ["induced alterations", "PROBLEM", 84, 103], ["DNA hydroxymethylation patterns", "TREATMENT", 107, 138], ["mouse spermatogenic cells", "PROBLEM", 142, 167], ["decreased Dnmt3b", "PROBLEM", 186, 202], ["Tet1 mRNAs", "PROBLEM", 207, 217], ["increased Dnmt3a", "PROBLEM", 222, 238], ["DNA methylation", "TEST", 243, 258], ["MethamphetamineMethamphetamine", "TREATMENT", 265, 295], ["a synthetic neurotoxic psychostimulant", "TREATMENT", 299, 337], ["cocaine", "OBSERVATION", 76, 83], ["mouse spermatogenic cells", "OBSERVATION", 142, 167], ["increased", "OBSERVATION_MODIFIER", 222, 231], ["Dnmt3a", "OBSERVATION", 232, 238]]], ["Its intake causes increase in TET1 and TET3 protein levels and changes hydroxymethylation levels in rat nucleus accumbens [82] .", [["nucleus accumbens", "ANATOMY", 104, 121], ["TET1", "GENE_OR_GENE_PRODUCT", 30, 34], ["TET3", "GENE_OR_GENE_PRODUCT", 39, 43], ["rat", "ORGANISM", 100, 103], ["nucleus accumbens", "ORGANISM", 104, 121], ["TET1", "PROTEIN", 30, 34], ["TET3", "PROTEIN", 39, 43], ["rat", "SPECIES", 100, 103], ["increase in TET1", "PROBLEM", 18, 34], ["TET3 protein levels", "TEST", 39, 58], ["changes hydroxymethylation levels in rat nucleus accumbens", "PROBLEM", 63, 121], ["increase", "OBSERVATION_MODIFIER", 18, 26]]], ["Increased 5hmC concomitant with a decrease in DNA methylation was detected in corticotropin-releasing hormone (Crh/Crf ) gene promoter and at a CpG-rich region within the arginine vasopressin (Avp) gene body [82] .", [["5hmC", "CHEMICAL", 10, 14], ["arginine vasopressin", "CHEMICAL", 171, 191], ["CpG", "CHEMICAL", 144, 147], ["arginine", "CHEMICAL", 171, 179], ["5hmC", "CELLULAR_COMPONENT", 10, 14], ["DNA", "CELLULAR_COMPONENT", 46, 49], ["corticotropin-releasing hormone", "GENE_OR_GENE_PRODUCT", 78, 109], ["Crh", "GENE_OR_GENE_PRODUCT", 111, 114], ["Crf", "GENE_OR_GENE_PRODUCT", 115, 118], ["arginine vasopressin", "GENE_OR_GENE_PRODUCT", 171, 191], ["Avp", "GENE_OR_GENE_PRODUCT", 193, 196], ["5hmC", "PROTEIN", 10, 14], ["corticotropin-releasing hormone (Crh/Crf ) gene promoter", "DNA", 78, 134], ["CpG-rich region", "DNA", 144, 159], ["arginine vasopressin (Avp) gene", "DNA", 171, 202], ["Increased 5hmC", "PROBLEM", 0, 14], ["a decrease in DNA methylation", "PROBLEM", 32, 61], ["corticotropin-releasing hormone", "TREATMENT", 78, 109], ["Crh/Crf ) gene promoter", "TREATMENT", 111, 134], ["a CpG-rich region", "TREATMENT", 142, 159], ["the arginine vasopressin", "TREATMENT", 167, 191], ["decrease", "OBSERVATION_MODIFIER", 34, 42]]], ["On the contrary, promoter sequences of GluA1 and GluA2 alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) undergo a decrease in both striatal DNA methylation and hydroxymethylation [83] .", [["striatal", "ANATOMY", 157, 165], ["alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid", "CHEMICAL", 55, 112], ["alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid", "CHEMICAL", 55, 112], ["GluA1", "GENE_OR_GENE_PRODUCT", 39, 44], ["GluA2 alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid", "SIMPLE_CHEMICAL", 49, 112], ["AMPAR", "SIMPLE_CHEMICAL", 123, 128], ["striatal DNA", "CELLULAR_COMPONENT", 157, 169], ["promoter sequences", "DNA", 17, 35], ["GluA1", "PROTEIN", 39, 44], ["GluA2", "PROTEIN", 49, 54], ["AMPAR", "PROTEIN", 123, 128], ["GluA1", "TEST", 39, 44], ["GluA2", "TEST", 49, 54], ["alpha-amino", "TEST", 55, 66], ["hydroxy", "TEST", 69, 76], ["methyl", "TREATMENT", 79, 85], ["isoxazole propionic acid receptor", "TREATMENT", 88, 121], ["a decrease in both striatal DNA methylation and hydroxymethylation", "TREATMENT", 138, 204], ["decrease", "OBSERVATION_MODIFIER", 140, 148]]], ["These changes, combined with histone modifications [83] , seem to suppress striatal glutamate receptor expression, observed in systemic methamphetamine intake.", [["striatal", "ANATOMY", 75, 83], ["glutamate", "CHEMICAL", 84, 93], ["methamphetamine", "CHEMICAL", 136, 151], ["glutamate", "CHEMICAL", 84, 93], ["methamphetamine", "CHEMICAL", 136, 151], ["histone", "GENE_OR_GENE_PRODUCT", 29, 36], ["striatal glutamate receptor", "GENE_OR_GENE_PRODUCT", 75, 102], ["methamphetamine", "SIMPLE_CHEMICAL", 136, 151], ["histone", "PROTEIN", 29, 36], ["striatal glutamate receptor", "PROTEIN", 75, 102], ["These changes", "PROBLEM", 0, 13], ["histone modifications", "TREATMENT", 29, 50], ["striatal glutamate receptor expression", "PROBLEM", 75, 113]]], ["Other genomic regions are also affected by methamphetamine-driven changes in 5hmC.", [["methamphetamine", "CHEMICAL", 43, 58], ["methamphetamine", "CHEMICAL", 43, 58], ["methamphetamine", "SIMPLE_CHEMICAL", 43, 58], ["5hmC", "CELLULAR_COMPONENT", 77, 81], ["genomic regions", "DNA", 6, 21], ["5hmC", "PROTEIN", 77, 81], ["methamphetamine", "TREATMENT", 43, 58]]], ["In rats addicted to methamphetamine, nucleus accumbens cells subjected to immunoprecipitation with polyclonal anti-5hmC antibodies followed by next-generation sequencing showed numerous differentially hydroxymethylated regions, predominantly in intergenic sites located on long and short interspersed elements [84] .MethamphetamineThe available data provides supporting evidence that cocaine-and methamphetamine-driven changes in DNA hydroxymethylation patterns can be a vital factor in promoting drug addiction.EthanolPrenatal exposure to ethanol causes disturbances in normal methylation and hydroxymethylation dynamics of developing mouse hippocampus and cortex [85, 86] .", [["nucleus accumbens cells", "ANATOMY", 37, 60], ["sites", "ANATOMY", 256, 261], ["hippocampus", "ANATOMY", 642, 653], ["cortex", "ANATOMY", 658, 664], ["methamphetamine", "CHEMICAL", 20, 35], ["Methamphetamine", "CHEMICAL", 316, 331], ["cocaine", "CHEMICAL", 384, 391], ["methamphetamine", "CHEMICAL", 396, 411], ["drug addiction", "DISEASE", 497, 511], ["EthanolPrenatal", "CHEMICAL", 512, 527], ["ethanol", "CHEMICAL", 540, 547], ["methamphetamine", "CHEMICAL", 20, 35], ["Methamphetamine", "CHEMICAL", 316, 331], ["cocaine", "CHEMICAL", 384, 391], ["methamphetamine", "CHEMICAL", 396, 411], ["ethanol", "CHEMICAL", 540, 547], ["rats", "ORGANISM", 3, 7], ["methamphetamine", "SIMPLE_CHEMICAL", 20, 35], ["nucleus accumbens cells", "CELL", 37, 60], ["anti-5hmC", "GENE_OR_GENE_PRODUCT", 110, 119], ["Methamphetamine", "SIMPLE_CHEMICAL", 316, 331], ["cocaine", "SIMPLE_CHEMICAL", 384, 391], ["methamphetamine", "SIMPLE_CHEMICAL", 396, 411], ["DNA", "CELLULAR_COMPONENT", 430, 433], ["ethanol", "SIMPLE_CHEMICAL", 540, 547], ["mouse", "ORGANISM", 636, 641], ["hippocampus", "MULTI-TISSUE_STRUCTURE", 642, 653], ["cortex", "CANCER", 658, 664], ["nucleus accumbens cells", "CELL_TYPE", 37, 60], ["polyclonal anti-5hmC antibodies", "PROTEIN", 99, 130], ["hydroxymethylated regions", "DNA", 201, 226], ["intergenic sites", "DNA", 245, 261], ["long and short interspersed elements", "DNA", 273, 309], ["rats", "SPECIES", 3, 7], ["mouse", "SPECIES", 636, 641], ["mouse", "SPECIES", 636, 641], ["methamphetamine, nucleus accumbens cells", "TREATMENT", 20, 60], ["immunoprecipitation", "TEST", 74, 93], ["polyclonal anti-5hmC antibodies", "TREATMENT", 99, 130], ["next-generation sequencing", "TEST", 143, 169], ["numerous differentially hydroxymethylated regions", "PROBLEM", 177, 226], ["intergenic sites", "PROBLEM", 245, 261], ["Methamphetamine", "TREATMENT", 316, 331], ["cocaine", "TREATMENT", 384, 391], ["methamphetamine", "TREATMENT", 396, 411], ["DNA hydroxymethylation patterns", "TREATMENT", 430, 461], ["a vital factor", "PROBLEM", 469, 483], ["EthanolPrenatal exposure", "PROBLEM", 512, 536], ["disturbances", "PROBLEM", 555, 567], ["numerous", "OBSERVATION_MODIFIER", 177, 185], ["differentially hydroxymethylated", "OBSERVATION", 186, 218], ["predominantly", "OBSERVATION_MODIFIER", 228, 241], ["intergenic sites", "OBSERVATION", 245, 261], ["normal methylation", "OBSERVATION", 571, 589], ["mouse hippocampus", "ANATOMY", 636, 653]]], ["Delayed 5mC and 5hmC increase is observed in the neuroepithelial stem cells.", [["neuroepithelial stem cells", "ANATOMY", 49, 75], ["5mC", "CHEMICAL", 8, 11], ["5hmC", "CELLULAR_COMPONENT", 16, 20], ["neuroepithelial stem cells", "CELL", 49, 75], ["neuroepithelial stem cells", "CELL_TYPE", 49, 75], ["Delayed 5mC and 5hmC increase", "PROBLEM", 0, 29], ["increase", "OBSERVATION_MODIFIER", 21, 29], ["neuroepithelial stem cells", "OBSERVATION", 49, 75]]], ["In early maturing neurons, ethanol disrupts the timely decrease of DNA methylation and increase of hydroxymethylation [85] .", [["neurons", "ANATOMY", 18, 25], ["ethanol", "CHEMICAL", 27, 34], ["ethanol", "CHEMICAL", 27, 34], ["neurons", "CELL", 18, 25], ["ethanol", "SIMPLE_CHEMICAL", 27, 34], ["DNA", "CELLULAR_COMPONENT", 67, 70], ["early maturing neurons", "CELL_TYPE", 3, 25], ["DNA methylation", "TREATMENT", 67, 82], ["increase of hydroxymethylation", "TREATMENT", 87, 117]]], ["Prenatal exposure to ethanol has prolonged action: after withdrawal, developing gyrus dentatus undergoes significant changes in programmed DNA methylation and hydroxymethylation dynamics during the third trimester of pregnancy [85] .", [["gyrus dentatus", "ANATOMY", 80, 94], ["ethanol", "CHEMICAL", 21, 28], ["ethanol", "CHEMICAL", 21, 28], ["ethanol", "SIMPLE_CHEMICAL", 21, 28], ["gyrus dentatus", "ORGANISM", 80, 94], ["DNA", "CELLULAR_COMPONENT", 139, 142], ["withdrawal", "PROBLEM", 57, 67], ["gyrus dentatus", "PROBLEM", 80, 94], ["significant changes", "PROBLEM", 105, 124], ["programmed DNA methylation", "TREATMENT", 128, 154], ["hydroxymethylation dynamics", "TREATMENT", 159, 186], ["gyrus dentatus", "ANATOMY", 80, 94], ["significant", "OBSERVATION_MODIFIER", 105, 116]]], ["After 8 days of ethanol exposure in vitro, mouse neural stem cells demonstrate an increased global DNA methylation level, whereas the total 5hmC level remains unaffected.", [["neural stem cells", "ANATOMY", 49, 66], ["ethanol", "CHEMICAL", 16, 23], ["ethanol", "CHEMICAL", 16, 23], ["ethanol", "SIMPLE_CHEMICAL", 16, 23], ["mouse", "ORGANISM", 43, 48], ["neural stem cells", "CELL", 49, 66], ["DNA", "CELLULAR_COMPONENT", 99, 102], ["5hmC", "GENE_OR_GENE_PRODUCT", 140, 144], ["mouse neural stem cells", "CELL_TYPE", 43, 66], ["5hmC", "PROTEIN", 140, 144], ["mouse", "SPECIES", 43, 48], ["mouse", "SPECIES", 43, 48], ["ethanol exposure", "TREATMENT", 16, 32], ["an increased global DNA methylation level", "PROBLEM", 79, 120], ["the total 5hmC level", "TEST", 130, 150], ["neural stem cells", "OBSERVATION", 49, 66], ["increased", "OBSERVATION_MODIFIER", 82, 91]]], ["After withdrawal, however, the DNA hydroxylation level plummets significantly [87] .", [["DNA", "CELLULAR_COMPONENT", 31, 34], ["withdrawal", "PROBLEM", 6, 16], ["the DNA hydroxylation level plummets", "TEST", 27, 63]]], ["In blood samples of alcohol-dependent humans, hydroxymethylation is significantly lower compared to controls.", [["blood samples", "ANATOMY", 3, 16], ["alcohol", "CHEMICAL", 20, 27], ["alcohol", "CHEMICAL", 20, 27], ["blood samples", "ORGANISM_SUBSTANCE", 3, 16], ["alcohol", "SIMPLE_CHEMICAL", 20, 27], ["humans", "ORGANISM", 38, 44], ["humans", "SPECIES", 38, 44], ["humans", "SPECIES", 38, 44], ["blood samples", "TEST", 3, 16], ["hydroxymethylation", "TREATMENT", 46, 64]]], ["During detoxification, a rise of hydroxymethylation is observed [88] .", [["a rise of hydroxymethylation", "PROBLEM", 23, 51]]], ["Chronic alcohol consumption in rats decreases hydroxymethylation levels in liver cells by half [89] and intensifies apoptosis of hepatocytes [90] .", [["liver cells", "ANATOMY", 75, 86], ["hepatocytes", "ANATOMY", 129, 140], ["alcohol", "CHEMICAL", 8, 15], ["alcohol", "CHEMICAL", 8, 15], ["alcohol", "SIMPLE_CHEMICAL", 8, 15], ["rats", "ORGANISM", 31, 35], ["liver cells", "CELL", 75, 86], ["hepatocytes", "CELL", 129, 140], ["liver cells", "CELL_TYPE", 75, 86], ["hepatocytes", "CELL_TYPE", 129, 140], ["rats", "SPECIES", 31, 35], ["Chronic alcohol consumption", "PROBLEM", 0, 27], ["hydroxymethylation levels in liver cells", "PROBLEM", 46, 86], ["hepatocytes", "TEST", 129, 140], ["alcohol consumption", "OBSERVATION", 8, 27], ["liver", "ANATOMY", 75, 80], ["hepatocytes", "ANATOMY", 129, 140]]], ["This is accompanied by decreasing TET1 levels, while TET2 and TET3 remain unchanged [90] .", [["TET1", "GENE_OR_GENE_PRODUCT", 34, 38], ["TET2", "GENE_OR_GENE_PRODUCT", 53, 57], ["TET3", "GENE_OR_GENE_PRODUCT", 62, 66], ["TET1", "PROTEIN", 34, 38], ["TET2", "PROTEIN", 53, 57], ["TET3", "PROTEIN", 62, 66], ["decreasing TET1 levels", "PROBLEM", 23, 45], ["TET2", "TEST", 53, 57], ["TET3", "TEST", 62, 66], ["decreasing", "OBSERVATION_MODIFIER", 23, 33], ["TET1 levels", "OBSERVATION", 34, 45], ["unchanged", "OBSERVATION_MODIFIER", 74, 83]]], ["However, iron supplementation to an alcohol diet prevents changes in DNA hydroxymethylation levels [89] .Dimethyl SulfoxideDimethyl sulfoxide (DMSO) is a bipolar aprotic solvent.", [["iron", "CHEMICAL", 9, 13], ["alcohol", "CHEMICAL", 36, 43], ["Dimethyl SulfoxideDimethyl sulfoxide", "CHEMICAL", 105, 141], ["DMSO", "CHEMICAL", 143, 147], ["bipolar", "DISEASE", 154, 161], ["iron", "CHEMICAL", 9, 13], ["alcohol", "CHEMICAL", 36, 43], ["Dimethyl SulfoxideDimethyl sulfoxide", "CHEMICAL", 105, 141], ["DMSO", "CHEMICAL", 143, 147], ["iron", "SIMPLE_CHEMICAL", 9, 13], ["alcohol", "SIMPLE_CHEMICAL", 36, 43], ["DNA", "CELLULAR_COMPONENT", 69, 72], ["Dimethyl SulfoxideDimethyl sulfoxide", "SIMPLE_CHEMICAL", 105, 141], ["DMSO", "SIMPLE_CHEMICAL", 143, 147], ["iron supplementation", "TREATMENT", 9, 29], ["an alcohol diet", "TREATMENT", 33, 48], ["DNA hydroxymethylation levels", "TEST", 69, 98], ["Dimethyl SulfoxideDimethyl sulfoxide (DMSO)", "TREATMENT", 105, 148], ["a bipolar aprotic solvent", "TREATMENT", 152, 177]]], ["DMSO has been known for its enhanced permeability and capacity to significantly facilitate transdermal permeation of active substances; therefore, DMSO is extensively used in local cosmetic products and medicines for transdermal delivery of local anti-inflammatory and pain-killing agents.", [["DMSO", "CHEMICAL", 0, 4], ["DMSO", "CHEMICAL", 147, 151], ["pain", "DISEASE", 269, 273], ["DMSO", "CHEMICAL", 0, 4], ["DMSO", "CHEMICAL", 147, 151], ["DMSO", "SIMPLE_CHEMICAL", 0, 4], ["transdermal", "SIMPLE_CHEMICAL", 91, 102], ["DMSO", "SIMPLE_CHEMICAL", 147, 151], ["transdermal", "IMMATERIAL_ANATOMICAL_ENTITY", 217, 228], ["DMSO", "TREATMENT", 0, 4], ["its enhanced permeability", "PROBLEM", 24, 49], ["transdermal permeation of active substances", "TREATMENT", 91, 134], ["DMSO", "TREATMENT", 147, 151], ["local cosmetic products", "TREATMENT", 175, 198], ["medicines", "TREATMENT", 203, 212], ["transdermal delivery", "TREATMENT", 217, 237], ["local anti-inflammatory", "TREATMENT", 241, 264], ["pain-killing agents", "TREATMENT", 269, 288], ["active", "OBSERVATION_MODIFIER", 117, 123], ["substances", "OBSERVATION", 124, 134]]], ["DMSO is also used in cryopreservation of different types of cells.", [["cells", "ANATOMY", 60, 65], ["DMSO", "CHEMICAL", 0, 4], ["DMSO", "CHEMICAL", 0, 4], ["DMSO", "SIMPLE_CHEMICAL", 0, 4], ["cells", "CELL", 60, 65], ["DMSO", "TREATMENT", 0, 4], ["cryopreservation", "TREATMENT", 21, 37], ["different types", "OBSERVATION_MODIFIER", 41, 56], ["of cells", "OBSERVATION", 57, 65]]], ["Thaler et al. showed that DMSO exposure induced an increase of both global and gene-specific 5hmC levels in pre-osteoblastic MC3T3-E1 cell line [91] .", [["pre-osteoblastic MC3T3-E1 cell line", "ANATOMY", 108, 143], ["DMSO", "CHEMICAL", 26, 30], ["DMSO", "CHEMICAL", 26, 30], ["DMSO", "SIMPLE_CHEMICAL", 26, 30], ["5hmC", "GENE_OR_GENE_PRODUCT", 93, 97], ["pre-osteoblastic MC3T3-E1 cell line [91]", "CELL", 108, 148], ["5hmC", "PROTEIN", 93, 97], ["pre-osteoblastic MC3T3-E1 cell line", "CELL_LINE", 108, 143], ["DMSO exposure", "PROBLEM", 26, 39], ["an increase of both global and gene-specific 5hmC levels", "PROBLEM", 48, 104], ["DMSO exposure", "OBSERVATION", 26, 39], ["increase", "OBSERVATION_MODIFIER", 51, 59], ["MC3T3", "ANATOMY", 125, 130], ["E1 cell line", "OBSERVATION", 131, 143]]], ["The authors report that 12 to 24 h after DMSO exposure Tet and Gadd45 genes-the key players in DNA hydroxymethylation and nucleotide excision repair-demonstrated increased expression.", [["DMSO", "CHEMICAL", 41, 45], ["nucleotide", "CHEMICAL", 122, 132], ["DMSO", "CHEMICAL", 41, 45], ["nucleotide", "CHEMICAL", 122, 132], ["DMSO", "SIMPLE_CHEMICAL", 41, 45], ["Tet", "GENE_OR_GENE_PRODUCT", 55, 58], ["Gadd45", "GENE_OR_GENE_PRODUCT", 63, 69], ["DNA", "CELLULAR_COMPONENT", 95, 98], ["Tet and Gadd45 genes", "DNA", 55, 75], ["Tet and Gadd45 genes", "TREATMENT", 55, 75], ["DNA hydroxymethylation", "TREATMENT", 95, 117], ["nucleotide excision repair", "TREATMENT", 122, 148], ["increased expression", "PROBLEM", 162, 182], ["excision repair", "OBSERVATION", 133, 148], ["increased", "OBSERVATION_MODIFIER", 162, 171], ["expression", "OBSERVATION_MODIFIER", 172, 182]]], ["There was a concurrent decreased expression of genes related to DNA methylation: Dnmt1, Dnmt3b, and Hells [91] .", [["DNA", "CELLULAR_COMPONENT", 64, 67], ["Dnmt1", "GENE_OR_GENE_PRODUCT", 81, 86], ["Dnmt3b", "GENE_OR_GENE_PRODUCT", 88, 94], ["Dnmt1", "PROTEIN", 81, 86], ["Dnmt3b", "PROTEIN", 88, 94], ["Dnmt3b", "TEST", 88, 94], ["Hells", "TEST", 100, 105]]], ["The Tet1-dependent pro-apoptotic gene Fas and the early osteoblastic factor Dlx5 demonstrated expression increase.", [["Tet1", "GENE_OR_GENE_PRODUCT", 4, 8], ["Fas", "GENE_OR_GENE_PRODUCT", 38, 41], ["Dlx5", "GENE_OR_GENE_PRODUCT", 76, 80], ["Tet1", "PROTEIN", 4, 8], ["pro-apoptotic gene Fas", "PROTEIN", 19, 41], ["early osteoblastic factor", "PROTEIN", 50, 75], ["Dlx5", "PROTEIN", 76, 80], ["The Tet1-dependent pro-apoptotic gene Fas", "TREATMENT", 0, 41], ["the early osteoblastic factor Dlx5", "PROBLEM", 46, 80], ["expression increase", "PROBLEM", 94, 113], ["dependent", "OBSERVATION_MODIFIER", 9, 18], ["pro-apoptotic gene Fas", "OBSERVATION", 19, 41], ["early", "OBSERVATION_MODIFIER", 50, 55], ["osteoblastic", "ANATOMY", 56, 68], ["expression", "OBSERVATION_MODIFIER", 94, 104], ["increase", "OBSERVATION_MODIFIER", 105, 113]]], ["The aforesaid changes in gene expression are associated with a global and gene-specific increase in hydroxymethylation and concomitant gene-specific loss of DNA methylation at Fas and Dlx5 promoters [91] .", [["DNA", "CELLULAR_COMPONENT", 157, 160], ["Fas", "GENE_OR_GENE_PRODUCT", 176, 179], ["Dlx5", "GENE_OR_GENE_PRODUCT", 184, 188], ["Fas", "PROTEIN", 176, 179], ["Dlx5 promoters", "DNA", 184, 198], ["The aforesaid changes in gene expression", "PROBLEM", 0, 40], ["a global and gene-specific increase in hydroxymethylation", "PROBLEM", 61, 118], ["DNA methylation at Fas and Dlx5 promoters", "TREATMENT", 157, 198]]], ["By day 5, the DMSO impact on promoter-specific and global methylation/hydroxylation is reduced or reversed [91] .", [["DMSO", "CHEMICAL", 14, 18], ["DMSO", "CHEMICAL", 14, 18], ["DMSO", "SIMPLE_CHEMICAL", 14, 18], ["the DMSO impact on promoter", "TREATMENT", 10, 37], ["global methylation/hydroxylation", "TREATMENT", 51, 83]]], ["The 3D microtissues of a maturing cardiac model and a mature hepatic model provide indirect evidence of DMSO effect on DNA hydroxymethylation in human cells.", [["cardiac", "ANATOMY", 34, 41], ["hepatic", "ANATOMY", 61, 68], ["cells", "ANATOMY", 151, 156], ["DMSO", "CHEMICAL", 104, 108], ["DMSO", "CHEMICAL", 104, 108], ["cardiac", "ORGAN", 34, 41], ["hepatic", "ORGAN", 61, 68], ["DMSO", "SIMPLE_CHEMICAL", 104, 108], ["DNA", "CELLULAR_COMPONENT", 119, 122], ["human", "ORGANISM", 145, 150], ["cells", "CELL", 151, 156], ["human cells", "CELL_TYPE", 145, 156], ["human", "SPECIES", 145, 150], ["human", "SPECIES", 145, 150], ["a maturing cardiac model", "PROBLEM", 23, 47], ["DMSO effect", "PROBLEM", 104, 115], ["DNA hydroxymethylation in human cells", "TREATMENT", 119, 156], ["maturing cardiac model", "OBSERVATION", 25, 47], ["hepatic", "ANATOMY", 61, 68], ["DMSO effect", "OBSERVATION", 104, 115], ["human cells", "OBSERVATION", 145, 156]]], ["Adding DMSO at 0.1% to human 3D cardiac microtissue culture promotes up-regulation of methyltransferases DNMT1 and DNMT3A and down-regulation of TET1.", [["cardiac microtissue culture", "ANATOMY", 32, 59], ["DMSO", "CHEMICAL", 7, 11], ["DMSO", "CHEMICAL", 7, 11], ["DMSO", "SIMPLE_CHEMICAL", 7, 11], ["human", "ORGANISM", 23, 28], ["cardiac microtissue culture", "CELL", 32, 59], ["DNMT1", "GENE_OR_GENE_PRODUCT", 105, 110], ["DNMT3A", "GENE_OR_GENE_PRODUCT", 115, 121], ["TET1", "GENE_OR_GENE_PRODUCT", 145, 149], ["human 3D cardiac microtissue culture", "CELL_LINE", 23, 59], ["methyltransferases", "PROTEIN", 86, 104], ["DNMT1", "PROTEIN", 105, 110], ["DNMT3A", "PROTEIN", 115, 121], ["TET1", "PROTEIN", 145, 149], ["human", "SPECIES", 23, 28], ["human", "SPECIES", 23, 28], ["DMSO", "TREATMENT", 7, 11], ["human 3D cardiac microtissue culture", "TEST", 23, 59], ["methyltransferases DNMT1", "TREATMENT", 86, 110], ["DNMT3A", "TEST", 115, 121], ["cardiac", "ANATOMY", 32, 39], ["methyltransferases DNMT1", "OBSERVATION", 86, 110]]], ["Transcriptional changes of DNA methylation writers and erasers are associated with changes of methylation levels in 66,178 regions, where 71% show gain of DNA methylation [92] .", [["DNA", "CELLULAR_COMPONENT", 27, 30], ["DNA", "CELLULAR_COMPONENT", 155, 158], ["66,178 regions", "DNA", 116, 130], ["Transcriptional changes", "PROBLEM", 0, 23], ["DNA methylation writers", "TREATMENT", 27, 50], ["methylation levels", "TEST", 94, 112], ["DNA methylation", "PROBLEM", 155, 170]]], ["In contrast, no deregulation of DNA methylation is observed in DMSO-exposed 3D hepatic microtissue [92] .Heavy MetalsArsenic is listed among the most dangerous substances in the United Nations Environment Programme guidelines.", [["hepatic microtissue", "ANATOMY", 79, 98], ["DMSO", "CHEMICAL", 63, 67], ["MetalsArsenic", "CHEMICAL", 111, 124], ["DMSO", "CHEMICAL", 63, 67], ["DNA", "CELLULAR_COMPONENT", 32, 35], ["DMSO", "SIMPLE_CHEMICAL", 63, 67], ["DNA methylation", "PROBLEM", 32, 47], ["DMSO", "TEST", 63, 67], ["no", "UNCERTAINTY", 13, 15], ["hepatic", "ANATOMY", 79, 86]]], ["The International Agency for Research on Cancer includes arsenic in Group 1 'Carcinogenic to humans'.", [["Cancer", "DISEASE", 41, 47], ["arsenic", "CHEMICAL", 57, 64], ["arsenic", "CHEMICAL", 57, 64], ["Cancer", "CANCER", 41, 47], ["arsenic", "SIMPLE_CHEMICAL", 57, 64], ["humans", "ORGANISM", 93, 99], ["humans", "SPECIES", 93, 99], ["humans", "SPECIES", 93, 99], ["Research on Cancer", "PROBLEM", 29, 47], ["Cancer", "OBSERVATION", 41, 47]]], ["Arsenic exposure is associated with cardiovascular diseases, diabetes mellitus, and neurological and reproductive disorders [93] .", [["cardiovascular", "ANATOMY", 36, 50], ["neurological", "ANATOMY", 84, 96], ["Arsenic", "CHEMICAL", 0, 7], ["cardiovascular diseases", "DISEASE", 36, 59], ["diabetes mellitus", "DISEASE", 61, 78], ["neurological and reproductive disorders", "DISEASE", 84, 123], ["Arsenic", "CHEMICAL", 0, 7], ["Arsenic", "SIMPLE_CHEMICAL", 0, 7], ["cardiovascular", "ANATOMICAL_SYSTEM", 36, 50], ["Arsenic exposure", "PROBLEM", 0, 16], ["cardiovascular diseases", "PROBLEM", 36, 59], ["diabetes mellitus", "PROBLEM", 61, 78], ["neurological and reproductive disorders", "PROBLEM", 84, 123], ["associated with", "UNCERTAINTY", 20, 35], ["cardiovascular diseases", "OBSERVATION", 36, 59], ["diabetes mellitus", "OBSERVATION", 61, 78]]], ["Once ingested, inorganic arsenic compounds undergo enzymatic methylation, a pathway of detoxification utilizing SAM as the methyl donor.", [["arsenic", "CHEMICAL", 25, 32], ["SAM", "CHEMICAL", 112, 115], ["methyl", "CHEMICAL", 123, 129], ["arsenic", "CHEMICAL", 25, 32], ["SAM", "CHEMICAL", 112, 115], ["methyl", "CHEMICAL", 123, 129], ["inorganic arsenic compounds", "SIMPLE_CHEMICAL", 15, 42], ["SAM", "SIMPLE_CHEMICAL", 112, 115], ["methyl donor", "SIMPLE_CHEMICAL", 123, 135], ["inorganic arsenic compounds", "TREATMENT", 15, 42], ["enzymatic methylation", "TREATMENT", 51, 72], ["detoxification", "TREATMENT", 87, 101], ["the methyl donor", "TREATMENT", 119, 135]]], ["Significant amounts of arsenic induce SAM depletion, loss in global DNA methylation, and aberrant locus-specific hypermethylation in multiple regions including p53 and p16 promoters.", [["arsenic", "CHEMICAL", 23, 30], ["arsenic", "CHEMICAL", 23, 30], ["SAM", "CHEMICAL", 38, 41], ["arsenic", "SIMPLE_CHEMICAL", 23, 30], ["SAM", "SIMPLE_CHEMICAL", 38, 41], ["DNA", "CELLULAR_COMPONENT", 68, 71], ["locus", "CELLULAR_COMPONENT", 98, 103], ["p53", "GENE_OR_GENE_PRODUCT", 160, 163], ["p16", "GENE_OR_GENE_PRODUCT", 168, 171], ["p53 and p16 promoters", "DNA", 160, 181], ["arsenic induce SAM depletion", "PROBLEM", 23, 51], ["loss in global DNA methylation", "PROBLEM", 53, 83], ["aberrant locus", "PROBLEM", 89, 103], ["specific hypermethylation in multiple regions", "PROBLEM", 104, 149], ["p53 and p16 promoters", "TREATMENT", 160, 181], ["amounts", "OBSERVATION_MODIFIER", 12, 19], ["arsenic induce", "OBSERVATION", 23, 37], ["SAM depletion", "OBSERVATION", 38, 51], ["loss", "OBSERVATION_MODIFIER", 53, 57], ["global", "OBSERVATION_MODIFIER", 61, 67], ["DNA methylation", "OBSERVATION", 68, 83], ["aberrant", "OBSERVATION_MODIFIER", 89, 97], ["locus", "OBSERVATION_MODIFIER", 98, 103], ["specific", "OBSERVATION_MODIFIER", 104, 112], ["hypermethylation", "OBSERVATION", 113, 129], ["multiple", "OBSERVATION_MODIFIER", 133, 141], ["p16 promoters", "OBSERVATION", 168, 181]]], ["Disrupted DNA methylation patterns, particularly in proto-oncogenes and onco-suppressor genes, increase the risk of malignization [94] .Heavy MetalsThe effect of arsenic on DNA hydroxymethylation has been recently demonstrated in both animal and human models.", [["malignization", "DISEASE", 116, 129], ["arsenic", "CHEMICAL", 162, 169], ["arsenic", "CHEMICAL", 162, 169], ["DNA", "CELLULAR_COMPONENT", 10, 13], ["onco-suppressor", "GENE_OR_GENE_PRODUCT", 72, 87], ["arsenic", "SIMPLE_CHEMICAL", 162, 169], ["DNA", "CELLULAR_COMPONENT", 173, 176], ["human", "ORGANISM", 246, 251], ["proto-oncogenes", "DNA", 52, 67], ["onco-suppressor genes", "DNA", 72, 93], ["human", "SPECIES", 246, 251], ["human", "SPECIES", 246, 251], ["Disrupted DNA methylation patterns", "PROBLEM", 0, 34], ["onco-suppressor genes", "TREATMENT", 72, 93], ["Heavy Metals", "PROBLEM", 136, 148], ["DNA hydroxymethylation", "TREATMENT", 173, 195], ["Metals", "OBSERVATION", 142, 148], ["arsenic", "OBSERVATION_MODIFIER", 162, 169]]], ["After 8 weeks of exposure to sodium arsenite dissolved in drinking water, male Sprague-Dawley rats showed elevated DNA hydroxymethylation levels in lungs, heart, spleen, and pancreas, while liver and kidney were unaffected.", [["lungs", "ANATOMY", 148, 153], ["heart", "ANATOMY", 155, 160], ["spleen", "ANATOMY", 162, 168], ["pancreas", "ANATOMY", 174, 182], ["liver", "ANATOMY", 190, 195], ["kidney", "ANATOMY", 200, 206], ["sodium arsenite", "CHEMICAL", 29, 44], ["sodium arsenite", "CHEMICAL", 29, 44], ["sodium arsenite", "SIMPLE_CHEMICAL", 29, 44], ["Sprague-Dawley rats", "ORGANISM", 79, 98], ["DNA", "CELLULAR_COMPONENT", 115, 118], ["lungs", "ORGAN", 148, 153], ["heart", "ORGAN", 155, 160], ["spleen", "ORGAN", 162, 168], ["pancreas", "ORGAN", 174, 182], ["liver", "ORGAN", 190, 195], ["kidney", "ORGAN", 200, 206], ["Sprague-Dawley rats", "SPECIES", 79, 98], ["Sprague-Dawley", "SPECIES", 79, 93], ["sodium arsenite", "TREATMENT", 29, 44], ["elevated DNA hydroxymethylation levels in lungs, heart, spleen, and pancreas", "PROBLEM", 106, 182], ["lungs", "ANATOMY", 148, 153], ["heart", "ANATOMY", 155, 160], ["spleen", "ANATOMY", 162, 168], ["pancreas", "ANATOMY", 174, 182], ["liver", "ANATOMY", 190, 195], ["kidney", "ANATOMY", 200, 206], ["unaffected", "OBSERVATION", 212, 222]]], ["DNA methylation, however, remained unchanged in these types of organs, except for spleen, where the methylation level was elevated [95] .", [["organs", "ANATOMY", 63, 69], ["spleen", "ANATOMY", 82, 88], ["DNA", "CELLULAR_COMPONENT", 0, 3], ["organs", "ORGAN", 63, 69], ["spleen", "ORGAN", 82, 88], ["DNA methylation", "PROBLEM", 0, 15], ["spleen", "PROBLEM", 82, 88], ["the methylation level", "TEST", 96, 117], ["elevated", "PROBLEM", 122, 130], ["unchanged", "OBSERVATION_MODIFIER", 35, 44], ["organs", "ANATOMY", 63, 69], ["spleen", "ANATOMY", 82, 88]]], ["Exposure to arsenic trioxide in drinking water for 6 months induced a decrease in DNA methylation and hydroxymethylation in hippocampus and cortex, presumably promoted by down-regulation of Dnmts and Tets expression [96] .", [["hippocampus", "ANATOMY", 124, 135], ["cortex", "ANATOMY", 140, 146], ["arsenic trioxide", "CHEMICAL", 12, 28], ["arsenic trioxide", "CHEMICAL", 12, 28], ["arsenic trioxide", "SIMPLE_CHEMICAL", 12, 28], ["DNA", "CELLULAR_COMPONENT", 82, 85], ["hippocampus", "MULTI-TISSUE_STRUCTURE", 124, 135], ["cortex", "CANCER", 140, 146], ["Dnmts", "GENE_OR_GENE_PRODUCT", 190, 195], ["Tets", "GENE_OR_GENE_PRODUCT", 200, 204], ["Dnmts", "PROTEIN", 190, 195], ["Tets", "PROTEIN", 200, 204], ["arsenic trioxide", "TREATMENT", 12, 28], ["a decrease in DNA methylation and hydroxymethylation in hippocampus", "TREATMENT", 68, 135], ["arsenic trioxide", "OBSERVATION", 12, 28], ["decrease", "OBSERVATION_MODIFIER", 70, 78], ["hippocampus", "ANATOMY", 124, 135], ["cortex", "ANATOMY_MODIFIER", 140, 146]]], ["These changes driven by oxidative stress cause deregulation of tricarboxylic acid cycle and alpha-ketoglutarate pathway.", [["tricarboxylic acid", "CHEMICAL", 63, 81], ["alpha-ketoglutarate", "CHEMICAL", 92, 111], ["tricarboxylic acid", "CHEMICAL", 63, 81], ["alpha-ketoglutarate", "CHEMICAL", 92, 111], ["tricarboxylic acid", "SIMPLE_CHEMICAL", 63, 81], ["alpha-ketoglutarate", "SIMPLE_CHEMICAL", 92, 111], ["These changes", "PROBLEM", 0, 13], ["tricarboxylic acid cycle", "TREATMENT", 63, 87], ["alpha-ketoglutarate pathway", "TREATMENT", 92, 119]]], ["No concurrent SAM decrease was reported [96] .", [["concurrent SAM decrease", "PROBLEM", 3, 26], ["SAM", "OBSERVATION_MODIFIER", 14, 17], ["decrease", "OBSERVATION_MODIFIER", 18, 26]]], ["Tricarboxylic acid cycle deregulation and reduced Tet protein activity associated with loss of 5hmC, 5fC, and 5caC are also observed in mESCs under arsenic exposure [97] .", [["mESCs", "ANATOMY", 136, 141], ["Tricarboxylic acid", "CHEMICAL", 0, 18], ["arsenic", "CHEMICAL", 148, 155], ["Tricarboxylic acid", "CHEMICAL", 0, 18], ["arsenic", "CHEMICAL", 148, 155], ["Tricarboxylic acid", "SIMPLE_CHEMICAL", 0, 18], ["Tet", "GENE_OR_GENE_PRODUCT", 50, 53], ["5hmC", "GENE_OR_GENE_PRODUCT", 95, 99], ["5fC", "GENE_OR_GENE_PRODUCT", 101, 104], ["5caC", "GENE_OR_GENE_PRODUCT", 110, 114], ["mESCs", "CELL", 136, 141], ["arsenic", "SIMPLE_CHEMICAL", 148, 155], ["Tet protein", "PROTEIN", 50, 61], ["5hmC", "PROTEIN", 95, 99], ["5fC", "PROTEIN", 101, 104], ["5caC", "PROTEIN", 110, 114], ["mESCs", "CELL_TYPE", 136, 141], ["Tricarboxylic acid cycle deregulation", "TREATMENT", 0, 37], ["reduced Tet protein activity", "PROBLEM", 42, 70], ["loss of 5hmC", "PROBLEM", 87, 99], ["5fC", "TREATMENT", 101, 104], ["5caC", "TREATMENT", 110, 114], ["protein activity", "OBSERVATION", 54, 70]]], ["Human embryonic kidney cells (HEK293T) were used to show that arsenite can bind directly to the zinc fingers of Tet proteins, thus causing loss of catalytic activity to catalyze oxidation of 5mC to yield 5hmC, 5fC, and 5caC.", [["embryonic kidney cells", "ANATOMY", 6, 28], ["HEK293T", "ANATOMY", 30, 37], ["arsenite", "CHEMICAL", 62, 70], ["arsenite", "CHEMICAL", 62, 70], ["zinc", "CHEMICAL", 96, 100], ["5mC", "CHEMICAL", 191, 194], ["5hmC", "CHEMICAL", 204, 208], ["Human", "ORGANISM", 0, 5], ["embryonic kidney cells", "CELL", 6, 28], ["HEK293T", "CELL", 30, 37], ["arsenite", "SIMPLE_CHEMICAL", 62, 70], ["Tet proteins", "GENE_OR_GENE_PRODUCT", 112, 124], ["5mC", "SIMPLE_CHEMICAL", 191, 194], ["5hmC", "SIMPLE_CHEMICAL", 204, 208], ["5fC", "SIMPLE_CHEMICAL", 210, 213], ["5caC", "SIMPLE_CHEMICAL", 219, 223], ["Human embryonic kidney cells", "CELL_LINE", 0, 28], ["HEK293T", "CELL_LINE", 30, 37], ["zinc fingers", "PROTEIN", 96, 108], ["Tet proteins", "PROTEIN", 112, 124], ["5mC", "PROTEIN", 191, 194], ["5hmC", "PROTEIN", 204, 208], ["5fC", "PROTEIN", 210, 213], ["5caC", "PROTEIN", 219, 223], ["Human", "SPECIES", 0, 5], ["Human", "SPECIES", 0, 5], ["Human embryonic kidney cells", "PROBLEM", 0, 28], ["Tet proteins", "PROBLEM", 112, 124], ["loss of catalytic activity", "PROBLEM", 139, 165], ["5fC", "TREATMENT", 210, 213], ["kidney", "ANATOMY", 16, 22]]], ["A successive decrease in 5hmC and an increase in 5mC depends on arsenite concentration [98] .", [["5hmC", "CHEMICAL", 25, 29], ["arsenite", "CHEMICAL", 64, 72], ["5mC", "CHEMICAL", 49, 52], ["arsenite", "CHEMICAL", 64, 72], ["5hmC", "SIMPLE_CHEMICAL", 25, 29], ["5mC", "SIMPLE_CHEMICAL", 49, 52], ["arsenite", "SIMPLE_CHEMICAL", 64, 72], ["A successive decrease in 5hmC", "TREATMENT", 0, 29], ["successive", "OBSERVATION_MODIFIER", 2, 12], ["decrease", "OBSERVATION_MODIFIER", 13, 21], ["increase", "OBSERVATION_MODIFIER", 37, 45]]], ["Arsenic-containing hydrocarbons AsHC 332 and AsHC 360 increase global hydroxymethylation and alter expression of a number of genes, including FEN1, XPA, and DNMT3A in culture of human liver cells HepG2 [99] .", [["liver cells HepG2", "ANATOMY", 184, 201], ["Arsenic", "CHEMICAL", 0, 7], ["AsHC 332", "CHEMICAL", 32, 40], ["AsHC 360", "CHEMICAL", 45, 53], ["Arsenic", "CHEMICAL", 0, 7], ["hydrocarbons", "CHEMICAL", 19, 31], ["AsHC 332", "CHEMICAL", 32, 40], ["AsHC 360", "CHEMICAL", 45, 53], ["Arsenic-containing hydrocarbons AsHC 332", "SIMPLE_CHEMICAL", 0, 40], ["AsHC 360", "SIMPLE_CHEMICAL", 45, 53], ["FEN1", "GENE_OR_GENE_PRODUCT", 142, 146], ["XPA", "GENE_OR_GENE_PRODUCT", 148, 151], ["DNMT3A", "GENE_OR_GENE_PRODUCT", 157, 163], ["human", "ORGANISM", 178, 183], ["liver cells HepG2 [99]", "CELL", 184, 206], ["FEN1", "PROTEIN", 142, 146], ["XPA", "DNA", 148, 151], ["DNMT3A", "PROTEIN", 157, 163], ["human liver cells", "CELL_TYPE", 178, 195], ["human", "SPECIES", 178, 183], ["human", "SPECIES", 178, 183], ["Arsenic", "TEST", 0, 7], ["AsHC", "TEST", 45, 49], ["global hydroxymethylation", "TREATMENT", 63, 88], ["FEN1", "TREATMENT", 142, 146], ["XPA", "TREATMENT", 148, 151], ["DNMT3A in culture", "TEST", 157, 174], ["HepG2", "TEST", 196, 201], ["liver", "ANATOMY", 184, 189]]], ["In individuals with high urine concentration of dimethylarsinate over years, DNA methylation variation in blood correlates positively with changes in 5hmC levels [100] .", [["urine", "ANATOMY", 25, 30], ["blood", "ANATOMY", 106, 111], ["dimethylarsinate", "CHEMICAL", 48, 64], ["dimethylarsinate", "CHEMICAL", 48, 64], ["urine", "ORGANISM_SUBSTANCE", 25, 30], ["dimethylarsinate", "SIMPLE_CHEMICAL", 48, 64], ["DNA", "CELLULAR_COMPONENT", 77, 80], ["blood", "ORGANISM_SUBSTANCE", 106, 111], ["5hmC", "SIMPLE_CHEMICAL", 150, 154], ["5hmC", "PROTEIN", 150, 154], ["high urine concentration", "PROBLEM", 20, 44], ["DNA methylation variation", "PROBLEM", 77, 102], ["blood correlates", "TEST", 106, 122], ["5hmC levels", "TEST", 150, 161], ["high", "OBSERVATION_MODIFIER", 20, 24], ["urine concentration", "OBSERVATION_MODIFIER", 25, 44]]], ["Remarkably, a different analysis performed on blood samples of arsenic-exposed individuals demonstrated a positive correlation between arsenic exposure and global 5hmC levels in men and a negative correlation in women.", [["blood samples", "ANATOMY", 46, 59], ["arsenic", "CHEMICAL", 63, 70], ["arsenic", "CHEMICAL", 135, 142], ["arsenic", "CHEMICAL", 63, 70], ["arsenic", "CHEMICAL", 135, 142], ["blood samples", "ORGANISM_SUBSTANCE", 46, 59], ["arsenic", "SIMPLE_CHEMICAL", 63, 70], ["arsenic", "SIMPLE_CHEMICAL", 135, 142], ["5hmC", "GENE_OR_GENE_PRODUCT", 163, 167], ["men", "ORGANISM", 178, 181], ["women", "ORGANISM", 212, 217], ["5hmC", "PROTEIN", 163, 167], ["men", "SPECIES", 178, 181], ["women", "SPECIES", 212, 217], ["a different analysis", "TEST", 12, 32], ["blood samples", "TEST", 46, 59], ["arsenic exposure", "PROBLEM", 135, 151], ["global 5hmC levels", "TEST", 156, 174]]], ["Apparently, it is the plasma total homocysteine level that seems to contribute to this sex difference, as positive correlation is stronger in men with normal plasma total homocysteine, whereas negative correlation is stronger in hyperhomocysteinemic women [101] .Heavy MetalsSporadic studies investigated the effect of other heavy metals on 5hmC patterns.", [["plasma", "ANATOMY", 22, 28], ["plasma", "ANATOMY", 158, 164], ["homocysteine", "CHEMICAL", 35, 47], ["homocysteine", "CHEMICAL", 171, 183], ["homocysteine", "CHEMICAL", 35, 47], ["homocysteine", "CHEMICAL", 171, 183], ["plasma", "ORGANISM_SUBSTANCE", 22, 28], ["homocysteine", "SIMPLE_CHEMICAL", 35, 47], ["men", "ORGANISM", 142, 145], ["plasma", "ORGANISM_SUBSTANCE", 158, 164], ["homocysteine", "SIMPLE_CHEMICAL", 171, 183], ["women", "ORGANISM", 250, 255], ["5hmC", "SIMPLE_CHEMICAL", 341, 345], ["men", "SPECIES", 142, 145], ["women", "SPECIES", 250, 255], ["the plasma total homocysteine level", "TEST", 18, 53], ["Heavy MetalsSporadic studies", "TEST", 263, 291]]], ["In mESCs culture, cadmium exposure induces a decrease in TET protein activity and a decrease in 5hmC, 5mC, and 5caC levels, while the 5mC level remains unchanged [97] .", [["mESCs", "ANATOMY", 3, 8], ["cadmium", "CHEMICAL", 18, 25], ["TET", "CHEMICAL", 57, 60], ["cadmium", "CHEMICAL", 18, 25], ["5mC", "CHEMICAL", 134, 137], ["mESCs", "CELL", 3, 8], ["cadmium", "SIMPLE_CHEMICAL", 18, 25], ["TET", "GENE_OR_GENE_PRODUCT", 57, 60], ["5hmC", "SIMPLE_CHEMICAL", 96, 100], ["5mC", "SIMPLE_CHEMICAL", 102, 105], ["5caC", "GENE_OR_GENE_PRODUCT", 111, 115], ["5mC", "SIMPLE_CHEMICAL", 134, 137], ["mESCs culture", "CELL_LINE", 3, 16], ["TET protein", "PROTEIN", 57, 68], ["5caC", "PROTEIN", 111, 115], ["5mC", "PROTEIN", 134, 137], ["mESCs culture", "TEST", 3, 16], ["cadmium exposure", "PROBLEM", 18, 34], ["a decrease in TET protein activity", "PROBLEM", 43, 77], ["a decrease in 5hmC", "PROBLEM", 82, 100], ["5mC", "TEST", 102, 105], ["5caC levels", "TEST", 111, 122], ["the 5mC level", "TEST", 130, 143], ["decrease", "OBSERVATION_MODIFIER", 45, 53], ["decrease", "OBSERVATION_MODIFIER", 84, 92], ["unchanged", "OBSERVATION_MODIFIER", 152, 161]]], ["Exposure to chromium and antimony has a similar action on mESCs [97] .", [["mESCs", "ANATOMY", 58, 63], ["chromium", "CHEMICAL", 12, 20], ["antimony", "CHEMICAL", 25, 33], ["chromium", "CHEMICAL", 12, 20], ["antimony", "CHEMICAL", 25, 33], ["chromium", "SIMPLE_CHEMICAL", 12, 20], ["antimony", "SIMPLE_CHEMICAL", 25, 33], ["mESCs", "CELL", 58, 63], ["antimony", "TREATMENT", 25, 33]]], ["In the Central Zhejiang Province of China, children who live in the vicinity of waste incinerators and have elevated blood levels of chromium, cadmium, and lead show lower mean serum levels of 5mC and 5hmC and a higher mean level of percent tail DNA than children living in unpolluted areas.", [["blood", "ANATOMY", 117, 122], ["serum", "ANATOMY", 177, 182], ["tail", "ANATOMY", 241, 245], ["chromium", "CHEMICAL", 133, 141], ["cadmium", "CHEMICAL", 143, 150], ["chromium", "CHEMICAL", 133, 141], ["cadmium", "CHEMICAL", 143, 150], ["5mC", "CHEMICAL", 193, 196], ["children", "ORGANISM", 43, 51], ["blood", "ORGANISM_SUBSTANCE", 117, 122], ["chromium", "SIMPLE_CHEMICAL", 133, 141], ["cadmium", "SIMPLE_CHEMICAL", 143, 150], ["serum", "ORGANISM_SUBSTANCE", 177, 182], ["5mC", "SIMPLE_CHEMICAL", 193, 196], ["5hmC", "CELLULAR_COMPONENT", 201, 205], ["DNA", "CELLULAR_COMPONENT", 246, 249], ["children", "ORGANISM", 255, 263], ["children", "SPECIES", 43, 51], ["children", "SPECIES", 255, 263], ["elevated blood levels of chromium", "PROBLEM", 108, 141], ["lower mean serum levels", "TEST", 166, 189], ["5hmC", "TEST", 201, 205], ["Central", "ANATOMY_MODIFIER", 7, 14], ["unpolluted", "OBSERVATION", 274, 284]]], ["There is a sex difference in correlation with heavy metals in blood and epigenetic changes: in boys, chromium in blood is negatively correlated with 5mC, while cadmium in blood is positively correlated with 5mC and 5hmC; in girls, however, chromium in blood alone is negatively correlated with 5mC [102] .", [["blood", "ANATOMY", 62, 67], ["blood", "ANATOMY", 113, 118], ["blood", "ANATOMY", 171, 176], ["blood", "ANATOMY", 252, 257], ["metals", "CHEMICAL", 52, 58], ["chromium", "CHEMICAL", 101, 109], ["5mC", "CHEMICAL", 149, 152], ["cadmium", "CHEMICAL", 160, 167], ["chromium", "CHEMICAL", 240, 248], ["chromium", "CHEMICAL", 101, 109], ["5mC", "CHEMICAL", 149, 152], ["cadmium", "CHEMICAL", 160, 167], ["5mC", "CHEMICAL", 207, 210], ["5hmC", "CHEMICAL", 215, 219], ["chromium", "CHEMICAL", 240, 248], ["blood", "ORGANISM_SUBSTANCE", 62, 67], ["chromium", "SIMPLE_CHEMICAL", 101, 109], ["blood", "ORGANISM_SUBSTANCE", 113, 118], ["5mC", "SIMPLE_CHEMICAL", 149, 152], ["cadmium", "SIMPLE_CHEMICAL", 160, 167], ["blood", "ORGANISM_SUBSTANCE", 171, 176], ["5mC", "SIMPLE_CHEMICAL", 207, 210], ["5hmC", "SIMPLE_CHEMICAL", 215, 219], ["chromium", "SIMPLE_CHEMICAL", 240, 248], ["blood", "ORGANISM_SUBSTANCE", 252, 257], ["boys", "SPECIES", 95, 99], ["girls", "SPECIES", 224, 229], ["heavy metals in blood and epigenetic changes", "PROBLEM", 46, 90], ["cadmium in blood", "TEST", 160, 176]]], ["Mercury exposure in utero is associated with a decrease in 5hmC genomic content and an increase in the 5mC to 5hmC ratio in cord blood at birth and until the age of 5 years [103] .", [["cord blood", "ANATOMY", 124, 134], ["Mercury", "CHEMICAL", 0, 7], ["Mercury", "CHEMICAL", 0, 7], ["Mercury", "SIMPLE_CHEMICAL", 0, 7], ["5hmC", "SIMPLE_CHEMICAL", 59, 63], ["5hmC", "GENE_OR_GENE_PRODUCT", 110, 114], ["cord blood", "ORGANISM_SUBSTANCE", 124, 134], ["Mercury exposure in utero", "PROBLEM", 0, 25], ["a decrease in 5hmC genomic content", "PROBLEM", 45, 79], ["cord blood", "PROBLEM", 124, 134], ["decrease", "OBSERVATION_MODIFIER", 47, 55], ["5hmC genomic content", "OBSERVATION", 59, 79], ["increase", "OBSERVATION_MODIFIER", 87, 95], ["cord", "ANATOMY", 124, 128]]], ["Nickel inhibits TET-mediated 5mC oxidation in human embryonic lung fibroblasts cell culture (MRC5) and HEK293T cells as well as in mESCs and significantly reduces the global 5hmC level [104] .", [["embryonic lung fibroblasts cell culture", "ANATOMY", 52, 91], ["MRC5", "ANATOMY", 93, 97], ["HEK293T cells", "ANATOMY", 103, 116], ["mESCs", "ANATOMY", 131, 136], ["Nickel", "CHEMICAL", 0, 6], ["TET", "CHEMICAL", 16, 19], ["5mC", "CHEMICAL", 29, 32], ["Nickel", "CHEMICAL", 0, 6], ["5mC", "CHEMICAL", 29, 32], ["Nickel", "SIMPLE_CHEMICAL", 0, 6], ["TET", "SIMPLE_CHEMICAL", 16, 19], ["5mC", "SIMPLE_CHEMICAL", 29, 32], ["human", "ORGANISM", 46, 51], ["embryonic lung fibroblasts cell culture", "CELL", 52, 91], ["MRC5", "CELL", 93, 97], ["HEK293T cells", "CELL", 103, 116], ["mESCs", "CELL", 131, 136], ["5hmC", "CELLULAR_COMPONENT", 174, 178], ["human embryonic lung fibroblasts cell culture", "CELL_LINE", 46, 91], ["MRC5", "CELL_LINE", 93, 97], ["HEK293T cells", "CELL_LINE", 103, 116], ["mESCs", "CELL_TYPE", 131, 136], ["human", "SPECIES", 46, 51], ["human", "SPECIES", 46, 51], ["Nickel", "TREATMENT", 0, 6], ["TET-mediated 5mC oxidation", "TREATMENT", 16, 42], ["human embryonic lung fibroblasts cell culture", "TEST", 46, 91], ["MRC5", "TEST", 93, 97], ["HEK293T cells", "TEST", 103, 116], ["the global 5hmC level", "TEST", 163, 184], ["lung", "ANATOMY", 62, 66], ["fibroblasts cell", "OBSERVATION", 67, 83]]], ["Lead exposure alters hydroxymethylation patterns in CpG islands in hESCs and in the cord blood of newborns [105] .", [["hESCs", "ANATOMY", 67, 72], ["cord blood", "ANATOMY", 84, 94], ["Lead", "CHEMICAL", 0, 4], ["CpG", "CHEMICAL", 52, 55], ["hESCs", "CELL", 67, 72], ["cord blood", "ORGANISM_SUBSTANCE", 84, 94], ["CpG islands", "DNA", 52, 63], ["hESCs", "CELL_TYPE", 67, 72], ["Lead exposure alters hydroxymethylation patterns", "PROBLEM", 0, 48], ["CpG islands in hESCs", "PROBLEM", 52, 72], ["CpG islands", "OBSERVATION", 52, 63], ["cord", "ANATOMY", 84, 88]]], ["The epigenetic toxicity of other heavy metals is questionable and requires future in-depth research.Particulate Air PollutionThe relationship between particulate air pollution-a mixture of particles, ranging in diameter-and compromised health has been well documented; this includes a potential progression of respiratory and neurodevelopmental disorders and neurodegenerative diseases [106, 107] .", [["respiratory", "ANATOMY", 310, 321], ["toxicity", "DISEASE", 15, 23], ["respiratory and neurodevelopmental disorders", "DISEASE", 310, 354], ["neurodegenerative diseases", "DISEASE", 359, 385], ["Particulate Air Pollution", "PROBLEM", 100, 125], ["particulate air pollution", "PROBLEM", 150, 175], ["respiratory and neurodevelopmental disorders", "PROBLEM", 310, 354], ["neurodegenerative diseases", "PROBLEM", 359, 385], ["toxicity", "OBSERVATION_MODIFIER", 15, 23], ["Air Pollution", "OBSERVATION", 112, 125], ["particulate", "OBSERVATION_MODIFIER", 150, 161], ["air pollution", "OBSERVATION", 162, 175], ["particles", "OBSERVATION_MODIFIER", 189, 198], ["ranging", "OBSERVATION_MODIFIER", 200, 207], ["diameter", "OBSERVATION_MODIFIER", 211, 219], ["progression", "OBSERVATION_MODIFIER", 295, 306], ["respiratory", "ANATOMY", 310, 321], ["neurodevelopmental disorders", "OBSERVATION", 326, 354], ["neurodegenerative", "OBSERVATION_MODIFIER", 359, 376]]], ["Mechanisms for the neuronal pathology of fine particulate matter (PM 2.5 ) involve oxidative stress-mediated neurocytotoxicity and abnormal DNA hydroxymethylation increase at the genome level and in promoters of neural genes, including MeCP2, GRIN1, GABRB3, NRXN1, and NLGN3, as shown on SH-SY5Y human neuroblastoma cell line [108] .", [["neuronal", "ANATOMY", 19, 27], ["neural", "ANATOMY", 212, 218], ["SH-SY5Y human neuroblastoma cell line", "ANATOMY", 288, 325], ["neuronal", "CELL", 19, 27], ["DNA", "CELLULAR_COMPONENT", 140, 143], ["genome", "CELLULAR_COMPONENT", 179, 185], ["MeCP2", "GENE_OR_GENE_PRODUCT", 236, 241], ["GRIN1", "GENE_OR_GENE_PRODUCT", 243, 248], ["GABRB3", "GENE_OR_GENE_PRODUCT", 250, 256], ["NRXN1", "GENE_OR_GENE_PRODUCT", 258, 263], ["NLGN3", "GENE_OR_GENE_PRODUCT", 269, 274], ["SH-SY5Y human neuroblastoma cell line [108]", "CELL", 288, 331], ["promoters", "DNA", 199, 208], ["neural genes", "DNA", 212, 224], ["MeCP2", "DNA", 236, 241], ["GRIN1", "DNA", 243, 248], ["GABRB3", "DNA", 250, 256], ["NRXN1", "DNA", 258, 263], ["NLGN3", "DNA", 269, 274], ["SH-SY5Y human neuroblastoma cell line [108", "CELL_LINE", 288, 330], ["human", "SPECIES", 296, 301], ["human", "SPECIES", 296, 301], ["the neuronal pathology", "TEST", 15, 37], ["fine particulate matter", "PROBLEM", 41, 64], ["oxidative stress-mediated neurocytotoxicity", "PROBLEM", 83, 126], ["abnormal DNA hydroxymethylation", "PROBLEM", 131, 162], ["MeCP2", "TEST", 236, 241], ["GABRB3", "TREATMENT", 250, 256], ["NRXN1", "TREATMENT", 258, 263], ["DNA hydroxymethylation", "OBSERVATION", 140, 162], ["neural genes", "ANATOMY", 212, 224], ["neuroblastoma cell line", "OBSERVATION", 302, 325]]], ["Mice systematically exposed to concentrated ambient PM 2.5 showed a decrease in global 5hmC levels in lung and liver but not in kidney DNA, while DNA methylation in these organs remained unchanged [109] .", [["lung", "ANATOMY", 102, 106], ["liver", "ANATOMY", 111, 116], ["kidney", "ANATOMY", 128, 134], ["organs", "ANATOMY", 171, 177], ["Mice", "ORGANISM", 0, 4], ["5hmC", "GENE_OR_GENE_PRODUCT", 87, 91], ["lung", "ORGAN", 102, 106], ["liver", "ORGAN", 111, 116], ["kidney", "ORGAN", 128, 134], ["DNA", "CELLULAR_COMPONENT", 135, 138], ["DNA", "CELLULAR_COMPONENT", 146, 149], ["organs", "ORGAN", 171, 177], ["5hmC", "PROTEIN", 87, 91], ["kidney DNA", "DNA", 128, 138], ["Mice", "SPECIES", 0, 4], ["a decrease in global 5hmC levels in lung and liver", "PROBLEM", 66, 116], ["kidney DNA", "PROBLEM", 128, 138], ["DNA methylation in these organs", "PROBLEM", 146, 177], ["decrease", "OBSERVATION_MODIFIER", 68, 76], ["global", "OBSERVATION_MODIFIER", 80, 86], ["5hmC levels", "OBSERVATION", 87, 98], ["lung", "ANATOMY", 102, 106], ["liver", "ANATOMY", 111, 116], ["kidney", "ANATOMY", 128, 134], ["DNA", "OBSERVATION", 135, 138], ["unchanged", "OBSERVATION_MODIFIER", 187, 196]]], ["Interestingly, a longitudinal panel study enrolling 36 healthy college students in Shanghai, China, showed a decrease in methylation of angiotensin converting enzyme (ACE) and an increase in blood ACE levels concomitant with elevated blood pressure upon short-term exposure to PM 2.5 [110] .", [["blood", "ANATOMY", 191, 196], ["blood", "ANATOMY", 234, 239], ["angiotensin", "CHEMICAL", 136, 147], ["angiotensin converting enzyme", "GENE_OR_GENE_PRODUCT", 136, 165], ["ACE", "GENE_OR_GENE_PRODUCT", 167, 170], ["blood", "ORGANISM_SUBSTANCE", 191, 196], ["ACE", "GENE_OR_GENE_PRODUCT", 197, 200], ["blood", "ORGANISM_SUBSTANCE", 234, 239], ["angiotensin converting enzyme", "PROTEIN", 136, 165], ["ACE", "PROTEIN", 167, 170], ["a longitudinal panel study", "TEST", 15, 41], ["angiotensin converting enzyme", "TREATMENT", 136, 165], ["an increase", "PROBLEM", 176, 187], ["blood ACE levels", "TEST", 191, 207], ["elevated blood pressure", "PROBLEM", 225, 248], ["short-term exposure", "PROBLEM", 254, 273], ["decrease", "OBSERVATION_MODIFIER", 109, 117], ["increase", "OBSERVATION_MODIFIER", 179, 187], ["elevated", "OBSERVATION", 225, 233], ["pressure", "OBSERVATION_MODIFIER", 240, 248]]], ["In mice exposed to PM 2.5 through intratracheal instillation, an increase of pulmonary ACE production is accompanied by elevated angiotensin converting enzyme 2 (ACE2) level [111] .", [["pulmonary", "ANATOMY", 77, 86], ["angiotensin", "CHEMICAL", 129, 140], ["mice", "ORGANISM", 3, 7], ["intratracheal", "IMMATERIAL_ANATOMICAL_ENTITY", 34, 47], ["pulmonary", "ORGAN", 77, 86], ["ACE", "GENE_OR_GENE_PRODUCT", 87, 90], ["angiotensin converting enzyme 2", "GENE_OR_GENE_PRODUCT", 129, 160], ["ACE2", "GENE_OR_GENE_PRODUCT", 162, 166], ["ACE", "PROTEIN", 87, 90], ["angiotensin converting enzyme 2", "PROTEIN", 129, 160], ["ACE2", "PROTEIN", 162, 166], ["mice", "SPECIES", 3, 7], ["mice", "SPECIES", 3, 7], ["intratracheal instillation", "TREATMENT", 34, 60], ["pulmonary ACE production", "PROBLEM", 77, 101], ["elevated angiotensin converting enzyme", "PROBLEM", 120, 158], ["increase", "OBSERVATION_MODIFIER", 65, 73], ["pulmonary", "ANATOMY", 77, 86], ["ACE production", "OBSERVATION", 87, 101], ["elevated", "OBSERVATION_MODIFIER", 120, 128], ["angiotensin", "OBSERVATION", 129, 140]]], ["ACE2 is used for host cell entry by severe acute respiratory syndrome coronaviruses (SARS-CoVs) including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [112, 113] detected in Wuhan, China, in December 2019 and causing coronavirus disease 2019 (COVID-19) .", [["cell", "ANATOMY", 22, 26], ["acute respiratory syndrome coronaviruses", "DISEASE", 43, 83], ["SARS-CoVs", "DISEASE", 85, 94], ["acute respiratory syndrome coronavirus", "DISEASE", 113, 151], ["coronavirus disease", "DISEASE", 233, 252], ["ACE2", "GENE_OR_GENE_PRODUCT", 0, 4], ["host cell", "CELL", 17, 26], ["severe acute respiratory syndrome coronaviruses", "ORGANISM", 36, 83], ["SARS-CoVs", "ORGANISM", 85, 94], ["severe acute respiratory syndrome coronavirus 2", "ORGANISM", 106, 153], ["SARS-CoV-2", "ORGANISM", 155, 165], ["ACE2", "PROTEIN", 0, 4], ["severe acute respiratory syndrome coronaviruses", "SPECIES", 36, 83], ["SARS-CoVs", "SPECIES", 85, 94], ["severe acute respiratory syndrome coronavirus", "SPECIES", 106, 151], ["SARS-CoV-2", "SPECIES", 155, 165], ["ACE2", "TREATMENT", 0, 4], ["host cell entry", "TREATMENT", 17, 32], ["severe acute respiratory syndrome coronaviruses", "PROBLEM", 36, 83], ["SARS-CoVs)", "PROBLEM", 85, 95], ["severe acute respiratory syndrome coronavirus", "PROBLEM", 106, 151], ["SARS-CoV", "TEST", 155, 163], ["coronavirus disease", "PROBLEM", 233, 252], ["COVID", "TEST", 259, 264], ["severe", "OBSERVATION_MODIFIER", 36, 42], ["acute", "OBSERVATION_MODIFIER", 43, 48], ["respiratory syndrome", "OBSERVATION", 49, 69], ["severe", "OBSERVATION_MODIFIER", 106, 112], ["acute", "OBSERVATION_MODIFIER", 113, 118], ["respiratory syndrome", "OBSERVATION", 119, 139], ["coronavirus disease", "OBSERVATION", 233, 252]]], ["Recent studies demonstrated that ACE2 is epigenetically regulated and characterized by age and gender difference in DNA methylation in the respiratory system [114] .", [["ACE2", "GENE_OR_GENE_PRODUCT", 33, 37], ["DNA", "CELLULAR_COMPONENT", 116, 119], ["ACE2", "PROTEIN", 33, 37], ["Recent studies", "TEST", 0, 14], ["ACE2", "PROBLEM", 33, 37], ["DNA methylation in the respiratory system", "PROBLEM", 116, 157], ["respiratory system", "ANATOMY", 139, 157]]], ["Aberrant hypomethylation and overexpression of ACE2 in lupus patients may increase their susceptibility to SARS-CoV-2 infection and severity of COVID-19 [115] .", [["lupus", "DISEASE", 55, 60], ["SARS", "DISEASE", 107, 111], ["infection", "DISEASE", 118, 127], ["COVID-19", "CHEMICAL", 144, 152], ["ACE2", "GENE_OR_GENE_PRODUCT", 47, 51], ["patients", "ORGANISM", 61, 69], ["SARS-CoV-2", "ORGANISM", 107, 117], ["ACE2", "PROTEIN", 47, 51], ["patients", "SPECIES", 61, 69], ["SARS-CoV", "SPECIES", 107, 115], ["Aberrant hypomethylation", "PROBLEM", 0, 24], ["ACE2 in lupus", "PROBLEM", 47, 60], ["SARS", "TEST", 107, 111], ["CoV", "TEST", 112, 115], ["2 infection", "PROBLEM", 116, 127], ["COVID", "TEST", 144, 149], ["hypomethylation", "OBSERVATION", 9, 24], ["overexpression", "OBSERVATION_MODIFIER", 29, 43], ["lupus", "OBSERVATION", 55, 60]]], ["Although direct evidence of 5hmC involvement into ACE2 regulation by environmental and other factors is to be found, the existing data strongly suggest that DNA methylation/demethylation control of the ACE2 gene, especially in persons exposed to certain hazards, should be considered as a possible approach for COVID-19 prevention and treatment.Particulate Air PollutionPM 10 exposure causes a decrease in 5mC and an increase in 5hmC levels in human peripheral blood mononuclear cells in vitro [116] .", [["peripheral blood mononuclear cells", "ANATOMY", 450, 484], ["PollutionPM", "CHEMICAL", 361, 372], ["5hmC", "GENE_OR_GENE_PRODUCT", 28, 32], ["ACE2", "GENE_OR_GENE_PRODUCT", 50, 54], ["DNA", "CELLULAR_COMPONENT", 157, 160], ["ACE2", "GENE_OR_GENE_PRODUCT", 202, 206], ["5mC", "SIMPLE_CHEMICAL", 406, 409], ["5hmC", "SIMPLE_CHEMICAL", 429, 433], ["human", "ORGANISM", 444, 449], ["peripheral blood mononuclear cells", "CELL", 450, 484], ["5hmC", "PROTEIN", 28, 32], ["ACE2", "PROTEIN", 50, 54], ["ACE2 gene", "DNA", 202, 211], ["5hmC", "PROTEIN", 429, 433], ["human peripheral blood mononuclear cells", "CELL_TYPE", 444, 484], ["persons", "SPECIES", 227, 234], ["human", "SPECIES", 444, 449], ["human", "SPECIES", 444, 449], ["5hmC involvement into ACE2 regulation", "PROBLEM", 28, 65], ["DNA methylation/demethylation control", "TREATMENT", 157, 194], ["the ACE2 gene", "TREATMENT", 198, 211], ["COVID-19 prevention", "TREATMENT", 311, 330], ["treatment", "TREATMENT", 335, 344], ["Particulate Air PollutionPM", "PROBLEM", 345, 372], ["a decrease in 5mC", "PROBLEM", 392, 409], ["an increase in 5hmC levels", "PROBLEM", 414, 440], ["human peripheral blood mononuclear cells", "TREATMENT", 444, 484], ["decrease", "OBSERVATION_MODIFIER", 394, 402], ["increase", "OBSERVATION_MODIFIER", 417, 425]]], ["In office workers and truck drivers, ambient PM 10 exposure is positively correlated with blood 5hmC, but not 5mC-most probably due to the generation of reactive oxygen species, which can stimulate oxidation of 5mC into 5hmC [117] .", [["blood", "ANATOMY", 90, 95], ["5hmC", "CHEMICAL", 96, 100], ["5mC", "CHEMICAL", 110, 113], ["oxygen", "CHEMICAL", 162, 168], ["5mC", "CHEMICAL", 211, 214], ["5hmC", "CHEMICAL", 220, 224], ["5hmC", "CHEMICAL", 96, 100], ["5mC", "CHEMICAL", 110, 113], ["oxygen", "CHEMICAL", 162, 168], ["5mC", "CHEMICAL", 211, 214], ["5hmC", "CHEMICAL", 220, 224], ["blood", "ORGANISM_SUBSTANCE", 90, 95], ["5hmC", "SIMPLE_CHEMICAL", 96, 100], ["5mC", "SIMPLE_CHEMICAL", 110, 113], ["reactive oxygen species", "SIMPLE_CHEMICAL", 153, 176], ["5mC", "SIMPLE_CHEMICAL", 211, 214], ["blood 5hmC", "TEST", 90, 100], ["reactive oxygen species", "TREATMENT", 153, 176], ["reactive oxygen species", "OBSERVATION", 153, 176]]], ["In contrast, buccal cells demonstrate a decrease both in 5hmC and 5mC upon exposure to ambient PM 2.5 and PM 10 levels [118] .", [["buccal cells", "ANATOMY", 13, 25], ["5hmC", "CHEMICAL", 57, 61], ["5mC", "CHEMICAL", 66, 69], ["5mC", "CHEMICAL", 66, 69], ["buccal cells", "CELL", 13, 25], ["5hmC", "CELLULAR_COMPONENT", 57, 61], ["5mC", "SIMPLE_CHEMICAL", 66, 69], ["buccal cells", "CELL_TYPE", 13, 25], ["a decrease both in 5hmC", "PROBLEM", 38, 61], ["ambient PM", "TEST", 87, 97], ["buccal cells", "ANATOMY", 13, 25], ["decrease", "OBSERVATION_MODIFIER", 40, 48]]], ["The aforementioned data indicate that particulate air pollution has significant genome-wide and gene-specific epigenetic effects resulting in altered gene function and thus mediating development of different disorders.Bisphenol ABPA or 4,4 -dihydroxy-2,2-diphenylpropane is one of the highest volume chemicals produced worldwide.", [["Bisphenol", "CHEMICAL", 218, 227], ["ABPA", "DISEASE", 228, 232], ["4,4 -dihydroxy-2,2-diphenylpropane", "CHEMICAL", 236, 270], ["Bisphenol", "CHEMICAL", 218, 227], ["4,4 -dihydroxy-2,2-diphenylpropane", "CHEMICAL", 236, 270], ["Bisphenol ABPA", "SIMPLE_CHEMICAL", 218, 232], ["4,4 -dihydroxy-2,2-diphenylpropane", "SIMPLE_CHEMICAL", 236, 270], ["particulate air pollution", "PROBLEM", 38, 63], ["significant genome-wide and gene-specific epigenetic effects", "PROBLEM", 68, 128], ["altered gene function", "PROBLEM", 142, 163], ["different disorders", "PROBLEM", 198, 217], ["Bisphenol ABPA", "TEST", 218, 232], ["dihydroxy", "TREATMENT", 241, 250], ["diphenylpropane", "TREATMENT", 255, 270], ["particulate", "OBSERVATION_MODIFIER", 38, 49], ["air pollution", "OBSERVATION", 50, 63], ["significant", "OBSERVATION_MODIFIER", 68, 79], ["wide", "OBSERVATION_MODIFIER", 87, 91], ["epigenetic effects", "OBSERVATION", 110, 128], ["altered", "OBSERVATION_MODIFIER", 142, 149], ["gene function", "OBSERVATION", 150, 163]]], ["BPA is a plastic monomer and plasticizer used in the production of polycarbonate plastics and epoxy resins, which are components of many consumer products including metal jar lids, food-contact surface lacquer coatings for cans, protective coatings and finishes, automobile parts, adhesives, food packaging, and plastic bottles.", [["surface", "ANATOMY", 194, 201], ["BPA", "CHEMICAL", 0, 3], ["BPA", "CHEMICAL", 0, 3], ["polycarbonate", "CHEMICAL", 67, 80], ["epoxy", "CHEMICAL", 94, 99], ["BPA", "SIMPLE_CHEMICAL", 0, 3], ["polycarbonate plastics", "SIMPLE_CHEMICAL", 67, 89], ["epoxy resins", "SIMPLE_CHEMICAL", 94, 106], ["a plastic monomer and plasticizer", "TREATMENT", 7, 40], ["polycarbonate plastics", "TREATMENT", 67, 89], ["epoxy resins", "TREATMENT", 94, 106], ["metal jar lids", "TREATMENT", 165, 179], ["contact surface lacquer coatings", "TREATMENT", 186, 218], ["protective coatings", "TREATMENT", 229, 248], ["adhesives", "TREATMENT", 281, 290], ["plastic monomer", "OBSERVATION", 9, 24], ["epoxy resins", "OBSERVATION", 94, 106]]], ["BPA is ubiquitous in the environment, as it is released from polycarbonate plastics and epoxy resins during sterilization, autoclaving, and re-heating.", [["BPA", "CHEMICAL", 0, 3], ["epoxy resins", "CHEMICAL", 88, 100], ["BPA", "CHEMICAL", 0, 3], ["polycarbonate", "CHEMICAL", 61, 74], ["epoxy", "CHEMICAL", 88, 93], ["BPA", "SIMPLE_CHEMICAL", 0, 3], ["polycarbonate plastics", "TREATMENT", 61, 83], ["epoxy resins", "TREATMENT", 88, 100], ["sterilization", "TREATMENT", 108, 121], ["autoclaving", "TREATMENT", 123, 134], ["ubiquitous", "OBSERVATION_MODIFIER", 7, 17], ["epoxy resins", "OBSERVATION", 88, 100]]], ["BPA is a toxin known to exert low estrogen activity [119] .", [["BPA", "CHEMICAL", 0, 3], ["estrogen", "CHEMICAL", 34, 42], ["BPA", "CHEMICAL", 0, 3], ["estrogen", "CHEMICAL", 34, 42], ["BPA", "SIMPLE_CHEMICAL", 0, 3], ["estrogen", "SIMPLE_CHEMICAL", 34, 42], ["a toxin", "PROBLEM", 7, 14], ["low estrogen activity", "PROBLEM", 30, 51]]], ["In mice, high-dose BPA exposure increased fetal loss, whereas low-dose exposure can cause long-term disrupting effects on sexual differentiation, brain development, immune system, and behavior [120, 121] .", [["fetal", "ANATOMY", 42, 47], ["brain", "ANATOMY", 146, 151], ["immune system", "ANATOMY", 165, 178], ["BPA", "CHEMICAL", 19, 22], ["fetal loss", "DISEASE", 42, 52], ["BPA", "CHEMICAL", 19, 22], ["mice", "ORGANISM", 3, 7], ["BPA", "SIMPLE_CHEMICAL", 19, 22], ["fetal", "DEVELOPING_ANATOMICAL_STRUCTURE", 42, 47], ["brain", "ORGAN", 146, 151], ["mice", "SPECIES", 3, 7], ["mice", "SPECIES", 3, 7], ["high-dose BPA exposure", "TREATMENT", 9, 31], ["fetal loss", "PROBLEM", 42, 52], ["long-term disrupting effects", "PROBLEM", 90, 118], ["increased", "OBSERVATION_MODIFIER", 32, 41], ["fetal loss", "OBSERVATION", 42, 52]]], ["BPA exposure can have a transgenerational effect [122, 123] .", [["BPA", "CHEMICAL", 0, 3], ["BPA", "CHEMICAL", 0, 3], ["BPA", "SIMPLE_CHEMICAL", 0, 3]]], ["In humans, BPA exposure can induce diabetes mellitus, cardiovascular diseases, obesity, deterioration of sperm quality, and increased risk of reproductive losses [124] [125] [126] [127] .Bisphenol AA few papers report specific BPA-induced alterations in DNA hydroxymethylation patterns in human sperm cells.", [["cardiovascular", "ANATOMY", 54, 68], ["sperm", "ANATOMY", 105, 110], ["sperm cells", "ANATOMY", 295, 306], ["BPA", "CHEMICAL", 11, 14], ["diabetes mellitus", "DISEASE", 35, 52], ["cardiovascular diseases", "DISEASE", 54, 77], ["obesity", "DISEASE", 79, 86], ["Bisphenol AA", "CHEMICAL", 187, 199], ["BPA", "CHEMICAL", 227, 230], ["BPA", "CHEMICAL", 11, 14], ["Bisphenol AA", "CHEMICAL", 187, 199], ["BPA", "CHEMICAL", 227, 230], ["humans", "ORGANISM", 3, 9], ["BPA", "SIMPLE_CHEMICAL", 11, 14], ["cardiovascular", "ANATOMICAL_SYSTEM", 54, 68], ["sperm", "ORGANISM_SUBSTANCE", 105, 110], ["Bisphenol AA", "SIMPLE_CHEMICAL", 187, 199], ["BPA", "SIMPLE_CHEMICAL", 227, 230], ["DNA", "CELLULAR_COMPONENT", 254, 257], ["human", "ORGANISM", 289, 294], ["sperm cells", "CELL", 295, 306], ["human sperm cells", "CELL_TYPE", 289, 306], ["humans", "SPECIES", 3, 9], ["human", "SPECIES", 289, 294], ["humans", "SPECIES", 3, 9], ["human", "SPECIES", 289, 294], ["diabetes mellitus", "PROBLEM", 35, 52], ["cardiovascular diseases", "PROBLEM", 54, 77], ["obesity", "PROBLEM", 79, 86], ["deterioration of sperm quality", "PROBLEM", 88, 118], ["reproductive losses", "PROBLEM", 142, 161], ["induced alterations", "PROBLEM", 231, 250], ["DNA hydroxymethylation patterns in human sperm cells", "TREATMENT", 254, 306], ["obesity", "OBSERVATION", 79, 86], ["increased", "OBSERVATION_MODIFIER", 124, 133], ["human sperm cells", "OBSERVATION", 289, 306]]], ["Workers in factories manufacturing BPA showed increased total 5hmC and LINE-1 hydroxymethylation levels in sperm cells [128, 129] .", [["sperm cells", "ANATOMY", 107, 118], ["BPA", "CHEMICAL", 35, 38], ["BPA", "CHEMICAL", 35, 38], ["BPA", "SIMPLE_CHEMICAL", 35, 38], ["5hmC", "SIMPLE_CHEMICAL", 62, 66], ["LINE-1", "GENE_OR_GENE_PRODUCT", 71, 77], ["sperm cells", "CELL", 107, 118], ["LINE", "DNA", 71, 75], ["sperm cells", "CELL_TYPE", 107, 118], ["increased total 5hmC", "TREATMENT", 46, 66], ["LINE-1 hydroxymethylation levels", "TEST", 71, 103], ["sperm cells", "TEST", 107, 118]]], ["Moreover, BPA-exposed individuals contained in sperm DNA 8670 hyper-hydroxymethylated regions and 940 hypo-hydroxymethylated regions affecting genes associated with the nervous system, development, cardiovascular diseases and signal transduction, some maternally expressed imprinted genes, and sperm-expressed genes, including ACHE gene [128, 130] .Bisphenol APerinatal BPA exposure alters DNA hydroxymethylation patterns in 5950 regions, including 12 regions annotated to imprinted genes (Gnas, Grb10, Plagl1, Klf14, Pde10a, Snrpn, Airn, Cmah, Ppp1r9a, Kcnq1, Phactr2, and Pde4d) in mouse blood; these changes persist throughout adulthood, indicating longitudinal effects of BPA on 5hmC [131] .", [["sperm", "ANATOMY", 47, 52], ["nervous system", "ANATOMY", 169, 183], ["cardiovascular", "ANATOMY", 198, 212], ["sperm", "ANATOMY", 294, 299], ["blood", "ANATOMY", 590, 595], ["BPA", "CHEMICAL", 10, 13], ["cardiovascular diseases", "DISEASE", 198, 221], ["Bisphenol", "CHEMICAL", 349, 358], ["BPA", "CHEMICAL", 370, 373], ["BPA", "CHEMICAL", 676, 679], ["5hmC", "CHEMICAL", 683, 687], ["BPA", "CHEMICAL", 10, 13], ["Bisphenol", "CHEMICAL", 349, 358], ["BPA", "CHEMICAL", 370, 373], ["BPA", "CHEMICAL", 676, 679], ["5hmC", "CHEMICAL", 683, 687], ["BPA", "SIMPLE_CHEMICAL", 10, 13], ["sperm DNA", "CELLULAR_COMPONENT", 47, 56], ["nervous system", "ANATOMICAL_SYSTEM", 169, 183], ["cardiovascular", "ANATOMICAL_SYSTEM", 198, 212], ["sperm", "CELLULAR_COMPONENT", 294, 299], ["ACHE", "GENE_OR_GENE_PRODUCT", 327, 331], ["Bisphenol APerinatal BPA", "SIMPLE_CHEMICAL", 349, 373], ["DNA", "CELLULAR_COMPONENT", 390, 393], ["Gnas", "GENE_OR_GENE_PRODUCT", 490, 494], ["Grb10", "GENE_OR_GENE_PRODUCT", 496, 501], ["Plagl1", "GENE_OR_GENE_PRODUCT", 503, 509], ["Klf14", "GENE_OR_GENE_PRODUCT", 511, 516], ["Pde10a", "GENE_OR_GENE_PRODUCT", 518, 524], ["Snrpn", "GENE_OR_GENE_PRODUCT", 526, 531], ["Airn", "GENE_OR_GENE_PRODUCT", 533, 537], ["Cmah", "GENE_OR_GENE_PRODUCT", 539, 543], ["Ppp1r9a", "GENE_OR_GENE_PRODUCT", 545, 552], ["Kcnq1", "GENE_OR_GENE_PRODUCT", 554, 559], ["Phactr2", "GENE_OR_GENE_PRODUCT", 561, 568], ["Pde4d", "GENE_OR_GENE_PRODUCT", 574, 579], ["mouse", "ORGANISM", 584, 589], ["blood", "ORGANISM_SUBSTANCE", 590, 595], ["BPA", "SIMPLE_CHEMICAL", 676, 679], ["sperm DNA 8670 hyper-hydroxymethylated regions", "DNA", 47, 93], ["940 hypo-hydroxymethylated regions", "DNA", 98, 132], ["maternally expressed imprinted genes", "DNA", 252, 288], ["sperm-expressed genes", "DNA", 294, 315], ["ACHE gene", "DNA", 327, 336], ["5950 regions", "DNA", 425, 437], ["imprinted genes", "DNA", 473, 488], ["Gnas", "DNA", 490, 494], ["Grb10", "DNA", 496, 501], ["Plagl1", "DNA", 503, 509], ["Klf14", "DNA", 511, 516], ["Pde10a", "DNA", 518, 524], ["Snrpn", "DNA", 526, 531], ["Airn", "DNA", 533, 537], ["Cmah", "DNA", 539, 543], ["Ppp1r9a", "DNA", 545, 552], ["Kcnq1", "DNA", 554, 559], ["Phactr2", "DNA", 561, 568], ["Pde4d", "DNA", 574, 579], ["mouse", "SPECIES", 584, 589], ["mouse", "SPECIES", 584, 589], ["BPA", "TEST", 10, 13], ["exposed individuals", "PROBLEM", 14, 33], ["sperm DNA", "TEST", 47, 56], ["hyper-hydroxymethylated regions", "PROBLEM", 62, 93], ["hypo-hydroxymethylated regions", "PROBLEM", 102, 132], ["the nervous system", "PROBLEM", 165, 183], ["cardiovascular diseases", "PROBLEM", 198, 221], ["signal transduction", "PROBLEM", 226, 245], ["Bisphenol APerinatal BPA exposure", "TREATMENT", 349, 382], ["DNA hydroxymethylation patterns", "TREATMENT", 390, 421], ["Gnas", "TEST", 490, 494], ["Grb10", "TEST", 496, 501], ["Plagl1", "TEST", 503, 509], ["Klf14", "TEST", 511, 516], ["Pde10a", "TEST", 518, 524], ["Snrpn", "TEST", 526, 531], ["Airn", "TEST", 533, 537], ["Cmah", "TEST", 539, 543], ["Ppp1r9a", "TEST", 545, 552], ["Kcnq1", "TEST", 554, 559], ["Phactr2", "TREATMENT", 561, 568], ["mouse blood", "PROBLEM", 584, 595], ["cardiovascular", "ANATOMY", 198, 212], ["diseases", "OBSERVATION", 213, 221]]], ["Perinatal BPA exposure increases Kcnq1 expression in the brains of adult mice, as well as reprograms expression of epigenetic writers Dnmt1 and Tet2 [132] .", [["brains", "ANATOMY", 57, 63], ["BPA", "CHEMICAL", 10, 13], ["BPA", "CHEMICAL", 10, 13], ["BPA", "SIMPLE_CHEMICAL", 10, 13], ["Kcnq1", "GENE_OR_GENE_PRODUCT", 33, 38], ["brains", "ORGAN", 57, 63], ["mice", "ORGANISM", 73, 77], ["Dnmt1", "GENE_OR_GENE_PRODUCT", 134, 139], ["Tet2 [132]", "GENE_OR_GENE_PRODUCT", 144, 154], ["Kcnq1", "PROTEIN", 33, 38], ["Dnmt1", "PROTEIN", 134, 139], ["Tet2", "PROTEIN", 144, 148], ["mice", "SPECIES", 73, 77], ["mice", "SPECIES", 73, 77], ["Perinatal BPA exposure", "PROBLEM", 0, 22]]], ["However, 5hmC and 5mC enrichment in Kcnq1 is not affected by BPA, suggesting that alterations in Kcnq1, Dnmt1, and Tet2 expression are not linked to epigenetic changes in this locus [132] .", [["BPA", "CHEMICAL", 61, 64], ["5hmC", "CHEMICAL", 9, 13], ["5mC", "CHEMICAL", 18, 21], ["BPA", "CHEMICAL", 61, 64], ["5hmC", "CELLULAR_COMPONENT", 9, 13], ["5mC", "SIMPLE_CHEMICAL", 18, 21], ["Kcnq1", "GENE_OR_GENE_PRODUCT", 36, 41], ["BPA", "SIMPLE_CHEMICAL", 61, 64], ["Kcnq1", "GENE_OR_GENE_PRODUCT", 97, 102], ["Dnmt1", "GENE_OR_GENE_PRODUCT", 104, 109], ["Tet2", "GENE_OR_GENE_PRODUCT", 115, 119], ["5hmC", "PROTEIN", 9, 13], ["5mC", "PROTEIN", 18, 21], ["Kcnq1", "PROTEIN", 36, 41], ["Kcnq1", "PROTEIN", 97, 102], ["Dnmt1", "PROTEIN", 104, 109], ["Tet2", "PROTEIN", 115, 119], ["5hmC", "PROBLEM", 9, 13], ["5mC enrichment in Kcnq1", "TREATMENT", 18, 41], ["alterations in Kcnq1", "PROBLEM", 82, 102], ["Tet2 expression", "PROBLEM", 115, 130]]], ["In human estrogen-receptor positive breast cancer cells, BPA represses TET2 expression, reduces TET2 protein production and decreases DNA hydroxymethylation, indicating the involvement of the epigenetic pathway in the BPA-mediated tumor cell proliferation [133] .HydroquinoneHydroquinone is a metabolite of benzene-an environmental toxicant found in cigarette smoke and petroleum products.", [["estrogen-receptor positive breast cancer cells", "ANATOMY", 9, 55], ["tumor cell", "ANATOMY", 231, 241], ["estrogen", "CHEMICAL", 9, 17], ["breast cancer", "DISEASE", 36, 49], ["BPA", "CHEMICAL", 57, 60], ["BPA", "CHEMICAL", 218, 221], ["tumor", "DISEASE", 231, 236], ["Hydroquinone", "CHEMICAL", 263, 275], ["Hydroquinone", "CHEMICAL", 275, 287], ["benzene", "CHEMICAL", 307, 314], ["estrogen", "CHEMICAL", 9, 17], ["BPA", "CHEMICAL", 57, 60], ["BPA", "CHEMICAL", 218, 221], ["Hydroquinone", "CHEMICAL", 263, 275], ["Hydroquinone", "CHEMICAL", 275, 287], ["benzene", "CHEMICAL", 307, 314], ["human", "ORGANISM", 3, 8], ["estrogen-receptor", "GENE_OR_GENE_PRODUCT", 9, 26], ["BPA", "SIMPLE_CHEMICAL", 57, 60], ["TET2", "GENE_OR_GENE_PRODUCT", 71, 75], ["TET2", "GENE_OR_GENE_PRODUCT", 96, 100], ["DNA", "CELLULAR_COMPONENT", 134, 137], ["BPA", "SIMPLE_CHEMICAL", 218, 221], ["tumor cell", "CELL", 231, 241], ["Hydroquinone", "SIMPLE_CHEMICAL", 263, 275], ["Hydroquinone", "SIMPLE_CHEMICAL", 275, 287], ["benzene", "SIMPLE_CHEMICAL", 307, 314], ["cigarette", "ORGANISM", 350, 359], ["petroleum products", "SIMPLE_CHEMICAL", 370, 388], ["human estrogen-receptor positive breast cancer cells", "CELL_TYPE", 3, 55], ["TET2", "PROTEIN", 71, 75], ["TET2", "PROTEIN", 96, 100], ["human", "SPECIES", 3, 8], ["human", "SPECIES", 3, 8], ["human estrogen", "TEST", 3, 17], ["receptor positive breast cancer cells", "PROBLEM", 18, 55], ["TET2 expression", "PROBLEM", 71, 86], ["TET2 protein production", "PROBLEM", 96, 119], ["DNA hydroxymethylation", "TREATMENT", 134, 156], ["mediated tumor cell proliferation", "PROBLEM", 222, 255], ["HydroquinoneHydroquinone", "TREATMENT", 263, 287], ["a metabolite of benzene", "PROBLEM", 291, 314], ["breast", "ANATOMY", 36, 42], ["cancer cells", "OBSERVATION", 43, 55], ["tumor cell proliferation", "OBSERVATION", 231, 255], ["cigarette smoke", "OBSERVATION", 350, 365], ["petroleum products", "OBSERVATION", 370, 388]]], ["In HEK293T cells, hydroquinone exposure promotes the generation of reactive oxygen species and enhances TET1 activity with a decrease in global 5mC and an increase in global 5hmC [134] .Pentachlorophenol metabolitesPentachlorophenol (PCP) is widely used in wood protection as a bactericide, fungicide, molluscicide, herbicide, algaecide, and insecticide.Pentachlorophenol metabolitesPCP is resistant to degradation and persists in soil and water systems for up to several months.Pentachlorophenol metabolitesThe International Agency for Research on Cancer classifies PCP as a B2 carcinogen (possibly carcinogenic to humans).", [["HEK293T cells", "ANATOMY", 3, 16], ["wood", "ANATOMY", 257, 261], ["Cancer", "ANATOMY", 549, 555], ["hydroquinone", "CHEMICAL", 18, 30], ["oxygen", "CHEMICAL", 76, 82], ["Pentachlorophenol", "CHEMICAL", 186, 203], ["Pentachlorophenol", "CHEMICAL", 215, 232], ["PCP", "CHEMICAL", 234, 237], ["fungicide", "CHEMICAL", 291, 300], ["molluscicide", "CHEMICAL", 302, 314], ["herbicide", "CHEMICAL", 316, 325], ["algaecide", "CHEMICAL", 327, 336], ["Pentachlorophenol", "CHEMICAL", 354, 371], ["metabolitesPCP", "CHEMICAL", 372, 386], ["Pentachlorophenol", "CHEMICAL", 479, 496], ["Cancer", "DISEASE", 549, 555], ["PCP", "DISEASE", 567, 570], ["hydroquinone", "CHEMICAL", 18, 30], ["oxygen", "CHEMICAL", 76, 82], ["Pentachlorophenol", "CHEMICAL", 186, 203], ["Pentachlorophenol", "CHEMICAL", 215, 232], ["PCP", "CHEMICAL", 234, 237], ["molluscicide", "CHEMICAL", 302, 314], ["algaecide", "CHEMICAL", 327, 336], ["Pentachlorophenol", "CHEMICAL", 354, 371], ["Pentachlorophenol", "CHEMICAL", 479, 496], ["PCP", "CHEMICAL", 567, 570], ["HEK293T cells", "CELL", 3, 16], ["hydroquinone", "SIMPLE_CHEMICAL", 18, 30], ["reactive oxygen species", "SIMPLE_CHEMICAL", 67, 90], ["TET1", "GENE_OR_GENE_PRODUCT", 104, 108], ["Pentachlorophenol", "SIMPLE_CHEMICAL", 186, 203], ["Pentachlorophenol", "SIMPLE_CHEMICAL", 215, 232], ["PCP", "SIMPLE_CHEMICAL", 234, 237], ["wood", "ORGANISM_SUBDIVISION", 257, 261], ["bactericide", "SIMPLE_CHEMICAL", 278, 289], ["fungicide", "SIMPLE_CHEMICAL", 291, 300], ["molluscicide", "SIMPLE_CHEMICAL", 302, 314], ["herbicide", "SIMPLE_CHEMICAL", 316, 325], ["algaecide", "SIMPLE_CHEMICAL", 327, 336], ["Pentachlorophenol", "SIMPLE_CHEMICAL", 354, 371], ["Pentachlorophenol", "SIMPLE_CHEMICAL", 479, 496], ["Cancer", "CANCER", 549, 555], ["humans", "ORGANISM", 616, 622], ["HEK293T cells", "CELL_LINE", 3, 16], ["TET1", "PROTEIN", 104, 108], ["humans", "SPECIES", 616, 622], ["humans", "SPECIES", 616, 622], ["hydroquinone exposure", "TREATMENT", 18, 39], ["reactive oxygen species", "TREATMENT", 67, 90], ["TET1 activity", "PROBLEM", 104, 117], ["a decrease in global 5mC", "PROBLEM", 123, 147], ["an increase in global 5hmC", "PROBLEM", 152, 178], ["Pentachlorophenol metabolites", "TEST", 186, 215], ["Pentachlorophenol (PCP)", "TREATMENT", 215, 238], ["a bactericide", "TREATMENT", 276, 289], ["fungicide", "TREATMENT", 291, 300], ["molluscicide", "TREATMENT", 302, 314], ["herbicide", "TREATMENT", 316, 325], ["algaecide", "TREATMENT", 327, 336], ["insecticide", "TREATMENT", 342, 353], ["Pentachlorophenol metabolitesPCP", "PROBLEM", 354, 386], ["Pentachlorophenol metabolites", "TEST", 479, 508], ["a B2 carcinogen", "TREATMENT", 574, 589], ["HEK293T cells", "OBSERVATION", 3, 16], ["hydroquinone exposure", "OBSERVATION", 18, 39], ["reactive", "OBSERVATION_MODIFIER", 67, 75], ["oxygen species", "OBSERVATION", 76, 90], ["decrease", "OBSERVATION_MODIFIER", 125, 133], ["increase", "OBSERVATION_MODIFIER", 155, 163], ["resistant", "OBSERVATION_MODIFIER", 390, 399]]], ["Tetrachlorohydroquinone and tetrachloro-1,4-benzoquinone are two reactive metabolites of PCP playing a central role in its genotoxicity [135] .", [["Tetrachlorohydroquinone", "CHEMICAL", 0, 23], ["tetrachloro-1,4-benzoquinone", "CHEMICAL", 28, 56], ["PCP", "CHEMICAL", 89, 92], ["Tetrachlorohydroquinone", "CHEMICAL", 0, 23], ["tetrachloro-1,4-benzoquinone", "CHEMICAL", 28, 56], ["PCP", "CHEMICAL", 89, 92], ["Tetrachlorohydroquinone", "SIMPLE_CHEMICAL", 0, 23], ["tetrachloro-1,4-benzoquinone", "SIMPLE_CHEMICAL", 28, 56], ["PCP", "SIMPLE_CHEMICAL", 89, 92], ["Tetrachlorohydroquinone", "TREATMENT", 0, 23], ["tetrachloro", "TREATMENT", 28, 39], ["benzoquinone", "TREATMENT", 44, 56]]], ["Both compounds are redox-active quinones that induce a 5hmC increase in lung adenocarcinoma (A549), HepG2, MRC5 cells, and mESCs [67, 136] .", [["lung adenocarcinoma", "ANATOMY", 72, 91], ["A549", "ANATOMY", 93, 97], ["HepG2", "ANATOMY", 100, 105], ["MRC5 cells", "ANATOMY", 107, 117], ["mESCs", "ANATOMY", 123, 128], ["lung adenocarcinoma", "DISEASE", 72, 91], ["quinones", "CHEMICAL", 32, 40], ["quinones", "SIMPLE_CHEMICAL", 32, 40], ["lung adenocarcinoma", "CANCER", 72, 91], ["A549", "CELL", 93, 97], ["HepG2", "CELL", 100, 105], ["MRC5 cells", "CELL", 107, 117], ["mESCs", "CELL", 123, 128], ["A549", "CELL_LINE", 93, 97], ["HepG2", "CELL_LINE", 100, 105], ["MRC5 cells", "CELL_LINE", 107, 117], ["mESCs", "CELL_LINE", 123, 128], ["active quinones", "PROBLEM", 25, 40], ["a 5hmC increase in lung adenocarcinoma", "PROBLEM", 53, 91], ["HepG2, MRC5 cells", "TEST", 100, 117], ["mESCs", "TEST", 123, 128], ["increase", "OBSERVATION_MODIFIER", 60, 68], ["lung", "ANATOMY", 72, 76], ["adenocarcinoma", "OBSERVATION", 77, 91], ["MRC5 cells", "OBSERVATION", 107, 117]]], ["The tetrachloro-1,4-benzoquinone-induced increase of hydroxymethylation in MRC5 cells affects 5751 genes and alters the expression in 3414 of them, including those related to the apoptosis signaling pathway [67] .", [["MRC5 cells", "ANATOMY", 75, 85], ["tetrachloro-1,4-benzoquinone", "CHEMICAL", 4, 32], ["tetrachloro-1,4-benzoquinone", "CHEMICAL", 4, 32], ["tetrachloro-1,4-benzoquinone", "SIMPLE_CHEMICAL", 4, 32], ["MRC5 cells", "CELL", 75, 85], ["MRC5 cells", "CELL_LINE", 75, 85], ["5751 genes", "DNA", 94, 104], ["The tetrachloro", "TEST", 0, 15], ["benzoquinone", "TREATMENT", 20, 32], ["hydroxymethylation in MRC5 cells", "TREATMENT", 53, 85]]], ["The mechanism of action of quinones involves the ability to increase the cellular level of Fe(II) which stimulates the enzymatic activity of TET proteins, thus promoting the oxidation of 5mC to 5hmC [67, 136] .Pentachlorophenol metabolitesThe data on 5hmC changes upon exposure to the aforementioned hypnotics, medications, and anthropogenic pollutants are summarized in Table 1 .", [["cellular", "ANATOMY", 73, 81], ["quinones", "CHEMICAL", 27, 35], ["Fe(II", "CHEMICAL", 91, 96], ["TET", "CHEMICAL", 141, 144], ["Pentachlorophenol", "CHEMICAL", 210, 227], ["quinones", "CHEMICAL", 27, 35], ["Fe(II)", "CHEMICAL", 91, 97], ["5mC", "CHEMICAL", 187, 190], ["5hmC", "CHEMICAL", 194, 198], ["Pentachlorophenol", "CHEMICAL", 210, 227], ["quinones", "SIMPLE_CHEMICAL", 27, 35], ["cellular", "CELL", 73, 81], ["Fe(II", "SIMPLE_CHEMICAL", 91, 96], ["TET proteins", "GENE_OR_GENE_PRODUCT", 141, 153], ["5mC", "SIMPLE_CHEMICAL", 187, 190], ["5hmC", "SIMPLE_CHEMICAL", 194, 198], ["Pentachlorophenol", "SIMPLE_CHEMICAL", 210, 227], ["5hmC", "SIMPLE_CHEMICAL", 251, 255], ["Fe(II)", "PROTEIN", 91, 97], ["TET proteins", "PROTEIN", 141, 153], ["quinones", "TREATMENT", 27, 35], ["Pentachlorophenol metabolites", "TEST", 210, 239], ["5hmC changes", "PROBLEM", 251, 263], ["the aforementioned hypnotics", "TREATMENT", 281, 309], ["medications", "TREATMENT", 311, 322], ["anthropogenic pollutants", "TREATMENT", 328, 352]]], ["Buccal cells Genomic DNA Decrease [118] In vitro Blood Genomic DNA Increase [116] Bisphenol AHumanIn vivo Sperm LINE1 Increase [129] Increase [128] Genomic DNA Increase [128] ACHE gene Increase [130] In vitro MCF-7 Genomic DNA Decrease [133] Mouse In vivo Brain (cortex) Kcnq1 locus No change [132] Brain (midbrain) Kcnq1 locus No change [132] Blood Gnas, Grb10, Plagl1, Pde10a, Pde4d genes Increase [131] Klf14,Airn, Cmah, Snrpn, Ppp1r9a, Kcnq1, Phactr2 genes Decrease [131] Hydroquinone Human In vitro HEK293 Genomic DNA Increase [134] Open reading frame 2 of LINE1 Decrease [134] Promoters of GCLC and 14-3-3\u03c3 genes Increase [134] Pentachlorophenol metabolitesConclusions and Future PerspectivesAlthough 5hmC has been known as one of the central components of the epigenetic network for over 10 years, our knowledge about molecular mechanisms underlying alterations in hydroxymethylation patterns and associated changes in mammalian cell gene expression in response to environmental factors is still in its early days.", [["Buccal cells", "ANATOMY", 0, 12], ["Sperm", "ANATOMY", 106, 111], ["Brain (cortex", "ANATOMY", 256, 269], ["midbrain", "ANATOMY", 306, 314], ["cell", "ANATOMY", 936, 940], ["Pentachlorophenol", "CHEMICAL", 634, 651], ["[131] Hydroquinone", "CHEMICAL", 470, 488], ["[134] Pentachlorophenol", "CHEMICAL", 628, 651], ["Buccal cells", "CELL", 0, 12], ["DNA", "CELLULAR_COMPONENT", 21, 24], ["DNA", "CELLULAR_COMPONENT", 63, 66], ["DNA", "CELLULAR_COMPONENT", 156, 159], ["DNA", "CELLULAR_COMPONENT", 223, 226], ["cortex", "MULTI-TISSUE_STRUCTURE", 263, 269], ["Gnas", "GENE_OR_GENE_PRODUCT", 350, 354], ["Grb10", "GENE_OR_GENE_PRODUCT", 356, 361], ["Plagl1", "GENE_OR_GENE_PRODUCT", 363, 369], ["Pde10a", "GENE_OR_GENE_PRODUCT", 371, 377], ["Pde4d", "GENE_OR_GENE_PRODUCT", 379, 384], ["Airn", "GENE_OR_GENE_PRODUCT", 412, 416], ["Cmah", "GENE_OR_GENE_PRODUCT", 418, 422], ["Snrpn", "GENE_OR_GENE_PRODUCT", 424, 429], ["Ppp1r9a", "GENE_OR_GENE_PRODUCT", 431, 438], ["Kcnq1", "GENE_OR_GENE_PRODUCT", 440, 445], ["Phactr2", "GENE_OR_GENE_PRODUCT", 447, 454], ["HEK293", "CELL", 504, 510], ["DNA", "CELLULAR_COMPONENT", 519, 522], ["GCLC", "GENE_OR_GENE_PRODUCT", 596, 600], ["\u03c3", "GENE_OR_GENE_PRODUCT", 611, 612], ["[134] Pentachlorophenol", "SIMPLE_CHEMICAL", 628, 651], ["5hmC", "GENE_OR_GENE_PRODUCT", 707, 711], ["mammalian cell", "CELL", 926, 940], ["ACHE gene", "DNA", 175, 184], ["Kcnq1 locus", "DNA", 271, 282], ["Kcnq1 locus", "DNA", 316, 327], ["Grb10", "DNA", 356, 361], ["Plagl1", "DNA", 363, 369], ["Pde10a", "DNA", 371, 377], ["Pde4d genes", "DNA", 379, 390], ["Klf14", "DNA", 406, 411], ["Airn", "DNA", 412, 416], ["Cmah", "DNA", 418, 422], ["Snrpn", "DNA", 424, 429], ["Ppp1r9a", "DNA", 431, 438], ["Kcnq1", "DNA", 440, 445], ["Phactr2 genes", "DNA", 447, 460], ["Open reading frame 2", "DNA", 538, 558], ["LINE1", "DNA", 562, 567], ["GCLC and 14-3-3\u03c3 genes", "DNA", 596, 618], ["5hmC", "PROTEIN", 707, 711], ["Mouse", "SPECIES", 242, 247], ["Human", "SPECIES", 489, 494], ["Buccal cells Genomic DNA", "PROBLEM", 0, 24], ["vitro Blood Genomic DNA Increase [116] Bisphenol AHumanIn vivo Sperm LINE1 Increase", "TREATMENT", 43, 126], ["Genomic DNA Increase [128] ACHE gene Increase [130] In vitro MCF", "TREATMENT", 148, 212], ["Genomic DNA Decrease [133] Mouse In vivo Brain (cortex)", "TREATMENT", 215, 270], ["Kcnq1 locus", "PROBLEM", 316, 327], ["Blood Gnas", "TEST", 344, 354], ["Grb10", "TEST", 356, 361], ["Pde10a, Pde4d genes Increase [131] Klf", "TREATMENT", 371, 409], ["Airn", "TREATMENT", 412, 416], ["Snrpn", "TREATMENT", 424, 429], ["Kcnq1, Phactr2 genes", "TREATMENT", 440, 460], ["Hydroquinone Human In vitro HEK293 Genomic DNA Increase", "TREATMENT", 476, 531], ["GCLC", "TEST", 596, 600], ["Pentachlorophenol metabolites", "TREATMENT", 634, 663], ["molecular mechanisms underlying alterations in hydroxymethylation patterns", "PROBLEM", 825, 899], ["associated changes in mammalian cell gene expression", "PROBLEM", 904, 956], ["Decrease", "OBSERVATION_MODIFIER", 25, 33], ["Brain", "ANATOMY", 256, 261], ["Brain", "ANATOMY", 299, 304], ["midbrain", "ANATOMY", 306, 314], ["hydroxymethylation patterns", "OBSERVATION", 872, 899], ["mammalian cell gene expression", "OBSERVATION", 926, 956]]], ["Accumulated research findings convincingly demonstrate that 5hmC is sensitive to environmental stimuli, and the associated alterations in 5hmC patterns can drive changes in gene expression, resulting in short-or long-term health effects.", [["5hmC", "CHEMICAL", 60, 64], ["5hmC", "SIMPLE_CHEMICAL", 60, 64], ["5hmC", "GENE_OR_GENE_PRODUCT", 138, 142], ["5hmC", "PROTEIN", 60, 64], ["environmental stimuli", "TEST", 81, 102], ["the associated alterations in 5hmC patterns", "PROBLEM", 108, 151], ["short-or long-term health effects", "PROBLEM", 203, 236]]], ["Most of such studies, however, are purely descriptive and merely establish a causal link between some environmental factor and alterations in DNA hydroxymethylation as a key finding, without shedding light on underlying molecular mechanisms.", [["DNA", "CELLULAR_COMPONENT", 142, 145], ["environmental factor", "PROTEIN", 102, 122], ["such studies", "TEST", 8, 20], ["some environmental factor", "PROBLEM", 97, 122], ["DNA hydroxymethylation", "TREATMENT", 142, 164]]], ["Rigorous studies on biochemical mechanisms of 5hmC modifications caused by environmental factors are scarce.", [["5hmC", "SIMPLE_CHEMICAL", 46, 50], ["Rigorous studies", "TEST", 0, 16], ["5hmC modifications", "PROBLEM", 46, 64]]], ["They give trustworthy evidence that environmental factors in their ability to affect DNA hydroxymethylation directly or indirectly modify key components of TET-mediated oxidation of 5mC to 5hmC.", [["TET", "CHEMICAL", 156, 159], ["TET", "CHEMICAL", 156, 159], ["5mC", "CHEMICAL", 182, 185], ["5hmC", "CHEMICAL", 189, 193], ["DNA", "CELLULAR_COMPONENT", 85, 88], ["TET", "SIMPLE_CHEMICAL", 156, 159], ["5mC", "SIMPLE_CHEMICAL", 182, 185], ["5hmC", "CELLULAR_COMPONENT", 189, 193], ["environmental factors", "PROBLEM", 36, 57], ["DNA hydroxymethylation", "TREATMENT", 85, 107], ["TET-mediated oxidation", "TREATMENT", 156, 178]]], ["Thus, different factors would apparently initiate different molecular mechanisms of epigenetic changes.Conclusions and Future PerspectivesThis review provides data showing that modifications in 5hmC patterns induced by environmental factors most often involve TET-mediated active DNA demethylation.", [["TET", "CHEMICAL", 260, 263], ["5hmC", "GENE_OR_GENE_PRODUCT", 194, 198], ["TET", "GENE_OR_GENE_PRODUCT", 260, 263], ["DNA", "CELLULAR_COMPONENT", 280, 283], ["TET", "PROTEIN", 260, 263], ["epigenetic changes", "PROBLEM", 84, 102], ["modifications in 5hmC patterns", "PROBLEM", 177, 207], ["active DNA demethylation", "TREATMENT", 273, 297], ["epigenetic changes", "OBSERVATION", 84, 102], ["DNA demethylation", "OBSERVATION", 280, 297]]], ["The latter induces increased DNA hydroxymethylation and decreased DNA methylation due to reactive oxygen species and iron(II) among other factors.", [["oxygen", "CHEMICAL", 98, 104], ["iron", "CHEMICAL", 117, 121], ["oxygen", "CHEMICAL", 98, 104], ["iron(II)", "CHEMICAL", 117, 125], ["DNA", "CELLULAR_COMPONENT", 29, 32], ["DNA", "CELLULAR_COMPONENT", 66, 69], ["reactive oxygen species", "SIMPLE_CHEMICAL", 89, 112], ["iron", "SIMPLE_CHEMICAL", 117, 121], ["increased DNA hydroxymethylation", "TREATMENT", 19, 51], ["decreased DNA methylation", "TREATMENT", 56, 81], ["reactive oxygen species", "TREATMENT", 89, 112], ["iron(II)", "TREATMENT", 117, 125], ["increased", "OBSERVATION_MODIFIER", 19, 28], ["DNA hydroxymethylation", "OBSERVATION", 29, 51], ["reactive", "OBSERVATION_MODIFIER", 89, 97], ["oxygen species", "OBSERVATION", 98, 112]]], ["Such a mechanism may be triggered in certain tissues/cell types by the exposure effect of phenobarbital, DMSO, particulate air pollution, PCP metabolites, and hydroquinone [67, 69, 70, 91, 116, 134, 136] .", [["tissues", "ANATOMY", 45, 52], ["cell", "ANATOMY", 53, 57], ["phenobarbital", "CHEMICAL", 90, 103], ["DMSO", "CHEMICAL", 105, 109], ["PCP", "CHEMICAL", 138, 141], ["hydroquinone", "CHEMICAL", 159, 171], ["phenobarbital", "CHEMICAL", 90, 103], ["DMSO", "CHEMICAL", 105, 109], ["PCP", "CHEMICAL", 138, 141], ["hydroquinone", "CHEMICAL", 159, 171], ["tissues", "TISSUE", 45, 52], ["cell", "CELL", 53, 57], ["phenobarbital", "SIMPLE_CHEMICAL", 90, 103], ["DMSO", "SIMPLE_CHEMICAL", 105, 109], ["PCP", "SIMPLE_CHEMICAL", 138, 141], ["hydroquinone", "SIMPLE_CHEMICAL", 159, 171], ["phenobarbital", "TREATMENT", 90, 103], ["DMSO", "TREATMENT", 105, 109], ["particulate air pollution", "PROBLEM", 111, 136], ["PCP metabolites", "TEST", 138, 153], ["hydroquinone", "TEST", 159, 171], ["may be", "UNCERTAINTY", 17, 23], ["cell types", "OBSERVATION", 53, 63], ["air pollution", "OBSERVATION", 123, 136]]], ["Decreased 5hmC levels can be associated with both TET down-regulation [73, 92, 96, 97, 104] and preceding reduction in 5mC-a substrate for oxidation [83, 96, 118] .", [["TET", "CHEMICAL", 50, 53], ["5hmC", "GENE_OR_GENE_PRODUCT", 10, 14], ["TET", "GENE_OR_GENE_PRODUCT", 50, 53], ["5mC", "SIMPLE_CHEMICAL", 119, 122], ["5hmC", "PROTEIN", 10, 14], ["5mC", "PROTEIN", 119, 122], ["Decreased 5hmC levels", "PROBLEM", 0, 21]]], ["In many cases, however, biochemical pathways of 5hmC alterations remain unknown.", [["5hmC", "GENE_OR_GENE_PRODUCT", 48, 52], ["5hmC alterations", "PROBLEM", 48, 64]]], ["An example of a challenging case in point are elevated 5hmC and unchanged 5mC levels in visceral organs exposed to sodium arsenite [95] .", [["visceral organs", "ANATOMY", 88, 103], ["sodium arsenite", "CHEMICAL", 115, 130], ["5mC", "CHEMICAL", 74, 77], ["sodium arsenite", "CHEMICAL", 115, 130], ["5hmC", "SIMPLE_CHEMICAL", 55, 59], ["5mC", "SIMPLE_CHEMICAL", 74, 77], ["visceral organs", "TISSUE", 88, 103], ["sodium arsenite", "SIMPLE_CHEMICAL", 115, 130], ["5mC", "PROTEIN", 74, 77], ["elevated 5hmC", "PROBLEM", 46, 59], ["sodium arsenite", "TEST", 115, 130], ["unchanged", "OBSERVATION_MODIFIER", 64, 73], ["visceral", "ANATOMY_MODIFIER", 88, 96], ["organs", "ANATOMY", 97, 103]]], ["A possible source for 5hmC here can be oxidation of de novo methylated cytosine as is the case for male pronucleus in mouse zygotes [137] .Conclusions and Future PerspectivesIt is still unclear what mechanisms underlie the gene-specific impact of environmental factors on 5hmC.", [["pronucleus", "ANATOMY", 104, 114], ["zygotes", "ANATOMY", 124, 131], ["5hmC", "CHEMICAL", 22, 26], ["cytosine", "CHEMICAL", 71, 79], ["5hmC", "CHEMICAL", 22, 26], ["cytosine", "CHEMICAL", 71, 79], ["5hmC", "SIMPLE_CHEMICAL", 22, 26], ["cytosine", "SIMPLE_CHEMICAL", 71, 79], ["mouse", "ORGANISM", 118, 123], ["5hmC", "SIMPLE_CHEMICAL", 272, 276], ["environmental factors", "PROTEIN", 247, 268], ["5hmC", "PROTEIN", 272, 276], ["mouse", "SPECIES", 118, 123], ["mouse", "SPECIES", 118, 123], ["5hmC", "PROBLEM", 22, 26], ["de novo methylated cytosine", "TREATMENT", 52, 79], ["male pronucleus in mouse zygotes", "PROBLEM", 99, 131]]], ["Studies investigating both global and gene-specific effects induced by environmental factors rigorously demonstrate that global increase/decrease in hydroxymethylation is accompanied by gene-specific 5hmC alterations-increased 5hmC in some genes and decreased 5hmC in other genes [67, 78, 84, 131] -which in turn can differentially impact gene expression.", [["5hmC", "GENE_OR_GENE_PRODUCT", 200, 204], ["5hmC", "GENE_OR_GENE_PRODUCT", 227, 231], ["5hmC", "GENE_OR_GENE_PRODUCT", 260, 264], ["5hmC", "DNA", 227, 231], ["5hmC", "DNA", 260, 264], ["Studies", "TEST", 0, 7], ["global increase/decrease in hydroxymethylation", "PROBLEM", 121, 167], ["gene-specific 5hmC alterations", "PROBLEM", 186, 216], ["increased 5hmC", "PROBLEM", 217, 231], ["increase", "OBSERVATION_MODIFIER", 128, 136], ["decrease", "OBSERVATION_MODIFIER", 137, 145]]], ["Another curious fact to investigate is cell-, organ-, and tissue-specificity of 5hmC alterations upon exposure to the same environmental factor.", [["cell", "ANATOMY", 39, 43], ["organ", "ANATOMY", 46, 51], ["tissue", "ANATOMY", 58, 64], ["cell", "CELL", 39, 43], ["organ", "ORGAN", 46, 51], ["tissue", "TISSUE", 58, 64], ["5hmC", "SIMPLE_CHEMICAL", 80, 84], ["environmental factor", "PROTEIN", 123, 143], ["5hmC alterations", "PROBLEM", 80, 96], ["organ", "ANATOMY", 46, 51]]], ["To some extent, such specificity may come from metabolic properties of affecting environmental chemicals.", [["some extent", "OBSERVATION_MODIFIER", 3, 14]]], ["This fact, as well as the observed sex difference in altered patterns of hydroxymethylation [101, 102] , demonstrates that changes in 5hmC levels are driven by a large set of metabolic pathways.Conclusions and Future PerspectivesAnother promising and compelling area to study refers to the effect of environmental factors on DNA hydroxymethylation during gametogenesis and embryogenesis, i.e., at stages when epigenetic genome reprogramming occurs [138] [139] [140] [141] .", [["5hmC", "GENE_OR_GENE_PRODUCT", 134, 138], ["DNA", "CELLULAR_COMPONENT", 325, 328], ["5hmC", "PROTEIN", 134, 138], ["environmental factors", "PROTEIN", 300, 321], ["changes in 5hmC levels", "PROBLEM", 123, 145], ["environmental factors", "PROBLEM", 300, 321], ["DNA hydroxymethylation", "TREATMENT", 325, 347], ["embryogenesis", "PROBLEM", 373, 386], ["epigenetic genome reprogramming", "PROBLEM", 409, 440], ["metabolic pathways", "OBSERVATION", 175, 193]]], ["At these particular stages, dynamic changes of 5hmC profiles determined by the developmental program may enhance susceptibility to environmental effects.", [["5hmC", "GENE_OR_GENE_PRODUCT", 47, 51], ["5hmC", "PROTEIN", 47, 51], ["dynamic changes of 5hmC profiles", "PROBLEM", 28, 60]]], ["In turn, environmentally induced epigenetic changes can have transgenerational effects in gametes and a long-term impact in adulthood in preimplantation embryos [142] .Conclusions and Future PerspectivesTo conclude, alterations in DNA hydroxymethylation patterns can be regarded as a sensitive response indicator to many environmental factors.", [["gametes", "ANATOMY", 90, 97], ["embryos", "ANATOMY", 153, 160], ["preimplantation", "DEVELOPING_ANATOMICAL_STRUCTURE", 137, 152], ["embryos", "DEVELOPING_ANATOMICAL_STRUCTURE", 153, 160], ["DNA", "CELLULAR_COMPONENT", 231, 234], ["epigenetic changes", "PROBLEM", 33, 51], ["transgenerational effects in gametes", "PROBLEM", 61, 97], ["alterations in DNA hydroxymethylation patterns", "PROBLEM", 216, 262]]], ["Underlying mechanisms and their impact on genome function differ in terms of environmental exposures that specifically target 5hmC in different organs, cell types, and DNA sequences.", [["organs", "ANATOMY", 144, 150], ["cell", "ANATOMY", 152, 156], ["5hmC", "GENE_OR_GENE_PRODUCT", 126, 130], ["organs", "ORGAN", 144, 150], ["cell", "CELL", 152, 156], ["DNA", "CELLULAR_COMPONENT", 168, 171], ["DNA sequences", "DNA", 168, 181], ["Underlying mechanisms", "PROBLEM", 0, 21], ["cell types", "TEST", 152, 162], ["DNA sequences", "TEST", 168, 181]]], ["The ability of 5hmC patterns to undergo alterations in response to harmful environmental exposure undoubtedly presents a 'weak link' within the epigenome.", [["5hmC", "GENE_OR_GENE_PRODUCT", 15, 19], ["a 'weak link'", "PROBLEM", 119, 132]]], ["It is epigenetic plasticity, however, which is based on the dynamic interplay between the regulatory effects of histone modifications and DNA methylation/hydroxymethylation, that apparently ensures genome flexibility and allows living organisms to adapt to the transforming environment.", [["histone", "GENE_OR_GENE_PRODUCT", 112, 119], ["DNA", "CELLULAR_COMPONENT", 138, 141], ["histone", "PROTEIN", 112, 119], ["histone modifications", "TREATMENT", 112, 133], ["DNA methylation/hydroxymethylation", "TREATMENT", 138, 172], ["genome flexibility", "PROBLEM", 198, 216], ["epigenetic plasticity", "OBSERVATION", 6, 27], ["genome flexibility", "OBSERVATION", 198, 216]]], ["The sensitivity of DNA hydroxymethylation to environmental factors provides the possibility of purposefully changing 5hmC patterns by different effectors.", [["DNA", "CELLULAR_COMPONENT", 19, 22], ["5hmC", "GENE_OR_GENE_PRODUCT", 117, 121], ["DNA hydroxymethylation", "TREATMENT", 19, 41]]], ["Once impaired, a recovery to normal DNA hydroxymethylation could be attempted through modifying the availability of components for DNA methylation/hydroxymethylation.", [["DNA", "CELLULAR_COMPONENT", 36, 39], ["DNA", "CELLULAR_COMPONENT", 131, 134], ["normal DNA hydroxymethylation", "TREATMENT", 29, 58], ["DNA methylation/hydroxymethylation", "TREATMENT", 131, 165]]], ["This may imply an appropriate SAM, Fe(II), and ascorbate supplementation as well as antioxidant therapy to reduce epigenetic consequences of oxidative stress.", [["Fe(II", "CHEMICAL", 35, 40], ["ascorbate", "CHEMICAL", 47, 56], ["SAM", "CHEMICAL", 30, 33], ["Fe(II)", "CHEMICAL", 35, 41], ["ascorbate", "CHEMICAL", 47, 56], ["Fe(II", "SIMPLE_CHEMICAL", 35, 40], ["ascorbate", "SIMPLE_CHEMICAL", 47, 56], ["an appropriate SAM, Fe(II)", "TREATMENT", 15, 41], ["ascorbate supplementation", "TREATMENT", 47, 72], ["antioxidant therapy", "TREATMENT", 84, 103], ["oxidative stress", "PROBLEM", 141, 157], ["oxidative stress", "OBSERVATION", 141, 157]]], ["Such approaches are going to give opportunities to prevent or ameliorate different pathological conditions that strike residents living in contaminated areas or those exposed to occupational hazards, anticipate potential epigenetic transgenerational effects, and ensure better safety for future generations.", [["different pathological conditions", "PROBLEM", 73, 106]]], ["Endeavors to develop effective epigenetic therapies and chemoprevention of environmentally induced epigenetic toxicity involving 5hmC patterns require a thorough understanding of molecular mechanisms underlying alterations in DNA hydroxymethylation to empower further rigorous investigation.Conflicts of Interest:The authors declare no conflict of interest.", [["toxicity", "DISEASE", 110, 118], ["DNA", "CELLULAR_COMPONENT", 226, 229], ["effective epigenetic therapies", "TREATMENT", 21, 51], ["chemoprevention of environmentally", "TREATMENT", 56, 90], ["epigenetic toxicity", "PROBLEM", 99, 118], ["DNA hydroxymethylation", "TREATMENT", 226, 248], ["further rigorous investigation", "TEST", 260, 290]]]], "PMC7275987": [["FundingNo funding or grants for this manuscript.Uncited references[12].Declaration of competing interestNone to declare.", [["No", "UNCERTAINTY", 7, 9], ["funding", "OBSERVATION", 10, 17]]]], "f81d18a6f44893dfcfcd98ab9897f0f5d577a6ed": [["IntroductionCoronaviruses are a large family of enveloped, single-stranded, zoonotic RNA viruses.", [["Coronaviruses", "GENE_OR_GENE_PRODUCT", 12, 25], ["large", "OBSERVATION_MODIFIER", 32, 37]]], ["A novel form of the coronavirus-SARS-CoV-2-causes COVID-19, which was first reported in China, and has caused a global pandemic [1] .", [["coronavirus-SARS-CoV-2", "ORGANISM", 20, 42], ["COVID-19", "CELL", 50, 58], ["coronavirus", "SPECIES", 20, 31], ["COVID-19", "SPECIES", 50, 58], ["the coronavirus", "TEST", 16, 31], ["CoV", "TEST", 37, 40], ["COVID", "TEST", 50, 55]]], ["The spread of COVID-19 infection requires continually improving knowledge about its epidemiology [2] .", [["COVID-19", "CHEMICAL", 14, 22], ["infection", "DISEASE", 23, 32], ["COVID-19", "ORGANISM", 14, 22], ["COVID-19", "SPECIES", 14, 22], ["COVID-19 infection", "PROBLEM", 14, 32], ["spread", "OBSERVATION_MODIFIER", 4, 10], ["infection", "OBSERVATION", 23, 32]]], ["In Brazil, SARS-CoV-2 has greatly influenced children nationwide; events such as school closures have affected daily life [1] .", [["SARS", "DISEASE", 11, 15], ["children", "ORGANISM", 45, 53], ["children", "SPECIES", 45, 53], ["SARS-CoV", "SPECIES", 11, 19]]], ["However, groups have expressed the importance of maintaining the educational opportunities of children, despite the COVID-19IntroductionInt.", [["children", "ORGANISM", 94, 102], ["children", "SPECIES", 94, 102]]], ["It is important that children have access to peers to maintain social and cognitive development.", [["children", "ORGANISM", 21, 29], ["children", "SPECIES", 21, 29]]], ["Additionally, the lack of access to such services can be particularly harmful for vulnerable children and/or families; notably, there has been an increase in physical, emotional, and sexual violence against children reported during the COVID-19 pandemic [4] .IntroductionThe COVID-19 symptoms in children are milder than in adults; children have a better prognosis, and deaths are extremely rare [5] .", [["physical, emotional, and sexual violence", "DISEASE", 158, 198], ["deaths", "DISEASE", 370, 376], ["children", "ORGANISM", 93, 101], ["children", "ORGANISM", 207, 215], ["children", "ORGANISM", 296, 304], ["children", "ORGANISM", 332, 340], ["children", "SPECIES", 93, 101], ["children", "SPECIES", 207, 215], ["children", "SPECIES", 296, 304], ["children", "SPECIES", 332, 340], ["symptoms", "PROBLEM", 284, 292], ["increase", "OBSERVATION_MODIFIER", 146, 154]]], ["A systematic review reported that children with COVID-19 often recovered within 1-2 weeks after disease onset.", [["children", "ORGANISM", 34, 42], ["children", "SPECIES", 34, 42], ["COVID", "TEST", 48, 53], ["disease onset", "PROBLEM", 96, 109]]], ["At that time, no cases of death from COVID-19 had been reported in the age range of 0 to 9 years, and only one death in the age range of 10 to 19 years [2] .", [["death", "DISEASE", 26, 31], ["COVID", "DISEASE", 37, 42], ["death", "DISEASE", 111, 116], ["death", "PROBLEM", 26, 31], ["COVID", "TEST", 37, 42]]], ["Although most children appear to experience less severe physical illness and have much lower mortality rates than other age groups from COVID-19 infection, they remain at substantial risk for negative outcomes given the widespread economic and societal disruption resulting from the pandemic [6] .", [["infection", "DISEASE", 145, 154], ["children", "ORGANISM", 14, 22], ["COVID-19", "ORGANISM", 136, 144], ["children", "SPECIES", 14, 22], ["COVID-19", "SPECIES", 136, 144], ["less severe physical illness", "PROBLEM", 44, 72], ["much lower mortality rates", "PROBLEM", 82, 108], ["COVID-19 infection", "PROBLEM", 136, 154], ["the widespread economic and societal disruption", "PROBLEM", 216, 263], ["infection", "OBSERVATION", 145, 154], ["widespread", "OBSERVATION_MODIFIER", 220, 230], ["economic", "OBSERVATION_MODIFIER", 231, 239], ["societal disruption", "OBSERVATION", 244, 263]]], ["The consequences of COVID-19 on children are vast in terms of their health, safety, and well-being [7] .IntroductionThe influence of changes in the daily lives of children should not be underestimated.", [["children", "ORGANISM", 32, 40], ["children", "ORGANISM", 163, 171], ["children", "SPECIES", 32, 40], ["children", "SPECIES", 163, 171], ["COVID", "TEST", 20, 25]]], ["Other family members' health and emotional states will affect children, and negative influences from the environment could greatly impact their health.", [["children", "ORGANISM", 62, 70], ["children", "SPECIES", 62, 70]]], ["The COVID-19 pandemic has led to isolation and restrictions, which are significantly disrupting for children; they are not well understood, and have been shown to be both confusing and frightening [7] .IntroductionStudies have consistently concluded that quarantine was an important public health measure to reduce the number of people infected and the number of deaths [8] .", [["deaths", "DISEASE", 363, 369], ["children", "ORGANISM", 100, 108], ["people", "ORGANISM", 329, 335], ["children", "SPECIES", 100, 108], ["people", "SPECIES", 329, 335]]], ["However, the social distancing that has been imposed on children has caused massive upheaval [7] .", [["children", "ORGANISM", 56, 64], ["children", "SPECIES", 56, 64]]], ["Children have received home schooling under the guidance of their parents or carers, whose attention was divided among taking care of the children, the home, and the home office.IntroductionMost publications about people\u00b4s anxiety levels in conjunction with COVID-19 have focussed on adults; attention should also be paid to children's situations.", [["anxiety", "DISEASE", 223, 230], ["Children", "ORGANISM", 0, 8], ["children", "ORGANISM", 138, 146], ["adults", "ORGANISM", 284, 290], ["children", "ORGANISM", 325, 333], ["Children", "SPECIES", 0, 8], ["children", "SPECIES", 138, 146], ["children", "SPECIES", 325, 333], ["anxiety levels", "TEST", 223, 237]]], ["An increase in the prevalence of depression, insomnia, post-traumatic stress disorders, and feelings of anger and frustration was observed in a population from the city of Wuhan, China [9] .", [["depression", "DISEASE", 33, 43], ["insomnia", "DISEASE", 45, 53], ["traumatic stress disorders", "DISEASE", 60, 86], ["feelings of anger and frustration", "DISEASE", 92, 125], ["depression", "PROBLEM", 33, 43], ["insomnia", "PROBLEM", 45, 53], ["post-traumatic stress disorders", "PROBLEM", 55, 86], ["frustration", "PROBLEM", 114, 125], ["increase", "OBSERVATION_MODIFIER", 3, 11], ["depression", "OBSERVATION", 33, 43]]], ["A population-based study in Hong Kong during the COVID-19 pandemic showed that 14% had anxiety [10] .", [["anxiety", "DISEASE", 87, 94], ["based study", "TEST", 13, 24], ["the COVID", "TEST", 45, 54], ["anxiety", "PROBLEM", 87, 94]]], ["The majority of the respondents in a Chinese study during COVID-19 were women, and 28.8% reported moderate to severe anxiety [11] .", [["anxiety", "DISEASE", 117, 124], ["women", "ORGANISM", 72, 77], ["women", "SPECIES", 72, 77], ["a Chinese study", "TEST", 35, 50], ["COVID", "TEST", 58, 63], ["moderate to severe anxiety", "PROBLEM", 98, 124], ["majority", "OBSERVATION_MODIFIER", 4, 12]]], ["The World Health Organisation has presented recommendations for facing the psychological and mental consequences of the pandemic, which is essential for children.", [["children", "ORGANISM", 153, 161], ["children", "SPECIES", 153, 161]]], ["It was therefore important to measure the experiences of children at the height of the pandemic of the century.IntroductionIt was necessary to listen to how children described their experiences, anxiety levels, and perspectives during the COVID-19 pandemic [13] .IntroductionThe present study highlights children\u00b4s perspectives by using a questionnaire adapted for children.", [["anxiety", "DISEASE", 195, 202], ["children", "ORGANISM", 57, 65], ["children", "ORGANISM", 157, 165], ["children", "ORGANISM", 365, 373], ["children", "SPECIES", 57, 65], ["children", "SPECIES", 157, 165], ["children", "SPECIES", 365, 373], ["anxiety levels", "PROBLEM", 195, 209], ["the COVID", "TEST", 235, 244]]], ["The aim of the study was to assess the prevalence of anxiety among Brazilian schoolchildren and study the anxiety factors associated with social distancing during the global COVID-19 pandemic.Study DesignA cross-sectional study using non-probability and convenience sampling methods was conducted between 25 April and 25 May 2020 in Brazil.", [["anxiety", "DISEASE", 53, 60], ["anxiety", "DISEASE", 106, 113], ["schoolchildren", "SPECIES", 77, 91], ["the study", "TEST", 11, 20], ["anxiety", "PROBLEM", 53, 60], ["the anxiety factors", "PROBLEM", 102, 121], ["the global COVID", "TEST", 163, 179], ["pandemic", "PROBLEM", 183, 191], ["Study DesignA cross-sectional study", "TEST", 192, 227]]], ["We used an online survey to collect information (https://forms.gle/qhkt4hxqBUntZ4pc6).ParticipantsThe study sample consisted of Brazilian children between 6 and 12 years of age and their guardians, all of whom were social distancing.", [["children", "ORGANISM", 138, 146], ["children", "SPECIES", 138, 146], ["The study", "TEST", 98, 107]]], ["Guardians under 18 years of age were excluded from this study.Assessments of AnxietyThe Children\u00b4s Anxiety Questionnaire (CAQ, scores range from 4 to 12) and the Numerical Rating Scale (NRS, scores range 0 to 10) were used to measure anxiety in the children.", [["Anxiety", "DISEASE", 77, 84], ["anxiety", "DISEASE", 234, 241], ["Guardians", "ORGANISM", 0, 9], ["children", "ORGANISM", 249, 257], ["children", "SPECIES", 249, 257], ["this study", "TEST", 51, 61], ["Anxiety", "PROBLEM", 77, 84]]], ["The authors of the CAQ, a Swedish instrument, aimed to develop a questionnaire that would be easy to administer, had solid psychometric measures, and could be used to assess self-reported anxiety in young children [14, 15] .", [["anxiety", "DISEASE", 188, 195], ["children", "ORGANISM", 205, 213], ["children", "SPECIES", 205, 213], ["anxiety", "PROBLEM", 188, 195]]], ["The CAQ contains four items with four images of facial expressions, with three response options, each representative of a different level of emotional intensity [14, 15] .", [["facial", "ANATOMY", 48, 54], ["CAQ", "DNA", 4, 7], ["facial", "ANATOMY", 48, 54]]], ["The children give their responses based on the four facial expressions, one at a time, and then choose between three steps (i.e., a little (1), some (2) , and a lot (3)).", [["facial", "ANATOMY", 52, 58], ["children", "ORGANISM", 4, 12], ["children", "SPECIES", 4, 12]]], ["The faces of Happy/Content and Calm/Relaxed are measured as 3-2-1, and the faces of Tense/Nervous and Worried/Afraid are measured as 1-2-3.", [["Tense", "OBSERVATION", 84, 89], ["Nervous", "ANATOMY", 90, 97]]], ["The range for this instrument is 4 to 12 points, with 4 points signifying no anxiety and 12 points signifying the highest level of anxiety.", [["anxiety", "DISEASE", 77, 84], ["anxiety", "DISEASE", 131, 138], ["anxiety", "PROBLEM", 77, 84], ["anxiety", "PROBLEM", 131, 138], ["range", "OBSERVATION_MODIFIER", 4, 9], ["no", "UNCERTAINTY", 74, 76]]], ["Recently, the CAQ in Brazilian Portuguese was validated, as demonstrated by satisfactory results among professionals and children; however, these data are unpublished.", [["children", "ORGANISM", 121, 129], ["CAQ", "DNA", 14, 17], ["children", "SPECIES", 121, 129]]], ["The CAQ has previously shown construct validity in conjunction with out-patient surgery [14, 17] .Assessments of AnxietyThe NRS is an 11-point scale that is scored from 0 to 10.", [["Anxiety", "DISEASE", 113, 120], ["patient", "ORGANISM", 72, 79], ["CAQ", "DNA", 4, 7], ["patient", "SPECIES", 72, 79], ["out-patient surgery", "TREATMENT", 68, 87], ["Anxiety", "PROBLEM", 113, 120]]], ["In the past few decades, the NRS has been validated for the evaluation of pain intensity in children [18] and assessing unpleasantness.", [["pain", "DISEASE", 74, 78], ["children", "ORGANISM", 92, 100], ["children", "SPECIES", 92, 100], ["the evaluation", "TEST", 56, 70], ["pain intensity", "PROBLEM", 74, 88]]], ["However, there are no agreed upon NRS anchors for measuring unpleasantness in children [19] .", [["children", "ORGANISM", 78, 86], ["children", "SPECIES", 78, 86], ["no", "UNCERTAINTY", 19, 21]]], ["In this study, anxiety was assessed using the NRS, wherein 0 was equivalent to 'calm', and 10 meant 'very anxious'.", [["anxiety", "DISEASE", 15, 22], ["this study", "TEST", 3, 13], ["anxiety", "PROBLEM", 15, 22], ["very anxious", "PROBLEM", 101, 113]]], ["Mild anxiety is expressed with scores of 1, and 2; moderate anxiety: 3, 4, 5, 6, and 7; and intense anxiety 8, 9, and 10 [20] .", [["anxiety", "DISEASE", 5, 12], ["anxiety", "DISEASE", 60, 67], ["anxiety", "DISEASE", 100, 107], ["Mild anxiety", "PROBLEM", 0, 12], ["moderate anxiety", "PROBLEM", 51, 67], ["intense anxiety", "PROBLEM", 92, 107], ["anxiety", "OBSERVATION", 5, 12]]], ["Similar forms of self-reports have previously been validated for use in school-aged children who have undergone care in hospitals [21, 22] .Data CollectionAn online survey using the Google Forms platform was distributed by three researchers through social media (Twitter, Facebook, Instagram) and personal contacts (WhatsApp) that expanded through snowballing.", [["children", "ORGANISM", 84, 92], ["children", "SPECIES", 84, 92]]], ["A brief written description of the study and its objectives was sent to guardians.", [["the study", "TEST", 31, 40]]], ["We instructed the guardians and children about how to participate and guided the guardians on how to fill in their data and conduct the interview with their children.Data CollectionThe online survey evaluated the sociodemographic profiles and current conditions regarding the social distancing and isolation of the children and their guardians.", [["children", "ORGANISM", 32, 40], ["children", "ORGANISM", 157, 165], ["children", "ORGANISM", 315, 323], ["children", "SPECIES", 32, 40], ["children", "SPECIES", 157, 165], ["children", "SPECIES", 315, 323], ["Data Collection", "TEST", 166, 181]]], ["The guardians used the CAQ and the NRS following the survey instructions; the survey had a total of 25 questions.Data CollectionThe quantitative variables measured for children were: gender; age; if they were on vacation; if they were home schooling; social distancing with the father, mother, both, or others; if the parents had an essential job; if they had a chronic disease or disability; how many people were in the same house; suspected or confirmed diagnosis of COVID-19 in the house; for how long the children had been social distancing; and the size of their home.", [["chronic disease or disability", "DISEASE", 362, 391], ["children", "ORGANISM", 168, 176], ["people", "ORGANISM", 402, 408], ["children", "ORGANISM", 509, 517], ["children", "SPECIES", 168, 176], ["people", "SPECIES", 402, 408], ["children", "SPECIES", 509, 517], ["Data Collection", "TEST", 113, 128], ["a chronic disease or disability", "PROBLEM", 360, 391], ["COVID", "TEST", 469, 474]]], ["The quantitative variables for guardians were: relationship with the children (mother, father, and others), schooling (elementary school, high school, college, or postgraduate degree); income reduced during the pandemic (yes or no); and guardians were asked about how much they thought their children understood the pandemic (a lot, some, a little, or nothing).Statistical Analysis PerceivedTo test the normal distribution of the data, the Shapiro-Wilk test was used.", [["children", "ORGANISM", 69, 77], ["children", "ORGANISM", 292, 300], ["children", "SPECIES", 69, 77], ["children", "SPECIES", 292, 300], ["Statistical Analysis", "TEST", 361, 381], ["the Shapiro-Wilk test", "TEST", 436, 457]]], ["Comparisons between the groups were performed using the Mann-Whitney-U test for unpaired data that were not normally distributed.", [["the Mann-Whitney-U test", "TEST", 52, 75], ["unpaired data", "TEST", 80, 93]]], ["For multiple-group comparisons, the Kruskal-Wallis tests, followed by Dunn's tests, were performed.", [["the Kruskal-Wallis tests", "TEST", 32, 56], ["Dunn's tests", "TEST", 70, 82]]], ["The scores were handled as ordinal data, and thus, the Spearman\u00b4s rho correlation coefficients were calculated between the CAQ and NRS scores.", [["ordinal data", "TEST", 27, 39], ["the Spearman\u00b4s rho correlation coefficients", "TEST", 51, 94]]], ["The chi-square test, as a two-tailed test (n > 30), and Fisher\u00b4s exact test were employed to compare proportions in the different groups.", [["The chi-square test", "TEST", 0, 19], ["a two-tailed test", "TEST", 24, 41]]], ["Odds ratios (OR) were calculated to test the association between the outcome variables, such as the dependent variable (NRS or CAQ), as binary categories defined (</>): for the CAQ, a score higher/lower than the mean value plus a standard deviation, the cut-off value was set at the level [low < 9 or high \u2265 9]); scores of 9 and higher than 9 indicated intense anxiety.", [["anxiety", "DISEASE", 361, 368], ["the dependent variable (NRS or CAQ)", "PROBLEM", 96, 131], ["a score", "TEST", 182, 189], ["a standard deviation", "PROBLEM", 228, 248], ["the cut", "TEST", 250, 257], ["scores", "TEST", 313, 319], ["intense anxiety", "PROBLEM", 353, 368], ["intense", "OBSERVATION_MODIFIER", 353, 360], ["anxiety", "OBSERVATION", 361, 368]]], ["For the NRS, the cut-off value was set at the level [low \u2264 7 or high > 7]; thus, scores of 8 or higher indicated intense anxiety.Statistical Analysis PerceivedA logistic regression was performed to test associations between the dependent variable (i.e., high (\u22659) or low anxiety scores of the CAQ and (>7) NRS, respectively) and the independent variables.", [["anxiety", "DISEASE", 121, 128], ["anxiety", "DISEASE", 271, 278], ["the NRS", "TEST", 4, 11], ["the cut-off value", "TEST", 13, 30], ["scores", "TEST", 81, 87], ["intense anxiety", "PROBLEM", 113, 128], ["low anxiety scores of the CAQ", "PROBLEM", 267, 296], ["intense", "OBSERVATION_MODIFIER", 113, 120], ["anxiety", "OBSERVATION", 121, 128], ["dependent", "OBSERVATION_MODIFIER", 228, 237], ["variable", "OBSERVATION_MODIFIER", 238, 246], ["high", "OBSERVATION_MODIFIER", 254, 258]]], ["For all tests, the level of statistical significance was set at 5%.", [["all tests", "TEST", 4, 13]]], ["For the statistical analyses, we used IBM SPSS Statistics for MacBook, version 24 (IBM Corp., Armonk, N.Y., USA).Ethical AspectsThis research was approved by the Research Ethics Committee of Brazil (CAAE: 30547320.0.0000.0008 and Opinion N \u2022 4.128.847) and complied with resolution No. 510/2016, which establishes the guidelines and regulatory rules for research involving humans.", [["humans", "ORGANISM", 373, 379], ["humans", "SPECIES", 373, 379], ["humans", "SPECIES", 373, 379], ["the statistical analyses", "TEST", 4, 28]]], ["The guardians and children agreed to participate in the research through an electronic record/register.ResultsOf the 289 children and their guardians who were included in this study, 54.3% (n = 157) were girls, and 45.7% (n = 132) were boys, with a median age of 9 years (interquartile range = 4).", [["children", "ORGANISM", 18, 26], ["children", "ORGANISM", 121, 129], ["children", "SPECIES", 18, 26], ["children", "SPECIES", 121, 129], ["girls", "SPECIES", 204, 209], ["boys", "SPECIES", 236, 240], ["this study", "TEST", 171, 181]]], ["Few children had a suspected or confirmed diagnosis of COVID-19 (1.7%, n = 5 and 5.9%, n = 17, respectively).", [["COVID", "DISEASE", 55, 60], ["children", "ORGANISM", 4, 12], ["children", "SPECIES", 4, 12], ["COVID", "TEST", 55, 60]]], ["Over half of the children were on vacation (53%, n = 153), and 90% (n = 261) of the children were being home schooled; they did not attend physically.", [["children", "ORGANISM", 17, 25], ["children", "ORGANISM", 84, 92], ["children", "SPECIES", 17, 25], ["children", "SPECIES", 84, 92]]], ["Nearly sixty percent (58%, n = 168) of the guardians reported that their children understood the actual pandemic situation relatively well.ResultsAmong the guardians, 257 (88.9%) were mothers, 11 (4%) were fathers, and 20 (7%) had another type of relationship with the children.", [["children", "ORGANISM", 73, 81], ["mothers", "ORGANISM", 184, 191], ["children", "ORGANISM", 269, 277], ["children", "SPECIES", 73, 81], ["children", "SPECIES", 269, 277]]], ["Of the guardians, 46.4% (n = 134) had completed postgraduate studies, 31.1% (n = 90) had graduated from university, 16.3% (n = 47) had finished high school, and 6.2% (n = 18) had completed elementary school.", [["postgraduate studies", "TEST", 48, 68]]], ["On average, roughly four people (\u00b11.38) were living at home, the house size was 212.02 m 2 (\u00b1SD 402.85), and the hours spent social distancing was 22/day (\u00b17.71).", [["people", "ORGANISM", 25, 31], ["people", "SPECIES", 25, 31]]], ["Over half (53%, n = 153) said their normal income had decreased, and 18% (n = 51) replied that the mother or father had maintained an essential job.ResultsAccording to the descriptive analyses, the girls scored higher on CAQ than the boys did (p = 0.047, median test); however, these differences were not found for the NRS (p = 0.929).", [["girls", "SPECIES", 198, 203], ["boys", "SPECIES", 234, 238], ["the descriptive analyses", "TEST", 168, 192], ["median test", "TEST", 255, 266], ["the NRS", "TEST", 315, 322]]], ["Children who were maintaining social distance with both their parents had lower scores on the CAQ than those who were isolated with a person other than their parents (p = 0.002).", [["Children", "ORGANISM", 0, 8], ["Children", "SPECIES", 0, 8], ["person", "SPECIES", 134, 140]]], ["There were no significant differences in the scores of CAQ or NRS in terms of whether the child was on vacation, was being home schooled, or had an immediate connection to someone with a COVID-19 diagnosis, the level of the child's comprehension, or a decrease in household income.ResultsThere were no statistical differences between the prevalence of anxiety, for CAQ (p = 0.879), or for NRS by the age of the children (p = 0.408) ( Table 1) .", [["anxiety", "DISEASE", 352, 359], ["children", "ORGANISM", 411, 419], ["children", "SPECIES", 411, 419], ["anxiety", "PROBLEM", 352, 359], ["no", "UNCERTAINTY", 11, 13], ["significant", "OBSERVATION_MODIFIER", 14, 25], ["differences", "OBSERVATION_MODIFIER", 26, 37], ["no", "UNCERTAINTY", 299, 301]]], ["Table 2 shows the prevalence of anxiety according to both scales by the associated variables.", [["anxiety", "DISEASE", 32, 39], ["anxiety", "PROBLEM", 32, 39]]], ["According to CAQ (CAQ \u2265 9), the prevalence of anxiety was 19.4% (n = 56).", [["anxiety", "DISEASE", 46, 53], ["anxiety", "PROBLEM", 46, 53]]], ["For girls, the prevalence was 21% (n = 33) and, for boys, 17.4% (n= 23), without statistical difference.", [["girls", "SPECIES", 4, 9], ["boys", "SPECIES", 52, 56], ["the prevalence", "TEST", 11, 25], ["boys", "TEST", 52, 56], ["statistical difference", "PROBLEM", 81, 103]]], ["The prevalence of anxiety according to NRS (NRS > 7) was 21.8% (n = 63), and there were no statistically significant differences in the prevalence between the girls 22.3% (n = 35) and boys 21.2% (n = 28) ( Table 2 ).", [["anxiety", "DISEASE", 18, 25], ["girls", "SPECIES", 159, 164], ["boys", "SPECIES", 184, 188], ["anxiety", "PROBLEM", 18, 25], ["NRS", "TEST", 39, 42], ["NRS", "TEST", 44, 47], ["the girls", "TEST", 155, 164], ["boys", "TEST", 184, 188], ["no", "UNCERTAINTY", 88, 90]]], ["According to the CAQ scores, the prevalence of anxiety was higher among the children with parents with essential jobs, 31.4% (n = 16) vs. 16 .8% (n = 40), and when keeping social distance without parents (35.7%, n = 20).", [["anxiety", "DISEASE", 47, 54], ["children", "ORGANISM", 76, 84], ["children", "SPECIES", 76, 84], ["anxiety", "PROBLEM", 47, 54]]], ["Lower scores were found among children who were staying only with their fathers or with both guardians.", [["children", "ORGANISM", 30, 38], ["children", "SPECIES", 30, 38]]], ["There were no statistically significant differences for NRS and the studied variables, but the prevalence of anxiety was highest among the children who maintained social distance with someone other than the parents (28.6%, n = 16).ResultsRegarding the age of the guardians (Figure 1) , there was an inverse association between the age of the caregiver and the children's scores on the CAQ (p = 0.002).", [["anxiety", "DISEASE", 109, 116], ["children", "ORGANISM", 139, 147], ["children", "ORGANISM", 360, 368], ["children", "SPECIES", 139, 147], ["children", "SPECIES", 360, 368], ["anxiety", "PROBLEM", 109, 116], ["no", "UNCERTAINTY", 11, 13], ["statistically", "OBSERVATION_MODIFIER", 14, 27], ["significant", "OBSERVATION_MODIFIER", 28, 39]]], ["This association did not reach statistical significance for the NRS scores (p = 0.078).", [["the NRS scores", "TEST", 60, 74]]], ["Furthermore, the correlation between the CAQ and NRS scores was weak but significant (r = 0.461; p < 0.001).Resultsthe prevalence of anxiety was highest among the children who maintained social distance with someone other than the parents (28.6%, n = 16).ResultsRegarding the age of the guardians (Figure 1) , there was an inverse association between the age of the caregiver and the children's scores on the CAQ (p = 0.002).", [["anxiety", "DISEASE", 133, 140], ["children", "ORGANISM", 163, 171], ["children", "ORGANISM", 384, 392], ["children", "SPECIES", 163, 171], ["children", "SPECIES", 384, 392], ["the CAQ and NRS scores", "TEST", 37, 59], ["anxiety", "PROBLEM", 133, 140], ["significant", "OBSERVATION_MODIFIER", 73, 84]]], ["This association did not reach statistical significance for the NRS scores (p = 0.078).", [["the NRS scores", "TEST", 60, 74]]], ["Furthermore, the correlation between the CAQ and NRS scores was weak but significant (r = 0.461; p < 0.001).", [["the CAQ and NRS scores", "TEST", 37, 59], ["significant", "OBSERVATION_MODIFIER", 73, 84]]], ["As shown in Table 3 , children with guardians who had a higher educational level exhibited more comprehension of the pandemic than did children whose guardians received less education.", [["pandemic", "DISEASE", 117, 125], ["children", "ORGANISM", 22, 30], ["children", "ORGANISM", 135, 143], ["children", "SPECIES", 22, 30], ["children", "SPECIES", 135, 143]]], ["Among the six children with no comprehension of the situation, three were cared for by guardians with the lowest level of education.", [["children", "ORGANISM", 14, 22], ["children", "SPECIES", 14, 22]]], ["Figure 2 shows the respective CAQ and NRS scores of the children and their perceived comprehension of the pandemic categorised as a lot, some, a little, and nothing.", [["children", "ORGANISM", 56, 64], ["children", "SPECIES", 56, 64]]], ["There was no association between the children's perceived comprehension of the situation and their scores on CAQ (p = 0.416) or NRS (p = 0.283).", [["children", "ORGANISM", 37, 45], ["children", "SPECIES", 37, 45], ["no association between", "UNCERTAINTY", 10, 32]]], ["The children who understood the pandemic situation did not exhibit more anxiety than those who did not understand it at all (Figure 2 ).", [["anxiety", "DISEASE", 72, 79], ["children", "ORGANISM", 4, 12], ["children", "SPECIES", 4, 12]]], ["As shown in Table 3 , children with guardians who had a higher educational level exhibited more comprehension of the pandemic than did children whose guardians received less education.", [["pandemic", "DISEASE", 117, 125], ["children", "ORGANISM", 22, 30], ["children", "ORGANISM", 135, 143], ["children", "SPECIES", 22, 30], ["children", "SPECIES", 135, 143]]], ["Among the six children with no comprehension of the situation, three were cared for by guardians with the lowest level of education.", [["children", "ORGANISM", 14, 22], ["children", "SPECIES", 14, 22]]], ["Post hoc analysis showed that the difference was between high school and postgraduate; postgraduates were older than those who had only finished high school (p = 0.001).", [["Post hoc analysis", "TEST", 0, 17]]], ["Table 3 shows the association between CAQ scores and the independent variables included in the study.", [["CAQ", "PROTEIN", 38, 41], ["the study", "TEST", 91, 100]]], ["Higher levels of anxiety (CAQ \u2265 9) were associated with social distancing, the number of persons at home, guardians' age, and education level of the guardians.", [["anxiety", "DISEASE", 17, 24], ["persons", "ORGANISM", 89, 96], ["persons", "SPECIES", 89, 96], ["anxiety", "PROBLEM", 17, 24]]], ["Children keeping social distance without their parents had higher levels of anxiety than children with both parents at home (p = 0.029).", [["anxiety", "DISEASE", 76, 83], ["Children", "ORGANISM", 0, 8], ["children", "ORGANISM", 89, 97], ["Children", "SPECIES", 0, 8], ["children", "SPECIES", 89, 97]]], ["The greater the number of persons at home, the greater the anxiety score (p = 0.024).", [["anxiety", "DISEASE", 59, 66], ["persons", "ORGANISM", 26, 33], ["persons", "SPECIES", 26, 33], ["greater", "OBSERVATION_MODIFIER", 4, 11]]], ["Regarding the guardians' education level, children whose guardians had a postgraduate (p = 0.019) or university education level (p = 0.024) had lower anxiety scores on the CAQ than those whose guardians had only elementary school (reference category).", [["anxiety", "DISEASE", 150, 157], ["children", "ORGANISM", 42, 50], ["children", "SPECIES", 42, 50], ["lower anxiety scores", "PROBLEM", 144, 164]]], ["In line with the descriptive analyses, a positive statistical significance was found for the interaction between the guardians' age and education level (p = 0.022).", [["the descriptive analyses", "TEST", 13, 37]]], ["Children whose guardians were among the youngest and with the lowest levels of education among the participants had higher CAQ scores than children whose guardians were older and more educated (for postgraduate B = 0.996, for university graduate B = 0.995, p < 0.05; Table 4 ).", [["Children", "ORGANISM", 0, 8], ["children", "ORGANISM", 139, 147], ["Children", "SPECIES", 0, 8], ["participants", "SPECIES", 99, 111], ["children", "SPECIES", 139, 147]]], ["Post hoc analysis showed that the difference was between high school and postgraduate; postgraduates were older than those who had only finished high school (p = 0.001).", [["Post hoc analysis", "TEST", 0, 17]]], ["Table 3 shows the association between CAQ scores and the independent variables included in the study.", [["CAQ", "PROTEIN", 38, 41], ["the study", "TEST", 91, 100]]], ["Higher levels of anxiety (CAQ \u2265 9) were associated with social distancing, the number of persons at home, guardians' age, and education level of the guardians.", [["anxiety", "DISEASE", 17, 24], ["persons", "ORGANISM", 89, 96], ["persons", "SPECIES", 89, 96], ["anxiety", "PROBLEM", 17, 24]]], ["Children keeping social distance without their parents had higher levels of anxiety than children with both parents at home (p = 0.029).", [["anxiety", "DISEASE", 76, 83], ["Children", "ORGANISM", 0, 8], ["children", "ORGANISM", 89, 97], ["Children", "SPECIES", 0, 8], ["children", "SPECIES", 89, 97]]], ["The greater the number of persons at home, the greater the anxiety score (p = 0.024).", [["anxiety", "DISEASE", 59, 66], ["persons", "ORGANISM", 26, 33], ["persons", "SPECIES", 26, 33], ["greater", "OBSERVATION_MODIFIER", 4, 11]]], ["Regarding the guardians' education level, children whose guardians had a postgraduate (p = 0.019) or university education level (p = 0.024) had lower anxiety scores on the CAQ than those whose guardians had only elementary school (reference category).", [["anxiety", "DISEASE", 150, 157], ["children", "ORGANISM", 42, 50], ["children", "SPECIES", 42, 50], ["lower anxiety scores", "PROBLEM", 144, 164]]], ["In line with the descriptive analyses, a positive statistical significance was found for the interaction between the guardians' age and education level (p = 0.022).", [["the descriptive analyses", "TEST", 13, 37]]], ["Children whose guardians were among the youngest and with the lowest levels of education among the participants had higher CAQ scores than children whose guardians were older and more educated (for postgraduate B = 0.996, for university graduate B = 0.995, p < 0.05; Table 4 ).", [["Children", "ORGANISM", 0, 8], ["children", "ORGANISM", 139, 147], ["Children", "SPECIES", 0, 8], ["participants", "SPECIES", 99, 111], ["children", "SPECIES", 139, 147]]], ["Table 5 shows the results of the binary logistic regression for NRS and the independent variables included in the study.", [["the study", "TEST", 110, 119]]], ["No association was found between the NRS scores and the studied variables.", [["NRS", "PROTEIN", 37, 40], ["the NRS scores", "TEST", 33, 47]]], ["Independent of the selected cut-off value of NRS > 6, > 7, or \u2265 9, there was no association between the NRS scores and the covariates, or when using logistic regression or multinomial regression analyses.", [["NRS", "TEST", 45, 48], ["the NRS scores", "PROBLEM", 100, 114], ["multinomial regression analyses", "TEST", 172, 203]]], ["Multinomial regression analysis revealed that when the dependent variable was set as a group of anxiety (mild, moderate, and intense), unlike the CAQ score, none of the variables was guardians for the anxiety reported with the NRS scores, except for confirmed COVID-19 cases at home, which was guardians for a difference between mild and moderate anxiety (data not shown).DiscussionThe present study assessed children's anxiety during the COVID-19 pandemic in order to assist healthcare professionals in understanding children\u00b4s reports of anxiety.", [["anxiety", "DISEASE", 96, 103], ["anxiety", "DISEASE", 201, 208], ["anxiety", "DISEASE", 347, 354], ["anxiety", "DISEASE", 420, 427], ["anxiety", "DISEASE", 540, 547], ["children", "ORGANISM", 409, 417], ["children", "SPECIES", 409, 417], ["Multinomial regression analysis", "TEST", 0, 31], ["anxiety (mild, moderate, and intense)", "PROBLEM", 96, 133], ["the anxiety", "PROBLEM", 197, 208], ["the NRS scores", "TEST", 223, 237], ["a difference between mild and moderate anxiety", "PROBLEM", 308, 354], ["The present study", "TEST", 382, 399], ["anxiety", "PROBLEM", 420, 427], ["anxiety", "PROBLEM", 540, 547], ["mild", "OBSERVATION_MODIFIER", 105, 109], ["moderate", "OBSERVATION_MODIFIER", 111, 119], ["moderate", "OBSERVATION_MODIFIER", 338, 346]]], ["Comprehending children's emotions was quite challenging, because the situations they experienced may not have characteristics in common with any previous event in their lives.", [["children", "ORGANISM", 14, 22], ["children", "SPECIES", 14, 22]]], ["Thus, giving them a voice was an essential strategy.DiscussionIn the present study, the prevalence of anxiety among children was between 19.4% (n = 56), using the CAQ, and 21.8% (n = 63), using the NRS.", [["anxiety", "DISEASE", 102, 109], ["children", "ORGANISM", 116, 124], ["children", "SPECIES", 116, 124], ["the present study", "TEST", 65, 82], ["anxiety", "PROBLEM", 102, 109]]], ["Compared to previous research, this study found a high prevalence of anxiety.", [["anxiety", "DISEASE", 69, 76], ["previous research", "TEST", 12, 29], ["this study", "TEST", 31, 41], ["anxiety", "PROBLEM", 69, 76]]], ["The worldwide prevalence of any anxiety disorder among children according to Diagnostic and Statistical Manual (DSM) and International Statistical Classification of Diseases and Related Health Problems (ICD) was shown to be 6.5% [23] .", [["anxiety disorder", "DISEASE", 32, 48], ["children", "ORGANISM", 55, 63], ["children", "SPECIES", 55, 63], ["any anxiety disorder", "PROBLEM", 28, 48], ["Diseases", "PROBLEM", 165, 173], ["Diseases", "OBSERVATION", 165, 173]]], ["In Brazilian preadolescents (aged 11-12 years), the prevalence of anxiety was 6.2% according to the ICD-10 classification [24] .", [["anxiety", "DISEASE", 66, 73], ["anxiety", "PROBLEM", 66, 73]]], ["In the United States, a study that analysed data from the 2016 National Survey of Children's Health (NSCH), reported that the prevalence of anxiety was 7.1% among children aged 3-17 years (6.6% in children aged 6-11 years and 10.5% in children aged 12-17) [25] .", [["anxiety", "DISEASE", 140, 147], ["children", "ORGANISM", 163, 171], ["children", "ORGANISM", 197, 205], ["children", "ORGANISM", 235, 243], ["Children", "SPECIES", 82, 90], ["children", "SPECIES", 163, 171], ["children", "SPECIES", 197, 205], ["children", "SPECIES", 235, 243], ["a study", "TEST", 22, 29], ["anxiety", "PROBLEM", 140, 147]]], ["However, the criteria for DSM and ICD were not used in our study.DiscussionPrevious research suggested an association between seropositivity for coronaviruses and a history of mood disorders [26] .", [["coronaviruses", "DISEASE", 145, 158], ["mood disorders", "DISEASE", 176, 190], ["DSM", "PROBLEM", 26, 29], ["ICD", "TREATMENT", 34, 37], ["our study", "TEST", 55, 64], ["coronaviruses", "PROBLEM", 145, 158], ["mood disorders", "PROBLEM", 176, 190], ["ICD", "OBSERVATION", 34, 37]]], ["It is also thought that the severity of a stress reaction is related to the degree of exposure to a disaster.", [["stress reaction", "DISEASE", 42, 57], ["a stress reaction", "PROBLEM", 40, 57], ["stress reaction", "OBSERVATION", 42, 57]]], ["For example, earthquakes that damaged houses and family members were associated with more severe fear, anxiety, depression, or physical symptoms.", [["anxiety", "DISEASE", 103, 110], ["depression", "DISEASE", 112, 122], ["anxiety", "PROBLEM", 103, 110], ["depression", "PROBLEM", 112, 122], ["physical symptoms", "PROBLEM", 127, 144]]], ["Young schoolchildren and girls were especially vulnerable [27] .", [["schoolchildren", "SPECIES", 6, 20], ["girls", "SPECIES", 25, 30]]], ["Another study demonstrated that these anxiety symptoms were more often associated with girls [28] .", [["anxiety", "DISEASE", 38, 45], ["girls", "SPECIES", 87, 92], ["Another study", "TEST", 0, 13], ["these anxiety symptoms", "PROBLEM", 32, 54]]], ["In our study, greater levels of anxiety were also exhibited by girls than boys.DiscussionOur data collection was based on children's self-reports of anxiety.", [["anxiety", "DISEASE", 32, 39], ["anxiety", "DISEASE", 149, 156], ["children", "ORGANISM", 122, 130], ["girls", "SPECIES", 63, 68], ["boys", "SPECIES", 74, 78], ["children", "SPECIES", 122, 130], ["our study", "TEST", 3, 12], ["anxiety", "PROBLEM", 32, 39], ["anxiety", "PROBLEM", 149, 156], ["greater", "OBSERVATION_MODIFIER", 14, 21]]], ["It is important to use validated instruments that can gauge what they are intended to measure.", [["validated instruments", "TREATMENT", 23, 44]]], ["The CAQ is a newly developed instrument that needs further validation.", [["CAQ", "DNA", 4, 7], ["further validation", "TEST", 51, 69], ["instrument", "OBSERVATION", 29, 39]]], ["However, the CAQ has been used in a couple of studies [14, 17] .DiscussionAs for the children's characterisation, the mean age group was approximately 8.8 years, with a slight increase in girls.", [["children", "ORGANISM", 85, 93], ["CAQ", "DNA", 13, 16], ["children", "SPECIES", 85, 93], ["girls", "SPECIES", 188, 193], ["a slight increase in girls", "PROBLEM", 167, 193], ["slight", "OBSERVATION_MODIFIER", 169, 175], ["increase", "OBSERVATION_MODIFIER", 176, 184]]], ["The possibility of selection bias should be considered because of the exclusion of digital illiterates who were not involved in this study.", [["selection bias", "PROBLEM", 19, 33], ["this study", "TEST", 128, 138]]], ["However, the use of digital environments for data collection was the most suitable for the current pandemic, and internet research was safer and more convenient for participants.DiscussionThe present study shows that guardians\u00b4education levels affect their children's perceived comprehension of the situation but not their anxiety levels.", [["anxiety", "DISEASE", 323, 330], ["children", "ORGANISM", 257, 265], ["participants", "SPECIES", 165, 177], ["children", "SPECIES", 257, 265], ["data collection", "TEST", 45, 60], ["The present study", "TEST", 188, 205]]], ["However, the guardians\u00b4age in combination with their education level directly affect their children's anxiety level.", [["anxiety", "DISEASE", 102, 109], ["children", "ORGANISM", 91, 99], ["children", "SPECIES", 91, 99]]], ["Guardians with higher education could probably offer more support to their children in several ways.", [["children", "ORGANISM", 75, 83], ["children", "SPECIES", 75, 83]]], ["They could invite their children to speak about COVID-19, could listen with the aim of understanding what their children knew, and explain misunderstandings.", [["children", "ORGANISM", 24, 32], ["children", "ORGANISM", 112, 120], ["children", "SPECIES", 24, 32], ["children", "SPECIES", 112, 120]]], ["These parents may be providing further information about the prevention of virus contagion.", [["virus contagion", "PROBLEM", 75, 90]]], ["They could be creating a safe environment where emotions can be freely expressed so that they can pay attention to their children's anxiety levels and filling evenings/after-dinner time with pleasant activities [31] .", [["anxiety", "DISEASE", 132, 139], ["children", "ORGANISM", 121, 129], ["children", "SPECIES", 121, 129]]], ["The lowest education level in parents corresponds to the highest prevalence of obese school children (aged 8 to 9 years) [32] , and an association has been found between parental education and parent-reported child mental health (for children aged 4 to 11 years old) [33] .DiscussionChildren have the right to understand what is happening around them as it can affect them.", [["children", "ORGANISM", 92, 100], ["children", "ORGANISM", 234, 242], ["Children", "ORGANISM", 283, 291], ["children", "SPECIES", 92, 100], ["children", "SPECIES", 234, 242], ["Children", "SPECIES", 283, 291]]], ["COVID-19 is a global threat, which children can hear about even as it affects them and their loved ones.", [["children", "ORGANISM", 35, 43], ["children", "SPECIES", 35, 43]]], ["The rights of children [34] continue to matter even during COVID-19, including the articles of the child convention in terms of development, democratic rights education, protection, right to one's own family, and right to support.", [["children", "ORGANISM", 14, 22], ["children", "SPECIES", 14, 22], ["right", "ANATOMY_MODIFIER", 182, 187], ["right", "ANATOMY_MODIFIER", 213, 218]]], ["Children's perceived comprehension can be a positive aspect during the pandemic.", [["Children", "ORGANISM", 0, 8], ["Children", "SPECIES", 0, 8], ["a positive aspect", "PROBLEM", 42, 59]]], ["According to UNICEF, children might find it difficult to understand what they are seeing online or on TV, and they are vulnerable to anxiety, stress, and sadness.", [["anxiety", "DISEASE", 133, 140], ["children", "ORGANISM", 21, 29], ["children", "SPECIES", 21, 29], ["anxiety", "PROBLEM", 133, 140], ["stress", "PROBLEM", 142, 148], ["sadness", "PROBLEM", 154, 161]]], ["The guideline 'How to talk to your child about COVID-19 recommends that parents ask their children open questions and that they listen to the answers.", [["children", "ORGANISM", 90, 98], ["children", "SPECIES", 90, 98]]], ["Other recommendations include that parents be honest and use age-appropriate language, watch their children's reactions, show sensitivity to their anxiety levels, and close conversations with care [35] .DiscussionPlay is an essential part of children's physical and social development; however, during isolation and social distancing, the world is relying on technology to learn, live, and stay connected [36] .", [["anxiety", "DISEASE", 147, 154], ["children", "ORGANISM", 99, 107], ["children", "ORGANISM", 242, 250], ["children", "SPECIES", 99, 107], ["children", "SPECIES", 242, 250]]], ["The most important thing for children is to have adults around them to meet their needs and to help them feel secure, calm, and supported in their own sense of control [37] .", [["children", "ORGANISM", 29, 37], ["children", "SPECIES", 29, 37]]], ["Children feel better when they can communicate their feelings in a supportive environment.", [["Children", "ORGANISM", 0, 8], ["Children", "SPECIES", 0, 8]]], ["Adults need to be authentic about the uncertainty and psychological challenges of the pandemic, without overwhelming children with their own fears.", [["Adults", "ORGANISM", 0, 6], ["children", "ORGANISM", 117, 125], ["Adults", "SPECIES", 0, 6], ["children", "SPECIES", 117, 125]]], ["This honesty should encompass a coherent explanation for what the children are observing and grant permission for children to safely talk about their feelings [38] .DiscussionThe majority of the guardians in this study were older (mean age: 38.97 years); however, we found that the younger the guardians were, the higher the anxiety levels exhibited by the children.", [["anxiety", "DISEASE", 325, 332], ["children", "ORGANISM", 66, 74], ["children", "ORGANISM", 114, 122], ["children", "ORGANISM", 357, 365], ["children", "SPECIES", 66, 74], ["children", "SPECIES", 114, 122], ["children", "SPECIES", 357, 365], ["the higher the anxiety levels", "PROBLEM", 310, 339]]], ["Another factor to consider was that young guardians in this socioeconomic group had fewer children; it was possible that these children did not have other children to play together with.", [["children", "ORGANISM", 90, 98], ["children", "ORGANISM", 127, 135], ["children", "ORGANISM", 155, 163], ["children", "SPECIES", 90, 98], ["children", "SPECIES", 127, 135], ["children", "SPECIES", 155, 163]]], ["Neither possibility was investigated in this study.", [["this study", "TEST", 40, 50]]], ["These findings were in line with previous studies of how the age of parents, especially the mother, affect the mental health of children, among other health conditions and outcomes.", [["children", "ORGANISM", 128, 136], ["children", "SPECIES", 128, 136], ["previous studies", "TEST", 33, 49]]], ["Remmerswaal and Muris [39] found during the previous swine flu that children aged 7-12 years had a significant relationship between their level of fear and their parents' level of fear.", [["children", "ORGANISM", 68, 76], ["swine", "SPECIES", 53, 58], ["children", "SPECIES", 68, 76]]], ["In another study, children whose mothers had a high level of education, compared to children with uneducated mothers, showed a reduced risk of suffering from emotional difficulties [40] .", [["emotional difficulties", "DISEASE", 158, 180], ["children", "ORGANISM", 18, 26], ["mothers", "ORGANISM", 33, 40], ["children", "ORGANISM", 84, 92], ["children", "SPECIES", 18, 26], ["children", "SPECIES", 84, 92], ["emotional difficulties", "PROBLEM", 158, 180]]], ["Similar results have also been reported during the COVID-19 pandemic; a correlation was found between mothers' state of anxiety scores and the trait anxiety scores of their children (ages 9 to 12 years old) [41] .DiscussionChildren who were keeping social distance with both their mother and father had lower CAQ scores than those who were isolated with a person other than their parents.", [["anxiety", "DISEASE", 120, 127], ["anxiety", "DISEASE", 149, 156], ["children", "ORGANISM", 173, 181], ["Children", "ORGANISM", 223, 231], ["children", "SPECIES", 173, 181], ["Children", "SPECIES", 223, 231], ["person", "SPECIES", 356, 362], ["the COVID", "TEST", 47, 56], ["anxiety scores", "PROBLEM", 120, 134]]], ["This finding confirmed the important role of parents in children's lives, perhaps especially in this pandemic.", [["children", "ORGANISM", 56, 64], ["children", "SPECIES", 56, 64]]], ["A study conducted in China reported the presence of psychological difficulties in children during the COVID-19 pandemic, with fear, clinging, inattention, and irritability as the most severe symptoms for younger children [42] .", [["inattention", "DISEASE", 142, 153], ["irritability", "DISEASE", 159, 171], ["children", "ORGANISM", 82, 90], ["children", "ORGANISM", 212, 220], ["children", "SPECIES", 82, 90], ["children", "SPECIES", 212, 220], ["A study", "TEST", 0, 7], ["psychological difficulties", "PROBLEM", 52, 78], ["the COVID", "TEST", 98, 107], ["fear", "PROBLEM", 126, 130], ["inattention", "PROBLEM", 142, 153], ["irritability", "PROBLEM", 159, 171], ["the most severe symptoms", "PROBLEM", 175, 199]]], ["Parents and other family members are encouraged to increase their communication with children to address their fears and concerns, play games, engage in physical activity, and use music therapy in the form of singing to reduce the worry, fear, and stress that children may feel [43] .", [["children", "ORGANISM", 85, 93], ["children", "ORGANISM", 260, 268], ["children", "SPECIES", 85, 93], ["children", "SPECIES", 260, 268], ["music therapy", "TREATMENT", 180, 193]]], ["Another interesting result in the present study showed the opposite: parents who kept their jobs had children who experienced more anxiety.", [["anxiety", "DISEASE", 131, 138], ["children", "ORGANISM", 101, 109], ["children", "SPECIES", 101, 109], ["the present study", "TEST", 30, 47], ["anxiety", "PROBLEM", 131, 138]]], ["The serious implications of this finding and experiences from the COVID-19 pandemic highlight the need for effective strategies to strengthen families and help them protect the children [44] .", [["children", "ORGANISM", 177, 185], ["children", "SPECIES", 177, 185], ["the COVID", "TEST", 62, 71], ["effective strategies", "TREATMENT", 107, 127], ["serious", "OBSERVATION_MODIFIER", 4, 11]]], ["Parents' presence is important for children, and children need to feel safe within their families.", [["children", "ORGANISM", 35, 43], ["children", "ORGANISM", 49, 57], ["children", "SPECIES", 35, 43], ["children", "SPECIES", 49, 57]]], ["If children lack emotion-focused conversations with their parents, it can lead to anxiety about the emotional state of their parents [32] .DiscussionThe significance of the correlations between children\u00b4s anxiety levels and other factors was only shown in CAQ scores, not in the NRS scores.", [["anxiety", "DISEASE", 82, 89], ["anxiety", "DISEASE", 205, 212], ["children", "ORGANISM", 3, 11], ["children", "SPECIES", 3, 11], ["anxiety", "PROBLEM", 82, 89], ["children\u00b4s anxiety levels", "PROBLEM", 194, 219]]], ["The CAQ considers different feelings/domains in measuring a child's anxiety than the NRS.", [["anxiety", "DISEASE", 68, 75], ["CAQ", "PROTEIN", 4, 7], ["different feelings/domains", "PROBLEM", 18, 44], ["a child's anxiety", "PROBLEM", 58, 75]]], ["The focus of the CAQ on anxiety-compared to the NRS, which only has one item on anxiety-may explain this difference; however, further studies are needed to investigate the causes of this difference.", [["anxiety", "DISEASE", 24, 31], ["anxiety", "DISEASE", 80, 87], ["the CAQ", "PROBLEM", 13, 20], ["anxiety", "PROBLEM", 24, 31], ["anxiety", "PROBLEM", 80, 87], ["further studies", "TEST", 126, 141], ["this difference", "PROBLEM", 182, 197]]], ["However, the prevalence of anxiety found in this group was similar between the CAQ and NRS.", [["anxiety", "DISEASE", 27, 34], ["anxiety", "PROBLEM", 27, 34]]], ["Minimising children's anxiety may depend on addressing children's restriction from engaging in their regular activities.DiscussionOther aspects of the pandemic will appear with time.", [["anxiety", "DISEASE", 22, 29], ["children", "ORGANISM", 11, 19], ["children", "ORGANISM", 55, 63], ["children", "SPECIES", 11, 19], ["children", "SPECIES", 55, 63], ["Minimising children's anxiety", "PROBLEM", 0, 29]]], ["Intensive research to find a vaccination will provide new research questions among children.", [["children", "ORGANISM", 83, 91], ["children", "SPECIES", 83, 91], ["a vaccination", "TREATMENT", 27, 40]]], ["The experience of benefits and risks with vaccination, and accessibility to vaccination will prompt repeating this study on children\u00b4s reported anxiety.LimitationsThis study had several limitations.", [["anxiety", "DISEASE", 144, 151], ["vaccination", "TREATMENT", 42, 53], ["vaccination", "TREATMENT", 76, 87], ["this study", "TEST", 110, 120], ["anxiety", "PROBLEM", 144, 151], ["This study", "TEST", 163, 173]]], ["First, the data collection occurred online; this excluded participants without the computer skills necessary to access the survey, and probably there was a selection bias arising from the social media interpersonal connections through which the survey was circulated.", [["participants", "SPECIES", 58, 70], ["the data collection", "TEST", 7, 26], ["the survey", "TEST", 119, 129], ["a selection bias", "PROBLEM", 154, 170]]], ["Second, we guided participants on how to use the CAQ and NRS with their children, but we are unsure if they filled in the instruments according to our recommendations.", [["children", "ORGANISM", 72, 80], ["participants", "SPECIES", 18, 30], ["children", "SPECIES", 72, 80]]], ["Third, we did not investigate how many children were in the same house; we did not exclude guardians who participated twice, since they had two children.", [["children", "ORGANISM", 39, 47], ["children", "ORGANISM", 144, 152], ["children", "SPECIES", 39, 47], ["children", "SPECIES", 144, 152]]], ["Finally, the questionnaire did not capture how well the children actually comprehended the situation, but the adults' opinion on this.", [["children", "ORGANISM", 56, 64], ["children", "SPECIES", 56, 64]]], ["There was no objective measurement of the children's understanding; the adult respondents were asked their subjective opinion of the extent to which the children understood the pandemic, taking age into consideration.", [["children", "ORGANISM", 42, 50], ["children", "ORGANISM", 153, 161], ["children", "SPECIES", 42, 50], ["children", "SPECIES", 153, 161], ["no", "UNCERTAINTY", 10, 12]]], ["Therefore, caution should be taken in generalising the results to the Brazilian population.ConclusionsThe prevalence of anxiety among the children during the COVID-19 pandemic in this group was 19.4% (n = 56), according to the CAQ, and 21.8% (n = 63), according to the NRS.", [["anxiety", "DISEASE", 120, 127], ["children", "ORGANISM", 138, 146], ["children", "SPECIES", 138, 146], ["anxiety", "PROBLEM", 120, 127], ["the COVID", "TEST", 154, 163]]], ["These results are higher than the prevalence reported for children under normal conditions (6.5%).", [["children", "ORGANISM", 58, 66], ["children", "SPECIES", 58, 66], ["higher", "OBSERVATION_MODIFIER", 18, 24]]], ["Higher levels of anxiety were associated with social distancing without parents, a higher number of persons living at home, and a low education level reported for the parent or guardian.", [["anxiety", "DISEASE", 17, 24], ["persons", "ORGANISM", 100, 107], ["persons", "SPECIES", 100, 107], ["anxiety", "PROBLEM", 17, 24]]], ["The highest levels of anxiety were found among children with both young and less educated guardians.", [["anxiety", "DISEASE", 22, 29], ["children", "ORGANISM", 47, 55], ["children", "SPECIES", 47, 55], ["anxiety", "PROBLEM", 22, 29]]], ["These findings suggest the necessity of implementing public health actions targeting these parents and their children at the population level.", [["children", "ORGANISM", 109, 117], ["children", "SPECIES", 109, 117]]]]}